Body,Head,Head_Coverage,Std_Confidence,PCA_Confidence,Positive_Examples,Body_size,PCA_Body_size,Functional_variable
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  PDL1_Negative,0.01242236,0.166666667,0.166666667,20,120,120,?a
?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Negative,0.018012422,0.077956989,0.146464646,29,372,198,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Negative,0.022360248,0.072874494,0.193548387,36,494,186,?a
?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Negative,0.01863354,0.25,0.326086957,30,120,92,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Negative,0.039130435,0.239543726,0.239543726,63,263,263,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Negative,0.013664596,0.086614173,0.201834862,22,254,109,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  PDL1_Negative,0.040993789,0.155660377,0.155660377,66,424,424,?a
?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Negative,0.016149068,0.30952381,0.393939394,26,84,66,?a
?a  hasGender  Male   ,?a  hasBiomarker  PDL1_Negative,0.044720497,0.082758621,0.195652174,72,870,368,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Negative,0.034782609,0.091503268,0.202166065,56,612,277,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  PDL1_Negative,0.046583851,0.201612903,0.201612903,75,372,372,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  PDL1_Negative,0.040372671,0.072463768,0.167958656,65,897,387,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  PDL1_Negative,0.011801242,0.067375887,0.112426036,19,282,169,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Negative,0.01552795,0.063613232,0.154320988,25,393,162,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  PDL1_Negative,0.022360248,0.104651163,0.201117318,36,344,179,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Negative,0.013043478,0.155555556,0.198113208,21,135,106,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Negative,0.018012422,0.099315068,0.183544304,29,292,158,?a
?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Negative,0.018012422,0.233870968,0.329545455,29,124,88,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Negative,0.019875776,0.170212766,0.225352113,32,188,142,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  PDL1_Negative,0.020496894,0.098507463,0.1875,33,335,176,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Negative,0.023602484,0.150197628,0.177570093,38,253,214,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.037888199,0.123481781,0.214788732,61,494,284,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.033540373,0.109311741,0.290322581,54,494,186,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Positive,0.043478261,0.114379085,0.252707581,70,612,277,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  PDL1_Positive,0.02484472,0.333333333,0.333333333,40,120,120,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Negative,0.041614907,0.106012658,0.243636364,67,632,275,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  PDL1_Negative,0.041614907,0.098674521,0.174479167,67,679,384,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  PDL1_Positive,0.062732919,0.271505376,0.271505376,101,372,372,?a
?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.034782609,0.150537634,0.282828283,56,372,198,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Positive,0.063975155,0.391634981,0.391634981,103,263,263,?a
?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.019875776,0.380952381,0.484848485,32,84,66,?a
?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.032298137,0.433333333,0.565217391,52,120,92,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  PDL1_Positive,0.026086957,0.122093023,0.234636872,42,344,179,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  PDL1_Positive,0.065217391,0.247641509,0.247641509,105,424,424,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.017391304,0.207407407,0.264150943,28,135,106,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  PDL1_Positive,0.060869565,0.109253066,0.253229974,98,897,387,?a
?a  hasGender  Male   ,?a  hasBiomarker  PDL1_Positive,0.052173913,0.096551724,0.22826087,84,870,368,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.020496894,0.083969466,0.203703704,33,393,162,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.037888199,0.123481781,0.214788732,61,494,284,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  PDL1_Positive,0.011180124,0.18,0.214285714,18,100,84,?a
?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Positive,0.016770186,0.217741935,0.306818182,27,124,88,?a
?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  PDL1_Positive,0.013664596,0.061971831,0.20952381,22,355,105,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.024223602,0.582089552,0.75,39,67,52,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  PDL1_Positive,0.011180124,0.063829787,0.106508876,18,282,169,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  PDL1_Positive,0.02173913,0.104477612,0.198863636,35,335,176,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.016770186,0.106299213,0.247706422,27,254,109,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.011801242,0.138686131,0.146153846,19,137,130,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Positive,0.026086957,0.166007905,0.196261682,42,253,214,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.040372671,0.345744681,0.457746479,65,188,142,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.042857143,0.109177215,0.250909091,69,632,275,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  PDL1_Positive,0.052173913,0.12371134,0.21875,84,679,384,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Positive,0.018012422,0.099315068,0.183544304,29,292,158,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  BRAF_Negative,0.01242236,0.198019802,0.198019802,20,101,101,?a
?a  hasGender  Female   ,?a  hasBiomarker  BRAF_Negative,0.017391304,0.075268817,0.141414141,28,372,198,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  BRAF_Negative,0.034161491,0.111336032,0.295698925,55,494,186,?a
?a  hasStage  IVA   ,?a  hasBiomarker  BRAF_Negative,0.011801242,0.226190476,0.287878788,19,84,66,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  BRAF_Negative,0.070186335,0.429657795,0.429657795,113,263,263,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  BRAF_Negative,0.02484472,0.285714286,0.285714286,40,140,140,?a
?a  hasStage  IVB   ,?a  hasBiomarker  BRAF_Negative,0.016149068,0.216666667,0.282608696,26,120,92,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  BRAF_Negative,0.068944099,0.298387097,0.298387097,111,372,372,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  BRAF_Negative,0.020496894,0.095930233,0.184357542,33,344,179,?a
?a  hasGender  Male   ,?a  hasBiomarker  BRAF_Negative,0.057142857,0.105747126,0.25,92,870,368,?a
?a  hasStage  IIIA   ,?a  hasBiomarker  BRAF_Negative,0.021118012,0.140495868,0.306306306,34,242,111,?a
?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  BRAF_Negative,0.013043478,0.05915493,0.2,21,355,105,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  BRAF_Negative,0.011801242,0.138686131,0.146153846,19,137,130,?a
?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  BRAF_Negative,0.029813665,0.923076923,0.923076923,48,52,52,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.023602484,0.166666667,0.38,38,228,100,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.022360248,0.091603053,0.222222222,36,393,162,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  BRAF_Negative,0.034782609,0.091503268,0.202166065,56,612,277,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  BRAF_Negative,0.054037267,0.096989967,0.224806202,87,897,387,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  BRAF_Negative,0.011801242,0.126666667,0.279411765,19,150,68,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.268656716,0.346153846,18,67,52,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  BRAF_Negative,0.026086957,0.085020243,0.147887324,42,494,284,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  BRAF_Negative,0.01552795,0.132978723,0.176056338,25,188,142,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  BRAF_Negative,0.02173913,0.124113475,0.207100592,35,282,169,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  BRAF_Negative,0.018012422,0.114624506,0.135514019,29,253,214,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  BRAF_Negative,0.069565217,0.264150943,0.264150943,112,424,424,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.029813665,0.143283582,0.272727273,48,335,176,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  BRAF_Negative,0.019875776,0.109589041,0.202531646,32,292,158,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  BRAF_Negative,0.032298137,0.082278481,0.189090909,52,632,275,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  BRAF_Negative,0.037888199,0.089837997,0.158854167,61,679,384,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  BRAF_Negative,0.016149068,0.157575758,0.337662338,26,165,77,?a
?a  hasStage  IA   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.133333333,0.133333333,14,105,105,?a
?a  hasStage  IVB   ,?a  hasSmokingHabit  NonSmoker,0.016129032,0.166666667,0.166666667,20,120,120,?a
?a  hasStage  IV   ,?a  hasSmokingHabit  NonSmoker,0.030645161,0.132404181,0.133333333,38,287,285,?a
?a  hasGender  Female   ,?a  hasSmokingHabit  NonSmoker,0.074193548,0.247311828,0.247311828,92,372,372,?a
?a  hasAgeCategory  Young   ,?a  hasSmokingHabit  NonSmoker,0.032258065,0.11627907,0.11627907,40,344,344,?a
?a  treatmentType  Surgery   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.164835165,0.164835165,15,91,91,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  NonSmoker,0.013709677,0.125925926,0.125925926,17,135,135,?a
?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  NonSmoker,0.034677419,0.121126761,0.121126761,43,355,355,?a
?a  hasAgeCategory  Old   ,?a  hasSmokingHabit  NonSmoker,0.075806452,0.104793757,0.105027933,94,897,895,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  NonSmoker,0.014516129,0.109090909,0.109090909,18,165,165,?a
?a  hasBiomarker  ALK_Positive   ,?a  hasSmokingHabit  NonSmoker,0.012903226,0.484848485,0.484848485,16,33,33,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  NonSmoker,0.053225806,0.481751825,0.481751825,66,137,137,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasSmokingHabit  NonSmoker,0.033870968,0.112903226,0.112903226,42,372,372,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  NonSmoker,0.012903226,0.114285714,0.114285714,16,140,140,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  NonSmoker,0.039516129,0.115566038,0.115566038,49,424,424,?a
?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  NonSmoker,0.064516129,0.117820324,0.11816839,80,679,677,?a
?a  patientDrug  Erlotinib   ,?a  hasSmokingHabit  NonSmoker,0.02016129,0.431034483,0.431034483,25,58,58,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasSmokingHabit  NonSmoker,0.041129032,0.614457831,0.614457831,51,83,83,?a
?a  patientDrug  Gefitinib   ,?a  hasSmokingHabit  NonSmoker,0.012903226,0.457142857,0.457142857,16,35,35,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  NonSmoker,0.025806452,0.121673004,0.121673004,32,263,263,?a
?a  patientDrug  Osimertinib   ,?a  hasSmokingHabit  NonSmoker,0.021774194,0.6,0.6,27,45,45,?a
?a  patientDrug  Afatinib   ,?a  hasSmokingHabit  NonSmoker,0.018548387,0.522727273,0.522727273,23,44,44,?a
?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  NonSmoker,0.029032258,0.14229249,0.14229249,36,253,253,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasBiomarker  ROS1_Negative,0.019875776,0.23880597,0.310679612,32,134,103,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ROS1_Negative,0.08136646,0.214052288,0.472924188,131,612,277,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ROS1_Negative,0.039130435,0.623762376,0.623762376,63,101,101,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.265060241,0.265060241,22,83,83,?a
?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ROS1_Negative,0.031677019,0.980769231,0.980769231,51,52,52,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.063975155,0.735714286,0.735714286,103,140,140,?a
?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.026708075,0.511904762,0.651515152,43,84,66,?a
?a  hasStage  IIIB   ,?a  hasBiomarker  ROS1_Negative,0.01552795,0.177304965,0.446428571,25,141,56,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  ROS1_Negative,0.153416149,0.663978495,0.663978495,247,372,372,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ROS1_Negative,0.147204969,0.558962264,0.558962264,237,424,424,?a
?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.051552795,0.22311828,0.419191919,83,372,198,?a
?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.041614907,0.558333333,0.72826087,67,120,92,?a
?a  hasStage  IIIA   ,?a  hasBiomarker  ROS1_Negative,0.036024845,0.239669421,0.522522523,58,242,111,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.062111801,0.20242915,0.537634409,100,494,186,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.034782609,0.245614035,0.56,56,228,100,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  ROS1_Negative,0.054658385,0.255813953,0.491620112,88,344,179,?a
?a  hasStage  IV   ,?a  hasBiomarker  ROS1_Negative,0.023602484,0.132404181,0.22754491,38,287,167,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ROS1_Negative,0.070186335,0.941666667,0.941666667,113,120,120,?a
?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ROS1_Negative,0.027950311,0.126760563,0.428571429,45,355,105,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.030434783,0.192913386,0.449541284,49,254,109,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.022981366,0.224242424,0.480519481,37,165,77,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.026708075,0.313868613,0.330769231,43,137,130,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ROS1_Negative,0.026708075,0.318518519,0.405660377,43,135,106,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  ROS1_Negative,0.108695652,0.19509476,0.452196382,175,897,387,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.019254658,0.206666667,0.455882353,31,150,68,?a
?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ROS1_Negative,0.024223602,0.314516129,0.443181818,39,124,88,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.026708075,0.43,0.511904762,43,100,84,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.042236025,0.17302799,0.419753086,68,393,162,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.01863354,0.218978102,0.428571429,30,137,70,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.025465839,0.611940299,0.788461538,41,67,52,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  ROS1_Negative,0.017391304,0.113821138,0.538461538,28,246,52,?a
?a  hasGender  Male   ,?a  hasBiomarker  ROS1_Negative,0.111801242,0.206896552,0.489130435,180,870,368,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.040372671,0.22260274,0.411392405,65,292,158,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.060869565,0.387351779,0.457943925,98,253,214,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.052173913,0.250746269,0.477272727,84,335,176,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.047826087,0.409574468,0.542253521,77,188,142,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.046583851,0.265957447,0.443786982,75,282,169,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.075776398,0.246963563,0.429577465,122,494,284,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ROS1_Negative,0.1,0.237113402,0.419270833,161,679,384,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.07826087,0.199367089,0.458181818,126,632,275,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.021298523,0.10130719,0.105084746,62,612,590,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.019237375,0.113360324,0.117154812,56,494,478,?a
?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Bone,0.01580213,0.123655914,0.128851541,46,372,357,?a
?a  hasGender  Male   ,?a  treatmentType  Radiotherapy_To_Bone,0.030573686,0.102298851,0.105450237,89,870,844,?a
?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.014428032,0.223404255,0.223404255,42,188,188,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.031260735,0.184210526,0.184210526,91,494,494,?a
?a  hasStage  IVB   ,?a  treatmentType  Radiotherapy_To_Bone,0.011679835,0.283333333,0.300884956,34,120,113,?a
?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.016145654,0.163763066,0.173431734,47,287,271,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Radiotherapy_To_Bone,0.018893851,0.159883721,0.161290323,55,344,341,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.013397458,0.138297872,0.138790036,39,282,281,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Bone,0.01202336,0.104477612,0.104790419,35,335,334,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.020954998,0.241106719,0.24497992,61,253,249,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Bone,0.01202336,0.119863014,0.119863014,35,292,292,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.021298523,0.166666667,0.175637394,62,372,353,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.026107867,0.179245283,0.187654321,76,424,405,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Bone,0.041222947,0.176730486,0.179640719,120,679,668,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.014771556,0.163498099,0.174796748,43,263,246,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.026794916,0.123417722,0.125401929,78,632,622,?a
?a  hasStage  IIA   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.392156863,0.392156863,20,51,51,?a
?a  hasStage  IA   ,?a  hasSmokingHabit  CurrentSmoker,0.030645161,0.361904762,0.361904762,38,105,105,?a
?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.026612903,0.392857143,0.392857143,33,84,84,?a
?a  hasGender  Female   ,?a  hasSmokingHabit  CurrentSmoker,0.113709677,0.379032258,0.379032258,141,372,372,?a
?a  hasStage  IIIB   ,?a  hasSmokingHabit  CurrentSmoker,0.048387097,0.425531915,0.425531915,60,141,141,?a
?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.039516129,0.408333333,0.408333333,49,120,120,?a
?a  hasStage  IIB   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.294117647,0.294117647,20,68,68,?a
?a  hasStage  IB   ,?a  hasSmokingHabit  CurrentSmoker,0.031451613,0.410526316,0.410526316,39,95,95,?a
?a  hasStage  IIIA   ,?a  hasSmokingHabit  CurrentSmoker,0.081451613,0.417355372,0.417355372,101,242,242,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.077419355,0.421052632,0.421052632,96,228,228,?a
?a  hasAgeCategory  Young   ,?a  hasSmokingHabit  CurrentSmoker,0.135483871,0.488372093,0.488372093,168,344,344,?a
?a  hasStage  IV   ,?a  hasSmokingHabit  CurrentSmoker,0.089516129,0.386759582,0.389473684,111,287,285,?a
?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.284677419,0.405747126,0.406682028,353,870,868,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.04516129,0.414814815,0.414814815,56,135,135,?a
?a  treatmentType  Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.031451613,0.557142857,0.565217391,39,70,69,?a
?a  treatmentType  Surgery   ,?a  hasSmokingHabit  CurrentSmoker,0.023387097,0.318681319,0.318681319,29,91,91,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.167883212,0.167883212,23,137,137,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  CurrentSmoker,0.021774194,0.457627119,0.457627119,27,59,59,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.095967742,0.468503937,0.472222222,119,254,252,?a
?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.096774194,0.338028169,0.338028169,120,355,355,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.054032258,0.446666667,0.446666667,67,150,150,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  CurrentSmoker,0.045967742,0.345454545,0.345454545,57,165,165,?a
?a  hasAgeCategory  Old   ,?a  hasSmokingHabit  CurrentSmoker,0.262096774,0.362318841,0.363128492,325,897,895,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.133064516,0.419847328,0.419847328,165,393,393,?a
?a  patientDrug  Cyclophosphamide   ,?a  hasSmokingHabit  CurrentSmoker,0.025806452,0.533333333,0.542372881,32,60,59,?a
?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.042741935,0.427419355,0.427419355,53,124,124,?a
?a  patientDrug  Other   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.454545455,0.454545455,15,33,33,?a
?a  patientDrug  Doxorubicin   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.516666667,0.525423729,31,60,59,?a
?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.027419355,0.507462687,0.507462687,34,67,67,?a
?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.069354839,0.457446809,0.457446809,86,188,188,?a
?a  patientDrug  Gemcitabine   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.357142857,0.357142857,20,56,56,?a
?a  patientDrug  Vincristine   ,?a  hasSmokingHabit  CurrentSmoker,0.026612903,0.55,0.559322034,33,60,59,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.049193548,0.445255474,0.445255474,61,137,137,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.162096774,0.406882591,0.407707911,201,494,493,?a
?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.028225806,0.35,0.35,35,100,100,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasSmokingHabit  CurrentSmoker,0.021774194,0.36,0.36,27,75,75,?a
?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  CurrentSmoker,0.094354839,0.55450237,0.559808612,117,211,209,?a
?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.073387097,0.359683794,0.359683794,91,253,253,?a
?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.111290323,0.411940299,0.411940299,138,335,335,?a
?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.091935484,0.390410959,0.390410959,114,292,292,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.029032258,0.356435644,0.356435644,36,101,101,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.044354839,0.458333333,0.458333333,55,120,120,?a
?a  hasBiomarker  RET_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.020967742,0.5,0.5,26,52,52,?a
?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.1,0.439716312,0.439716312,124,282,282,?a
?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.214516129,0.420886076,0.422222222,266,632,630,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  CurrentSmoker,0.043548387,0.385714286,0.385714286,54,140,140,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.079032258,0.398373984,0.398373984,98,246,246,?a
?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.212096774,0.387334315,0.388478582,263,679,677,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.125806452,0.367924528,0.367924528,156,424,424,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.080645161,0.380228137,0.380228137,100,263,263,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Open_Surgical_Procedure,0.037787702,0.179738562,0.186440678,110,612,590,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Open_Surgical_Procedure,0.032978358,0.194331984,0.20083682,96,494,478,?a
?a  hasGender  Female   ,?a  treatmentType  Open_Surgical_Procedure,0.0195809,0.153225806,0.159663866,57,372,357,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Open_Surgical_Procedure,0.010992786,0.125984252,0.125984252,32,254,254,?a
?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Open_Surgical_Procedure,0.02335967,0.191549296,0.191549296,68,355,355,?a
?a  hasGender  Male   ,?a  treatmentType  Open_Surgical_Procedure,0.0587427,0.196551724,0.202606635,171,870,844,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Open_Surgical_Procedure,0.019924425,0.147582697,0.147582697,58,393,393,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.032291309,0.56969697,0.56969697,94,165,165,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Open_Surgical_Procedure,0.01580213,0.306666667,0.306666667,46,150,150,?a
?a  hasStage  IIB   ,?a  treatmentType  Open_Surgical_Procedure,0.010992786,0.470588235,0.470588235,32,68,68,?a
?a  hasStage  IIIA   ,?a  treatmentType  Open_Surgical_Procedure,0.028169014,0.338842975,0.340248963,82,242,241,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Open_Surgical_Procedure,0.022329097,0.188953488,0.190615836,65,344,341,?a
?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Open_Surgical_Procedure,0.019924425,0.235772358,0.247863248,58,246,234,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.113709677,0.379032258,0.379032258,141,372,372,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Open_Surgical_Procedure,0.034352456,0.147275405,0.149700599,100,679,668,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Open_Surgical_Procedure,0.02713844,0.280141844,0.28113879,79,282,281,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Open_Surgical_Procedure,0.032634833,0.28358209,0.284431138,95,335,334,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Open_Surgical_Procedure,0.010305737,0.118577075,0.120481928,30,253,249,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Open_Surgical_Procedure,0.055994504,0.181716834,0.189534884,163,897,860,?a
?a  hasBiomarker  BRAF_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.013053933,0.316666667,0.333333333,38,120,114,?a
?a  hasBiomarker  RET_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.011679835,0.653846154,0.653846154,34,52,52,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Open_Surgical_Procedure,0.028856063,0.132911392,0.135048232,84,632,622,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.025420818,0.198924731,0.209631728,74,372,353,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Open_Surgical_Procedure,0.019237375,0.191780822,0.191780822,56,292,292,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.028856063,0.198113208,0.207407407,84,424,405,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasGender  Female,0.074074074,0.686567164,0.686567164,92,134,134,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.019237375,0.212927757,0.227642276,56,263,246,?a
?a  hasStage  IA   ,?a  hasGender  Female,0.026570048,0.314285714,0.314285714,33,105,105,?a
?a  hasStage  IVA   ,?a  hasGender  Female,0.020128824,0.297619048,0.297619048,25,84,84,?a
?a  hasStage  IIIB   ,?a  hasGender  Female,0.033011272,0.290780142,0.290780142,41,141,141,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Female,0.11352657,0.285425101,0.285425101,141,494,494,?a
?a  hasStage  IIB   ,?a  hasGender  Female,0.011272142,0.205882353,0.205882353,14,68,68,?a
?a  hasStage  IV   ,?a  hasGender  Female,0.072463768,0.31358885,0.31358885,90,287,287,?a
?a  hasStage  IB   ,?a  hasGender  Female,0.020933977,0.273684211,0.273684211,26,95,95,?a
?a  hasStage  IVB   ,?a  hasGender  Female,0.037037037,0.383333333,0.383333333,46,120,120,?a
?a  treatmentType  Chemotherapy   ,?a  hasGender  Female,0.013687601,0.242857143,0.242857143,17,70,70,?a
?a  hasStage  IIIA   ,?a  hasGender  Female,0.054750403,0.280991736,0.280991736,68,242,242,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.037037037,0.340740741,0.340740741,46,135,135,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Female,0.111916264,0.227124183,0.227124183,139,612,612,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.04589372,0.25,0.25,57,228,228,?a
?a  treatmentType  Surgery   ,?a  hasGender  Female,0.026570048,0.362637363,0.362637363,33,91,91,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.08373591,0.409448819,0.409448819,104,254,254,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Female,0.015297907,0.322033898,0.322033898,19,59,59,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.057971014,0.525547445,0.525547445,72,137,137,?a
?a  hasAgeCategory  Young   ,?a  hasGender  Female,0.115942029,0.418604651,0.418604651,144,344,344,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.042673108,0.321212121,0.321212121,53,165,165,?a
?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.090982287,0.318309859,0.318309859,113,355,355,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.101449275,0.320610687,0.320610687,126,393,393,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Female,0.035426731,0.293333333,0.293333333,44,150,150,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasGender  Female,0.018518519,0.306666667,0.306666667,23,75,75,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.112721417,0.28340081,0.28340081,140,494,494,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.035426731,0.321167883,0.321167883,44,137,137,?a
?a  patientDrug  Cyclophosphamide   ,?a  hasGender  Female,0.011272142,0.233333333,0.233333333,14,60,60,?a
?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.049114332,0.324468085,0.324468085,61,188,188,?a
?a  patientDrug  Erlotinib   ,?a  hasGender  Female,0.024959742,0.534482759,0.534482759,31,58,58,?a
?a  patientDrug  Vincristine   ,?a  hasGender  Female,0.011272142,0.233333333,0.233333333,14,60,60,?a
?a  patientDrug  Gefitinib   ,?a  hasGender  Female,0.017713366,0.628571429,0.628571429,22,35,35,?a
?a  hasAgeCategory  Old   ,?a  hasGender  Female,0.183574879,0.254180602,0.254180602,228,897,897,?a
?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.025764895,0.32,0.32,32,100,100,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasGender  Female,0.057971014,0.292682927,0.292682927,72,246,246,?a
?a  patientDrug  Other   ,?a  hasGender  Female,0.014492754,0.545454545,0.545454545,18,33,33,?a
?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.019323671,0.358208955,0.358208955,24,67,67,?a
?a  hasRelapse_Progression  Progression   ,?a  hasGender  Female,0.171497585,0.313696613,0.313696613,213,679,679,?a
?a  patientDrug  Gemcitabine   ,?a  hasGender  Female,0.016908213,0.375,0.375,21,56,56,?a
?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.070048309,0.259701493,0.259701493,87,335,335,?a
?a  patientDrug  Afatinib   ,?a  hasGender  Female,0.018518519,0.522727273,0.522727273,23,44,44,?a
?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.070853462,0.347826087,0.347826087,88,253,253,?a
?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.027375201,0.274193548,0.274193548,34,124,124,?a
?a  patientDrug  Osimertinib   ,?a  hasGender  Female,0.022544283,0.622222222,0.622222222,28,45,45,?a
?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.073268921,0.311643836,0.311643836,91,292,292,?a
?a  patientDrug  Vp-16   ,?a  hasGender  Female,0.052334944,0.308056872,0.308056872,65,211,211,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasGender  Female,0.023349436,0.287128713,0.287128713,29,101,101,?a
?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.071658615,0.315602837,0.315602837,89,282,282,?a
?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.147342995,0.289556962,0.289556962,183,632,632,?a
?a  hasBiomarker  ALK_Positive   ,?a  hasGender  Female,0.012077295,0.454545455,0.454545455,15,33,33,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasGender  Female,0.022544283,0.233333333,0.233333333,28,120,120,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Female,0.10547504,0.308962264,0.308962264,131,424,424,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Female,0.066827697,0.315589354,0.315589354,83,263,263,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.024733768,0.117647059,0.122033898,72,612,590,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.023016146,0.13562753,0.140167364,67,494,478,?a
?a  hasGender  Female   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.015115081,0.11827957,0.1232493,44,372,357,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.01580213,0.201754386,0.201754386,46,228,228,?a
?a  hasGender  Male   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.036413604,0.12183908,0.125592417,106,870,844,?a
?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.017519753,0.143661972,0.143661972,51,355,355,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.016832704,0.357664234,0.357664234,49,137,137,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.029199588,0.216284987,0.216284987,85,393,393,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.013740982,0.11627907,0.117302053,40,344,341,?a
?a  hasStage  IIIA   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.038131226,0.458677686,0.460580913,111,242,241,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.037787702,0.122630992,0.127906977,110,897,860,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.030230161,0.312056738,0.31316726,88,282,281,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.035726554,0.310447761,0.311377246,104,335,334,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.028856063,0.287671233,0.287671233,84,292,292,?a
?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.01202336,0.142276423,0.14957265,35,246,234,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.026794916,0.123417722,0.125401929,78,632,622,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.028856063,0.12371134,0.125748503,84,679,668,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.010649261,0.117870722,0.12601626,31,263,246,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.018550326,0.127358491,0.133333333,54,424,405,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasGender  Female,0.041867955,0.626506024,0.626506024,52,83,83,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Female,0.045088567,0.4,0.4,56,140,140,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasGender  Female,0.092592593,0.309139785,0.309139785,115,372,372,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.016145654,0.126344086,0.133144476,47,372,353,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasBiomarker  EGFR_Negative,0.030434783,0.365671642,0.475728155,49,134,103,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.040993789,0.653465347,0.653465347,66,101,101,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.136024845,0.357843137,0.790613718,219,612,277,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  EGFR_Negative,0.065217391,0.75,0.75,105,140,140,?a
?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  EGFR_Negative,0.029813665,0.923076923,0.923076923,48,52,52,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.09689441,0.315789474,0.838709677,156,494,186,?a
?a  hasBiomarker  ALK_Positive   ,?a  hasBiomarker  EGFR_Negative,0.019875776,0.96969697,0.96969697,32,33,33,?a
?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Negative,0.026708075,0.511904762,0.651515152,43,84,66,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  EGFR_Negative,0.069565217,0.933333333,0.933333333,112,120,120,?a
?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.027950311,0.319148936,0.803571429,45,141,56,?a
?a  hasStage  IB   ,?a  hasBiomarker  EGFR_Negative,0.010559006,0.178947368,0.80952381,17,95,21,?a
?a  hasGender  Female   ,?a  hasBiomarker  EGFR_Negative,0.08136646,0.352150538,0.661616162,131,372,198,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.147204969,0.901140684,0.901140684,237,263,263,?a
?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.037267081,0.5,0.652173913,60,120,92,?a
?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.080745342,0.452961672,0.778443114,130,287,167,?a
?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.055279503,0.367768595,0.801801802,89,242,111,?a
?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.181987578,0.336781609,0.796195652,293,870,368,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.052173913,0.368421053,0.84,84,228,100,?a
?a  treatmentType  Surgery   ,?a  hasBiomarker  EGFR_Negative,0.024223602,0.428571429,0.684210526,39,91,57,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.047204969,0.562962963,0.716981132,76,135,106,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  EGFR_Negative,0.085714286,0.401162791,0.770949721,138,344,179,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.050931677,0.322834646,0.752293578,82,254,109,?a
?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.050931677,0.230985915,0.780952381,82,355,105,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  EGFR_Negative,0.177639752,0.31884058,0.739018088,286,897,387,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.036645963,0.430656934,0.453846154,59,137,130,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.033540373,0.36,0.794117647,54,150,68,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.036645963,0.357575758,0.766233766,59,165,77,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.071428571,0.611702128,0.809859155,115,188,142,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.077639752,0.318066158,0.771604938,125,393,162,?a
?a  patientDrug  Crizotinib   ,?a  hasBiomarker  EGFR_Negative,0.010559006,0.944444444,0.944444444,17,18,18,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  EGFR_Negative,0.206832298,0.89516129,0.89516129,333,372,372,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.034161491,0.401459854,0.785714286,55,137,70,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.044720497,0.72,0.857142857,72,100,84,?a
?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.041614907,0.540322581,0.761363636,67,124,88,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.030434783,0.731343284,0.942307692,49,67,52,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasBiomarker  EGFR_Negative,0.011180124,0.305084746,0.9,18,59,20,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasBiomarker  EGFR_Negative,0.013043478,0.28,0.84,21,75,25,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.089440994,0.510638298,0.852071006,144,282,169,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.139130435,0.453441296,0.788732394,224,494,284,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.077018634,0.424657534,0.784810127,124,292,158,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.077639752,0.373134328,0.710227273,125,335,176,?a
?a  patientDrug  Gemcitabine   ,?a  hasBiomarker  EGFR_Negative,0.01242236,0.357142857,0.625,20,56,32,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.027329193,0.178861789,0.846153846,44,246,52,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.113664596,0.723320158,0.855140187,183,253,214,?a
?a  patientDrug  Erlotinib   ,?a  hasBiomarker  EGFR_Negative,0.011801242,0.327586207,0.351851852,19,58,54,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.177018634,0.419734904,0.7421875,285,679,384,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.126708075,0.32278481,0.741818182,204,632,275,?a
?a  hasGender  Female   ,?a  hasSmokingHabit  FormerSmoker,0.112096774,0.373655914,0.373655914,139,372,372,?a
?a  hasStage  IIA   ,?a  hasSmokingHabit  FormerSmoker,0.021774194,0.529411765,0.529411765,27,51,51,?a
?a  hasStage  IA   ,?a  hasSmokingHabit  FormerSmoker,0.042741935,0.504761905,0.504761905,53,105,105,?a
?a  hasStage  IVB   ,?a  hasSmokingHabit  FormerSmoker,0.041129032,0.425,0.425,51,120,120,?a
?a  hasStage  IIIB   ,?a  hasSmokingHabit  FormerSmoker,0.057258065,0.503546099,0.503546099,71,141,141,?a
?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.035483871,0.523809524,0.523809524,44,84,84,?a
?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.109677419,0.473867596,0.477192982,136,287,285,?a
?a  hasStage  IIB   ,?a  hasSmokingHabit  FormerSmoker,0.033870968,0.617647059,0.617647059,42,68,68,?a
?a  hasStage  IB   ,?a  hasSmokingHabit  FormerSmoker,0.037096774,0.484210526,0.484210526,46,95,95,?a
?a  hasStage  IIIA   ,?a  hasSmokingHabit  FormerSmoker,0.096774194,0.495867769,0.495867769,120,242,242,?a
?a  treatmentType  Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.024193548,0.428571429,0.434782609,30,70,69,?a
?a  hasAgeCategory  Young   ,?a  hasSmokingHabit  FormerSmoker,0.109677419,0.395348837,0.395348837,136,344,344,?a
?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.037903226,0.516483516,0.516483516,47,91,91,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.05,0.459259259,0.459259259,62,135,135,?a
?a  hasAgeCategory  Old   ,?a  hasSmokingHabit  FormerSmoker,0.383870968,0.530657748,0.531843575,476,897,895,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.087903226,0.429133858,0.432539683,109,254,252,?a
?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.15483871,0.54084507,0.54084507,192,355,355,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.038709677,0.350364964,0.350364964,48,137,137,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.162096774,0.511450382,0.511450382,201,393,393,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  FormerSmoker,0.020967742,0.440677966,0.440677966,26,59,59,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.072580645,0.545454545,0.545454545,90,165,165,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.055645161,0.503649635,0.503649635,69,137,137,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasSmokingHabit  FormerSmoker,0.102419355,0.516260163,0.516260163,127,246,246,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.201612903,0.506072874,0.507099391,250,494,493,?a
?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.078225806,0.515957447,0.515957447,97,188,188,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.058064516,0.48,0.48,72,150,150,?a
?a  patientDrug  Erlotinib   ,?a  hasSmokingHabit  FormerSmoker,0.016935484,0.362068966,0.362068966,21,58,58,?a
?a  patientDrug  Cyclophosphamide   ,?a  hasSmokingHabit  FormerSmoker,0.020967742,0.433333333,0.440677966,26,60,59,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasSmokingHabit  FormerSmoker,0.033870968,0.56,0.56,42,75,75,?a
?a  patientDrug  Vincristine   ,?a  hasSmokingHabit  FormerSmoker,0.02016129,0.416666667,0.423728814,25,60,59,?a
?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.046774194,0.58,0.58,58,100,100,?a
?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.055645161,0.556451613,0.556451613,69,124,124,?a
?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.024193548,0.447761194,0.447761194,30,67,67,?a
?a  patientDrug  Gefitinib   ,?a  hasSmokingHabit  FormerSmoker,0.010483871,0.371428571,0.371428571,13,35,35,?a
?a  patientDrug  Doxorubicin   ,?a  hasSmokingHabit  FormerSmoker,0.020967742,0.433333333,0.440677966,26,60,59,?a
?a  patientDrug  Gemcitabine   ,?a  hasSmokingHabit  FormerSmoker,0.025806452,0.571428571,0.571428571,32,56,56,?a
?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  FormerSmoker,0.071774194,0.421800948,0.425837321,89,211,209,?a
?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.105645161,0.464539007,0.464539007,131,282,282,?a
?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  FormerSmoker,0.269354839,0.491899853,0.493353028,334,679,677,?a
?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.101612903,0.498023715,0.498023715,126,253,253,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.04516129,0.554455446,0.554455446,56,101,101,?a
?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.141935484,0.525373134,0.525373134,176,335,335,?a
?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.381451613,0.543678161,0.544930876,473,870,868,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.04516129,0.466666667,0.466666667,56,120,120,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasSmokingHabit  FormerSmoker,0.017741935,0.265060241,0.265060241,22,83,83,?a
?a  hasBiomarker  RET_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.017741935,0.423076923,0.423076923,22,52,52,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  FormerSmoker,0.056451613,0.5,0.5,70,140,140,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.152419355,0.508064516,0.508064516,189,372,372,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.176612903,0.516509434,0.516509434,219,424,424,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.105645161,0.498098859,0.498098859,131,263,263,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Chemotherapy_Adjuvant,0.030917211,0.147058824,0.152542373,90,612,590,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Chemotherapy_Adjuvant,0.0195809,0.115384615,0.119246862,57,494,478,?a
?a  hasGender  Female   ,?a  treatmentType  Chemotherapy_Adjuvant,0.018206802,0.142473118,0.148459384,53,372,357,?a
?a  hasGender  Male   ,?a  treatmentType  Chemotherapy_Adjuvant,0.038474751,0.128735632,0.132701422,112,870,844,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.088709677,0.48245614,0.48245614,110,228,228,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.032291309,0.412280702,0.412280702,94,228,228,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Chemotherapy_Adjuvant,0.018550326,0.13740458,0.13740458,54,393,393,?a
?a  hasStage  IIB   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012710409,0.544117647,0.544117647,37,68,68,?a
?a  hasStage  IIIA   ,?a  treatmentType  Chemotherapy_Adjuvant,0.022672621,0.272727273,0.273858921,66,242,241,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Chemotherapy_Adjuvant,0.017519753,0.148255814,0.149560117,51,344,341,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Chemotherapy_Adjuvant,0.0391618,0.127090301,0.13255814,114,897,860,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.026107867,0.269503546,0.270462633,76,282,281,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Chemotherapy_Adjuvant,0.018893851,0.188356164,0.188356164,55,292,292,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Chemotherapy_Adjuvant,0.037787702,0.328358209,0.329341317,110,335,334,?a
?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.258064516,0.506329114,0.507936508,320,632,630,?a
?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Chemotherapy_Adjuvant,0.016489179,0.195121951,0.205128205,48,246,234,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.035039505,0.161392405,0.163987138,102,632,622,?a
?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.12016129,0.510273973,0.510273973,149,292,292,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012710409,0.140684411,0.150406504,37,263,246,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Chemotherapy_Adjuvant,0.017519753,0.137096774,0.144475921,51,372,353,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Chemotherapy_Adjuvant,0.020267949,0.139150943,0.145679012,59,424,405,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Chemotherapy_Adjuvant,0.024390244,0.104565538,0.106287425,71,679,668,?a
?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.033321883,0.273239437,0.273239437,97,355,355,?a
?a  hasGender  Female   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.035726554,0.279569892,0.291316527,104,372,357,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.010992786,0.140350877,0.140350877,32,228,228,?a
?a  treatmentType  Chemotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.011336311,0.471428571,0.471428571,33,70,70,?a
?a  hasGender  Male   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.051528684,0.172413793,0.177725118,150,870,844,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.012710409,0.270072993,0.270072993,37,137,137,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.038818276,0.287531807,0.287531807,113,393,393,?a
?a  treatmentType  Immunotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.014428032,0.223404255,0.223404255,42,188,188,?a
?a  hasStage  IIIB   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.012366884,0.255319149,0.264705882,36,141,136,?a
?a  hasStage  IVB   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.01202336,0.291666667,0.309734513,35,120,113,?a
?a  hasStage  IIIA   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.01580213,0.190082645,0.190871369,46,242,241,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.049467537,0.291497976,0.291497976,144,494,494,?a
?a  patientDrug  Cyclophosphamide   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.013397458,0.65,0.65,39,60,60,?a
?a  patientDrug  Vincristine   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.013740982,0.666666667,0.666666667,40,60,60,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.036757128,0.311046512,0.313782991,107,344,341,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.040879423,0.240890688,0.248953975,119,494,478,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.050498111,0.163879599,0.170930233,147,897,860,?a
?a  patientDrug  Doxorubicin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.013740982,0.666666667,0.666666667,40,60,60,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.016145654,0.140298507,0.140718563,47,335,334,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.018206802,0.187943262,0.1886121,53,282,281,?a
?a  hasStage  IV   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.030230161,0.306620209,0.324723247,88,287,271,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.020611474,0.23715415,0.240963855,60,253,249,?a
?a  patientDrug  Vp-16   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.0391618,0.54028436,0.556097561,114,211,205,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.017863277,0.178082192,0.178082192,52,292,292,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.037444177,0.178104575,0.184745763,109,612,590,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.016832704,0.186311787,0.199186992,49,263,246,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.060803847,0.280063291,0.284565916,177,632,622,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.067674339,0.290132548,0.29491018,197,679,668,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.028169014,0.193396226,0.202469136,82,424,405,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.024733768,0.193548387,0.203966006,72,372,353,?a
?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Thoracoscopy,0.014771556,0.320895522,0.328244275,43,134,131,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Thoracoscopy,0.065956716,0.31372549,0.325423729,192,612,590,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Thoracoscopy,0.041222947,0.24291498,0.251046025,120,494,478,?a
?a  hasGender  Female   ,?a  treatmentType  Thoracoscopy,0.038818276,0.303763441,0.316526611,113,372,357,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Thoracoscopy,0.02335967,0.298245614,0.298245614,68,228,228,?a
?a  hasGender  Male   ,?a  treatmentType  Thoracoscopy,0.083132944,0.27816092,0.286729858,242,870,844,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Thoracoscopy,0.026451391,0.195928753,0.195928753,77,393,393,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Thoracoscopy,0.017519753,0.34,0.34,51,150,150,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Thoracoscopy,0.018206802,0.107287449,0.107287449,53,494,494,?a
?a  treatmentType  Immunotherapy   ,?a  treatmentType  Thoracoscopy,0.012710409,0.196808511,0.196808511,37,188,188,?a
?a  hasStage  IIA   ,?a  treatmentType  Thoracoscopy,0.010649261,0.607843137,0.607843137,31,51,51,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Thoracoscopy,0.010305737,0.218978102,0.218978102,30,137,137,?a
?a  hasStage  IA   ,?a  treatmentType  Thoracoscopy,0.026451391,0.733333333,0.733333333,77,105,105,?a
?a  hasStage  IIB   ,?a  treatmentType  Thoracoscopy,0.014428032,0.617647059,0.617647059,42,68,68,?a
?a  hasStage  IB   ,?a  treatmentType  Thoracoscopy,0.023703195,0.726315789,0.726315789,69,95,95,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Thoracoscopy,0.033321883,0.587878788,0.587878788,97,165,165,?a
?a  hasStage  IIIA   ,?a  treatmentType  Thoracoscopy,0.030230161,0.363636364,0.365145228,88,242,241,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Thoracoscopy,0.030230161,0.255813953,0.258064516,88,344,341,?a
?a  hasRelapse_Progression  Relapse   ,?a  treatmentType  Thoracoscopy,0.015115081,0.586666667,0.594594595,44,75,74,?a
?a  patientDrug  Nivolumab   ,?a  treatmentType  Thoracoscopy,0.010992786,0.258064516,0.258064516,32,124,124,?a
?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Thoracoscopy,0.045688767,0.540650407,0.568376068,133,246,234,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Thoracoscopy,0.033665407,0.144329897,0.146706587,98,679,668,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Thoracoscopy,0.011336311,0.130434783,0.13253012,33,253,249,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Thoracoscopy,0.091721058,0.297658863,0.310465116,267,897,860,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Thoracoscopy,0.025420818,0.253424658,0.253424658,74,292,292,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Thoracoscopy,0.023016146,0.237588652,0.238434164,67,282,281,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Thoracoscopy,0.035039505,0.304477612,0.305389222,102,335,334,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Thoracoscopy,0.015458605,0.171102662,0.182926829,45,263,246,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Thoracoscopy,0.024733768,0.193548387,0.203966006,72,372,353,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Thoracoscopy,0.028169014,0.193396226,0.202469136,82,424,405,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Thoracoscopy,0.044658193,0.205696203,0.209003215,130,632,622,?a
?a  hasStage  IIA   ,?a  hasGender  Male,0.033011272,0.803921569,0.803921569,41,51,51,?a
?a  hasStage  IA   ,?a  hasGender  Male,0.057971014,0.685714286,0.685714286,72,105,105,?a
?a  hasStage  IVA   ,?a  hasGender  Male,0.047504026,0.702380952,0.702380952,59,84,84,?a
?a  hasStage  IIIB   ,?a  hasGender  Male,0.080515298,0.709219858,0.709219858,100,141,141,?a
?a  hasStage  IVB   ,?a  hasGender  Male,0.05958132,0.616666667,0.616666667,74,120,120,?a
?a  hasStage  IV   ,?a  hasGender  Male,0.158615137,0.68641115,0.68641115,197,287,287,?a
?a  hasStage  IIB   ,?a  hasGender  Male,0.043478261,0.794117647,0.794117647,54,68,68,?a
?a  hasStage  IB   ,?a  hasGender  Male,0.055555556,0.726315789,0.726315789,69,95,95,?a
?a  hasStage  IIIA   ,?a  hasGender  Male,0.140096618,0.719008264,0.719008264,174,242,242,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasGender  Male,0.033816425,0.313432836,0.313432836,42,134,134,?a
?a  hasAgeCategory  Young   ,?a  hasGender  Male,0.161030596,0.581395349,0.581395349,200,344,344,?a
?a  hasAgeCategory  Old   ,?a  hasGender  Male,0.538647343,0.745819398,0.745819398,669,897,897,?a
?a  treatmentType  Chemotherapy   ,?a  hasGender  Male,0.042673108,0.757142857,0.757142857,53,70,70,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Male,0.284219002,0.714574899,0.714574899,353,494,494,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.380837359,0.772875817,0.772875817,473,612,612,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.071658615,0.659259259,0.659259259,89,135,135,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Male,0.120772947,0.590551181,0.590551181,150,254,254,?a
?a  treatmentType  Oral_Chemotherapy   ,?a  hasGender  Male,0.011272142,0.7,0.7,14,20,20,?a
?a  treatmentType  Surgery   ,?a  hasGender  Male,0.046698873,0.637362637,0.637362637,58,91,91,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.137681159,0.75,0.75,171,228,228,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Male,0.032206119,0.677966102,0.677966102,40,59,59,?a
?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.194847021,0.681690141,0.681690141,242,355,355,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.214975845,0.679389313,0.679389313,267,393,393,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.090177134,0.678787879,0.678787879,112,165,165,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.074879227,0.678832117,0.678832117,93,137,137,?a
?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.102254428,0.675531915,0.675531915,127,188,188,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.052334944,0.474452555,0.474452555,65,137,137,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasGender  Male,0.041867955,0.693333333,0.693333333,52,75,75,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasGender  Male,0.140096618,0.707317073,0.707317073,174,246,246,?a
?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasGender  Male,0.011272142,0.7,0.7,14,20,20,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.285024155,0.71659919,0.71659919,354,494,494,?a
?a  patientDrug  Gefitinib   ,?a  hasGender  Male,0.010466989,0.371428571,0.371428571,13,35,35,?a
?a  patientDrug  Erlotinib   ,?a  hasGender  Male,0.02173913,0.465517241,0.465517241,27,58,58,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.085346216,0.706666667,0.706666667,106,150,150,?a
?a  patientDrug  Doxorubicin   ,?a  hasGender  Male,0.038647343,0.8,0.8,48,60,60,?a
?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.072463768,0.725806452,0.725806452,90,124,124,?a
?a  patientDrug  Atezolizumab   ,?a  hasGender  Male,0.010466989,0.65,0.65,13,20,20,?a
?a  patientDrug  Gemcitabine   ,?a  hasGender  Male,0.028180354,0.625,0.625,35,56,56,?a
?a  hasRelapse_Progression  Progression   ,?a  hasGender  Male,0.375201288,0.686303387,0.686303387,466,679,679,?a
?a  patientDrug  Vp-16   ,?a  hasGender  Male,0.117552335,0.691943128,0.691943128,146,211,211,?a
?a  patientDrug  Cyclophosphamide   ,?a  hasGender  Male,0.037037037,0.766666667,0.766666667,46,60,60,?a
?a  patientDrug  Pemetrexed   ,?a  hasGender  Male,0.132850242,0.652173913,0.652173913,165,253,253,?a
?a  patientDrug  Vincristine   ,?a  hasGender  Male,0.037037037,0.766666667,0.766666667,46,60,60,?a
?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.155394525,0.684397163,0.684397163,193,282,282,?a
?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.054750403,0.68,0.68,68,100,100,?a
?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.034621578,0.641791045,0.641791045,43,67,67,?a
?a  patientDrug  Other   ,?a  hasGender  Male,0.012077295,0.454545455,0.454545455,15,33,33,?a
?a  patientDrug  Ipilimumab   ,?a  hasGender  Male,0.012882448,0.761904762,0.761904762,16,21,21,?a
?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.199677939,0.740298507,0.740298507,248,335,335,?a
?a  patientDrug  Afatinib   ,?a  hasGender  Male,0.016908213,0.477272727,0.477272727,21,44,44,?a
?a  patientDrug  Osimertinib   ,?a  hasGender  Male,0.013687601,0.377777778,0.377777778,17,45,45,?a
?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.161835749,0.688356164,0.688356164,201,292,292,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasGender  Male,0.057971014,0.712871287,0.712871287,72,101,101,?a
?a  hasBiomarker  ALK_Positive   ,?a  hasGender  Male,0.014492754,0.545454545,0.545454545,18,33,33,?a
?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.361513688,0.710443038,0.710443038,449,632,632,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasGender  Male,0.024959742,0.373493976,0.373493976,31,83,83,?a
?a  hasBiomarker  RET_Negative   ,?a  hasGender  Male,0.036231884,0.865384615,0.865384615,45,52,52,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasGender  Male,0.206924316,0.690860215,0.690860215,257,372,372,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Male,0.06763285,0.6,0.6,84,140,140,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Male,0.235909823,0.691037736,0.691037736,293,424,424,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.023703195,0.112745098,0.116949153,69,612,590,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.020954998,0.123481781,0.127615063,61,494,478,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Male,0.144927536,0.684410646,0.684410646,180,263,263,?a
?a  hasGender  Female   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.015115081,0.11827957,0.1232493,44,372,357,?a
?a  hasGender  Male   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.031947784,0.106896552,0.110189573,93,870,844,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.046032291,0.340966921,0.340966921,134,393,393,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.016832704,0.326666667,0.326666667,49,150,150,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.0195809,0.115384615,0.115384615,57,494,494,?a
?a  treatmentType  Immunotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013053933,0.20212766,0.20212766,38,188,188,?a
?a  hasStage  IIIB   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013740982,0.283687943,0.294117647,40,141,136,?a
?a  hasStage  IIIA   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.020267949,0.243801653,0.244813278,59,242,241,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.021642047,0.223404255,0.224199288,63,282,281,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasGender  Male,0.074074074,0.766666667,0.766666667,92,120,120,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.030573686,0.265671642,0.266467066,89,335,334,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.030573686,0.140822785,0.143086817,89,632,622,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.014084507,0.119186047,0.120234604,41,344,341,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.040535898,0.404109589,0.404109589,118,292,292,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010305737,0.114068441,0.12195122,30,263,246,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.032978358,0.107023411,0.111627907,96,897,860,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.016145654,0.126344086,0.133144476,47,372,353,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.018893851,0.129716981,0.135802469,55,424,405,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.034695981,0.148748159,0.151197605,101,679,668,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.033321883,0.158496732,0.16440678,97,612,590,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.029543112,0.174089069,0.179916318,86,494,478,?a
?a  hasGender  Female   ,?a  treatmentType  Immunotherapy,0.020954998,0.163978495,0.170868347,61,372,357,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Immunotherapy,0.014428032,0.165354331,0.165354331,42,254,254,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Immunotherapy,0.014428032,0.311111111,0.311111111,42,135,135,?a
?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Immunotherapy,0.012710409,0.104225352,0.104225352,37,355,355,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.013053933,0.277372263,0.277372263,38,137,137,?a
?a  hasStage  IVA   ,?a  treatmentType  Immunotherapy,0.011336311,0.392857143,0.452054795,33,84,73,?a
?a  hasGender  Male   ,?a  treatmentType  Immunotherapy,0.043627619,0.145977011,0.150473934,127,870,844,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Immunotherapy,0.02335967,0.17302799,0.17302799,68,393,393,?a
?a  hasStage  IVB   ,?a  treatmentType  Immunotherapy,0.011679835,0.283333333,0.300884956,34,120,113,?a
?a  hasStage  IV   ,?a  treatmentType  Immunotherapy,0.016832704,0.170731707,0.180811808,49,287,271,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.039505325,0.232793522,0.232793522,115,494,494,?a
?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Immunotherapy,0.014084507,0.611940299,0.650793651,41,67,63,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Immunotherapy,0.023703195,0.200581395,0.202346041,69,344,341,?a
?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.036757128,0.862903226,0.862903226,107,124,124,?a
?a  patientDrug  Docetaxel   ,?a  treatmentType  Immunotherapy,0.012710409,0.37,0.37,37,100,100,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Immunotherapy,0.040879423,0.132664437,0.138372093,119,897,860,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.021298523,0.219858156,0.220640569,62,282,281,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Immunotherapy,0.022329097,0.194029851,0.194610778,65,335,334,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.023016146,0.229452055,0.229452055,67,292,292,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.026107867,0.300395257,0.305220884,76,253,249,?a
?a  hasBiomarker  PDL1_Negative   ,?a  treatmentType  Immunotherapy,0.010992786,0.316831683,0.344086022,32,101,93,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.038818276,0.178797468,0.181672026,113,632,622,?a
?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Immunotherapy,0.022329097,0.464285714,0.5,65,140,130,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.049124012,0.210603829,0.214071856,143,679,668,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Immunotherapy,0.035726554,0.279569892,0.294617564,104,372,353,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Immunotherapy,0.026451391,0.292775665,0.31300813,77,263,246,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Immunotherapy,0.039505325,0.271226415,0.283950617,115,424,405,?a
?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Molecular_Targeted_Therapy,0.022672621,0.492537313,0.503816794,66,134,131,?a
?a  hasGender  Female   ,?a  treatmentType  Molecular_Targeted_Therapy,0.024733768,0.193548387,0.201680672,72,372,357,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Molecular_Targeted_Therapy,0.012710409,0.145669291,0.145669291,37,254,254,?a
?a  patientDrug  Gefitinib   ,?a  treatmentType  Molecular_Targeted_Therapy,0.010305737,0.857142857,0.857142857,30,35,35,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Molecular_Targeted_Therapy,0.0195809,0.115384615,0.115384615,57,494,494,?a
?a  patientDrug  Osimertinib   ,?a  treatmentType  Molecular_Targeted_Therapy,0.015458605,1,1,45,45,45,?a
?a  hasStage  IV   ,?a  treatmentType  Molecular_Targeted_Therapy,0.019924425,0.202090592,0.21402214,58,287,271,?a
?a  patientDrug  Erlotinib   ,?a  treatmentType  Molecular_Targeted_Therapy,0.017863277,0.896551724,0.912280702,52,58,57,?a
?a  patientDrug  Afatinib   ,?a  treatmentType  Molecular_Targeted_Therapy,0.014771556,0.977272727,0.977272727,43,44,44,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Molecular_Targeted_Therapy,0.015115081,0.156028369,0.15658363,44,282,281,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Molecular_Targeted_Therapy,0.012710409,0.110447761,0.110778443,37,335,334,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Molecular_Targeted_Therapy,0.010305737,0.102739726,0.102739726,30,292,292,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Molecular_Targeted_Therapy,0.019237375,0.221343874,0.224899598,56,253,249,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Molecular_Targeted_Therapy,0.015458605,0.120967742,0.127478754,45,372,353,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Molecular_Targeted_Therapy,0.021298523,0.180232558,0.181818182,62,344,341,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Molecular_Targeted_Therapy,0.020267949,0.139150943,0.145679012,59,424,405,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Molecular_Targeted_Therapy,0.014771556,0.163498099,0.174796748,43,263,246,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Molecular_Targeted_Therapy,0.038131226,0.1634757,0.166167665,111,679,668,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasBiomarker  ALK_Negative,0.026086957,0.313432836,0.40776699,42,134,103,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.117391304,0.308823529,0.682310469,189,612,277,?a
?a  hasBiomarker  EGFR_Positive   ,?a  treatmentType  Molecular_Targeted_Therapy,0.024733768,0.86746988,0.87804878,72,83,82,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.08757764,0.285425101,0.758064516,141,494,186,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasBiomarker  ALK_Negative,0.01863354,0.361445783,0.361445783,30,83,83,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ALK_Negative,0.046583851,0.742574257,0.742574257,75,101,101,?a
?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ALK_Negative,0.031677019,0.980769231,0.980769231,51,52,52,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.062732919,0.721428571,0.721428571,101,140,140,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ALK_Negative,0.068944099,0.925,0.925,111,120,120,?a
?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.028571429,0.547619048,0.696969697,46,84,66,?a
?a  hasStage  IIIB   ,?a  hasBiomarker  ALK_Negative,0.019875776,0.226950355,0.571428571,32,141,56,?a
?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.042236025,0.566666667,0.739130435,68,120,92,?a
?a  hasStage  IV   ,?a  hasBiomarker  ALK_Negative,0.060869565,0.341463415,0.586826347,98,287,167,?a
?a  hasGender  Female   ,?a  hasBiomarker  ALK_Negative,0.071428571,0.309139785,0.580808081,115,372,198,?a
?a  hasStage  IIIA   ,?a  hasBiomarker  ALK_Negative,0.048447205,0.32231405,0.702702703,78,242,111,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.045962733,0.324561404,0.74,74,228,100,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.153416149,0.939163498,0.939163498,247,263,263,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ALK_Negative,0.206832298,0.785377358,0.785377358,333,424,424,?a
?a  treatmentType  Surgery   ,?a  hasBiomarker  ALK_Negative,0.019875776,0.351648352,0.561403509,32,91,57,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.038509317,0.459259259,0.58490566,62,135,106,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.044720497,0.283464567,0.660550459,72,254,109,?a
?a  hasAgeCategory  Old   ,?a  hasBiomarker  ALK_Negative,0.159006211,0.285395764,0.661498708,256,897,387,?a
?a  hasAgeCategory  Young   ,?a  hasBiomarker  ALK_Negative,0.072049689,0.337209302,0.648044693,116,344,179,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ALK_Negative,0.027950311,0.328467153,0.346153846,45,137,130,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.031677019,0.309090909,0.662337662,51,165,77,?a
?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.044720497,0.202816901,0.685714286,72,355,105,?a
?a  patientDrug  Erlotinib   ,?a  hasBiomarker  ALK_Negative,0.013043478,0.362068966,0.388888889,21,58,54,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.062732919,0.256997455,0.62345679,101,393,162,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.029192547,0.343065693,0.671428571,47,137,70,?a
?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.040993789,0.66,0.785714286,66,100,84,?a
?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.027950311,0.671641791,0.865384615,45,67,52,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.029192547,0.313333333,0.691176471,47,150,68,?a
?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.064596273,0.553191489,0.732394366,104,188,142,?a
?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ALK_Negative,0.011801242,0.422222222,0.441860465,19,45,43,?a
?a  hasGender  Male   ,?a  hasBiomarker  ALK_Negative,0.159627329,0.295402299,0.698369565,257,870,368,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.118012422,0.384615385,0.669014085,190,494,284,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  ALK_Negative,0.022360248,0.146341463,0.692307692,36,246,52,?a
?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.069565217,0.397163121,0.662721893,112,282,169,?a
?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.066459627,0.319402985,0.607954545,107,335,176,?a
?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.064596273,0.356164384,0.658227848,104,292,158,?a
?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.098757764,0.628458498,0.742990654,159,253,214,?a
?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.114285714,0.291139241,0.669090909,184,632,275,?a
?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ALK_Negative,0.038509317,0.5,0.704545455,62,124,88,?a
?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ALK_Negative,0.149068323,0.353460972,0.625,240,679,384,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Intravenous_Chemotherapy,0.01580213,0.201754386,0.201754386,46,228,228,?a
?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.121607695,0.406896552,0.41943128,354,870,844,?a
?a  treatmentType  Surgery   ,?a  treatmentType  Intravenous_Chemotherapy,0.016832704,0.538461538,0.538461538,49,91,91,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.031260735,0.674074074,0.674074074,91,135,135,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.049467537,0.566929134,0.566929134,144,254,254,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Intravenous_Chemotherapy,0.010305737,0.181818182,0.181818182,30,165,165,?a
?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Intravenous_Chemotherapy,0.018206802,0.149295775,0.149295775,53,355,355,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.0195809,0.416058394,0.416058394,57,137,137,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.012710409,0.246666667,0.246666667,37,150,150,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.0195809,0.416058394,0.416058394,57,137,137,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.06252147,0.463104326,0.463104326,182,393,393,?a
?a  hasStage  IIIA   ,?a  treatmentType  Intravenous_Chemotherapy,0.019924425,0.239669421,0.2406639,58,242,241,?a
?a  hasStage  IIIB   ,?a  treatmentType  Intravenous_Chemotherapy,0.024046719,0.496453901,0.514705882,70,141,136,?a
?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.039505325,0.611702128,0.611702128,115,188,188,?a
?a  hasStage  IVA   ,?a  treatmentType  Intravenous_Chemotherapy,0.017176228,0.595238095,0.684931507,50,84,73,?a
?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.059429749,0.602787456,0.638376384,173,287,271,?a
?a  patientDrug  Gemcitabine   ,?a  treatmentType  Intravenous_Chemotherapy,0.01580213,0.821428571,0.821428571,46,56,56,?a
?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.029886637,0.701612903,0.701612903,87,124,124,?a
?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.025420818,0.616666667,0.654867257,74,120,113,?a
?a  patientDrug  Vp-16   ,?a  treatmentType  Intravenous_Chemotherapy,0.041909997,0.578199052,0.595121951,122,211,205,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.047749914,0.492907801,0.494661922,139,282,281,?a
?a  patientDrug  Cyclophosphamide   ,?a  treatmentType  Intravenous_Chemotherapy,0.020267949,0.983333333,0.983333333,59,60,60,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.072827207,0.837944664,0.851405622,212,253,249,?a
?a  patientDrug  Vincristine   ,?a  treatmentType  Intravenous_Chemotherapy,0.020267949,0.983333333,0.983333333,59,60,60,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.058055651,0.578767123,0.578767123,169,292,292,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.050841635,0.441791045,0.443113772,148,335,334,?a
?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.014428032,0.313432836,0.320610687,42,134,131,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Intravenous_Chemotherapy,0.053246307,0.450581395,0.454545455,155,344,341,?a
?a  hasRelapse_Progression  Relapse   ,?a  treatmentType  Intravenous_Chemotherapy,0.010305737,0.4,0.405405405,30,75,74,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.133631055,0.615506329,0.625401929,389,632,622,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.085881141,0.408496732,0.423728814,250,612,590,?a
?a  hasBiomarker  PDL1_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.020954998,0.603960396,0.655913978,61,101,93,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Intravenous_Chemotherapy,0.116454827,0.377926421,0.394186047,339,897,860,?a
?a  hasBiomarker  BRAF_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.014428032,0.35,0.368421053,42,120,114,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.069048437,0.406882591,0.420502092,201,494,478,?a
?a  patientDrug  Docetaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.03160426,0.92,0.92,92,100,100,?a
?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Intravenous_Chemotherapy,0.020954998,0.435714286,0.469230769,61,140,130,?a
?a  patientDrug  Doxorubicin   ,?a  treatmentType  Intravenous_Chemotherapy,0.020267949,0.983333333,0.983333333,59,60,60,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.065269667,0.510752688,0.538243626,190,372,353,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.076949502,0.528301887,0.55308642,224,424,405,?a
?a  hasGender  Female   ,?a  treatmentType  Intravenous_Chemotherapy,0.048093439,0.376344086,0.392156863,140,372,357,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIB,0.048309179,0.12145749,0.12145749,60,494,494,?a
?a  hasGender  Female   ,?a  hasStage  IIIB,0.033011272,0.110215054,0.110215054,41,372,372,?a
?a  hasAgeCategory  Young   ,?a  hasStage  IIIB,0.037037037,0.13372093,0.13372093,46,344,344,?a
?a  hasGender  Male   ,?a  hasStage  IIIB,0.080515298,0.114942529,0.114942529,100,870,870,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.028985507,0.141732283,0.141732283,36,254,254,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.041909997,0.463878327,0.495934959,122,263,246,?a
?a  treatmentType  Surgery   ,?a  hasStage  IIIB,0.013687601,0.186813187,0.186813187,17,91,91,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIB,0.023349436,0.491525424,0.491525424,29,59,59,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIB,0.020128824,0.166666667,0.166666667,25,150,150,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.141188595,0.605301915,0.615269461,411,679,668,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.074074074,0.234096692,0.234096692,92,393,393,?a
?a  treatmentType  Immunotherapy   ,?a  hasStage  IIIB,0.018518519,0.122340426,0.122340426,23,188,188,?a
?a  patientDrug  Nivolumab   ,?a  hasStage  IIIB,0.010466989,0.10483871,0.10483871,13,124,124,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIB,0.032206119,0.291970803,0.291970803,40,137,137,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIB,0.056360709,0.141700405,0.141700405,70,494,494,?a
?a  patientDrug  Vp-16   ,?a  hasStage  IIIB,0.019323671,0.113744076,0.113744076,24,211,211,?a
?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIB,0.05394525,0.2,0.2,67,335,335,?a
?a  hasAgeCategory  Old   ,?a  hasStage  IIIB,0.076489533,0.105908584,0.105908584,95,897,897,?a
?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIB,0.049919485,0.212328767,0.212328767,62,292,292,?a
?a  patientDrug  Carboplatin   ,?a  hasStage  IIIB,0.070048309,0.137658228,0.137658228,87,632,632,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasStage  IIIB,0.010466989,0.108333333,0.108333333,13,120,120,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IIIB,0.057165862,0.116013072,0.116013072,71,612,612,?a
?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIB,0.074074074,0.135493373,0.135493373,92,679,679,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IIIB,0.036231884,0.106132075,0.106132075,45,424,424,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IIIA,0.096618357,0.196078431,0.196078431,120,612,612,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IIIA,0.016908213,0.156716418,0.156716418,21,134,134,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.081320451,0.204453441,0.204453441,101,494,494,?a
?a  hasGender  Female   ,?a  hasStage  IIIA,0.054750403,0.182795699,0.182795699,68,372,372,?a
?a  hasGender  Male   ,?a  hasStage  IIIA,0.140096618,0.2,0.2,174,870,870,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IIIA,0.011272142,0.103703704,0.103703704,14,135,135,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.066022544,0.359649123,0.359649123,82,228,228,?a
?a  hasAgeCategory  Young   ,?a  hasStage  IIIA,0.048309179,0.174418605,0.174418605,60,344,344,?a
?a  hasAgeCategory  Old   ,?a  hasStage  IIIA,0.146537842,0.202898551,0.202898551,182,897,897,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIA,0.037037037,0.181102362,0.181102362,46,254,254,?a
?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.070853462,0.247887324,0.247887324,88,355,355,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIA,0.020128824,0.423728814,0.423728814,25,59,59,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IIIA,0.020933977,0.189781022,0.189781022,26,137,137,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIA,0.046698873,0.117408907,0.117408907,58,494,494,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.117552335,0.371501272,0.371501272,146,393,393,?a
?a  treatmentType  Immunotherapy   ,?a  hasStage  IIIA,0.017713366,0.117021277,0.117021277,22,188,188,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.053140097,0.4,0.4,66,165,165,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasStage  IIIA,0.012077295,0.2,0.2,15,75,75,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.089371981,0.74,0.74,111,150,150,?a
?a  patientDrug  Nivolumab   ,?a  hasStage  IIIA,0.018518519,0.185483871,0.185483871,23,124,124,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.047504026,0.430656934,0.430656934,59,137,137,?a
?a  patientDrug  Docetaxel   ,?a  hasStage  IIIA,0.019323671,0.24,0.24,24,100,100,?a
?a  patientDrug  Gemcitabine   ,?a  hasStage  IIIA,0.013687601,0.303571429,0.303571429,17,56,56,?a
?a  patientDrug  Vp-16   ,?a  hasStage  IIIA,0.017713366,0.104265403,0.104265403,22,211,211,?a
?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIA,0.111111111,0.203240059,0.203240059,138,679,679,?a
?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.08373591,0.368794326,0.368794326,104,282,282,?a
?a  patientDrug  Pemetrexed   ,?a  hasStage  IIIA,0.025764895,0.126482213,0.126482213,32,253,253,?a
?a  patientDrug  Cisplatin   ,?a  hasStage  IIIB,0.040257649,0.177304965,0.177304965,50,282,282,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasStage  IIIA,0.027375201,0.283333333,0.283333333,34,120,120,?a
?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.106280193,0.394029851,0.394029851,132,335,335,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasStage  IIIA,0.053140097,0.268292683,0.268292683,66,246,246,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasStage  IIIA,0.012882448,0.114285714,0.114285714,16,140,140,?a
?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.073268921,0.311643836,0.311643836,91,292,292,?a
?a  patientDrug  Carboplatin   ,?a  hasStage  IIIA,0.09742351,0.191455696,0.191455696,121,632,632,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasStage  IIIA,0.011272142,0.168674699,0.168674699,14,83,83,?a
?a  hasBiomarker  RET_Negative   ,?a  hasStage  IIIA,0.016908213,0.403846154,0.403846154,21,52,52,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IIIA,0.071658615,0.20990566,0.20990566,89,424,424,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasStage  IIIA,0.062801932,0.209677419,0.209677419,78,372,372,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IIIA,0.046698873,0.220532319,0.220532319,58,263,263,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IA,0.011272142,0.104477612,0.104477612,14,134,134,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IA,0.023349436,0.127192982,0.127192982,29,228,228,?a
?a  treatmentType  Thoracoscopy   ,?a  hasStage  IA,0.061996779,0.216901408,0.216901408,77,355,355,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasStage  IA,0.010466989,0.173333333,0.173333333,13,75,75,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasStage  IA,0.039452496,0.199186992,0.199186992,49,246,246,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Radiotherapy_To_Lung,0.019924425,0.254385965,0.254385965,58,228,228,?a
?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Lung,0.043284095,0.338709677,0.352941176,126,372,357,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.056681553,0.334008097,0.345188285,165,494,478,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Radiotherapy_To_Lung,0.011336311,0.244444444,0.244444444,33,135,135,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.038818276,0.44488189,0.44488189,113,254,254,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.069048437,0.328431373,0.340677966,201,612,590,?a
?a  treatmentType  Surgery   ,?a  treatmentType  Radiotherapy_To_Lung,0.011336311,0.362637363,0.362637363,33,91,91,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  treatmentType  Radiotherapy_To_Lung,0.017176228,0.847457627,0.847457627,50,59,59,?a
?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Radiotherapy_To_Lung,0.026451391,0.216901408,0.216901408,77,355,355,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.012366884,0.262773723,0.262773723,36,137,137,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Radiotherapy_To_Lung,0.018550326,0.327272727,0.327272727,54,165,165,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.029199588,0.566666667,0.566666667,85,150,150,?a
?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.02335967,0.361702128,0.361702128,68,188,188,?a
?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Lung,0.016832704,0.170731707,0.180811808,49,287,271,?a
?a  hasStage  IIIB   ,?a  treatmentType  Radiotherapy_To_Lung,0.03160426,0.65248227,0.676470588,92,141,136,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.046032291,0.97810219,0.97810219,134,137,137,?a
?a  patientDrug  Cyclophosphamide   ,?a  treatmentType  Radiotherapy_To_Lung,0.010649261,0.516666667,0.516666667,31,60,60,?a
?a  patientDrug  Docetaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.013740982,0.4,0.4,40,100,100,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.06252147,0.368421053,0.368421053,182,494,494,?a
?a  hasAgeCategory  Young   ,?a  treatmentType  Radiotherapy_To_Lung,0.038474751,0.325581395,0.328445748,112,344,341,?a
?a  patientDrug  Vincristine   ,?a  treatmentType  Radiotherapy_To_Lung,0.010305737,0.5,0.5,30,60,60,?a
?a  hasStage  IIIA   ,?a  treatmentType  Radiotherapy_To_Lung,0.050154586,0.603305785,0.605809129,146,242,241,?a
?a  patientDrug  Nivolumab   ,?a  treatmentType  Radiotherapy_To_Lung,0.015115081,0.35483871,0.35483871,44,124,124,?a
?a  patientDrug  Doxorubicin   ,?a  treatmentType  Radiotherapy_To_Lung,0.010305737,0.5,0.5,30,60,60,?a
?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Radiotherapy_To_Lung,0.019237375,0.227642276,0.239316239,56,246,234,?a
?a  patientDrug  Vp-16   ,?a  treatmentType  Radiotherapy_To_Lung,0.031947784,0.440758294,0.453658537,93,211,205,?a
?a  hasGender  Male   ,?a  treatmentType  Radiotherapy_To_Lung,0.091721058,0.306896552,0.316350711,267,870,844,?a
?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Lung,0.024046719,0.276679842,0.281124498,70,253,249,?a
?a  hasAgeCategory  Old   ,?a  treatmentType  Radiotherapy_To_Lung,0.096530402,0.313266444,0.326744186,281,897,860,?a
?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.046375816,0.478723404,0.480427046,135,282,281,?a
?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.060460323,0.602739726,0.602739726,176,292,292,?a
?a  hasBiomarker  BRAF_Negative   ,?a  treatmentType  Radiotherapy_To_Lung,0.012366884,0.3,0.315789474,36,120,114,?a
?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.058055651,0.504477612,0.505988024,169,335,334,?a
?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Radiotherapy_To_Lung,0.011336311,0.235714286,0.253846154,33,140,130,?a
?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.087255239,0.401898734,0.408360129,254,632,622,?a
?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Lung,0.0979045,0.419734904,0.426646707,285,679,668,?a
?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Radiotherapy_To_Lung,0.04294057,0.294811321,0.308641975,125,424,405,?a
?a  hasRelapse_Progression  Relapse   ,?a  treatmentType  Radiotherapy_To_Lung,0.012366884,0.48,0.486486486,36,75,74,?a
?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Radiotherapy_To_Lung,0.034695981,0.271505376,0.28611898,101,372,353,?a
?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Radiotherapy_To_Lung,0.02335967,0.258555133,0.276422764,68,263,246,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IVB,0.01610306,0.149253731,0.149253731,20,134,134,?a
?a  hasGender  Female   ,?a  hasStage  IVB,0.037037037,0.123655914,0.123655914,46,372,372,?a
?a  hasAgeCategory  Young   ,?a  hasStage  IVB,0.035426731,0.127906977,0.127906977,44,344,344,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.028180354,0.137795276,0.137795276,35,254,254,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.027375201,0.251851852,0.251851852,34,135,135,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IVB,0.018518519,0.167883212,0.167883212,23,137,137,?a
?a  patientDrug  Erlotinib   ,?a  hasStage  IVB,0.010466989,0.224137931,0.224137931,13,58,58,?a
?a  treatmentType  Immunotherapy   ,?a  hasStage  IVB,0.027375201,0.180851064,0.180851064,34,188,188,?a
?a  patientDrug  Docetaxel   ,?a  hasStage  IVB,0.015297907,0.19,0.19,19,100,100,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.05958132,0.149797571,0.149797571,74,494,494,?a
?a  patientDrug  Nivolumab   ,?a  hasStage  IVB,0.011272142,0.112903226,0.112903226,14,124,124,?a
?a  patientDrug  Osimertinib   ,?a  hasStage  IVB,0.012077295,0.333333333,0.333333333,15,45,45,?a
?a  patientDrug  Pembrolizumab   ,?a  hasStage  IVB,0.018518519,0.343283582,0.343283582,23,67,67,?a
?a  patientDrug  Vp-16   ,?a  hasStage  IVB,0.017713366,0.104265403,0.104265403,22,211,211,?a
?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.033011272,0.162055336,0.162055336,41,253,253,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasStage  IVB,0.024154589,0.297029703,0.297029703,30,101,101,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasStage  IVB,0.020933977,0.216666667,0.216666667,26,120,120,?a
?a  patientDrug  Carboplatin   ,?a  hasStage  IVB,0.058776167,0.115506329,0.115506329,73,632,632,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasStage  IVB,0.01610306,0.240963855,0.240963855,20,83,83,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasStage  IVB,0.054750403,0.182795699,0.182795699,68,372,372,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasStage  IVB,0.041867955,0.371428571,0.371428571,52,140,140,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IVB,0.048309179,0.141509434,0.141509434,60,424,424,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IVB,0.05394525,0.254752852,0.254752852,67,263,263,?a
?a  hasRelapse_Progression  Progression   ,?a  hasStage  IVB,0.066827697,0.122238586,0.122238586,83,679,679,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Nivolumab,0.023169913,0.112745098,0.147435897,69,612,468,?a
?a  hasGender  Female   ,?a  patientDrug  Nivolumab,0.011417058,0.091397849,0.114864865,34,372,296,?a
?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Nivolumab,0.010745467,0.090140845,0.165803109,32,355,193,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Nivolumab,0.017797179,0.107287449,0.135204082,53,494,392,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Nivolumab,0.014775017,0.111959288,0.119565217,44,393,368,?a
?a  hasStage  IV   ,?a  patientDrug  Nivolumab,0.014439221,0.149825784,0.166023166,43,287,259,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.029214238,0.17611336,0.17611336,87,494,494,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.035930154,0.569148936,0.572192513,107,188,187,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Nivolumab,0.010073875,0.3,0.3,30,100,100,?a
?a  hasGender  Male   ,?a  patientDrug  Nivolumab,0.030221625,0.103448276,0.135542169,90,870,664,?a
?a  patientDrug  Cisplatin   ,?a  patientDrug  Nivolumab,0.014439221,0.15248227,0.15248227,43,282,282,?a
?a  patientDrug  Vinorelbine   ,?a  patientDrug  Nivolumab,0.013767629,0.12238806,0.12238806,41,335,335,?a
?a  patientDrug  Pemetrexed   ,?a  patientDrug  Nivolumab,0.018804567,0.221343874,0.221343874,56,253,253,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Nivolumab,0.019140363,0.195205479,0.195205479,57,292,292,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Nivolumab,0.014439221,0.125,0.146757679,43,344,293,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Nivolumab,0.027199463,0.090301003,0.12143928,81,897,667,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Nivolumab,0.020819342,0.166666667,0.194968553,62,372,318,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Nivolumab,0.034251175,0.150220913,0.164251208,102,679,621,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Nivolumab,0.022498321,0.158018868,0.184065934,67,424,364,?a
?a  patientDrug  Carboplatin   ,?a  patientDrug  Nivolumab,0.028878442,0.136075949,0.136075949,86,632,632,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasRelapse_Progression  No_Progression,0.021,0.156716418,0.201923077,21,134,104,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasRelapse_Progression  No_Progression,0.127,0.20751634,0.264583333,127,612,480,?a
?a  hasStage  IIA   ,?a  hasRelapse_Progression  No_Progression,0.019,0.37254902,0.558823529,19,51,34,?a
?a  hasGender  Female   ,?a  hasRelapse_Progression  No_Progression,0.072,0.193548387,0.242424242,72,372,297,?a
?a  hasStage  IA   ,?a  hasRelapse_Progression  No_Progression,0.049,0.466666667,0.628205128,49,105,78,?a
?a  hasStage  IIIB   ,?a  hasRelapse_Progression  No_Progression,0.017,0.120567376,0.151785714,17,141,112,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasRelapse_Progression  No_Progression,0.098,0.198380567,0.260638298,98,494,376,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Nivolumab,0.013096038,0.148288973,0.172566372,39,263,226,?a
?a  hasGender  Male   ,?a  hasRelapse_Progression  No_Progression,0.174,0.2,0.261654135,174,870,665,?a
?a  hasStage  IIB   ,?a  hasRelapse_Progression  No_Progression,0.024,0.352941176,0.510638298,24,68,47,?a
?a  hasStage  IB   ,?a  hasRelapse_Progression  No_Progression,0.029,0.305263158,0.467741935,29,95,62,?a
?a  hasAgeCategory  Young   ,?a  hasRelapse_Progression  No_Progression,0.055,0.159883721,0.204460967,55,344,269,?a
?a  hasStage  IV   ,?a  hasRelapse_Progression  No_Progression,0.031,0.108013937,0.130252101,31,287,238,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  No_Progression,0.024,0.094488189,0.105726872,24,254,227,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  No_Progression,0.058,0.254385965,0.341176471,58,228,170,?a
?a  treatmentType  Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.018,0.257142857,0.321428571,18,70,56,?a
?a  hasAgeCategory  Old   ,?a  hasRelapse_Progression  No_Progression,0.191,0.212931996,0.276011561,191,897,692,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  No_Progression,0.056,0.142493639,0.157746479,56,393,355,?a
?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  No_Progression,0.133,0.374647887,0.521568627,133,355,255,?a
?a  hasStage  IIIA   ,?a  hasRelapse_Progression  No_Progression,0.066,0.272727273,0.317307692,66,242,208,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.035,0.233333333,0.289256198,35,150,121,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  No_Progression,0.048,0.290909091,0.372093023,48,165,129,?a
?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  No_Progression,0.017,0.090425532,0.104938272,17,188,162,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  No_Progression,0.019,0.138686131,0.1484375,19,137,128,?a
?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  No_Progression,0.015,0.120967742,0.128205128,15,124,117,?a
?a  patientDrug  Durvalumab   ,?a  hasRelapse_Progression  No_Progression,0.011,0.523809524,0.611111111,11,21,18,?a
?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  No_Progression,0.031,0.109929078,0.128099174,31,282,242,?a
?a  patientDrug  Vp-16   ,?a  hasRelapse_Progression  No_Progression,0.033,0.156398104,0.189655172,33,211,174,?a
?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  No_Progression,0.036,0.123287671,0.138996139,36,292,259,?a
?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  No_Progression,0.054,0.16119403,0.195652174,54,335,276,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasRelapse_Progression  No_Progression,0.036,0.096774194,0.127659574,36,372,282,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasRelapse_Progression  No_Progression,0.013,0.092857143,0.132653061,13,140,98,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasRelapse_Progression  No_Progression,0.044,0.103773585,0.130177515,44,424,338,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasRelapse_Progression  No_Progression,0.028,0.106463878,0.145833333,28,263,192,?a
?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  No_Progression,0.092,0.14556962,0.175238095,92,632,525,?a
?a  hasGender  Female   ,?a  hasStage  IV,0.072463768,0.241935484,0.241935484,90,372,372,?a
?a  hasAgeCategory  Young   ,?a  hasStage  IV,0.070853462,0.255813953,0.255813953,88,344,344,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IV,0.030595813,0.28358209,0.28358209,38,134,134,?a
?a  hasAgeCategory  Old   ,?a  hasStage  IV,0.160225443,0.221850613,0.221850613,199,897,897,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IV,0.109500805,0.222222222,0.222222222,136,612,612,?a
?a  treatmentType  Chemotherapy   ,?a  hasStage  IV,0.035426731,0.628571429,0.628571429,44,70,70,?a
?a  hasGender  Male   ,?a  hasStage  IV,0.158615137,0.226436782,0.226436782,197,870,870,?a
?a  treatmentType  Surgery   ,?a  hasStage  IV,0.034621578,0.472527473,0.472527473,43,91,91,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.070853462,0.346456693,0.346456693,88,254,254,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IV,0.03784219,0.348148148,0.348148148,47,135,135,?a
?a  patientDrug  Cyclophosphamide   ,?a  hasStage  IV,0.025764895,0.533333333,0.533333333,32,60,60,?a
?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.039452496,0.260638298,0.260638298,49,188,188,?a
?a  patientDrug  Erlotinib   ,?a  hasStage  IV,0.017713366,0.379310345,0.379310345,22,58,58,?a
?a  patientDrug  Nivolumab   ,?a  hasStage  IV,0.034621578,0.346774194,0.346774194,43,124,124,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.046698873,0.423357664,0.423357664,58,137,137,?a
?a  patientDrug  Docetaxel   ,?a  hasStage  IV,0.023349436,0.29,0.29,29,100,100,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IV,0.089371981,0.224696356,0.224696356,111,494,494,?a
?a  patientDrug  Vincristine   ,?a  hasStage  IV,0.024959742,0.516666667,0.516666667,31,60,60,?a
?a  patientDrug  Gefitinib   ,?a  hasStage  IV,0.013687601,0.485714286,0.485714286,17,35,35,?a
?a  patientDrug  Doxorubicin   ,?a  hasStage  IV,0.024154589,0.5,0.5,30,60,60,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.139291465,0.350202429,0.350202429,173,494,494,?a
?a  patientDrug  Afatinib   ,?a  hasStage  IV,0.017713366,0.5,0.5,22,44,44,?a
?a  patientDrug  Osimertinib   ,?a  hasStage  IV,0.011272142,0.311111111,0.311111111,14,45,45,?a
?a  patientDrug  Cisplatin   ,?a  hasStage  IV,0.042673108,0.187943262,0.187943262,53,282,282,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasStage  IV,0.010466989,0.128712871,0.128712871,13,101,101,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasStage  IV,0.024959742,0.12601626,0.12601626,31,246,246,?a
?a  patientDrug  Vp-16   ,?a  hasStage  IV,0.073268921,0.431279621,0.431279621,91,211,211,?a
?a  patientDrug  Paclitaxel   ,?a  hasStage  IV,0.040257649,0.171232877,0.171232877,50,292,292,?a
?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.084541063,0.415019763,0.415019763,105,253,253,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasStage  IV,0.011272142,0.1,0.1,14,140,140,?a
?a  hasBiomarker  ALK_Positive   ,?a  hasStage  IV,0.012882448,0.484848485,0.484848485,16,33,33,?a
?a  patientDrug  Carboplatin   ,?a  hasStage  IV,0.144122383,0.283227848,0.283227848,179,632,632,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IV,0.039452496,0.124681934,0.124681934,49,393,393,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasStage  IV,0.025764895,0.385542169,0.385542169,32,83,83,?a
?a  hasRelapse_Progression  Progression   ,?a  hasStage  IV,0.165056361,0.30191458,0.30191458,205,679,679,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IV,0.030595813,0.144486692,0.144486692,38,263,263,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasStage  IV,0.078904992,0.26344086,0.26344086,98,372,372,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IV,0.104669887,0.306603774,0.306603774,130,424,424,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Cisplatin,0.043989255,0.214052288,0.27991453,131,612,468,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.041638684,0.251012146,0.316326531,124,494,392,?a
?a  hasGender  Female   ,?a  patientDrug  Cisplatin,0.029885829,0.239247312,0.300675676,89,372,296,?a
?a  hasStage  IIIB   ,?a  patientDrug  Cisplatin,0.016789792,0.354609929,0.37593985,50,141,133,?a
?a  hasStage  IV   ,?a  patientDrug  Cisplatin,0.017797179,0.18466899,0.204633205,53,287,259,?a
?a  hasGender  Male   ,?a  patientDrug  Cisplatin,0.064808596,0.22183908,0.290662651,193,870,664,?a
?a  hasStage  IIIA   ,?a  patientDrug  Cisplatin,0.034922767,0.429752066,0.502415459,104,242,207,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.018804567,0.56,0.56,56,100,100,?a
?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.014439221,0.346774194,0.346774194,43,124,124,?a
?a  patientDrug  Gemcitabine   ,?a  patientDrug  Cisplatin,0.010745467,0.571428571,0.571428571,32,56,56,?a
?a  patientDrug  Carboplatin   ,?a  patientDrug  Cisplatin,0.021490934,0.101265823,0.101265823,64,632,632,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.031564809,0.321917808,0.321917808,94,292,292,?a
?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.034922767,0.411067194,0.411067194,104,253,253,?a
?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.063801209,0.567164179,0.567164179,190,335,335,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Cisplatin,0.039959704,0.345930233,0.406143345,119,344,293,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Cisplatin,0.013096038,0.288888889,0.317073171,39,135,123,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Cisplatin,0.054734721,0.181716834,0.244377811,163,897,667,?a
?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Cisplatin,0.022498321,0.188732394,0.347150259,67,355,193,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.017797179,0.208661417,0.220833333,53,254,240,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.026527871,0.346491228,0.523178808,79,228,151,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.014775017,0.321167883,0.321167883,44,137,137,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Cisplatin,0.025520484,0.460606061,0.472049689,76,165,161,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.045332438,0.34351145,0.366847826,135,393,368,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.021155138,0.459854015,0.459854015,63,137,137,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.020819342,0.329787234,0.331550802,62,188,187,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.046675621,0.281376518,0.281376518,139,494,494,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.029550034,0.586666667,0.602739726,88,150,146,?a
?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Cisplatin,0.010409671,0.12601626,0.231343284,31,246,134,?a
?a  hasBiomarker  BRAF_Negative   ,?a  patientDrug  Cisplatin,0.011752854,0.291666667,0.35,35,120,100,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Cisplatin,0.025184688,0.285171103,0.331858407,75,263,226,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Cisplatin,0.037609134,0.301075269,0.352201258,112,372,318,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Cisplatin,0.0483546,0.339622642,0.395604396,144,424,364,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.042310275,0.205882353,0.269230769,126,612,468,?a
?a  hasSmokingHabit  NonSmoker   ,?a  patientDrug  Pemetrexed,0.01208865,0.268656716,0.367346939,36,134,98,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.030557421,0.184210526,0.232142857,91,494,392,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.068502351,0.300441826,0.328502415,204,679,621,?a
?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.013767629,0.341666667,0.372727273,41,120,110,?a
?a  hasStage  IIIA   ,?a  patientDrug  Pemetrexed,0.010745467,0.132231405,0.154589372,32,242,207,?a
?a  hasGender  Male   ,?a  patientDrug  Pemetrexed,0.055406313,0.189655172,0.248493976,165,870,664,?a
?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.035258563,0.365853659,0.405405405,105,287,259,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.019811954,0.59,0.59,59,100,100,?a
?a  patientDrug  Vinorelbine   ,?a  patientDrug  Pemetrexed,0.015446608,0.137313433,0.137313433,46,335,335,?a
?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.018804567,0.451612903,0.451612903,56,124,124,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.021826729,0.22260274,0.22260274,65,292,292,?a
?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.034922767,0.368794326,0.368794326,104,282,282,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Pemetrexed,0.010073875,0.131578947,0.198675497,30,228,151,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Pemetrexed,0.032572196,0.281976744,0.33105802,97,344,293,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Pemetrexed,0.05238415,0.173913043,0.233883058,156,897,667,?a
?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.057756884,0.272151899,0.272151899,172,632,632,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.020483546,0.451851852,0.495934959,61,135,123,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.02014775,0.236220472,0.25,60,254,240,?a
?a  treatmentType  Surgery   ,?a  patientDrug  Pemetrexed,0.010745467,0.351648352,0.385542169,32,91,83,?a
?a  hasGender  Female   ,?a  patientDrug  Pemetrexed,0.029550034,0.23655914,0.297297297,88,372,296,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.018804567,0.408759124,0.408759124,56,137,137,?a
?a  hasBiomarker  PDL1_Negative   ,?a  patientDrug  Pemetrexed,0.012760242,0.376237624,0.417582418,38,101,91,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.025520484,0.404255319,0.406417112,76,188,187,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Pemetrexed,0.023505709,0.178117048,0.190217391,70,393,368,?a
?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Pemetrexed,0.014103425,0.3,0.344262295,42,140,122,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Pemetrexed,0.053391538,0.427419355,0.5,159,372,318,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.071188717,0.429149798,0.429149798,212,494,494,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.071524513,0.313696613,0.342995169,213,679,621,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Pemetrexed,0.061450638,0.431603774,0.502747253,183,424,364,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Pemetrexed,0.032907992,0.372623574,0.433628319,98,263,226,?a
?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Pemetrexed,0.011081263,0.092957746,0.170984456,33,355,193,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasRelapse_Progression  Progression,0.037,0.493333333,0.493333333,37,75,75,?a
?a  hasStage  IIA   ,?a  hasRelapse_Progression  Progression,0.012,0.235294118,0.352941176,12,51,34,?a
?a  hasGender  Female   ,?a  hasRelapse_Progression  Progression,0.213,0.572580645,0.717171717,213,372,297,?a
?a  hasStage  IA   ,?a  hasRelapse_Progression  Progression,0.021,0.2,0.269230769,21,105,78,?a
?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.062,0.738095238,0.984126984,62,84,63,?a
?a  hasStage  IVB   ,?a  hasRelapse_Progression  Progression,0.083,0.691666667,0.988095238,83,120,84,?a
?a  hasStage  IIIB   ,?a  hasRelapse_Progression  Progression,0.092,0.65248227,0.821428571,92,141,112,?a
?a  hasStage  IIB   ,?a  hasRelapse_Progression  Progression,0.02,0.294117647,0.425531915,20,68,47,?a
?a  hasStage  IB   ,?a  hasRelapse_Progression  Progression,0.022,0.231578947,0.35483871,22,95,62,?a
?a  hasStage  IIIA   ,?a  hasRelapse_Progression  Progression,0.138,0.570247934,0.663461538,138,242,208,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasRelapse_Progression  Progression,0.08,0.597014925,0.769230769,80,134,104,?a
?a  hasStage  IV   ,?a  hasRelapse_Progression  Progression,0.205,0.714285714,0.861344538,205,287,238,?a
?a  hasAgeCategory  Young   ,?a  hasRelapse_Progression  Progression,0.21,0.610465116,0.780669145,210,344,269,?a
?a  hasGender  Male   ,?a  hasRelapse_Progression  Progression,0.466,0.535632184,0.70075188,466,870,665,?a
?a  treatmentType  Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.037,0.528571429,0.660714286,37,70,56,?a
?a  treatmentType  Radiotherapy   ,?a  hasRelapse_Progression  Progression,0.012,0.705882353,0.8,12,17,15,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  Progression,0.1,0.438596491,0.588235294,100,228,170,?a
?a  treatmentType  Chemoradiotherapy_Adjuvant   ,?a  hasRelapse_Progression  Progression,0.012,1,1,12,12,12,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasRelapse_Progression  Progression,0.334,0.545751634,0.695833333,334,612,480,?a
?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.075,0.824175824,0.914634146,75,91,82,?a
?a  treatmentType  Oral_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.019,0.95,0.95,19,20,20,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.12,0.888888889,0.983606557,120,135,122,?a
?a  hasAgeCategory  Old   ,?a  hasRelapse_Progression  Progression,0.468,0.52173913,0.676300578,468,897,692,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.042,0.711864407,0.807692308,42,59,52,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.197,0.775590551,0.86784141,197,254,227,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasRelapse_Progression  Progression,0.263,0.532388664,0.699468085,263,494,376,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  Progression,0.071,0.43030303,0.550387597,71,165,129,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.111,0.810218978,0.948717949,111,137,117,?a
?a  patientDrug  Crizotinib   ,?a  hasRelapse_Progression  Progression,0.018,1,1,18,18,18,?a
?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  Progression,0.098,0.276056338,0.384313725,98,355,255,?a
?a  patientDrug  Gefitinib   ,?a  hasRelapse_Progression  Progression,0.032,0.914285714,1,32,35,32,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.285,0.72519084,0.802816901,285,393,355,?a
?a  patientDrug  Placebo%20Controlled%20Study   ,?a  hasRelapse_Progression  Progression,0.011,0.55,0.578947368,11,20,19,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.084,0.56,0.694214876,84,150,121,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.101,0.737226277,0.7890625,101,137,128,?a
?a  patientDrug  Nintedanib   ,?a  hasRelapse_Progression  Progression,0.018,0.947368421,0.947368421,18,19,19,?a
?a  patientDrug  Atezolizumab   ,?a  hasRelapse_Progression  Progression,0.015,0.75,0.9375,15,20,16,?a
?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.048,0.827586207,0.979591837,48,58,49,?a
?a  patientDrug  Doxorubicin   ,?a  hasRelapse_Progression  Progression,0.057,0.95,0.95,57,60,60,?a
?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.143,0.760638298,0.882716049,143,188,162,?a
?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.102,0.822580645,0.871794872,102,124,117,?a
?a  patientDrug  Bevacizumab   ,?a  hasRelapse_Progression  Progression,0.013,0.722222222,1,13,18,13,?a
?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.052,0.928571429,0.962962963,52,56,54,?a
?a  patientDrug  Topotecan   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.204,0.723404255,0.842975207,204,282,242,?a
?a  patientDrug  Cyclophosphamide   ,?a  hasRelapse_Progression  Progression,0.057,0.95,0.95,57,60,60,?a
?a  patientDrug  Vp-16   ,?a  hasRelapse_Progression  Progression,0.133,0.630331754,0.764367816,133,211,174,?a
?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.213,0.841897233,0.938325991,213,253,227,?a
?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.214,0.63880597,0.775362319,214,335,276,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.411,0.831983806,0.949191686,411,494,433,?a
?a  patientDrug  Alectinib   ,?a  hasRelapse_Progression  Progression,0.011,0.846153846,1,11,13,11,?a
?a  patientDrug  Ipilimumab   ,?a  hasRelapse_Progression  Progression,0.018,0.857142857,0.9,18,21,20,?a
?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.093,0.93,0.96875,93,100,96,?a
?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.214,0.732876712,0.826254826,214,292,259,?a
?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.028,0.848484848,0.965517241,28,33,29,?a
?a  patientDrug  Vincristine   ,?a  hasRelapse_Progression  Progression,0.057,0.95,0.95,57,60,60,?a
?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.044,0.656716418,0.88,44,67,50,?a
?a  patientDrug  Afatinib   ,?a  hasRelapse_Progression  Progression,0.038,0.863636364,0.95,38,44,40,?a
?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.415,0.65664557,0.79047619,415,632,525,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasRelapse_Progression  Progression,0.067,0.663366337,0.905405405,67,101,74,?a
?a  hasBiomarker  ALK_Positive   ,?a  hasRelapse_Progression  Progression,0.027,0.818181818,0.870967742,27,33,31,?a
?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.035,0.777777778,0.945945946,35,45,37,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasRelapse_Progression  Progression,0.061,0.508333333,0.847222222,61,120,72,?a
?a  hasBiomarker  RET_Negative   ,?a  hasRelapse_Progression  Progression,0.032,0.615384615,0.914285714,32,52,35,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasRelapse_Progression  Progression,0.058,0.698795181,0.920634921,58,83,63,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasRelapse_Progression  Progression,0.24,0.64516129,0.85106383,240,372,282,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasRelapse_Progression  Progression,0.161,0.6121673,0.838541667,161,263,192,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasRelapse_Progression  Progression,0.084,0.6,0.857142857,84,140,98,?a
?a  hasGender  Female   ,?a  patientDrug  Vp-16,0.021826729,0.174731183,0.219594595,65,372,296,?a
?a  hasStage  IV   ,?a  patientDrug  Vp-16,0.030557421,0.317073171,0.351351351,91,287,259,?a
?a  hasGender  Male   ,?a  patientDrug  Vp-16,0.049026192,0.167816092,0.219879518,146,870,664,?a
?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Vp-16,0.019476158,0.966666667,0.966666667,58,60,60,?a
?a  patientDrug  Vincristine   ,?a  patientDrug  Vp-16,0.019811954,0.983333333,0.983333333,59,60,60,?a
?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.019140363,0.95,0.95,57,60,60,?a
?a  patientDrug  Carboplatin   ,?a  patientDrug  Vp-16,0.069173942,0.325949367,0.325949367,206,632,632,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Vp-16,0.05003358,0.166109253,0.223388306,149,897,667,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasRelapse_Progression  Progression,0.285,0.672169811,0.843195266,285,424,338,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Vp-16,0.029885829,0.145424837,0.19017094,89,612,468,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Vp-16,0.039288113,0.236842105,0.298469388,117,494,392,?a
?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.019140363,0.814285714,0.876923077,57,70,65,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.038280725,0.448818898,0.475,114,254,240,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Vp-16,0.020819342,0.180232558,0.211604096,62,344,293,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vp-16,0.031229013,0.236641221,0.252717391,93,393,368,?a
?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Vp-16,0.011081263,0.134146341,0.246268657,33,246,134,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vp-16,0.040967092,0.246963563,0.246963563,122,494,494,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Vp-16,0.044660846,0.195876289,0.214170692,133,679,621,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Docetaxel,0.019476158,0.094771242,0.123931624,58,612,468,?a
?a  hasGender  Female   ,?a  patientDrug  Docetaxel,0.010745467,0.086021505,0.108108108,32,372,296,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Docetaxel,0.013431833,0.10178117,0.108695652,40,393,368,?a
?a  hasGender  Male   ,?a  patientDrug  Docetaxel,0.022834117,0.07816092,0.102409639,68,870,664,?a
?a  patientDrug  Nivolumab   ,?a  patientDrug  Docetaxel,0.010073875,0.241935484,0.241935484,30,124,124,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Docetaxel,0.012424446,0.196808511,0.197860963,37,188,187,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.030893217,0.186234818,0.186234818,92,494,494,?a
?a  patientDrug  Cisplatin   ,?a  patientDrug  Docetaxel,0.018804567,0.19858156,0.19858156,56,282,282,?a
?a  patientDrug  Vinorelbine   ,?a  patientDrug  Docetaxel,0.015110813,0.134328358,0.134328358,45,335,335,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Docetaxel,0.010073875,0.102739726,0.102739726,30,292,292,?a
?a  patientDrug  Pemetrexed   ,?a  patientDrug  Docetaxel,0.019811954,0.233201581,0.233201581,59,253,253,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Docetaxel,0.014775017,0.127906977,0.150170648,44,344,293,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Docetaxel,0.022162525,0.177419355,0.20754717,66,372,318,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Docetaxel,0.014439221,0.163498099,0.190265487,43,263,226,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Docetaxel,0.0241773,0.169811321,0.197802198,72,424,364,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Docetaxel,0.031229013,0.136966127,0.149758454,93,679,621,?a
?a  hasGender  Female   ,?a  patientDrug  Paclitaxel,0.030557421,0.244623656,0.307432432,91,372,296,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Paclitaxel,0.018804567,0.245614035,0.370860927,56,228,151,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Paclitaxel,0.038280725,0.230769231,0.290816327,114,494,392,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Paclitaxel,0.05003358,0.243464052,0.318376068,149,612,468,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Paclitaxel,0.017461383,0.204724409,0.216666667,52,254,240,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Paclitaxel,0.011752854,0.259259259,0.284552846,35,135,123,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Paclitaxel,0.010073875,0.218978102,0.218978102,30,137,137,?a
?a  hasGender  Male   ,?a  patientDrug  Paclitaxel,0.067494963,0.231034483,0.302710843,201,870,664,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Paclitaxel,0.018468771,0.333333333,0.341614907,55,165,161,?a
?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Paclitaxel,0.024848892,0.208450704,0.383419689,74,355,193,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.02820685,0.56,0.575342466,84,150,146,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Paclitaxel,0.022498321,0.356382979,0.35828877,67,188,187,?a
?a  hasStage  IIIB   ,?a  patientDrug  Paclitaxel,0.020819342,0.439716312,0.466165414,62,141,133,?a
?a  hasStage  IV   ,?a  patientDrug  Paclitaxel,0.016789792,0.174216028,0.193050193,50,287,259,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.039623909,0.861313869,0.861313869,118,137,137,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.059100067,0.44783715,0.47826087,176,393,368,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.056749496,0.342105263,0.342105263,169,494,494,?a
?a  patientDrug  Nivolumab   ,?a  patientDrug  Paclitaxel,0.019140363,0.459677419,0.459677419,57,124,124,?a
?a  hasStage  IIIA   ,?a  patientDrug  Paclitaxel,0.030557421,0.376033058,0.439613527,91,242,207,?a
?a  patientDrug  Pemetrexed   ,?a  patientDrug  Paclitaxel,0.021826729,0.256916996,0.256916996,65,253,253,?a
?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Paclitaxel,0.01208865,0.146341463,0.268656716,36,246,134,?a
?a  patientDrug  Cisplatin   ,?a  patientDrug  Paclitaxel,0.031564809,0.333333333,0.333333333,94,282,282,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Paclitaxel,0.02820685,0.244186047,0.28668942,84,344,293,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Paclitaxel,0.010073875,0.3,0.3,30,100,100,?a
?a  hasBiomarker  BRAF_Negative   ,?a  patientDrug  Paclitaxel,0.010745467,0.266666667,0.32,32,120,100,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Paclitaxel,0.069845534,0.231884058,0.311844078,208,897,667,?a
?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.080255205,0.378164557,0.378164557,239,632,632,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Paclitaxel,0.034922767,0.279569892,0.327044025,104,372,318,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Paclitaxel,0.021826729,0.247148289,0.287610619,65,263,226,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Paclitaxel,0.071860309,0.315169367,0.344605475,214,679,621,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Paclitaxel,0.041638684,0.29245283,0.340659341,124,424,364,?a
?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.040967092,0.364179104,0.364179104,122,335,335,?a
?a  hasGender  Female   ,?a  patientDrug  Carboplatin,0.061450638,0.491935484,0.618243243,183,372,296,?a
?a  hasStage  IIIB   ,?a  patientDrug  Carboplatin,0.029214238,0.617021277,0.654135338,87,141,133,?a
?a  hasStage  IVA   ,?a  patientDrug  Carboplatin,0.0161182,0.571428571,0.685714286,48,84,70,?a
?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.060107455,0.62369338,0.691119691,179,287,259,?a
?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.024513096,0.608333333,0.663636364,73,120,110,?a
?a  hasGender  Male   ,?a  patientDrug  Carboplatin,0.15077233,0.516091954,0.676204819,449,870,664,?a
?a  hasStage  IIB   ,?a  patientDrug  Carboplatin,0.010745467,0.470588235,0.653061224,32,68,49,?a
?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Carboplatin,0.019476158,0.966666667,0.966666667,58,60,60,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.019476158,0.58,0.58,58,100,100,?a
?a  hasStage  IIIA   ,?a  patientDrug  Carboplatin,0.040631296,0.5,0.584541063,121,242,207,?a
?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.028878442,0.693548387,0.693548387,86,124,124,?a
?a  patientDrug  Vincristine   ,?a  patientDrug  Carboplatin,0.019811954,0.983333333,0.983333333,59,60,60,?a
?a  patientDrug  Doxorubicin   ,?a  patientDrug  Carboplatin,0.019140363,0.95,0.95,57,60,60,?a
?a  patientDrug  Cisplatin   ,?a  patientDrug  Carboplatin,0.021490934,0.226950355,0.226950355,64,282,282,?a
?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.012424446,0.552238806,0.552238806,37,67,67,?a
?a  patientDrug  Gemcitabine   ,?a  patientDrug  Carboplatin,0.011417058,0.607142857,0.607142857,34,56,56,?a
?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.060443251,0.537313433,0.537313433,180,335,335,?a
?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.069173942,0.976303318,0.976303318,206,211,211,?a
?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.057756884,0.679841897,0.679841897,172,253,253,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.080255205,0.818493151,0.818493151,239,292,292,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Carboplatin,0.05809268,0.502906977,0.590443686,173,344,293,?a
?a  hasSmokingHabit  NonSmoker   ,?a  patientDrug  Carboplatin,0.014775017,0.328358209,0.448979592,44,134,98,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Carboplatin,0.107454668,0.522875817,0.683760684,320,612,468,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Carboplatin,0.154130289,0.511705686,0.688155922,459,897,667,?a
?a  treatmentType  Chemotherapy   ,?a  patientDrug  Carboplatin,0.019811954,0.842857143,0.907692308,59,70,65,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Carboplatin,0.02820685,0.368421053,0.556291391,84,228,151,?a
?a  treatmentType  Surgery   ,?a  patientDrug  Carboplatin,0.014775017,0.483516484,0.530120482,44,91,83,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.059435863,0.696850394,0.7375,177,254,240,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.026192075,0.577777778,0.634146341,78,135,123,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.089321692,0.538461538,0.678571429,266,494,392,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  patientDrug  Carboplatin,0.013096038,0.661016949,0.661016949,39,59,59,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Carboplatin,0.018804567,0.408759124,0.408759124,56,137,137,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Carboplatin,0.034251175,0.618181818,0.633540373,102,165,161,?a
?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.043653459,0.366197183,0.67357513,130,355,193,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.085292142,0.646310433,0.690217391,254,393,368,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Carboplatin,0.026192075,0.52,0.534246575,78,150,146,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Carboplatin,0.029885829,0.649635036,0.649635036,89,137,137,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.037944929,0.60106383,0.604278075,113,188,187,?a
?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Carboplatin,0.030893217,0.37398374,0.686567164,92,246,134,?a
?a  hasRelapse_Progression  Relapse   ,?a  patientDrug  Carboplatin,0.014103425,0.56,0.677419355,42,75,62,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.13062458,0.787449393,0.787449393,389,494,494,?a
?a  hasBiomarker  PDL1_Negative   ,?a  patientDrug  Carboplatin,0.022498321,0.663366337,0.736263736,67,101,91,?a
?a  hasBiomarker  BRAF_Negative   ,?a  patientDrug  Carboplatin,0.017461383,0.433333333,0.52,52,120,100,?a
?a  hasBiomarker  EGFR_Positive   ,?a  patientDrug  Carboplatin,0.010073875,0.361445783,0.379746835,30,83,79,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Carboplatin,0.061786434,0.494623656,0.578616352,184,372,318,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.139355272,0.611192931,0.668276973,415,679,621,?a
?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Carboplatin,0.023169913,0.492857143,0.56557377,69,140,122,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Carboplatin,0.042310275,0.479087452,0.557522124,126,263,226,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Carboplatin,0.068502351,0.481132075,0.56043956,204,424,364,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Vinorelbine,0.046339825,0.279352227,0.352040816,138,494,392,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Vinorelbine,0.059100067,0.287581699,0.376068376,176,612,468,?a
?a  hasGender  Female   ,?a  patientDrug  Vinorelbine,0.029214238,0.233870968,0.293918919,87,372,296,?a
?a  hasStage  IIIB   ,?a  patientDrug  Vinorelbine,0.022498321,0.475177305,0.503759398,67,141,133,?a
?a  hasStage  IIB   ,?a  patientDrug  Vinorelbine,0.011081263,0.485294118,0.673469388,33,68,49,?a
?a  hasGender  Male   ,?a  patientDrug  Vinorelbine,0.083277367,0.285057471,0.373493976,248,870,664,?a
?a  patientDrug  Docetaxel   ,?a  patientDrug  Vinorelbine,0.015110813,0.45,0.45,45,100,100,?a
?a  patientDrug  Nivolumab   ,?a  patientDrug  Vinorelbine,0.013767629,0.330645161,0.330645161,41,124,124,?a
?a  patientDrug  Pemetrexed   ,?a  patientDrug  Vinorelbine,0.015446608,0.181818182,0.181818182,46,253,253,?a
?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.063801209,0.673758865,0.673758865,190,282,282,?a
?a  patientDrug  Paclitaxel   ,?a  patientDrug  Vinorelbine,0.040967092,0.417808219,0.417808219,122,292,292,?a
?a  hasAgeCategory  Young   ,?a  patientDrug  Vinorelbine,0.033579584,0.290697674,0.341296928,100,344,293,?a
?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.04432505,0.545454545,0.637681159,132,242,207,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vinorelbine,0.015782404,0.18503937,0.195833333,47,254,240,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Vinorelbine,0.011752854,0.259259259,0.284552846,35,135,123,?a
?a  patientDrug  Carboplatin   ,?a  patientDrug  Vinorelbine,0.060443251,0.284810127,0.284810127,180,632,632,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.031900604,0.416666667,0.629139073,95,228,151,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Vinorelbine,0.012424446,0.270072993,0.270072993,37,137,137,?a
?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.034251175,0.287323944,0.528497409,102,355,193,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.034922767,0.693333333,0.712328767,104,150,146,?a
?a  treatmentType  Immunotherapy   ,?a  patientDrug  Vinorelbine,0.021826729,0.345744681,0.347593583,65,188,187,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.029885829,0.649635036,0.649635036,89,137,137,?a
?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Vinorelbine,0.018132975,0.219512195,0.402985075,54,246,134,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.049697784,0.299595142,0.299595142,148,494,494,?a
?a  hasBiomarker  PDL1_Negative   ,?a  patientDrug  Vinorelbine,0.011081263,0.326732673,0.362637363,33,101,91,?a
?a  hasAgeCategory  Old   ,?a  patientDrug  Vinorelbine,0.078912021,0.261984392,0.352323838,235,897,667,?a
?a  hasBiomarker  BRAF_Negative   ,?a  patientDrug  Vinorelbine,0.0161182,0.4,0.48,48,120,100,?a
?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Vinorelbine,0.071860309,0.315169367,0.344605475,214,679,621,?a
?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Vinorelbine,0.011752854,0.25,0.286885246,35,140,122,?a
?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Vinorelbine,0.035930154,0.287634409,0.336477987,107,372,318,?a
?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Vinorelbine,0.02820685,0.319391635,0.371681416,84,263,226,?a
?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Vinorelbine,0.04197448,0.294811321,0.343406593,125,424,364,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.056749496,0.430025445,0.45923913,169,393,368,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.036937542,0.666666667,0.683229814,110,165,161,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Young,0.032232071,0.298507463,0.298507463,40,134,134,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.135374698,0.340080972,0.340770791,168,494,493,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Young,0.109589041,0.222222222,0.222222222,136,612,612,?a
?a  hasStage  IA   ,?a  hasAgeCategory  Young,0.020145044,0.238095238,0.238095238,25,105,105,?a
?a  hasGender  Male   ,?a  hasAgeCategory  Young,0.161160355,0.229885057,0.230149597,200,870,869,?a
?a  hasStage  IVA   ,?a  hasAgeCategory  Young,0.015310234,0.226190476,0.228915663,19,84,83,?a
?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.116035455,0.387096774,0.387096774,144,372,372,?a
?a  hasStage  IIIB   ,?a  hasAgeCategory  Young,0.037066882,0.326241135,0.326241135,46,141,141,?a
?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.035455278,0.366666667,0.366666667,44,120,120,?a
?a  hasStage  IV   ,?a  hasAgeCategory  Young,0.070910556,0.306620209,0.306620209,88,287,287,?a
?a  hasStage  IIB   ,?a  hasAgeCategory  Young,0.01369863,0.25,0.25,17,68,68,?a
?a  hasStage  IB   ,?a  hasAgeCategory  Young,0.018533441,0.242105263,0.242105263,23,95,95,?a
?a  hasStage  IIIA   ,?a  hasAgeCategory  Young,0.048348106,0.247933884,0.247933884,60,242,242,?a
?a  treatmentType  Chemotherapy   ,?a  hasAgeCategory  Young,0.024174053,0.428571429,0.428571429,30,70,70,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.052377115,0.285087719,0.285087719,65,228,228,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.044319098,0.407407407,0.407407407,55,135,135,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.08622079,0.421259843,0.421259843,107,254,254,?a
?a  treatmentType  Surgery   ,?a  hasAgeCategory  Young,0.017727639,0.241758242,0.241758242,22,91,91,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.04995971,0.452554745,0.452554745,62,137,137,?a
?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Young,0.070910556,0.247887324,0.247887324,88,355,355,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.090249799,0.284987277,0.284987277,112,393,393,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasAgeCategory  Young,0.014504432,0.305084746,0.305084746,18,59,59,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasAgeCategory  Young,0.04109589,0.309090909,0.309090909,51,165,165,?a
?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.055600322,0.367021277,0.367021277,69,188,188,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Young,0.032232071,0.266666667,0.266666667,40,150,150,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.033037873,0.299270073,0.299270073,41,137,137,?a
?a  patientDrug  Cyclophosphamide   ,?a  hasAgeCategory  Young,0.019339243,0.4,0.4,24,60,60,?a
?a  patientDrug  Erlotinib   ,?a  hasAgeCategory  Young,0.016921837,0.362068966,0.362068966,21,58,58,?a
?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.035455278,0.44,0.44,44,100,100,?a
?a  patientDrug  Crizotinib   ,?a  hasAgeCategory  Young,0.010475423,0.722222222,0.722222222,13,18,18,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.124899275,0.313765182,0.313765182,155,494,494,?a
?a  patientDrug  Vincristine   ,?a  hasAgeCategory  Young,0.018533441,0.383333333,0.383333333,23,60,60,?a
?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Young,0.034649476,0.346774194,0.346774194,43,124,124,?a
?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.014504432,0.545454545,0.545454545,18,33,33,?a
?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.024174053,0.447761194,0.447761194,30,67,67,?a
?a  patientDrug  Doxorubicin   ,?a  hasAgeCategory  Young,0.016921837,0.35,0.35,21,60,60,?a
?a  patientDrug  Afatinib   ,?a  hasAgeCategory  Young,0.016921837,0.477272727,0.477272727,21,44,44,?a
?a  patientDrug  Gemcitabine   ,?a  hasAgeCategory  Young,0.014504432,0.321428571,0.321428571,18,56,56,?a
?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Young,0.016921837,0.466666667,0.466666667,21,45,45,?a
?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.095890411,0.421985816,0.421985816,119,282,282,?a
?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Young,0.080580177,0.298507463,0.298507463,100,335,335,?a
?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Young,0.04995971,0.293838863,0.293838863,62,211,211,?a
?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.078162772,0.383399209,0.383399209,97,253,253,?a
?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.067687349,0.287671233,0.287671233,84,292,292,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Young,0.044319098,0.223577236,0.223577236,55,246,246,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasAgeCategory  Young,0.01369863,0.226666667,0.226666667,17,75,75,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasAgeCategory  Young,0.029008864,0.356435644,0.356435644,36,101,101,?a
?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Young,0.139403707,0.273734177,0.273734177,173,632,632,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasAgeCategory  Young,0.026591459,0.275,0.275,33,120,120,?a
?a  hasBiomarker  ALK_Positive   ,?a  hasAgeCategory  Young,0.01369863,0.515151515,0.515151515,17,33,33,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasAgeCategory  Young,0.093473006,0.311827957,0.311827957,116,372,372,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasAgeCategory  Young,0.033843674,0.3,0.3,42,140,140,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasAgeCategory  Young,0.023368251,0.34939759,0.34939759,29,83,83,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasAgeCategory  Young,0.111200645,0.325471698,0.325471698,138,424,424,?a
?a  hasBiomarker  RET_Negative   ,?a  hasAgeCategory  Young,0.011281225,0.269230769,0.269230769,14,52,52,?a
?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.169218372,0.309278351,0.309734513,210,679,678,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Young,0.070910556,0.33460076,0.33460076,88,263,263,?a
?a  hasGender  Female   ,?a  hasAgeCategory  Old,0.183722804,0.612903226,0.612903226,228,372,372,?a
?a  hasStage  IIA   ,?a  hasAgeCategory  Old,0.031426269,0.764705882,0.764705882,39,51,51,?a
?a  hasStage  IA   ,?a  hasAgeCategory  Old,0.064464142,0.761904762,0.761904762,80,105,105,?a
?a  hasStage  IIIC   ,?a  hasAgeCategory  Old,0.012892828,0.842105263,0.842105263,16,19,19,?a
?a  hasGender  Male   ,?a  hasAgeCategory  Old,0.539081386,0.768965517,0.769850403,669,870,869,?a
?a  hasStage  IVA   ,?a  hasAgeCategory  Old,0.051571313,0.761904762,0.771084337,64,84,83,?a
?a  hasStage  IIIB   ,?a  hasAgeCategory  Old,0.076551168,0.673758865,0.673758865,95,141,141,?a
?a  hasStage  IVB   ,?a  hasAgeCategory  Old,0.061240935,0.633333333,0.633333333,76,120,120,?a
?a  hasStage  IV   ,?a  hasAgeCategory  Old,0.160354553,0.693379791,0.693379791,199,287,287,?a
?a  hasStage  IIB   ,?a  hasAgeCategory  Old,0.04109589,0.75,0.75,51,68,68,?a
?a  hasStage  IIIA   ,?a  hasAgeCategory  Old,0.146655923,0.752066116,0.752066116,182,242,242,?a
?a  hasStage  IB   ,?a  hasAgeCategory  Old,0.058017728,0.757894737,0.757894737,72,95,95,?a
?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Old,0.075745367,0.701492537,0.701492537,94,134,134,?a
?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.383561644,0.777777778,0.777777778,476,612,612,?a
?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Old,0.261885576,0.657894737,0.659229209,325,494,493,?a
?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Old,0.064464142,0.592592593,0.592592593,80,135,135,?a
?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Old,0.118452861,0.578740157,0.578740157,147,254,254,?a
?a  treatmentType  Chemotherapy   ,?a  hasAgeCategory  Old,0.032232071,0.571428571,0.571428571,40,70,70,?a
?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Old,0.131345689,0.714912281,0.714912281,163,228,228,?a
?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.055600322,0.758241758,0.758241758,69,91,91,?a
?a  treatmentType  Sequential_Chemoradiation   ,?a  hasAgeCategory  Old,0.033037873,0.694915254,0.694915254,41,59,59,?a
?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.215149073,0.752112676,0.752112676,267,355,355,?a
?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Old,0.060435133,0.547445255,0.547445255,75,137,137,?a
?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.226430298,0.715012723,0.715012723,281,393,393,?a
?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasAgeCategory  Old,0.091861402,0.690909091,0.690909091,114,165,165,?a
?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.088638195,0.733333333,0.733333333,110,150,150,?a
?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.095890411,0.632978723,0.632978723,119,188,188,?a
?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.07735697,0.700729927,0.700729927,96,137,137,?a
?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.153908139,0.776422764,0.776422764,191,246,246,?a
?a  hasRelapse_Progression  Relapse   ,?a  hasAgeCategory  Old,0.046736503,0.773333333,0.773333333,58,75,75,?a
?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.273166801,0.686234818,0.686234818,339,494,494,?a
?a  patientDrug  Cyclophosphamide   ,?a  hasAgeCategory  Old,0.029008864,0.6,0.6,36,60,60,?a
?a  patientDrug  Erlotinib   ,?a  hasAgeCategory  Old,0.029814666,0.637931034,0.637931034,37,58,58,?a
?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Old,0.37711523,0.689248895,0.690265487,468,679,678,?a
?a  patientDrug  Durvalumab   ,?a  hasAgeCategory  Old,0.012087027,0.714285714,0.714285714,15,21,21,?a
?a  patientDrug  Vincristine   ,?a  hasAgeCategory  Old,0.029814666,0.616666667,0.616666667,37,60,60,?a
?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Old,0.029814666,0.552238806,0.552238806,37,67,67,?a
?a  patientDrug  Other   ,?a  hasAgeCategory  Old,0.012087027,0.454545455,0.454545455,15,33,33,?a
?a  patientDrug  Gefitinib   ,?a  hasAgeCategory  Old,0.018533441,0.657142857,0.657142857,23,35,35,?a
?a  patientDrug  Doxorubicin   ,?a  hasAgeCategory  Old,0.031426269,0.65,0.65,39,60,60,?a
?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Old,0.045124899,0.56,0.56,56,100,100,?a
?a  patientDrug  Atezolizumab   ,?a  hasAgeCategory  Old,0.010475423,0.65,0.65,13,20,20,?a
?a  patientDrug  Afatinib   ,?a  hasAgeCategory  Old,0.018533441,0.522727273,0.522727273,23,44,44,?a
?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Old,0.019339243,0.533333333,0.533333333,24,45,45,?a
?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Old,0.131345689,0.578014184,0.578014184,163,282,282,?a
?a  patientDrug  Gemcitabine   ,?a  hasAgeCategory  Old,0.030620467,0.678571429,0.678571429,38,56,56,?a
?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Old,0.120064464,0.706161137,0.706161137,149,211,211,?a
?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.189363417,0.701492537,0.701492537,235,335,335,?a
?a  hasBiomarker  PDL1_Negative   ,?a  hasAgeCategory  Old,0.052377115,0.643564356,0.643564356,65,101,101,?a
?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Old,0.125705077,0.616600791,0.616600791,156,253,253,?a
?a  hasBiomarker  ALK_Positive   ,?a  hasAgeCategory  Old,0.012892828,0.484848485,0.484848485,16,33,33,?a
?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.167606769,0.712328767,0.712328767,208,292,292,?a
?a  hasBiomarker  BRAF_Negative   ,?a  hasAgeCategory  Old,0.070104754,0.725,0.725,87,120,120,?a
?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.065269944,0.653225806,0.653225806,81,124,124,?a
?a  hasBiomarker  ALK_Negative   ,?a  hasAgeCategory  Old,0.206285254,0.688172043,0.688172043,256,372,372,?a
?a  hasBiomarker  RET_Negative   ,?a  hasAgeCategory  Old,0.030620467,0.730769231,0.730769231,38,52,52,?a
?a  hasBiomarker  EGFR_Positive   ,?a  hasAgeCategory  Old,0.043513296,0.65060241,0.65060241,54,83,83,?a
?a  hasBiomarker  PDL1_Positive   ,?a  hasAgeCategory  Old,0.078968574,0.7,0.7,98,140,140,?a
?a  hasBiomarker  EGFR_Negative   ,?a  hasAgeCategory  Old,0.230459307,0.674528302,0.674528302,286,424,424,?a
?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.369863014,0.726265823,0.726265823,459,632,632,?a
?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Old,0.14101531,0.66539924,0.66539924,175,263,263,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Negative,0.01242236,0.240963855,0.240963855,20,83,83,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.013664596,0.109452736,0.23655914,22,201,93,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Negative,0.014906832,0.24,0.24,24,100,100,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Negative,0.014906832,0.208695652,0.208695652,24,115,115,?a
?a  hasStage  IVB  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Negative,0.014285714,0.315068493,0.450980392,23,73,51,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Negative,0.01242236,0.27027027,0.37037037,20,74,54,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Negative,0.011180124,0.107142857,0.257142857,18,168,70,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Negative,0.01552795,0.07082153,0.203252033,25,353,123,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Negative,0.016149068,0.097744361,0.288888889,26,266,90,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Negative,0.011180124,0.236842105,0.339622642,18,76,53,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Negative,0.014906832,0.091254753,0.196721311,24,263,122,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Negative,0.01242236,0.277777778,0.277777778,20,72,72,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Negative,0.021118012,0.259541985,0.259541985,34,131,131,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Negative,0.01242236,0.240963855,0.327868852,20,83,61,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Negative,0.014285714,0.261363636,0.261363636,23,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Negative,0.010559006,0.346938776,0.346938776,17,49,49,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.022981366,0.303278689,0.303278689,37,122,122,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Negative,0.019254658,0.316326531,0.316326531,31,98,98,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Negative,0.02484472,0.317460317,0.317460317,40,126,126,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Negative,0.011180124,0.219512195,0.219512195,18,82,82,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.014285714,0.310810811,0.450980392,23,74,51,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Negative,0.038509317,0.251012146,0.251012146,62,247,247,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Negative,0.013043478,0.106598985,0.223404255,21,197,94,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Negative,0.010559006,0.386363636,0.5,17,44,34,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Negative,0.021118012,0.18579235,0.18579235,34,183,183,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Negative,0.010559006,0.113333333,0.303571429,17,150,56,?a
?a  hasGender  Male  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Negative,0.016770186,0.212598425,0.290322581,27,127,93,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Negative,0.01242236,0.338983051,0.425531915,20,59,47,?a
?a  hasGender  Male  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Negative,0.014906832,0.266666667,0.363636364,24,90,66,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Negative,0.016770186,0.163636364,0.198529412,27,165,136,?a
?a  hasGender  Male  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.030434783,0.138418079,0.247474747,49,354,198,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Negative,0.014285714,0.182539683,0.212962963,23,126,108,?a
?a  hasGender  Male  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  PDL1_Negative,0.017391304,0.112903226,0.222222222,28,248,126,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  hasBiomarker  PDL1_Negative,0.014285714,0.115,0.234693878,23,200,98,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Negative,0.027329193,0.093023256,0.205607477,44,473,214,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.027329193,0.231578947,0.231578947,44,190,190,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Negative,0.013043478,0.104477612,0.205882353,21,201,102,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Negative,0.011180124,0.18556701,0.230769231,18,97,78,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  PDL1_Negative,0.030434783,0.105150215,0.198380567,49,466,247,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  PDL1_Negative,0.018012422,0.25,0.25,29,116,116,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Negative,0.013043478,0.338709677,0.338709677,21,62,62,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Negative,0.024223602,0.121875,0.265306122,39,320,147,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Negative,0.014906832,0.230769231,0.230769231,24,104,104,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Negative,0.032298137,0.115812918,0.279569892,52,449,186,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Negative,0.026086957,0.222222222,0.222222222,42,189,189,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.022981366,0.148,0.24025974,37,250,154,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Negative,0.029813665,0.260869565,0.260869565,48,184,184,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Negative,0.026086957,0.088235294,0.207920792,42,476,202,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.014906832,0.15483871,0.24,24,155,100,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  PDL1_Negative,0.01863354,0.142857143,0.230769231,30,210,130,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Negative,0.022981366,0.232704403,0.232704403,37,159,159,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Negative,0.010559006,0.096590909,0.188888889,17,176,90,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  PDL1_Negative,0.010559006,0.175257732,0.2125,17,97,80,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  PDL1_Negative,0.01552795,0.11682243,0.187969925,25,214,133,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Negative,0.01552795,0.144508671,0.3125,25,173,80,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Negative,0.013043478,0.185840708,0.2625,21,113,80,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.014906832,0.208695652,0.263736264,24,115,91,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Negative,0.010559006,0.186813187,0.226666667,17,91,75,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Negative,0.016149068,0.181818182,0.247619048,26,143,105,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Negative,0.01552795,0.11682243,0.19379845,25,214,129,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.014285714,0.264367816,0.333333333,23,87,69,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Negative,0.01242236,0.23255814,0.357142857,20,86,56,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.032298137,0.133676093,0.252427184,52,389,206,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  PDL1_Negative,0.01552795,0.138888889,0.252525253,25,180,99,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.013043478,0.617647059,0.807692308,21,34,26,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.026708075,0.304964539,0.304964539,43,141,141,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.01552795,0.177304965,0.396825397,25,141,63,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Positive,0.013664596,0.392857143,0.392857143,22,56,56,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Negative,0.014285714,0.155405405,0.244680851,23,148,94,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.013043478,0.428571429,0.567567568,21,49,37,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.02484472,0.4,0.4,40,100,100,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  PDL1_Positive,0.014285714,0.136904762,0.328571429,23,168,70,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.013664596,0.431372549,0.628571429,22,51,35,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.019254658,0.360465116,0.516666667,31,86,60,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  PDL1_Positive,0.034782609,0.117647059,0.277227723,56,476,202,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.024223602,0.121875,0.265306122,39,320,147,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  PDL1_Positive,0.023602484,0.339285714,0.339285714,38,112,112,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Positive,0.010559006,0.246376812,0.34,17,69,50,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  PDL1_Positive,0.01242236,0.134228188,0.253164557,20,149,79,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.011180124,0.692307692,0.692307692,18,26,26,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  PDL1_Positive,0.058385093,0.282282282,0.282282282,94,333,333,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.011180124,0.72,0.72,18,25,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.013043478,0.403846154,0.403846154,21,52,52,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.013043478,0.338709677,0.338709677,21,62,62,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.013664596,0.305555556,0.305555556,22,72,72,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  PDL1_Positive,0.022360248,0.310344828,0.310344828,36,116,116,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.027329193,0.382608696,0.382608696,44,115,115,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.014285714,0.5,0.5,23,46,46,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.025465839,0.602941176,0.602941176,41,68,68,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.030434783,0.471153846,0.471153846,49,104,104,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.026708075,0.518072289,0.518072289,43,83,83,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.014285714,0.5,0.605263158,23,46,38,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.031055901,0.27173913,0.27173913,50,184,184,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.014285714,0.159722222,0.283950617,23,144,81,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.017391304,0.459016393,0.571428571,28,61,49,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.022360248,0.8,0.8,36,45,45,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  PDL1_Positive,0.02484472,0.305343511,0.305343511,40,131,131,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.01552795,0.581395349,0.581395349,25,43,43,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Positive,0.022360248,0.409090909,0.409090909,36,88,88,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.013664596,0.448979592,0.448979592,22,49,49,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  PDL1_Positive,0.011180124,0.418604651,0.418604651,18,43,43,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  PDL1_Positive,0.059006211,0.400843882,0.400843882,95,237,237,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.016149068,0.142076503,0.292134831,26,183,89,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.029813665,0.623376623,0.623376623,48,77,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.013664596,0.511627907,0.511627907,22,43,43,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.026086957,0.626865672,0.626865672,42,67,67,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.014285714,0.389830508,0.489361702,23,59,47,?a
?a  hasStage  IVA  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.011180124,0.545454545,0.620689655,18,33,29,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.02484472,0.666666667,0.666666667,40,60,60,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  hasBiomarker  PDL1_Positive,0.01863354,0.394736842,0.566037736,30,76,53,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.021118012,0.829268293,0.829268293,34,41,41,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.014285714,0.676470588,0.766666667,23,34,30,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.01242236,0.869565217,0.869565217,20,23,23,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.014906832,0.375,0.489795918,24,64,49,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  hasBiomarker  PDL1_Positive,0.014906832,0.387096774,0.510638298,24,62,47,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.013664596,0.268292683,0.268292683,22,82,82,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.032919255,0.460869565,0.460869565,53,115,115,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  PDL1_Positive,0.01242236,0.074906367,0.25974026,20,267,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.033540373,0.264705882,0.264705882,54,204,204,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.01242236,0.540540541,0.8,20,37,25,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  PDL1_Positive,0.010559006,0.130769231,0.298245614,17,130,57,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.025465839,0.344537815,0.460674157,41,119,89,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Positive,0.013043478,0.259259259,0.362068966,21,81,58,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  PDL1_Positive,0.010559006,0.404761905,0.515151515,17,42,33,?a
?a  hasGender  Male  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  PDL1_Positive,0.013664596,0.511627907,0.75862069,22,43,29,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  PDL1_Positive,0.032298137,0.11328976,0.266666667,52,459,195,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  PDL1_Positive,0.01242236,0.118343195,0.224719101,20,169,89,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.011180124,0.195652174,0.230769231,18,92,78,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.033540373,0.131386861,0.220408163,54,411,245,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  PDL1_Positive,0.013664596,0.148648649,0.234042553,22,148,94,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  PDL1_Positive,0.018012422,0.707317073,0.852941176,29,41,34,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.272727273,0.272727273,18,66,66,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  PDL1_Positive,0.01863354,0.166666667,0.303030303,30,180,99,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Positive,0.014285714,0.225490196,0.310810811,23,102,74,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  PDL1_Positive,0.011180124,0.209302326,0.321428571,18,86,56,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  BRAF_Negative,0.034161491,0.352564103,0.352564103,55,156,156,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  BRAF_Negative,0.024223602,0.12,0.336206897,39,325,116,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  BRAF_Negative,0.026086957,0.11898017,0.341463415,42,353,123,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.01242236,0.208333333,0.526315789,20,96,38,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  BRAF_Negative,0.032298137,0.368794326,0.368794326,52,141,141,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.014285714,0.166666667,0.365079365,23,138,63,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  BRAF_Negative,0.031055901,0.5,0.5,50,100,100,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  hasBiomarker  BRAF_Negative,0.010559006,0.168316832,0.435897436,17,101,39,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.418604651,0.418604651,18,43,43,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.109090909,0.310344828,18,165,58,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  BRAF_Negative,0.01242236,0.161290323,0.317460317,20,124,63,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.391304348,0.391304348,18,46,46,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  BRAF_Negative,0.029813665,0.941176471,0.941176471,48,51,51,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  BRAF_Negative,0.054037267,0.483333333,0.483333333,87,180,180,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  BRAF_Negative,0.019875776,0.551724138,0.551724138,32,58,58,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  BRAF_Negative,0.065838509,0.447257384,0.447257384,106,237,237,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  BRAF_Negative,0.067701863,0.441295547,0.441295547,109,247,247,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  BRAF_Negative,0.013664596,0.314285714,0.314285714,22,70,70,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.580645161,0.580645161,18,31,31,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  BRAF_Negative,0.049689441,0.457142857,0.457142857,80,175,175,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.022360248,0.642857143,0.642857143,36,56,56,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  BRAF_Negative,0.01863354,0.461538462,0.461538462,30,65,65,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.020496894,0.485294118,0.485294118,33,68,68,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  BRAF_Negative,0.014906832,0.648648649,0.648648649,24,37,37,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  BRAF_Negative,0.023602484,0.361904762,0.361904762,38,105,105,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  BRAF_Negative,0.064596273,0.312312312,0.312312312,104,333,333,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.346153846,0.346153846,18,52,52,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.027950311,0.535714286,0.535714286,45,84,84,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  BRAF_Negative,0.019254658,0.397435897,0.397435897,31,78,78,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  BRAF_Negative,0.01552795,0.367647059,0.367647059,25,68,68,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  hasBiomarker  BRAF_Negative,0.010559006,0.223684211,0.320754717,17,76,53,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  BRAF_Negative,0.02173913,0.346534653,0.346534653,35,101,101,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  BRAF_Negative,0.029813665,0.941176471,0.941176471,48,51,51,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasBiomarker  BRAF_Negative,0.016770186,0.321428571,0.321428571,27,84,84,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  BRAF_Negative,0.052173913,0.326848249,0.326848249,84,257,257,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  BRAF_Negative,0.013043478,0.304347826,0.304347826,21,69,69,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.022360248,0.486486486,0.486486486,36,74,74,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  BRAF_Negative,0.014906832,0.4,0.4,24,60,60,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  hasBiomarker  BRAF_Negative,0.01242236,0.27027027,0.37037037,20,74,54,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.019875776,0.316831683,0.316831683,32,101,101,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  BRAF_Negative,0.014906832,0.470588235,0.470588235,24,51,51,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  BRAF_Negative,0.010559006,0.361702128,0.361702128,17,47,47,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  BRAF_Negative,0.049068323,0.30859375,0.30859375,79,256,256,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.4,0.4,18,45,45,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  hasBiomarker  BRAF_Negative,0.044720497,0.107623318,0.266666667,72,669,270,?a
?a  hasGender  Male  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  BRAF_Negative,0.013043478,0.1875,0.42,21,112,50,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.016149068,0.097378277,0.257425743,26,267,101,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.027329193,0.411214953,0.411214953,44,107,107,?a
?a  hasGender  Male  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.022360248,0.14516129,0.285714286,36,248,126,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  BRAF_Negative,0.054037267,0.296928328,0.296928328,87,293,293,?a
?a  hasGender  Male  ?a  hasStage  IIIA   ,?a  hasBiomarker  BRAF_Negative,0.017391304,0.16091954,0.368421053,28,174,76,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  BRAF_Negative,0.019254658,0.348314607,0.348314607,31,89,89,?a
?a  hasGender  Male  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.020496894,0.192982456,0.471428571,33,171,70,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  BRAF_Negative,0.013043478,1,1,21,21,21,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.014285714,0.280487805,0.425925926,23,82,54,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  hasBiomarker  BRAF_Negative,0.016149068,0.142857143,0.325,26,182,80,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.014285714,0.174242424,0.319444444,23,132,72,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.013043478,0.265822785,0.42,21,79,50,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  BRAF_Negative,0.028571429,0.958333333,0.958333333,46,48,48,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  BRAF_Negative,0.013664596,0.956521739,0.956521739,22,23,23,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.014906832,0.96,0.96,24,25,25,?a
?a  hasBiomarker  RET_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  BRAF_Negative,0.01863354,0.9375,0.9375,30,32,32,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.022360248,0.428571429,0.428571429,36,84,84,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.017391304,0.171779141,0.424242424,28,163,66,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  BRAF_Negative,0.020496894,0.970588235,0.970588235,33,34,34,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.010559006,1,1,17,17,17,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  BRAF_Negative,0.011180124,1,1,18,18,18,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  BRAF_Negative,0.022360248,0.947368421,0.947368421,36,38,38,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.021118012,0.272,0.272,34,125,125,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  BRAF_Negative,0.019875776,0.1,0.217687075,32,320,147,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.133333333,0.225,18,135,80,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.01552795,0.142045455,0.277777778,25,176,90,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  BRAF_Negative,0.01863354,0.106761566,0.267857143,30,281,112,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  BRAF_Negative,0.014906832,0.147239264,0.252631579,24,163,95,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  BRAF_Negative,0.051552795,0.29020979,0.29020979,83,286,286,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  BRAF_Negative,0.01552795,0.120192308,0.229357798,25,208,109,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  BRAF_Negative,0.010559006,0.314814815,0.314814815,17,54,54,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  BRAF_Negative,0.011180124,0.367346939,0.367346939,18,49,49,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  BRAF_Negative,0.01552795,0.423728814,0.423728814,25,59,59,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.022981366,0.157446809,0.305785124,37,235,121,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.01863354,0.157894737,0.291262136,30,190,103,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.027950311,0.36,0.36,45,125,125,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  BRAF_Negative,0.011801242,0.25,0.452380952,19,76,42,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  BRAF_Negative,0.01242236,0.163934426,0.303030303,20,122,66,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  BRAF_Negative,0.011801242,0.172727273,0.365384615,19,110,52,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.326086957,0.326086957,15,46,46,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.168674699,0.168674699,14,83,83,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  hasSmokingHabit  NonSmoker,0.022580645,0.311111111,0.311111111,28,90,90,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVB   ,?a  hasSmokingHabit  NonSmoker,0.010483871,0.65,0.65,13,20,20,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  hasSmokingHabit  NonSmoker,0.052419355,0.285087719,0.285087719,65,228,228,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  hasSmokingHabit  NonSmoker,0.014516129,0.138461538,0.138461538,18,130,130,?a
?a  hasStage  IVB  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.652173913,0.652173913,15,23,23,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  hasSmokingHabit  NonSmoker,0.010483871,0.194029851,0.194029851,13,67,67,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.25,0.25,14,56,56,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  hasSmokingHabit  NonSmoker,0.023387097,0.141463415,0.142857143,29,205,203,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Female   ,?a  hasSmokingHabit  NonSmoker,0.027419355,0.653846154,0.653846154,34,52,52,?a
?a  hasStage  IV  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  NonSmoker,0.022580645,0.482758621,0.482758621,28,58,58,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  NonSmoker,0.013709677,0.161904762,0.161904762,17,105,105,?a
?a  hasGender  Female  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  NonSmoker,0.035483871,0.611111111,0.611111111,44,72,72,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  NonSmoker,0.020967742,0.295454545,0.295454545,26,88,88,?a
?a  hasGender  Female  ?a  patientDrug  Erlotinib   ,?a  hasSmokingHabit  NonSmoker,0.012903226,0.516129032,0.516129032,16,31,31,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasSmokingHabit  NonSmoker,0.02016129,0.301204819,0.301204819,25,83,83,?a
?a  hasGender  Female  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.263157895,0.263157895,15,57,57,?a
?a  hasGender  Female  ?a  patientDrug  Afatinib   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.608695652,0.608695652,14,23,23,?a
?a  hasGender  Female  ?a  patientDrug  Osimertinib   ,?a  hasSmokingHabit  NonSmoker,0.013709677,0.607142857,0.607142857,17,28,28,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasSmokingHabit  NonSmoker,0.024193548,0.260869565,0.260869565,30,115,115,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasSmokingHabit  NonSmoker,0.029032258,0.27480916,0.27480916,36,131,131,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  NonSmoker,0.048387097,0.281690141,0.281690141,60,213,213,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  NonSmoker,0.015322581,0.137681159,0.137681159,19,138,138,?a
?a  hasGender  Female  ?a  patientDrug  Gefitinib   ,?a  hasSmokingHabit  NonSmoker,0.010483871,0.590909091,0.590909091,13,22,22,?a
?a  hasStage  IIIA  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  NonSmoker,0.010483871,0.125,0.125,13,104,104,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.117647059,0.117647059,14,119,119,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.14,0.14,14,100,100,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  NonSmoker,0.026612903,0.123595506,0.123595506,33,267,267,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.482758621,0.482758621,14,29,29,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  NonSmoker,0.012903226,0.108843537,0.110344828,16,147,145,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  NonSmoker,0.020967742,0.123809524,0.123809524,26,210,210,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  NonSmoker,0.012903226,0.133333333,0.133333333,16,120,120,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  NonSmoker,0.015322581,0.122580645,0.122580645,19,155,155,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  NonSmoker,0.032258065,0.533333333,0.533333333,40,75,75,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  NonSmoker,0.019354839,0.153846154,0.153846154,24,156,156,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Erlotinib   ,?a  hasSmokingHabit  NonSmoker,0.015322581,0.513513514,0.513513514,19,37,37,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  hasSmokingHabit  NonSmoker,0.025806452,0.125,0.125,32,256,256,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Afatinib   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.652173913,0.652173913,15,23,23,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.153061224,0.153061224,15,98,98,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Osimertinib   ,?a  hasSmokingHabit  NonSmoker,0.013709677,0.708333333,0.708333333,17,24,24,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Positive   ,?a  hasSmokingHabit  NonSmoker,0.02983871,0.685185185,0.685185185,37,54,54,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.111111111,0.111111111,15,135,135,?a
?a  hasBiomarker  ALK_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.7,0.7,14,20,20,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  NonSmoker,0.018548387,0.534883721,0.534883721,23,43,43,?a
?a  hasBiomarker  ALK_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.555555556,0.555555556,15,27,27,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.120967742,0.120967742,15,124,124,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  hasSmokingHabit  NonSmoker,0.015322581,0.633333333,0.633333333,19,30,30,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Erlotinib   ,?a  hasSmokingHabit  NonSmoker,0.017741935,0.458333333,0.458333333,22,48,48,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.13592233,0.13592233,14,103,103,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  NonSmoker,0.029032258,0.126315789,0.126315789,36,285,285,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  NonSmoker,0.012903226,0.64,0.64,16,25,25,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  NonSmoker,0.025806452,0.150234742,0.150234742,32,213,213,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Erlotinib   ,?a  hasSmokingHabit  NonSmoker,0.010483871,0.722222222,0.722222222,13,18,18,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  NonSmoker,0.016129032,0.124223602,0.124223602,20,161,161,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  NonSmoker,0.02016129,0.12254902,0.12254902,25,204,204,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  NonSmoker,0.012096774,0.681818182,0.681818182,15,22,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Gefitinib   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.636363636,0.636363636,14,22,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  NonSmoker,0.011290323,0.100719424,0.100719424,14,139,139,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  NonSmoker,0.019354839,0.10041841,0.10041841,24,239,239,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  NonSmoker,0.02016129,0.145348837,0.145348837,25,172,172,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasSmokingHabit  NonSmoker,0.019354839,0.615384615,0.615384615,24,39,39,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.016770186,0.529411765,0.771428571,27,51,35,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ROS1_Negative,0.066459627,0.226215645,0.5,107,473,214,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.011801242,0.211111111,0.527777778,19,90,36,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ROS1_Negative,0.033540373,0.964285714,0.964285714,54,56,56,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.014285714,0.522727273,0.676470588,23,44,34,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.01242236,0.666666667,0.869565217,20,30,23,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ROS1_Negative,0.016770186,0.140625,0.519230769,27,192,52,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.032919255,0.420634921,0.490740741,53,126,108,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ROS1_Negative,0.011801242,0.95,0.95,19,20,20,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ROS1_Negative,0.033540373,0.818181818,0.818181818,54,66,66,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ROS1_Negative,0.014285714,0.638888889,0.638888889,23,36,36,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.019254658,0.815789474,0.815789474,31,38,38,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.044099379,0.221875,0.482993197,71,320,147,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.014906832,0.666666667,0.666666667,24,36,36,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ROS1_Negative,0.038509317,0.826666667,0.826666667,62,75,75,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.01242236,0.689655172,0.689655172,20,29,29,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ROS1_Negative,0.031677019,1,1,51,51,51,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ROS1_Negative,0.029813665,1,1,48,48,48,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.010559006,0.772727273,0.772727273,17,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.02484472,0.740740741,0.740740741,40,54,54,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.058385093,0.930693069,0.930693069,94,101,101,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ROS1_Negative,0.029813665,1,1,48,48,48,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.733333333,0.733333333,22,30,30,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.010559006,1,1,17,17,17,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.026086957,0.807692308,0.807692308,42,52,52,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.011180124,1,1,18,18,18,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.022360248,0.857142857,0.857142857,36,42,42,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.814814815,0.814814815,22,27,27,?a
?a  hasBiomarker  RET_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.016149068,1,1,26,26,26,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.027950311,0.737704918,0.737704918,45,61,61,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ROS1_Negative,0.014285714,1,1,23,23,23,?a
?a  hasBiomarker  RET_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ROS1_Negative,0.019875776,1,1,32,32,32,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.021118012,1,1,34,34,34,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.059006211,0.904761905,0.904761905,95,105,105,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  hasBiomarker  ROS1_Negative,0.026708075,0.767857143,0.767857143,43,56,56,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.01552795,0.78125,0.78125,25,32,32,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.022360248,0.837209302,0.837209302,36,43,43,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.019254658,0.525423729,0.659574468,31,59,47,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  ROS1_Negative,0.013043478,1,1,21,21,21,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.029813665,0.738461538,0.738461538,48,65,65,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.014285714,0.479166667,0.657142857,23,48,35,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.022360248,0.857142857,0.857142857,36,42,42,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.75862069,0.75862069,22,29,29,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ROS1_Negative,0.023602484,0.95,0.95,38,40,40,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.02484472,0.869565217,0.869565217,40,46,46,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.011180124,0.947368421,0.947368421,18,19,19,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ROS1_Negative,0.067701863,0.981981982,0.981981982,109,111,111,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ROS1_Negative,0.137888199,0.666666667,0.666666667,222,333,333,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.040372671,0.955882353,0.955882353,65,68,68,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.011801242,0.730769231,0.791666667,19,26,24,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIB   ,?a  hasBiomarker  ROS1_Negative,0.014906832,0.75,0.75,24,32,32,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.021118012,0.871794872,0.871794872,34,39,39,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIB   ,?a  hasBiomarker  ROS1_Negative,0.011801242,0.2,0.475,19,95,40,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  hasBiomarker  ROS1_Negative,0.019875776,0.5,0.653061224,32,64,49,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.061490683,0.70212766,0.70212766,99,141,141,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  ROS1_Negative,0.106832298,0.6692607,0.6692607,172,257,257,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  ROS1_Negative,0.034782609,0.717948718,0.717948718,56,78,78,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.034161491,0.743243243,0.743243243,55,74,74,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.022981366,0.725490196,0.725490196,37,51,51,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.044099379,0.682692308,0.682692308,71,104,104,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.02484472,0.888888889,0.888888889,40,45,45,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  ROS1_Negative,0.050310559,0.698275862,0.698275862,81,116,116,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.050310559,0.757009346,0.757009346,81,107,107,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.019875776,0.711111111,0.711111111,32,45,45,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  ROS1_Negative,0.016149068,0.722222222,0.722222222,26,36,36,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ROS1_Negative,0.065838509,0.946428571,0.946428571,106,112,112,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.060869565,0.628205128,0.628205128,98,156,156,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  ROS1_Negative,0.104347826,0.57337884,0.57337884,168,293,293,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  ROS1_Negative,0.032298137,0.584269663,0.584269663,52,89,89,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ROS1_Negative,0.048447205,0.565217391,0.565217391,78,138,138,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.036024845,0.966666667,0.966666667,58,60,60,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.045962733,0.643478261,0.643478261,74,115,115,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.031677019,0.607142857,0.607142857,51,84,84,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.021118012,0.576271186,0.576271186,34,59,59,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.021118012,0.241134752,0.53968254,34,141,63,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.025465839,0.836734694,0.836734694,41,49,49,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.048447205,0.624,0.624,78,125,125,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  ROS1_Negative,0.016770186,0.613636364,0.613636364,27,44,44,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.073291925,0.578431373,0.578431373,118,204,204,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.01242236,0.571428571,0.8,20,35,25,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.018012422,0.475409836,0.591836735,29,61,49,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.021118012,0.829268293,0.871794872,34,41,39,?a
?a  hasGender  Female  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ROS1_Negative,0.011801242,0.168141593,0.475,19,113,40,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.026086957,0.567567568,0.777777778,42,74,54,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.014906832,0.705882353,0.8,24,34,30,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.016770186,0.551020408,0.72972973,27,49,37,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.016149068,1,1,26,26,26,?a
?a  hasGender  Male  ?a  hasStage  IIIA   ,?a  hasBiomarker  ROS1_Negative,0.027950311,0.25862069,0.592105263,45,174,76,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasBiomarker  ROS1_Negative,0.01863354,0.681818182,0.769230769,30,44,39,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ROS1_Negative,0.025465839,0.244047619,0.585714286,41,168,70,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.956521739,0.956521739,22,23,23,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  hasBiomarker  ROS1_Negative,0.016149068,0.257425743,0.666666667,26,101,39,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ROS1_Negative,0.016149068,0.285714286,0.553191489,26,91,47,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.02173913,0.426829268,0.648148148,35,82,54,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.018012422,0.239669421,0.568627451,29,121,51,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.014906832,0.363636364,0.585365854,24,66,41,?a
?a  hasStage  IIIA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.010559006,0.293103448,0.548387097,17,58,31,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  hasBiomarker  ROS1_Negative,0.027329193,0.241758242,0.55,44,182,80,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.017391304,0.291666667,0.736842105,28,96,38,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.022360248,0.947368421,0.947368421,36,38,38,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.02484472,0.303030303,0.555555556,40,132,72,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.18487395,0.564102564,22,119,39,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.02173913,0.406976744,0.583333333,35,86,60,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.020496894,0.2,0.568965517,33,165,58,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.010559006,0.485714286,0.653846154,17,35,26,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.02173913,0.253623188,0.555555556,35,138,63,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.013043478,0.362068966,0.583333333,21,58,36,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.023602484,0.233128834,0.575757576,38,163,66,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.018012422,0.367088608,0.58,29,79,50,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ROS1_Negative,0.020496894,1,1,33,33,33,?a
?a  hasGender  Male  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.027950311,0.263157895,0.642857143,45,171,70,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.020496894,0.347368421,0.589285714,33,95,56,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.392857143,0.6875,22,56,32,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.019254658,0.449275362,0.58490566,31,69,53,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.733333333,0.814814815,22,30,27,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  hasBiomarker  ROS1_Negative,0.031677019,0.255,0.520408163,51,200,98,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  ROS1_Negative,0.054037267,0.945652174,0.945652174,87,92,92,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ROS1_Negative,0.016770186,0.490909091,0.586956522,27,55,46,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.027329193,0.453608247,0.55,44,97,80,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.014285714,0.522727273,0.638888889,23,44,36,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ROS1_Negative,0.031055901,0.961538462,0.961538462,50,52,52,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.011180124,0.947368421,0.947368421,18,19,19,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.011180124,0.947368421,0.947368421,18,19,19,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.019254658,0.206666667,0.553571429,31,150,56,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.01242236,0.476190476,0.606060606,20,42,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.010559006,0.944444444,0.944444444,17,18,18,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.016149068,0.433333333,0.5,26,60,52,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.215686275,0.47826087,22,102,46,?a
?a  hasGender  Male  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.017391304,0.25,0.56,28,112,50,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.017391304,0.254545455,0.538461538,28,110,52,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ROS1_Negative,0.01242236,0.377358491,0.5,20,53,40,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ROS1_Negative,0.01552795,0.328947368,0.595238095,25,76,42,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.014285714,0.239583333,0.469387755,23,96,49,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  ROS1_Negative,0.014906832,0.12565445,0.558139535,24,191,43,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.011180124,0.214285714,0.461538462,18,84,39,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.01552795,0.446428571,0.581395349,25,56,43,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.019875776,0.367816092,0.463768116,32,87,69,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ROS1_Negative,0.011801242,0.441860465,0.575757576,19,43,33,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.037267081,0.255319149,0.495867769,60,235,121,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.014906832,0.428571429,0.52173913,24,56,46,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.02484472,0.434782609,0.512820513,40,92,78,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.011801242,0.223529412,0.463414634,19,85,41,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.211538462,0.47826087,22,104,46,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.019254658,0.525423729,0.563636364,31,59,55,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ROS1_Negative,0.025465839,0.440860215,0.518987342,41,93,79,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.014285714,0.338235294,0.56097561,23,68,41,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.01863354,0.223880597,0.434782609,30,134,69,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ROS1_Negative,0.020496894,0.323529412,0.445945946,33,102,74,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.011801242,0.730769231,0.791666667,19,26,24,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.026708075,0.25443787,0.483146067,43,169,89,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ROS1_Negative,0.025465839,0.232954545,0.455555556,41,176,90,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ROS1_Negative,0.014285714,0.258426966,0.479166667,23,89,48,?a
?a  hasGender  Male  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ROS1_Negative,0.014906832,0.558139535,0.827586207,24,43,29,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.013664596,0.47826087,0.564102564,22,46,39,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.024223602,0.513157895,0.6,39,76,65,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.021118012,0.278688525,0.515151515,34,122,66,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ROS1_Negative,0.040993789,0.38372093,0.464788732,66,172,142,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ROS1_Negative,0.031677019,0.268421053,0.495145631,51,190,103,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.011336311,0.174603175,0.184357542,33,189,179,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.014084507,0.187214612,0.196172249,41,219,209,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.016149068,0.419354839,0.553191489,26,62,47,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ROS1_Negative,0.027950311,0.398230088,0.5625,45,113,80,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.013053933,0.189054726,0.189054726,38,201,201,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.011336311,0.12406015,0.126436782,33,266,261,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.016832704,0.186311787,0.189189189,49,263,259,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Bone,0.013740982,0.187793427,0.19047619,40,213,210,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.011336311,0.190751445,0.190751445,33,173,173,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.011336311,0.237410072,0.237410072,33,139,139,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Bone,0.010305737,0.192307692,0.201342282,30,156,149,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.010992786,0.27826087,0.27826087,32,115,115,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.014084507,0.248484848,0.25,41,165,164,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.019924425,0.273584906,0.273584906,58,212,212,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.014428032,0.270967742,0.270967742,42,155,155,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.010305737,0.173410405,0.176470588,30,173,170,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.029543112,0.209245742,0.209245742,86,411,411,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.016145654,0.247368421,0.247368421,47,190,190,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.013053933,0.265734266,0.265734266,38,143,143,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.010649261,0.238461538,0.25,31,130,124,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Bone,0.016145654,0.223809524,0.223809524,47,210,210,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.011336311,0.284482759,0.292035398,33,116,113,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.0195809,0.267605634,0.267605634,57,213,213,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.013740982,0.251572327,0.258064516,40,159,155,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.012710409,0.268115942,0.274074074,37,138,135,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Bone,0.020267949,0.263392857,0.263392857,59,224,224,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Bone,0.010649261,0.129707113,0.129707113,31,239,239,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  treatmentType  Radiotherapy_To_Bone,0.013397458,0.190243902,0.191176471,39,205,204,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.011679835,0.184782609,0.189944134,34,184,179,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Bone,0.017863277,0.216666667,0.222222222,52,240,234,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.010305737,0.309278351,0.319148936,30,97,94,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.013053933,0.18627451,0.187192118,38,204,203,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Bone,0.016832704,0.267759563,0.273743017,49,183,179,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Radiotherapy_To_Bone,0.014084507,0.165991903,0.17826087,41,247,230,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Bone,0.011679835,0.211180124,0.217948718,34,161,156,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Bone,0.014084507,0.200980392,0.206030151,41,204,199,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.019354839,0.406779661,0.406779661,24,59,59,?a
?a  hasStage  IVA  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.764705882,0.764705882,13,17,17,?a
?a  hasGender  Female  ?a  hasStage  IIIB   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.487804878,0.487804878,20,41,41,?a
?a  hasStage  IVA  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.014516129,0.545454545,0.545454545,18,33,33,?a
?a  hasGender  Male  ?a  hasStage  IIA   ,?a  hasSmokingHabit  CurrentSmoker,0.014516129,0.43902439,0.43902439,18,41,41,?a
?a  hasStage  IIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.464285714,0.464285714,13,28,28,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Bone,0.022672621,0.231578947,0.23655914,66,285,279,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.05,0.442857143,0.442857143,62,140,140,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.015322581,0.441860465,0.441860465,19,43,43,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.46875,0.46875,15,32,32,?a
?a  hasGender  Female  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.014516129,0.529411765,0.529411765,18,34,34,?a
?a  hasStage  IA  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.023387097,0.376623377,0.376623377,29,77,77,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVA   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.4375,0.4375,14,32,32,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.024193548,0.491803279,0.491803279,30,61,61,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.477272727,0.477272727,21,44,44,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.583333333,0.583333333,14,24,24,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  hasSmokingHabit  CurrentSmoker,0.02016129,0.446428571,0.446428571,25,56,56,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.030645161,0.417582418,0.417582418,38,91,91,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.046774194,0.46031746,0.46031746,58,126,126,?a
?a  hasStage  IIIB  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.482758621,0.482758621,14,29,29,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Female   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.464285714,0.464285714,13,28,28,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasSmokingHabit  CurrentSmoker,0.041935484,0.396946565,0.396946565,52,131,131,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasSmokingHabit  CurrentSmoker,0.027419355,0.409638554,0.409638554,34,83,83,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIB   ,?a  hasSmokingHabit  CurrentSmoker,0.024193548,0.652173913,0.652173913,30,46,46,?a
?a  hasStage  IIIB  ?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.583333333,0.583333333,14,24,24,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.028225806,0.397727273,0.397727273,35,88,88,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.021774194,0.435483871,0.435483871,27,62,62,?a
?a  hasStage  IIIB  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.031451613,0.448275862,0.448275862,39,87,87,?a
?a  hasGender  Female  ?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  CurrentSmoker,0.032258065,0.615384615,0.615384615,40,65,65,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  hasSmokingHabit  CurrentSmoker,0.032258065,0.434782609,0.434782609,40,92,92,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.017741935,0.5,0.5,22,44,44,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.070967742,0.480874317,0.480874317,88,183,183,?a
?a  hasStage  IIIB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.583333333,0.583333333,21,36,36,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasSmokingHabit  CurrentSmoker,0.040322581,0.434782609,0.434782609,50,115,115,?a
?a  hasStage  IIIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.025806452,0.457142857,0.457142857,32,70,70,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.015322581,0.558823529,0.558823529,19,34,34,?a
?a  hasStage  IIIB  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.5,0.5,20,40,40,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.512195122,0.512195122,21,41,41,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.466666667,0.466666667,14,30,30,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.02016129,0.5,0.5,25,50,50,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.441176471,0.441176471,15,34,34,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.571428571,0.571428571,20,35,35,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.029032258,0.486486486,0.486486486,36,74,74,?a
?a  hasGender  Male  ?a  hasStage  IB   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.449275362,0.449275362,31,69,69,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.034677419,0.467391304,0.467391304,43,92,92,?a
?a  hasStage  IVB  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.025806452,0.438356164,0.438356164,32,73,73,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.462686567,0.462686567,31,67,67,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.020967742,0.433333333,0.433333333,26,60,60,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.025806452,0.432432432,0.432432432,32,74,74,?a
?a  hasGender  Male  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  CurrentSmoker,0.059677419,0.425287356,0.425287356,74,174,174,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.022580645,0.411764706,0.411764706,28,68,68,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  hasSmokingHabit  CurrentSmoker,0.027419355,0.409638554,0.409638554,34,83,83,?a
?a  hasStage  IB  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.482758621,0.482758621,14,29,29,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  CurrentSmoker,0.020967742,0.448275862,0.448275862,26,58,58,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.032258065,0.43956044,0.43956044,40,91,91,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.46969697,0.46969697,31,66,66,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  CurrentSmoker,0.013709677,0.5,0.5,17,34,34,?a
?a  hasStage  IIIA  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.040322581,0.45045045,0.45045045,50,111,111,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  CurrentSmoker,0.061290323,0.417582418,0.417582418,76,182,182,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.619047619,0.619047619,13,21,21,?a
?a  hasStage  IV  ?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  CurrentSmoker,0.044354839,0.604395604,0.617977528,55,91,89,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IV   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.419354839,0.419354839,13,31,31,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.428571429,0.428571429,21,49,49,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  CurrentSmoker,0.02983871,0.474358974,0.474358974,37,78,78,?a
?a  hasGender  Male  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.061290323,0.444444444,0.444444444,76,171,171,?a
?a  hasStage  IV  ?a  patientDrug  Vincristine   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.741935484,0.766666667,23,31,30,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.032258065,0.449438202,0.449438202,40,89,89,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.057258065,0.473333333,0.47972973,71,150,148,?a
?a  hasStage  IV  ?a  patientDrug  Cyclophosphamide   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.71875,0.741935484,23,32,31,?a
?a  hasStage  IV  ?a  patientDrug  Doxorubicin   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.7,0.724137931,21,30,29,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.064516129,0.446927374,0.451977401,80,179,177,?a
?a  hasGender  Male  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.5,0.5,20,40,40,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  hasSmokingHabit  CurrentSmoker,0.065322581,0.395121951,0.399014778,81,205,203,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.073387097,0.471502591,0.471502591,91,193,193,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.080645161,0.5,0.5,100,200,200,?a
?a  hasGender  Male  ?a  patientDrug  Doxorubicin   ,?a  hasSmokingHabit  CurrentSmoker,0.02016129,0.520833333,0.531914894,25,48,47,?a
?a  hasGender  Male  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.038709677,0.452830189,0.452830189,48,106,106,?a
?a  hasGender  Male  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.083064516,0.415322581,0.415322581,103,248,248,?a
?a  hasBiomarker  RET_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.511111111,0.511111111,23,45,45,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.056451613,0.429447853,0.429447853,70,163,163,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.043548387,0.504672897,0.504672897,54,107,107,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.033870968,0.442105263,0.442105263,42,95,95,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.026612903,0.445945946,0.445945946,33,74,74,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.029032258,0.52173913,0.52173913,36,69,69,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.56097561,0.56097561,23,41,41,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  CurrentSmoker,0.034677419,0.693548387,0.693548387,43,62,62,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.526315789,0.526315789,20,38,38,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vincristine   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.565217391,0.565217391,13,23,23,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.015322581,0.558823529,0.558823529,19,34,34,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.029032258,0.428571429,0.428571429,36,84,84,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.547619048,0.547619048,23,42,42,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  CurrentSmoker,0.022580645,0.5,0.5,28,56,56,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.518518519,0.518518519,14,27,27,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.766666667,0.766666667,23,30,30,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.030645161,0.417582418,0.417582418,38,91,91,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.045967742,0.508928571,0.508928571,57,112,112,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.071774194,0.514450867,0.514450867,89,173,173,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.014516129,0.5,0.5,18,36,36,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.026612903,0.423076923,0.423076923,33,78,78,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.535714286,0.535714286,15,28,28,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.027419355,0.576271186,0.586206897,34,59,58,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.013709677,0.485714286,0.485714286,17,35,35,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  No_Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.021774194,0.490909091,0.490909091,27,55,55,?a
?a  treatmentType  Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.636363636,0.65625,21,33,32,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.017741935,0.523809524,0.523809524,22,42,42,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.027419355,0.596491228,0.607142857,34,57,56,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.424242424,0.424242424,14,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.5,0.5,14,28,28,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.46,0.46,23,50,50,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  CurrentSmoker,0.014516129,0.461538462,0.461538462,18,39,39,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.5,0.5,21,42,42,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.04516129,0.495575221,0.495575221,56,113,113,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.056451613,0.486111111,0.48951049,70,144,143,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.5,0.5,21,42,42,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.538461538,0.538461538,14,26,26,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.518518519,0.518518519,14,27,27,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.013709677,0.459459459,0.459459459,17,37,37,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.012903226,0.666666667,0.666666667,16,24,24,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.4375,0.4375,14,32,32,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.450980392,0.450980392,23,51,51,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.051612903,0.561403509,0.571428571,64,114,112,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  CurrentSmoker,0.074193548,0.519774011,0.525714286,92,177,175,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.041129032,0.463636364,0.463636364,51,110,110,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.017741935,0.448979592,0.448979592,22,49,49,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.032258065,0.454545455,0.454545455,40,88,88,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.393939394,0.393939394,13,33,33,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.014516129,0.514285714,0.514285714,18,35,35,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.446808511,0.446808511,21,47,47,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.389830508,0.389830508,23,59,59,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.392156863,0.392156863,20,51,51,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Doxorubicin   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.512820513,0.526315789,20,39,38,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  CurrentSmoker,0.012903226,0.432432432,0.432432432,16,37,37,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cyclophosphamide   ,?a  hasSmokingHabit  CurrentSmoker,0.015322581,0.527777778,0.542857143,19,36,35,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.567567568,0.567567568,21,37,37,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.017741935,0.5,0.5,22,44,44,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.52,0.52,13,25,25,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.028225806,0.514705882,0.514705882,35,68,68,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.062903226,0.428571429,0.428571429,78,182,182,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.048387097,0.447761194,0.447761194,60,134,134,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.057258065,0.420118343,0.420118343,71,169,169,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.061290323,0.431818182,0.431818182,76,176,176,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.089516129,0.437007874,0.437007874,111,254,254,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.553571429,0.553571429,31,56,56,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.015322581,0.463414634,0.463414634,19,41,41,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.036290323,0.445544554,0.445544554,45,101,101,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cyclophosphamide   ,?a  hasSmokingHabit  CurrentSmoker,0.025806452,0.561403509,0.571428571,32,57,56,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  CurrentSmoker,0.025806452,0.551724138,0.561403509,32,58,57,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.013709677,0.435897436,0.435897436,17,39,39,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.014516129,0.5,0.5,18,36,36,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.019354839,0.428571429,0.428571429,24,56,56,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.021774194,0.473684211,0.473684211,27,57,57,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.033064516,0.476744186,0.476744186,41,86,86,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.035483871,0.431372549,0.431372549,44,102,102,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  CurrentSmoker,0.026612903,0.485294118,0.485294118,33,68,68,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.517241379,0.517241379,15,29,29,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Other   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.464285714,0.464285714,13,28,28,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Doxorubicin   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.543859649,0.553571429,31,57,56,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cyclophosphamide   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.534482759,0.543859649,31,58,57,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.567567568,0.567567568,21,37,37,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.538461538,0.538461538,14,26,26,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.555555556,0.555555556,15,27,27,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.043548387,0.477876106,0.477876106,54,113,113,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.56097561,0.56097561,23,41,41,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.511111111,0.511111111,23,45,45,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.042741935,0.460869565,0.460869565,53,115,115,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.526315789,0.526315789,20,38,38,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.020967742,0.456140351,0.456140351,26,57,57,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.476923077,0.476923077,31,65,65,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  CurrentSmoker,0.016935484,0.538461538,0.538461538,21,39,39,?a
?a  patientDrug  Vincristine  ?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  CurrentSmoker,0.026612903,0.559322034,0.568965517,33,59,58,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.476923077,0.476923077,31,65,65,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.025,0.492063492,0.492063492,31,63,63,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.026612903,0.492537313,0.492537313,33,67,67,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.032258065,0.449438202,0.449438202,40,89,89,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vincristine   ,?a  hasSmokingHabit  CurrentSmoker,0.026612903,0.578947368,0.589285714,33,57,56,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.017741935,0.468085106,0.468085106,22,47,47,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.011290323,0.466666667,0.466666667,14,30,30,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.448275862,0.448275862,13,29,29,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.056451613,0.573770492,0.578512397,70,122,121,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.044354839,0.466101695,0.466101695,55,118,118,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.036290323,0.445544554,0.445544554,45,101,101,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.444444444,0.444444444,20,45,45,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.013709677,0.395348837,0.395348837,17,43,43,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.020967742,0.4,0.4,26,65,65,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  CurrentSmoker,0.02016129,0.409836066,0.409836066,25,61,61,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.5,0.5,15,30,30,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  CurrentSmoker,0.017741935,0.666666667,0.666666667,22,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.476190476,0.476190476,20,42,42,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.069354839,0.452631579,0.452631579,86,190,190,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.034677419,0.457446809,0.457446809,43,94,94,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.454545455,0.454545455,15,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.018548387,0.479166667,0.479166667,23,48,48,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.52,0.52,13,25,25,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.05,0.389937107,0.389937107,62,159,159,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  CurrentSmoker,0.055645161,0.37704918,0.37704918,69,183,183,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.028225806,0.416666667,0.416666667,35,84,84,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.020967742,0.393939394,0.393939394,26,66,66,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.044354839,0.450819672,0.450819672,55,122,122,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.448275862,0.448275862,13,29,29,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  CurrentSmoker,0.036290323,0.420560748,0.420560748,45,107,107,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.069354839,0.401869159,0.401869159,86,214,214,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.034677419,0.413461538,0.413461538,43,104,104,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.016129032,0.571428571,0.571428571,20,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.023387097,0.475409836,0.475409836,29,61,61,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.021774194,0.415384615,0.415384615,27,65,65,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.019354839,0.380952381,0.380952381,24,63,63,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.416666667,0.416666667,15,36,36,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.041935484,0.468468468,0.468468468,52,111,111,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.044354839,0.491071429,0.491071429,55,112,112,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.46875,0.46875,15,32,32,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.020967742,0.509803922,0.509803922,26,51,51,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.020967742,0.509803922,0.509803922,26,51,51,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.010483871,0.565217391,0.565217391,13,23,23,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  CurrentSmoker,0.033870968,0.4,0.4,42,105,105,?a
?a  hasBiomarker  RET_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.013709677,0.53125,0.53125,17,32,32,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.032258065,0.388349515,0.388349515,40,103,103,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.041129032,0.455357143,0.455357143,51,112,112,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.020967742,0.541666667,0.541666667,26,48,48,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasSmokingHabit  CurrentSmoker,0.012096774,0.416666667,0.416666667,15,36,36,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.026612903,0.44,0.44,33,75,75,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  CurrentSmoker,0.037096774,0.5,0.5,46,92,92,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Open_Surgical_Procedure,0.011336311,0.25984252,0.275,33,127,120,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.079032258,0.41350211,0.41350211,98,237,237,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  CurrentSmoker,0.034677419,0.425742574,0.425742574,43,101,101,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.07983871,0.400809717,0.400809717,99,247,247,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Open_Surgical_Procedure,0.012710409,0.192708333,0.192708333,37,192,192,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  CurrentSmoker,0.110483871,0.411411411,0.411411411,137,333,333,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.012366884,0.631578947,0.631578947,36,57,57,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Open_Surgical_Procedure,0.026107867,0.21529745,0.221574344,76,353,343,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Open_Surgical_Procedure,0.012710409,0.282442748,0.282442748,37,131,131,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Open_Surgical_Procedure,0.011336311,0.234042553,0.246268657,33,141,134,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Open_Surgical_Procedure,0.012366884,0.230769231,0.241610738,36,156,149,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Open_Surgical_Procedure,0.014428032,0.304347826,0.304347826,42,138,138,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Open_Surgical_Procedure,0.024046719,0.215384615,0.224358974,70,325,312,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Open_Surgical_Procedure,0.011679835,0.159624413,0.161904762,34,213,210,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Open_Surgical_Procedure,0.017863277,0.214876033,0.214876033,52,242,242,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Open_Surgical_Procedure,0.010649261,0.303921569,0.303921569,31,102,102,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Open_Surgical_Procedure,0.018893851,0.284974093,0.286458333,55,193,192,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  treatmentType  Open_Surgical_Procedure,0.015458605,0.25,0.263157895,45,180,171,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  treatmentType  Open_Surgical_Procedure,0.045001718,0.195814649,0.203100775,131,669,645,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  treatmentType  Open_Surgical_Procedure,0.011336311,0.358695652,0.370786517,33,92,89,?a
?a  hasGender  Male  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.023703195,0.616071429,0.616071429,69,112,112,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Open_Surgical_Procedure,0.014771556,0.247126437,0.25748503,43,174,167,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  treatmentType  Open_Surgical_Procedure,0.021298523,0.211604096,0.219081272,62,293,283,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  treatmentType  Open_Surgical_Procedure,0.019924425,0.225680934,0.234817814,58,257,247,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.010992786,0.581818182,0.581818182,32,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.013397458,0.661016949,0.661016949,39,59,59,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Open_Surgical_Procedure,0.015115081,0.154385965,0.154385965,44,285,285,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.010649261,0.607843137,0.607843137,31,51,51,?a
?a  hasBiomarker  RET_Negative  ?a  hasGender  Male   ,?a  treatmentType  Open_Surgical_Procedure,0.010305737,0.666666667,0.666666667,30,45,45,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.017176228,0.657894737,0.657894737,50,76,76,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.022329097,0.590909091,0.590909091,65,110,110,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.014428032,0.636363636,0.636363636,42,66,66,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Open_Surgical_Procedure,0.017863277,0.393939394,0.393939394,52,132,132,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Open_Surgical_Procedure,0.010649261,0.248,0.248,31,125,125,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  treatmentType  Open_Surgical_Procedure,0.015115081,0.494382022,0.494382022,44,89,89,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.011679835,0.666666667,0.666666667,34,51,51,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Open_Surgical_Procedure,0.012366884,0.327272727,0.327272727,36,110,110,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Open_Surgical_Procedure,0.010992786,0.307692308,0.307692308,32,104,104,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  treatmentType  Open_Surgical_Procedure,0.021642047,0.346153846,0.348066298,63,182,181,?a
?a  hasStage  IIIA  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Open_Surgical_Procedure,0.015115081,0.423076923,0.423076923,44,104,104,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  treatmentType  Open_Surgical_Procedure,0.014428032,0.538461538,0.538461538,42,78,78,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Open_Surgical_Procedure,0.015458605,0.633802817,0.633802817,45,71,71,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  treatmentType  Open_Surgical_Procedure,0.01202336,0.603448276,0.603448276,35,58,58,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Open_Surgical_Procedure,0.014428032,0.291666667,0.291666667,42,144,144,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Open_Surgical_Procedure,0.010305737,0.340909091,0.340909091,30,88,88,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIA   ,?a  treatmentType  Open_Surgical_Procedure,0.017519753,0.369565217,0.369565217,51,138,138,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Open_Surgical_Procedure,0.012710409,0.330357143,0.330357143,37,112,112,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Open_Surgical_Procedure,0.023016146,0.285106383,0.286324786,67,235,234,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Open_Surgical_Procedure,0.01580213,0.368,0.370967742,46,125,124,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  RET_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.011679835,0.666666667,0.666666667,34,51,51,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Open_Surgical_Procedure,0.024390244,0.373684211,0.373684211,71,190,190,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Open_Surgical_Procedure,0.017519753,0.312883436,0.314814815,51,163,162,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.013053933,0.217142857,0.236024845,38,175,161,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.012366884,0.318584071,0.336448598,36,113,107,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Open_Surgical_Procedure,0.014428032,0.392523364,0.396226415,42,107,106,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Open_Surgical_Procedure,0.011336311,0.392857143,0.397590361,33,84,83,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  RET_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.010992786,0.666666667,0.666666667,32,48,48,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.011679835,0.666666667,0.666666667,34,51,51,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.012366884,0.324324324,0.342857143,36,111,105,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.012366884,0.321428571,0.339622642,36,112,106,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  RET_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.011336311,0.6875,0.6875,33,48,48,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.023016146,0.201201201,0.213375796,67,333,314,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.017519753,0.215189873,0.231818182,51,237,220,?a
?a  hasSmokingHabit  NonSmoker  ?a  hasStage  IVB   ,?a  hasGender  Female,0.012077295,0.75,0.75,15,20,20,?a
?a  hasSmokingHabit  NonSmoker  ?a  hasStage  IV   ,?a  hasGender  Female,0.022544283,0.736842105,0.736842105,28,38,38,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  NonSmoker   ,?a  hasGender  Female,0.052334944,0.691489362,0.691489362,65,94,94,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Open_Surgical_Procedure,0.018893851,0.222672065,0.239130435,55,247,230,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Open_Surgical_Procedure,0.016145654,0.19665272,0.19665272,47,239,239,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  NonSmoker   ,?a  hasGender  Female,0.048309179,0.75,0.75,60,80,80,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasGender  Female,0.028985507,0.734693878,0.734693878,36,49,49,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasGender  Female,0.024154589,0.714285714,0.714285714,30,42,42,?a
?a  hasStage  IA  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.02173913,0.350649351,0.350649351,27,77,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasGender  Female,0.020128824,0.78125,0.78125,25,32,32,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Gefitinib   ,?a  hasGender  Female,0.010466989,0.8125,0.8125,13,16,16,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.015297907,0.791666667,0.791666667,19,24,24,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.024154589,0.714285714,0.714285714,30,42,42,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIB   ,?a  hasGender  Female,0.01610306,0.333333333,0.333333333,20,60,60,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.020933977,0.722222222,0.722222222,26,36,36,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  NonSmoker   ,?a  hasGender  Female,0.011272142,0.875,0.875,14,16,16,?a
?a  hasAgeCategory  Young  ?a  hasStage  IA   ,?a  hasGender  Female,0.010466989,0.52,0.52,13,25,25,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IA   ,?a  hasGender  Female,0.014492754,0.367346939,0.367346939,18,49,49,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVA   ,?a  hasGender  Female,0.012077295,0.326086957,0.326086957,15,46,46,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.016908213,0.777777778,0.777777778,21,27,27,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIB   ,?a  hasGender  Female,0.017713366,0.47826087,0.47826087,22,46,46,?a
?a  hasStage  IIIB  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.02173913,0.310344828,0.310344828,27,87,87,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.024959742,0.336956522,0.336956522,31,92,92,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  hasGender  Female,0.016908213,0.328125,0.328125,21,64,64,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  hasGender  Female,0.024154589,0.326086957,0.326086957,30,92,92,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIB   ,?a  hasGender  Female,0.012882448,0.355555556,0.355555556,16,45,45,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Nivolumab   ,?a  hasGender  Female,0.014492754,0.339622642,0.339622642,18,53,53,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.046698873,0.351515152,0.351515152,58,165,165,?a
?a  hasStage  IIIB  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.010466989,0.325,0.325,13,40,40,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.049919485,0.308457711,0.308457711,62,201,201,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.024154589,0.348837209,0.348837209,30,86,86,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.016908213,0.344262295,0.344262295,21,61,61,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.012077295,0.428571429,0.428571429,15,35,35,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.011272142,0.411764706,0.411764706,14,34,34,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.070853462,0.330827068,0.330827068,88,266,266,?a
?a  hasAgeCategory  Young  ?a  hasStage  IV   ,?a  hasGender  Female,0.02979066,0.420454545,0.420454545,37,88,88,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.028180354,0.384615385,0.384615385,35,91,91,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.012882448,0.372093023,0.372093023,16,43,43,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.030595813,0.361904762,0.361904762,38,105,105,?a
?a  hasStage  IV  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.026570048,0.568965517,0.568965517,33,58,58,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vp-16   ,?a  hasGender  Female,0.032206119,0.341880342,0.341880342,40,117,117,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.030595813,0.333333333,0.333333333,38,114,114,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Female,0.040257649,0.354609929,0.354609929,50,141,141,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Female,0.041867955,0.333333333,0.333333333,52,156,156,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Female,0.020128824,0.462962963,0.462962963,25,54,54,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.014492754,0.367346939,0.367346939,18,49,49,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Female,0.027375201,0.34,0.34,34,100,100,?a
?a  hasStage  IV  ?a  patientDrug  Erlotinib   ,?a  hasGender  Female,0.011272142,0.636363636,0.636363636,14,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.01610306,0.4,0.4,20,50,50,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  hasGender  Female,0.053140097,0.32195122,0.32195122,66,205,205,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  hasGender  Female,0.024959742,0.316326531,0.316326531,31,98,98,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  hasGender  Female,0.035426731,0.338461538,0.338461538,44,130,130,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IV   ,?a  hasGender  Female,0.016908213,0.65625,0.65625,21,32,32,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IV   ,?a  hasGender  Female,0.012077295,0.394736842,0.394736842,15,38,38,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IB   ,?a  hasGender  Female,0.010466989,0.282608696,0.282608696,13,46,46,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasGender  Female,0.020933977,0.590909091,0.590909091,26,44,44,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.016908213,0.396226415,0.396226415,21,53,53,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.012882448,0.390243902,0.390243902,16,41,41,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.011272142,0.411764706,0.411764706,14,34,34,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVB   ,?a  hasGender  Female,0.010466989,0.65,0.65,13,20,20,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.03784219,0.321917808,0.321917808,47,146,146,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  hasGender  Female,0.028180354,0.421686747,0.421686747,35,83,83,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.019323671,0.292682927,0.292682927,24,82,82,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.014492754,0.514285714,0.514285714,18,35,35,?a
?a  hasStage  IIIA  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.023349436,0.329545455,0.329545455,29,88,88,?a
?a  hasStage  IVB  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.011272142,0.608695652,0.608695652,14,23,23,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IIIA   ,?a  hasGender  Female,0.016908213,0.318181818,0.318181818,21,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasGender  Female,0.018518519,0.442307692,0.442307692,23,52,52,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.019323671,0.363636364,0.363636364,24,66,66,?a
?a  hasStage  IIIA  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Female,0.02979066,0.333333333,0.333333333,37,111,111,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.011272142,0.518518519,0.518518519,14,27,27,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.020128824,0.454545455,0.454545455,25,55,55,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.012077295,0.357142857,0.357142857,15,42,42,?a
?a  hasStage  IIIA  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.02979066,0.355769231,0.355769231,37,104,104,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.030595813,0.287878788,0.287878788,38,132,132,?a
?a  hasStage  IIIA  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.010466989,0.40625,0.40625,13,32,32,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.02173913,0.346153846,0.346153846,27,78,78,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.011272142,0.5,0.5,14,28,28,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.017713366,0.35483871,0.35483871,22,62,62,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Female,0.012077295,0.348837209,0.348837209,15,43,43,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Female,0.011272142,0.636363636,0.636363636,14,22,22,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.012077295,0.46875,0.46875,15,32,32,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.011272142,0.304347826,0.304347826,14,46,46,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.027375201,0.34,0.34,34,100,100,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.01610306,0.344827586,0.344827586,20,58,58,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.011272142,0.304347826,0.304347826,14,46,46,?a
?a  treatmentType  Surgery  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.012077295,0.652173913,0.652173913,15,23,23,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.020933977,0.273684211,0.273684211,26,95,95,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Female,0.014492754,0.321428571,0.321428571,18,56,56,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.022544283,0.373333333,0.373333333,28,75,75,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.010466989,0.40625,0.40625,13,32,32,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.019323671,0.648648649,0.648648649,24,37,37,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.014492754,0.367346939,0.367346939,18,49,49,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Surgery   ,?a  hasGender  Female,0.010466989,0.40625,0.40625,13,32,32,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.011272142,0.583333333,0.583333333,14,24,24,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.010466989,0.464285714,0.464285714,13,28,28,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.023349436,0.483333333,0.483333333,29,60,60,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.020933977,0.5,0.5,26,52,52,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.016908213,0.5,0.5,21,42,42,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.04589372,0.53271028,0.53271028,57,107,107,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.010466989,0.722222222,0.722222222,13,18,18,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.028180354,0.426829268,0.426829268,35,82,82,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.011272142,0.518518519,0.518518519,14,27,27,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Female,0.015297907,0.475,0.475,19,40,40,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Female,0.010466989,0.65,0.65,13,20,20,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Female,0.011272142,0.358974359,0.358974359,14,39,39,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.048309179,0.540540541,0.540540541,60,111,111,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.018518519,0.450980392,0.450980392,23,51,51,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Female,0.032206119,0.533333333,0.533333333,40,75,75,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Erlotinib   ,?a  hasGender  Female,0.010466989,0.619047619,0.619047619,13,21,21,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.01610306,0.454545455,0.454545455,20,44,44,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  hasGender  Female,0.010466989,0.722222222,0.722222222,13,18,18,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.04589372,0.508928571,0.508928571,57,112,112,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.061996779,0.445086705,0.445086705,77,173,173,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.018518519,0.56097561,0.56097561,23,41,41,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Female,0.074879227,0.442857143,0.442857143,93,210,210,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.023349436,0.381578947,0.381578947,29,76,76,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.011272142,0.466666667,0.466666667,14,30,30,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vp-16   ,?a  hasGender  Female,0.024154589,0.483870968,0.483870968,30,62,62,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.034621578,0.511904762,0.511904762,43,84,84,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.027375201,0.350515464,0.350515464,34,97,97,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.019323671,0.444444444,0.444444444,24,54,54,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.030595813,0.345454545,0.345454545,38,110,110,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Female,0.018518519,0.547619048,0.547619048,23,42,42,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Female,0.047504026,0.427536232,0.427536232,59,138,138,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Female,0.02979066,0.420454545,0.420454545,37,88,88,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.023349436,0.376623377,0.376623377,29,77,77,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.013687601,0.333333333,0.333333333,17,51,51,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.010466989,0.433333333,0.433333333,13,30,30,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.015297907,0.345454545,0.345454545,19,55,55,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.024154589,0.352941176,0.352941176,30,85,85,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Female,0.024154589,0.422535211,0.422535211,30,71,71,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.013687601,0.386363636,0.386363636,17,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.02173913,0.402985075,0.402985075,27,67,67,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.022544283,0.378378378,0.378378378,28,74,74,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.014492754,0.339622642,0.339622642,18,53,53,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.018518519,0.319444444,0.319444444,23,72,72,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.025764895,0.457142857,0.457142857,32,70,70,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.015297907,0.422222222,0.422222222,19,45,45,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.028180354,0.357142857,0.357142857,35,98,98,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.020933977,0.382352941,0.382352941,26,68,68,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.011272142,0.35,0.35,14,40,40,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.012882448,0.363636364,0.363636364,16,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.042673108,0.392592593,0.392592593,53,135,135,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Female,0.022544283,0.341463415,0.341463415,28,82,82,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.014492754,0.321428571,0.321428571,18,56,56,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.037037037,0.368,0.368,46,125,125,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.017713366,0.323529412,0.323529412,22,68,68,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Female,0.024154589,0.340909091,0.340909091,30,88,88,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.026570048,0.35483871,0.35483871,33,93,93,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.074074074,0.322807018,0.322807018,92,285,285,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Female,0.028985507,0.356435644,0.356435644,36,101,101,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.09178744,0.293059126,0.293059126,114,389,389,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.015297907,0.333333333,0.333333333,19,57,57,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Female,0.010466989,0.371428571,0.371428571,13,35,35,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.031400966,0.319672131,0.319672131,39,122,122,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.010466989,0.722222222,0.722222222,13,18,18,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Vincristine   ,?a  hasGender  Female,0.011272142,0.237288136,0.237288136,14,59,59,?a
?a  patientDrug  Other  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Female,0.012882448,0.615384615,0.615384615,16,26,26,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Relapse   ,?a  hasGender  Female,0.014492754,0.310344828,0.310344828,18,58,58,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.012077295,0.365853659,0.365853659,15,41,41,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.011272142,0.333333333,0.333333333,14,42,42,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.027375201,0.336633663,0.336633663,34,101,101,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.012882448,0.340425532,0.340425532,16,47,47,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.012882448,0.421052632,0.421052632,16,38,38,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.020128824,0.396825397,0.396825397,25,63,63,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.012077295,0.517241379,0.517241379,15,29,29,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.02979066,0.327433628,0.327433628,37,113,113,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.032206119,0.338983051,0.338983051,40,118,118,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.025764895,0.359550562,0.359550562,32,89,89,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Female,0.01610306,0.363636364,0.363636364,20,55,55,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.028180354,0.336538462,0.336538462,35,104,104,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Erlotinib   ,?a  hasGender  Female,0.018518519,0.657142857,0.657142857,23,35,35,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.023349436,0.376623377,0.376623377,29,77,77,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.017713366,0.328358209,0.328358209,22,67,67,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Erlotinib   ,?a  hasGender  Female,0.02173913,0.5625,0.5625,27,48,48,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.011272142,0.538461538,0.538461538,14,26,26,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.015297907,0.422222222,0.422222222,19,45,45,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.016908213,0.428571429,0.428571429,21,49,49,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.033011272,0.356521739,0.356521739,41,115,115,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.013687601,0.435897436,0.435897436,17,39,39,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Female,0.022544283,0.430769231,0.430769231,28,65,65,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.013687601,0.414634146,0.414634146,17,41,41,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.012882448,0.363636364,0.363636364,16,44,44,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Gefitinib   ,?a  hasGender  Female,0.012882448,0.727272727,0.727272727,16,22,22,?a
?a  patientDrug  Gefitinib  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.011272142,0.736842105,0.736842105,14,19,19,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Female,0.012077295,0.405405405,0.405405405,15,37,37,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Gefitinib   ,?a  hasGender  Female,0.012882448,0.695652174,0.695652174,16,23,23,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Gefitinib   ,?a  hasGender  Female,0.016908213,0.65625,0.65625,21,32,32,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Positive   ,?a  hasGender  Female,0.028180354,0.648148148,0.648148148,35,54,54,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.015297907,0.339285714,0.339285714,19,56,56,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.013687601,0.377777778,0.377777778,17,45,45,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.010466989,0.419354839,0.419354839,13,31,31,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vp-16   ,?a  hasGender  Female,0.010466989,0.393939394,0.393939394,13,33,33,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Afatinib   ,?a  hasGender  Female,0.010466989,0.565217391,0.565217391,13,23,23,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Osimertinib   ,?a  hasGender  Female,0.012077295,0.625,0.625,15,24,24,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.012077295,0.348837209,0.348837209,15,43,43,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Other   ,?a  hasGender  Female,0.011272142,0.736842105,0.736842105,14,19,19,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.016908213,0.355932203,0.355932203,21,59,59,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.016908213,0.362068966,0.362068966,21,58,58,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  hasGender  Female,0.024959742,0.333333333,0.333333333,31,93,93,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Female,0.073268921,0.319298246,0.319298246,91,285,285,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.061191626,0.356807512,0.356807512,76,213,213,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Other   ,?a  hasGender  Female,0.012882448,0.571428571,0.571428571,16,28,28,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.058776167,0.341121495,0.341121495,73,214,214,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.053140097,0.323529412,0.323529412,66,204,204,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Osimertinib   ,?a  hasGender  Female,0.018518519,0.657142857,0.657142857,23,35,35,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Female,0.02979066,0.637931034,0.637931034,37,58,58,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Gemcitabine   ,?a  hasGender  Female,0.01610306,0.384615385,0.384615385,20,52,52,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.015297907,0.413043478,0.413043478,19,46,46,?a
?a  hasBiomarker  ALK_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Female,0.010466989,0.481481481,0.481481481,13,27,27,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Gemcitabine   ,?a  hasGender  Female,0.010466989,0.382352941,0.382352941,13,34,34,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.031400966,0.375,0.375,39,104,104,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.014492754,0.428571429,0.428571429,18,42,42,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.026570048,0.317307692,0.317307692,33,104,104,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Female,0.012077295,0.428571429,0.428571429,15,35,35,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.024154589,0.461538462,0.461538462,30,65,65,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.050724638,0.36627907,0.36627907,63,172,172,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.027375201,0.361702128,0.361702128,34,94,94,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Female,0.012882448,0.64,0.64,16,25,25,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.019323671,0.375,0.375,24,64,64,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.03784219,0.326388889,0.326388889,47,144,144,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasGender  Female,0.052334944,0.318627451,0.318627451,65,204,204,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasGender  Female,0.020128824,0.641025641,0.641025641,25,39,39,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasGender  Female,0.019323671,0.32,0.32,24,75,75,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vp-16   ,?a  hasGender  Female,0.051529791,0.310679612,0.310679612,64,206,206,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Female,0.01610306,0.317460317,0.317460317,20,63,63,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.034621578,0.346774194,0.346774194,43,124,124,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Female,0.016908213,0.323076923,0.323076923,21,65,65,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasGender  Female,0.028985507,0.321428571,0.321428571,36,112,112,?a
?a  hasBiomarker  ALK_Positive  ?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Female,0.012077295,0.46875,0.46875,15,32,32,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Female,0.011272142,0.636363636,0.636363636,14,22,22,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.010305737,0.136986301,0.14354067,30,219,209,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Female,0.034621578,0.417475728,0.417475728,43,103,103,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.017176228,0.495049505,0.495049505,50,101,101,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.012366884,0.315789474,0.315789474,36,114,114,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.014084507,0.128125,0.13015873,41,320,315,?a
?a  hasGender  Female  ?a  hasStage  IIIA   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.012710409,0.544117647,0.544117647,37,68,68,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.010305737,0.238095238,0.238095238,30,126,126,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.010305737,0.337078652,0.337078652,30,89,89,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.013740982,0.322580645,0.325203252,40,124,123,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.01580213,0.333333333,0.333333333,46,138,138,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.017519753,0.156923077,0.163461538,51,325,312,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.010305737,0.379746835,0.379746835,30,79,79,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.029199588,0.127055306,0.131782946,85,669,645,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.010992786,0.336842105,0.336842105,32,95,95,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.010305737,0.344827586,0.344827586,30,87,87,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.011679835,0.365591398,0.365591398,34,93,93,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.010649261,0.238461538,0.238461538,31,130,130,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.010305737,0.476190476,0.476190476,30,63,63,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.012366884,0.220858896,0.220858896,36,163,163,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.011336311,0.128404669,0.133603239,33,257,247,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.013740982,0.136518771,0.141342756,40,293,283,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.019924425,0.129175947,0.130925508,58,449,443,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.016489179,0.358208955,0.358208955,48,134,134,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.016489179,0.406779661,0.406779661,48,118,118,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.013740982,0.449438202,0.449438202,40,89,89,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.020267949,0.293532338,0.293532338,59,201,201,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.022672621,0.390532544,0.390532544,66,169,169,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.028856063,0.461538462,0.464088398,84,182,181,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.024733768,0.545454545,0.545454545,72,132,132,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.020267949,0.126609442,0.128820961,59,466,458,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.012366884,0.610169492,0.610169492,36,59,59,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.012366884,0.375,0.375,36,96,96,?a
?a  hasStage  IIIA  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.022329097,0.625,0.625,65,104,104,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.019924425,0.42962963,0.42962963,58,135,135,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.020954998,0.346590909,0.346590909,61,176,176,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.021642047,0.137254902,0.139380531,63,459,452,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.022672621,0.725274725,0.725274725,66,91,91,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.012710409,0.474358974,0.474358974,37,78,78,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.019924425,0.479338843,0.479338843,58,121,121,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.011679835,0.1328125,0.141666667,34,256,240,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.021985572,0.307692308,0.307692308,64,208,208,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.011336311,0.264,0.264,33,125,125,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.015115081,0.468085106,0.468085106,44,94,94,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.020267949,0.126068376,0.128820961,59,468,458,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.026451391,0.405263158,0.405263158,77,190,190,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.020267949,0.36196319,0.364197531,59,163,162,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.014428032,0.471910112,0.471910112,42,89,89,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.014771556,0.129129129,0.136942675,43,333,314,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.012710409,0.129370629,0.137037037,37,286,270,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.025764342,0.319148936,0.320512821,75,235,234,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.02335967,0.317757009,0.317757009,68,214,214,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  hasGender  Female,0.015297907,0.633333333,0.633333333,19,30,30,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Neoadjuvant_Chemotherapy,0.019237375,0.459016393,0.459016393,56,122,122,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasGender  Female,0.035426731,0.435643564,0.435643564,44,101,101,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.07515528,0.923664122,0.923664122,121,131,131,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.021118012,0.894736842,0.894736842,34,38,38,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.10931677,0.372093023,0.822429907,176,473,214,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.037888199,0.448529412,0.813333333,61,136,75,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.011180124,0.818181818,0.818181818,18,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.108074534,0.920634921,0.920634921,174,189,189,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.01863354,0.333333333,0.833333333,30,90,36,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.045962733,0.544117647,0.840909091,74,136,88,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.029813665,0.4,0.857142857,48,120,56,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.025465839,0.372727273,0.891304348,41,110,46,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.029192547,0.244791667,0.903846154,47,192,52,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.039751553,0.659793814,0.820512821,64,97,78,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.077639752,0.5,0.811688312,125,250,154,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.025465839,0.661290323,0.836734694,41,62,49,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.060869565,0.777777778,0.907407407,98,126,108,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.01863354,0.416666667,0.882352941,30,72,34,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.028571429,0.793103448,0.884615385,46,58,52,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  EGFR_Negative,0.014285714,0.181102362,0.92,23,127,25,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.013664596,0.733333333,0.956521739,22,30,23,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.059006211,0.922330097,0.922330097,95,103,103,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.044099379,0.541984733,0.87654321,71,131,81,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasBiomarker  EGFR_Negative,0.02484472,0.769230769,0.769230769,40,52,52,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.039751553,0.429530201,0.810126582,64,149,79,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  EGFR_Negative,0.021118012,0.80952381,0.80952381,34,42,42,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  EGFR_Negative,0.058385093,0.930693069,0.930693069,94,101,101,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  EGFR_Negative,0.029813665,0.941176471,0.941176471,48,51,51,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  EGFR_Negative,0.023602484,0.95,0.95,38,40,40,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.030434783,0.803278689,0.803278689,49,61,61,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.032919255,0.815384615,0.815384615,53,65,65,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.024223602,0.928571429,0.928571429,39,42,42,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.013664596,0.814814815,0.814814815,22,27,27,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.033540373,0.782608696,0.782608696,54,69,69,?a
?a  hasBiomarker  RET_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.016149068,1,1,26,26,26,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  EGFR_Negative,0.028571429,0.958333333,0.958333333,46,48,48,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.029813665,0.941176471,0.941176471,48,51,51,?a
?a  hasBiomarker  RET_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.026086957,0.933333333,0.933333333,42,45,45,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.019875776,0.941176471,0.941176471,32,34,34,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.010559006,0.944444444,0.944444444,17,18,18,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.023602484,0.342342342,0.88372093,38,111,43,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.014285714,0.793103448,0.793103448,23,29,29,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.022360248,0.375,0.947368421,36,96,38,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.039751553,0.761904762,0.761904762,64,84,84,?a
?a  hasBiomarker  RET_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.01863354,0.9375,0.9375,30,32,32,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.085093168,0.971631206,0.971631206,137,141,141,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.034161491,1,1,55,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.060869565,0.98,0.98,98,100,100,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.064596273,0.294617564,0.845528455,104,353,123,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.022360248,0.356435644,0.923076923,36,101,39,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.013664596,0.956521739,0.956521739,22,23,23,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.036645963,0.475806452,0.936507937,59,124,63,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  EGFR_Negative,0.060869565,0.301538462,0.844827586,98,325,116,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.032298137,0.315151515,0.896551724,52,165,58,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.010559006,0.283333333,0.894736842,17,60,19,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.049068323,0.393034826,0.849462366,79,201,93,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.042857143,0.758241758,0.945205479,69,91,73,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.014285714,0.403508772,0.958333333,23,57,24,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.014285714,0.37704918,0.851851852,23,61,27,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  EGFR_Negative,0.064596273,0.936936937,0.936936937,104,111,111,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.065838509,0.938053097,0.938053097,106,113,113,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  EGFR_Negative,0.011180124,0.947368421,0.947368421,18,19,19,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.013664596,0.846153846,0.916666667,22,26,24,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.016149068,0.541666667,0.742857143,26,48,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.022360248,0.947368421,0.947368421,36,38,38,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.020496894,0.942857143,0.942857143,33,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.054037267,0.945652174,0.945652174,87,92,92,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  EGFR_Negative,0.051552795,0.954022989,0.954022989,83,87,87,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.011180124,1,1,18,18,18,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.021118012,0.944444444,0.944444444,34,36,36,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.01552795,0.961538462,0.961538462,25,26,26,?a
?a  hasStage  IIIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.016770186,0.385714286,0.84375,27,70,32,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.014906832,0.96,0.96,24,25,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.027950311,0.9375,0.9375,45,48,48,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.019875776,1,1,32,32,32,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.01552795,1,1,25,25,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.019254658,0.96875,0.96875,31,32,32,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.031055901,0.961538462,0.961538462,50,52,52,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.014906832,0.48,0.96,24,50,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.035403727,0.93442623,0.93442623,57,61,61,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  hasBiomarker  EGFR_Negative,0.022981366,0.402173913,0.822222222,37,92,45,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.018012422,0.315217391,0.805555556,29,92,36,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.025465839,0.672131148,0.836734694,41,61,49,?a
?a  hasGender  Female  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.011180124,0.529411765,0.818181818,18,34,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.022360248,0.947368421,0.947368421,36,38,38,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.027950311,0.918367347,0.918367347,45,49,49,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  EGFR_Negative,0.098757764,0.908571429,0.908571429,159,175,175,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.02484472,0.930232558,0.930232558,40,43,43,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.104347826,0.933333333,0.933333333,168,180,180,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.021118012,0.918918919,0.918918919,34,37,37,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.031677019,0.910714286,0.910714286,51,56,56,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.048447205,0.928571429,0.928571429,78,84,84,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.055279503,0.908163265,0.908163265,89,98,98,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.02484472,0.930232558,0.930232558,40,43,43,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.039130435,0.969230769,0.969230769,63,65,65,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.022981366,0.948717949,0.948717949,37,39,39,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.01863354,1,1,30,30,30,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.016770186,0.964285714,0.964285714,27,28,28,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.025465839,1,1,41,41,41,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.025465839,0.911111111,0.911111111,41,45,45,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.040372671,0.955882353,0.955882353,65,68,68,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.044099379,0.946666667,0.946666667,71,75,75,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.070807453,0.93442623,0.93442623,114,122,122,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.017391304,0.903225806,0.903225806,28,31,31,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.045962733,0.961038961,0.961038961,74,77,77,?a
?a  hasAgeCategory  Young  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.026708075,0.488636364,0.781818182,43,88,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.073291925,0.936507937,0.936507937,118,126,126,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.055900621,0.918367347,0.918367347,90,98,98,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.019254658,0.659574468,0.837837838,31,47,37,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.016149068,0.896551724,0.896551724,26,29,29,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.059006211,0.549132948,0.848214286,95,173,112,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.01242236,0.571428571,0.8,20,35,25,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.013664596,0.956521739,0.956521739,22,23,23,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.053416149,0.436548223,0.843137255,86,197,102,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.010559006,0.607142857,0.894736842,17,28,19,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.038509317,0.346368715,0.794871795,62,179,78,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.043478261,0.897435897,0.897435897,70,78,78,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.02484472,0.816326531,0.888888889,40,49,45,?a
?a  hasGender  Male  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.040372671,0.373563218,0.855263158,65,174,76,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.02173913,0.813953488,0.875,35,43,40,?a
?a  hasStage  IIIA  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.010559006,0.708333333,1,17,24,17,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.026708075,0.811320755,0.934782609,43,53,46,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.019254658,0.62,0.837837838,31,50,37,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.020496894,0.5,0.804878049,33,66,41,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  hasBiomarker  EGFR_Negative,0.061490683,0.482926829,0.785714286,99,205,126,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.01552795,0.423728814,0.862068966,25,59,29,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.148447205,0.929961089,0.929961089,239,257,257,?a
?a  hasGender  Male  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.038509317,0.362573099,0.885714286,62,171,70,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.040372671,0.357142857,0.8125,65,182,80,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.036645963,0.446969697,0.819444444,59,132,72,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.033540373,0.369863014,0.818181818,54,146,66,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  hasBiomarker  EGFR_Negative,0.049068323,0.395,0.806122449,79,200,98,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.030434783,0.720588235,0.859649123,49,68,57,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.033540373,0.223140496,0.830769231,54,242,65,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.024223602,0.428571429,0.829787234,39,91,47,?a
?a  hasGender  Male  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.099378882,0.451977401,0.808080808,160,354,198,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IIIA   ,?a  hasBiomarker  EGFR_Negative,0.011801242,0.287878788,0.95,19,66,20,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.029192547,0.313333333,0.839285714,47,150,56,?a
?a  hasGender  Male  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.02484472,0.377358491,0.888888889,40,106,45,?a
?a  hasGender  Male  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.025465839,0.366071429,0.82,41,112,50,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.076397516,0.745454545,0.904411765,123,165,136,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.019254658,0.17816092,0.885714286,31,174,35,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.027329193,0.411214953,0.771929825,44,107,57,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.022981366,0.672727273,0.804347826,37,55,46,?a
?a  hasGender  Male  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.017391304,0.651162791,0.965517241,28,43,29,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.060248447,0.502590674,0.898148148,97,193,108,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.024223602,0.464285714,0.795918367,39,84,49,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.010559006,0.425,0.894736842,17,40,19,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.016149068,0.866666667,0.962962963,26,30,27,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.016770186,0.306818182,0.964285714,27,88,28,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.041614907,0.905405405,0.905405405,67,74,74,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.019254658,0.534482759,0.861111111,31,58,36,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Surgery   ,?a  hasBiomarker  EGFR_Negative,0.018012422,0.90625,0.90625,29,32,32,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.026708075,0.623188406,0.811320755,43,69,53,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.034782609,0.343558282,0.848484848,56,163,66,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.018012422,0.517857143,0.90625,29,56,32,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  EGFR_Negative,0.014906832,0.52173913,0.857142857,24,46,28,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.036024845,0.935483871,0.935483871,58,62,62,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.041614907,0.930555556,0.930555556,67,72,72,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.044099379,0.360406091,0.755319149,71,197,94,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.034161491,0.381944444,0.808823529,55,144,68,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.016770186,0.642857143,0.818181818,27,42,33,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  EGFR_Negative,0.030434783,0.803278689,0.875,49,61,56,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.027950311,0.75,0.865384615,45,60,52,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.011801242,0.513513514,0.904761905,19,37,21,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.011801242,0.791666667,0.863636364,19,24,22,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.018012422,0.547169811,0.90625,29,53,32,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.022360248,0.679245283,0.9,36,53,40,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  hasBiomarker  EGFR_Negative,0.142857143,0.8984375,0.8984375,230,256,256,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  EGFR_Negative,0.014285714,0.442307692,0.821428571,23,52,28,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.018012422,0.391891892,0.828571429,29,74,35,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.01863354,0.38961039,0.833333333,30,77,36,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.02484472,0.350877193,0.769230769,40,114,52,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.054658385,0.31316726,0.785714286,88,281,112,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.091925466,0.436578171,0.804347826,148,339,184,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.024223602,0.40625,0.795918367,39,96,49,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.026086957,0.75,0.875,42,56,48,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.013043478,0.636363636,1,21,33,21,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.027950311,0.346153846,0.789473684,45,130,57,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  EGFR_Negative,0.02484472,0.408163265,0.816326531,40,98,49,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.014906832,0.444444444,0.8,24,54,30,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.050931677,0.503067485,0.863157895,82,163,95,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.026708075,0.390909091,0.826923077,43,110,52,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.026708075,0.914893617,0.914893617,43,47,47,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.072670807,0.75,0.873134328,117,156,134,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.021118012,0.404761905,0.80952381,34,84,42,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.011180124,0.6,0.818181818,18,30,22,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.022360248,0.473684211,0.857142857,36,76,42,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.020496894,0.388235294,0.804878049,33,85,41,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.01242236,0.408163265,0.8,20,49,25,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.057763975,0.920792079,0.920792079,93,101,101,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.062111801,0.961538462,0.961538462,100,104,104,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.019254658,0.369047619,0.794871795,31,84,39,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.038509317,0.939393939,0.939393939,62,66,66,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  EGFR_Negative,0.036645963,0.951612903,0.951612903,59,62,62,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.027950311,1,1,45,45,45,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  EGFR_Negative,0.01242236,0.363636364,0.833333333,20,55,24,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  EGFR_Negative,0.065217391,0.9375,0.9375,105,112,112,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.060248447,0.906542056,0.906542056,97,107,107,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.108695652,0.921052632,0.921052632,175,190,190,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.060248447,0.932692308,0.932692308,97,104,104,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  EGFR_Negative,0.021118012,0.944444444,0.944444444,34,36,36,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.027950311,0.957446809,0.957446809,45,47,47,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  EGFR_Negative,0.134161491,0.9,0.9,216,240,240,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.088819876,0.899371069,0.899371069,143,159,159,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.10310559,0.902173913,0.902173913,166,184,184,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.037267081,0.789473684,0.923076923,60,76,65,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.034161491,0.410447761,0.797101449,55,134,69,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.029813665,0.685714286,0.872727273,48,70,55,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  EGFR_Negative,0.024223602,0.582089552,0.847826087,39,67,46,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.030434783,0.830508475,0.890909091,49,59,55,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.01242236,0.666666667,0.952380952,20,30,21,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.016149068,0.65,0.928571429,26,40,28,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  EGFR_Negative,0.045341615,0.414772727,0.811111111,73,176,90,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.042236025,0.731182796,0.860759494,68,93,79,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.052795031,0.611510791,0.858585859,85,139,99,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  EGFR_Negative,0.013664596,0.75862069,0.956521739,22,29,23,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  EGFR_Negative,0.025465839,0.732142857,0.953488372,41,56,43,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.020496894,0.75,0.970588235,33,44,34,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  EGFR_Negative,0.011180124,0.195652174,0.9,18,92,20,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.026086957,0.75,0.913043478,42,56,46,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.049689441,0.769230769,0.898876404,80,104,89,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.014906832,0.923076923,1,24,26,24,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.063354037,0.476635514,0.790697674,102,214,129,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  EGFR_Negative,0.016770186,0.72972973,1,27,37,27,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.014285714,0.851851852,1,23,27,23,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.050310559,0.479289941,0.794117647,81,169,102,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  EGFR_Negative,0.027950311,0.692307692,0.865384615,45,65,52,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  EGFR_Negative,0.032919255,0.43442623,0.803030303,53,122,66,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  EGFR_Negative,0.031055901,0.531914894,0.877192982,50,94,57,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  EGFR_Negative,0.099378882,0.754716981,0.855614973,160,212,187,?a
?a  hasGender  Female  ?a  hasStage  IB   ,?a  hasSmokingHabit  FormerSmoker,0.010483871,0.5,0.5,13,26,26,?a
?a  hasGender  Male  ?a  hasStage  IIA   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.56097561,0.56097561,23,41,41,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIA   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.58974359,0.58974359,23,39,39,?a
?a  hasStage  IA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.012096774,0.517241379,0.517241379,15,29,29,?a
?a  hasAgeCategory  Old  ?a  hasStage  IA   ,?a  hasSmokingHabit  FormerSmoker,0.035483871,0.55,0.55,44,80,80,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IA   ,?a  hasSmokingHabit  FormerSmoker,0.010483871,0.619047619,0.619047619,13,21,21,?a
?a  hasStage  IIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.012096774,0.6,0.6,15,25,25,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IA   ,?a  hasSmokingHabit  FormerSmoker,0.020967742,0.530612245,0.530612245,26,49,49,?a
?a  hasGender  Male  ?a  hasStage  IIIB   ,?a  hasSmokingHabit  FormerSmoker,0.04516129,0.56,0.56,56,100,100,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.010483871,0.565217391,0.565217391,13,23,23,?a
?a  hasStage  IIIB  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.010483871,0.52,0.52,13,25,25,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIB   ,?a  hasSmokingHabit  FormerSmoker,0.047580645,0.621052632,0.621052632,59,95,95,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIB   ,?a  hasSmokingHabit  FormerSmoker,0.014516129,0.5625,0.5625,18,32,32,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.022580645,0.56,0.56,28,50,50,?a
?a  hasStage  IIIB  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.011290323,0.608695652,0.608695652,14,23,23,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.024193548,0.625,0.625,30,48,48,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.534883721,0.534883721,23,43,43,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.027419355,0.576271186,0.576271186,34,59,59,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.028225806,0.546875,0.546875,35,64,64,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.013709677,0.653846154,0.653846154,17,26,26,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  hasSmokingHabit  FormerSmoker,0.026612903,0.532258065,0.532258065,33,62,62,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.087096774,0.54822335,0.553846154,108,197,195,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.793103448,0.793103448,23,29,29,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.023387097,0.674418605,0.674418605,29,43,43,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.024193548,0.566037736,0.566037736,30,53,53,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.047580645,0.561904762,0.561904762,59,105,105,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.025806452,0.653061224,0.653061224,32,49,49,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.02016129,0.657894737,0.657894737,25,38,38,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.059677419,0.569230769,0.569230769,74,130,130,?a
?a  hasGender  Male  ?a  hasStage  IIB   ,?a  hasSmokingHabit  FormerSmoker,0.028225806,0.648148148,0.648148148,35,54,54,?a
?a  hasStage  IIB  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.022580645,0.666666667,0.666666667,28,42,42,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.015322581,0.678571429,0.678571429,19,28,28,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIB   ,?a  hasSmokingHabit  FormerSmoker,0.026612903,0.647058824,0.647058824,33,51,51,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  hasSmokingHabit  FormerSmoker,0.05,0.632653061,0.632653061,62,98,98,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IB   ,?a  hasSmokingHabit  FormerSmoker,0.011290323,0.636363636,0.636363636,14,22,22,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IIB   ,?a  hasSmokingHabit  FormerSmoker,0.013709677,0.708333333,0.708333333,17,24,24,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIB   ,?a  hasSmokingHabit  FormerSmoker,0.010483871,0.65,0.65,13,20,20,?a
?a  hasStage  IIB  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.016935484,0.65625,0.65625,21,32,32,?a
?a  hasStage  IIIA  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasSmokingHabit  FormerSmoker,0.011290323,0.56,0.56,14,25,25,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IB   ,?a  hasSmokingHabit  FormerSmoker,0.012096774,0.517241379,0.517241379,15,29,29,?a
?a  hasStage  IIIA  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.011290323,0.583333333,0.583333333,14,24,24,?a
?a  hasStage  IIIA  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.038709677,0.545454545,0.545454545,48,88,88,?a
?a  hasStage  IIIA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.025806452,0.551724138,0.551724138,32,58,58,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.052419355,0.537190083,0.537190083,65,121,121,?a
?a  hasStage  IIIA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.011290323,0.538461538,0.538461538,14,26,26,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  FormerSmoker,0.023387097,0.5,0.5,29,58,58,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.016935484,0.525,0.525,21,40,40,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.575,0.58974359,23,40,39,?a
?a  hasStage  IIIA  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.010483871,0.565217391,0.565217391,13,23,23,?a
?a  hasStage  IIIA  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.013709677,0.53125,0.53125,17,32,32,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  hasSmokingHabit  FormerSmoker,0.038709677,0.539325843,0.539325843,48,89,89,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  hasSmokingHabit  FormerSmoker,0.012903226,0.533333333,0.533333333,16,30,30,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.014516129,0.545454545,0.545454545,18,33,33,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.021774194,0.551020408,0.551020408,27,49,49,?a
?a  hasGender  Male  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.02983871,0.637931034,0.637931034,37,58,58,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.013709677,0.515151515,0.515151515,17,33,33,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.031451613,0.565217391,0.565217391,39,69,69,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.012096774,0.6,0.6,15,25,25,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.012903226,0.64,0.64,16,25,25,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.014516129,0.5625,0.5625,18,32,32,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.522727273,0.522727273,23,44,44,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.031451613,0.52,0.52,39,75,75,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.013709677,0.53125,0.53125,17,32,32,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Surgery   ,?a  hasSmokingHabit  FormerSmoker,0.016935484,0.538461538,0.538461538,21,39,39,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.011290323,0.636363636,0.636363636,14,22,22,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.026612903,0.532258065,0.532258065,33,62,62,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.534883721,0.534883721,23,43,43,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.121774194,0.565543071,0.565543071,151,267,267,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.311290323,0.576980568,0.578710645,386,669,667,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.016129032,0.571428571,0.571428571,20,35,35,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.150806452,0.551622419,0.553254438,187,339,338,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasSmokingHabit  FormerSmoker,0.033064516,0.539473684,0.539473684,41,76,76,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.043548387,0.5625,0.5625,54,96,96,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.125806452,0.555160142,0.555160142,156,281,281,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.053225806,0.578947368,0.578947368,66,114,114,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.037096774,0.567901235,0.567901235,46,81,81,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.052419355,0.546218487,0.546218487,65,119,119,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  FormerSmoker,0.04516129,0.571428571,0.571428571,56,98,98,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Gemcitabine   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.605263158,0.605263158,23,38,38,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Relapse   ,?a  hasSmokingHabit  FormerSmoker,0.029032258,0.620689655,0.620689655,36,58,58,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.070967742,0.564102564,0.564102564,88,156,156,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.091129032,0.543269231,0.543269231,113,208,208,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.026612903,0.589285714,0.589285714,33,56,56,?a
?a  patientDrug  Vincristine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.015322581,0.475,0.487179487,19,40,39,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.200806452,0.54248366,0.544857768,249,459,457,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.103225806,0.544680851,0.544680851,128,235,235,?a
?a  treatmentType  Thoracoscopy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.011290323,0.583333333,0.583333333,14,24,24,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.015322581,0.487179487,0.5,19,39,38,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.033870968,0.646153846,0.646153846,42,65,65,?a
?a  patientDrug  Doxorubicin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.016129032,0.5,0.512820513,20,40,39,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.127419355,0.552447552,0.552447552,158,286,286,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.076612903,0.542857143,0.542857143,95,175,175,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.111290323,0.570247934,0.570247934,138,242,242,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.02983871,0.544117647,0.544117647,37,68,68,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.046774194,0.597938144,0.597938144,58,97,97,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.025,0.58490566,0.58490566,31,53,53,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasSmokingHabit  FormerSmoker,0.010483871,0.764705882,0.764705882,13,17,17,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.035483871,0.571428571,0.571428571,44,77,77,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.048387097,0.588235294,0.588235294,60,102,102,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.037903226,0.573170732,0.573170732,47,82,82,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.013709677,0.566666667,0.566666667,17,30,30,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.059677419,0.556390977,0.556390977,74,133,133,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.021774194,0.6,0.6,27,45,45,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.020967742,0.590909091,0.590909091,26,44,44,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.044354839,0.56122449,0.56122449,55,98,98,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.059677419,0.569230769,0.569230769,74,130,130,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Thoracoscopy   ,?a  hasSmokingHabit  FormerSmoker,0.011290323,0.636363636,0.636363636,14,22,22,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.121774194,0.565543071,0.565543071,151,267,267,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.075806452,0.516483516,0.516483516,94,182,182,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.071774194,0.526627219,0.526627219,89,169,169,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.014516129,0.580645161,0.580645161,18,31,31,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.024193548,0.555555556,0.555555556,30,54,54,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.12016129,0.522807018,0.522807018,149,285,285,?a
?a  patientDrug  Vincristine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.013709677,0.566666667,0.566666667,17,30,30,?a
?a  patientDrug  Doxorubicin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.013709677,0.566666667,0.566666667,17,30,30,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.012903226,0.592592593,0.592592593,16,27,27,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.107258065,0.523622047,0.523622047,133,254,254,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasSmokingHabit  FormerSmoker,0.014516129,0.545454545,0.545454545,18,33,33,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.014516129,0.6,0.6,18,30,30,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.025,0.645833333,0.645833333,31,48,48,?a
?a  hasGender  Male  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.051612903,0.571428571,0.571428571,64,112,112,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.048387097,0.588235294,0.588235294,60,102,102,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasSmokingHabit  FormerSmoker,0.012903226,0.666666667,0.666666667,16,24,24,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.041129032,0.548387097,0.548387097,51,93,93,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.025,0.574074074,0.574074074,31,54,54,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.019354839,0.510638298,0.510638298,24,47,47,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.522727273,0.522727273,23,44,44,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.012903226,0.533333333,0.533333333,16,30,30,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.026612903,0.568965517,0.568965517,33,58,58,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.02016129,0.543478261,0.543478261,25,46,46,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Cisplatin   ,?a  hasSmokingHabit  FormerSmoker,0.015322581,0.612903226,0.612903226,19,31,31,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.048387097,0.52173913,0.52173913,60,115,115,?a
?a  hasGender  Male  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.162903226,0.570621469,0.57223796,202,354,353,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.070967742,0.520710059,0.520710059,88,169,169,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.015322581,0.513513514,0.513513514,19,37,37,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.168548387,0.508515815,0.509756098,209,411,410,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.02983871,0.606557377,0.606557377,37,61,61,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.015322581,0.633333333,0.633333333,19,30,30,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.040322581,0.574712644,0.574712644,50,87,87,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.064516129,0.540540541,0.540540541,80,148,148,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.087903226,0.514150943,0.514150943,109,212,212,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.100806452,0.558035714,0.558035714,125,224,224,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.025806452,0.524590164,0.524590164,32,61,61,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.055645161,0.56557377,0.56557377,69,122,122,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.161290323,0.514138817,0.515463918,200,389,388,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.019354839,0.571428571,0.571428571,24,42,42,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.088709677,0.578947368,0.578947368,110,190,190,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.059677419,0.517482517,0.517482517,74,143,143,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.044354839,0.528846154,0.528846154,55,104,104,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.010483871,0.52,0.52,13,25,25,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.051612903,0.556521739,0.556521739,64,115,115,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.026612903,0.532258065,0.532258065,33,62,62,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.033870968,0.552631579,0.552631579,42,76,76,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.019354839,0.52173913,0.52173913,24,46,46,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.011290323,0.56,0.56,14,25,25,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.014516129,0.5625,0.5625,18,32,32,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.024193548,0.555555556,0.555555556,30,54,54,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.012903226,0.516129032,0.516129032,16,31,31,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.032258065,0.519480519,0.519480519,40,77,77,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Doxorubicin   ,?a  hasSmokingHabit  FormerSmoker,0.02016129,0.446428571,0.454545455,25,56,55,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Relapse   ,?a  hasSmokingHabit  FormerSmoker,0.024193548,0.576923077,0.576923077,30,52,52,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.012096774,0.576923077,0.576923077,15,26,26,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasSmokingHabit  FormerSmoker,0.033064516,0.525641026,0.525641026,41,78,78,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.021774194,0.642857143,0.642857143,27,42,42,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.012096774,0.789473684,0.789473684,15,19,19,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.621621622,0.621621622,23,37,37,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.030645161,0.644067797,0.644067797,38,59,59,?a
?a  patientDrug  Doxorubicin  ?a  patientDrug  Vincristine   ,?a  hasSmokingHabit  FormerSmoker,0.02016129,0.438596491,0.446428571,25,57,56,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.037096774,0.676470588,0.676470588,46,68,68,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.015322581,0.633333333,0.633333333,19,30,30,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.033064516,0.621212121,0.621212121,41,66,66,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.013709677,0.62962963,0.62962963,17,27,27,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  hasSmokingHabit  FormerSmoker,0.037096774,0.638888889,0.638888889,46,72,72,?a
?a  hasGender  Male  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.044354839,0.611111111,0.611111111,55,90,90,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.020967742,0.604651163,0.604651163,26,43,43,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.025806452,0.571428571,0.571428571,32,56,56,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.029032258,0.580645161,0.580645161,36,62,62,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  hasSmokingHabit  FormerSmoker,0.031451613,0.582089552,0.582089552,39,67,67,?a
?a  patientDrug  Doxorubicin  ?a  patientDrug  Vp-16   ,?a  hasSmokingHabit  FormerSmoker,0.02016129,0.438596491,0.446428571,25,57,56,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  hasSmokingHabit  FormerSmoker,0.019354839,0.685714286,0.685714286,24,35,35,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Gemcitabine   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.676470588,0.676470588,23,34,34,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.015322581,0.678571429,0.678571429,19,28,28,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.014516129,0.620689655,0.620689655,18,29,29,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  FormerSmoker,0.12016129,0.522807018,0.522807018,149,285,285,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Gemcitabine   ,?a  hasSmokingHabit  FormerSmoker,0.024193548,0.576923077,0.576923077,30,52,52,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  FormerSmoker,0.207258065,0.551502146,0.55387931,257,466,464,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  FormerSmoker,0.035483871,0.523809524,0.523809524,44,84,84,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.07983871,0.6,0.6,99,165,165,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.018548387,0.605263158,0.605263158,23,38,38,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasSmokingHabit  FormerSmoker,0.1,0.516666667,0.516666667,124,240,240,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.042741935,0.540816327,0.540816327,53,98,98,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.012903226,0.533333333,0.533333333,16,30,30,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.012096774,0.517241379,0.517241379,15,29,29,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.066935484,0.522012579,0.522012579,83,159,159,?a
?a  hasGender  Male  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.110483871,0.552419355,0.552419355,137,248,248,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasSmokingHabit  FormerSmoker,0.079032258,0.535519126,0.535519126,98,183,183,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.033870968,0.56,0.56,42,75,75,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.035483871,0.611111111,0.611111111,44,72,72,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.031451613,0.582089552,0.582089552,39,67,67,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.081451613,0.561111111,0.561111111,101,180,180,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.124193548,0.59922179,0.59922179,154,257,257,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.141935484,0.600682594,0.600682594,176,293,293,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.042741935,0.630952381,0.630952381,53,84,84,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasSmokingHabit  FormerSmoker,0.086290323,0.594444444,0.594444444,107,180,180,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.016935484,0.6,0.6,21,35,35,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasSmokingHabit  FormerSmoker,0.055645161,0.552,0.552,69,125,125,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.016129032,0.689655172,0.689655172,20,29,29,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.092741935,0.572139303,0.572139303,115,201,201,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasSmokingHabit  FormerSmoker,0.017741935,0.55,0.55,22,40,40,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.083870968,0.565217391,0.565217391,104,184,184,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.202419355,0.559020045,0.561521253,251,449,447,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasSmokingHabit  FormerSmoker,0.140322581,0.522522523,0.522522523,174,333,333,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.043548387,0.519230769,0.519230769,54,104,104,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.091129032,0.553921569,0.553921569,113,204,204,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.025806452,0.615384615,0.615384615,32,52,52,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.031451613,0.565217391,0.565217391,39,69,69,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.016489179,0.436363636,0.436363636,48,110,110,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIA   ,?a  treatmentType  Chemotherapy_Adjuvant,0.01202336,0.291666667,0.294117647,35,120,119,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.019924425,0.302083333,0.302083333,58,192,192,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.013053933,0.290076336,0.290076336,38,131,131,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.028225806,0.538461538,0.538461538,35,65,65,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010305737,0.201342282,0.201342282,30,149,149,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasSmokingHabit  FormerSmoker,0.057258065,0.563492063,0.563492063,71,126,126,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.020611474,0.1875,0.19047619,60,320,315,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Chemotherapy_Adjuvant,0.020267949,0.335227273,0.337142857,59,176,175,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Chemotherapy_Adjuvant,0.013053933,0.436781609,0.436781609,38,87,87,?a
?a  hasGender  Female  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.011679835,0.300884956,0.300884956,34,113,113,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Chemotherapy_Adjuvant,0.013740982,0.229885057,0.239520958,40,174,167,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010649261,0.244094488,0.258333333,31,127,120,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012710409,0.143968872,0.149797571,37,257,247,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.023387097,0.517857143,0.517857143,29,56,56,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.025077293,0.162583519,0.164785553,73,449,443,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasSmokingHabit  FormerSmoker,0.036290323,0.535714286,0.535714286,45,84,84,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.017176228,0.632911392,0.632911392,50,79,79,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.022329097,0.684210526,0.684210526,65,95,95,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010992786,0.571428571,0.571428571,32,56,56,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.018893851,0.654761905,0.654761905,55,84,84,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010992786,0.470588235,0.470588235,32,68,68,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.014428032,0.512195122,0.512195122,42,82,82,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.011679835,0.459459459,0.459459459,34,74,74,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.015458605,0.45,0.45,45,100,100,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010649261,0.402597403,0.402597403,31,77,77,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.013397458,0.464285714,0.464285714,39,84,84,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  treatmentType  Chemotherapy_Adjuvant,0.011336311,0.370786517,0.370786517,33,89,89,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010649261,0.476923077,0.476923077,31,65,65,?a
?a  hasStage  IIIA  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012710409,0.420454545,0.420454545,37,88,88,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Chemotherapy_Adjuvant,0.017176228,0.378787879,0.378787879,50,132,132,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIA   ,?a  treatmentType  Chemotherapy_Adjuvant,0.013740982,0.289855072,0.289855072,40,138,138,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010305737,0.384615385,0.384615385,30,78,78,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.014084507,0.338842975,0.338842975,41,121,121,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012710409,0.37,0.37,37,100,100,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.015115081,0.26993865,0.271604938,44,163,162,?a
?a  hasStage  IIIA  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010649261,0.298076923,0.298076923,31,104,104,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Chemotherapy_Adjuvant,0.017519753,0.213389121,0.213389121,51,239,239,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.025764342,0.163398693,0.165929204,75,459,452,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012366884,0.537313433,0.537313433,36,67,67,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Chemotherapy_Adjuvant,0.013740982,0.13986014,0.148148148,40,286,270,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010649261,0.276785714,0.276785714,31,112,112,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012710409,0.193717277,0.206703911,37,191,179,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.02335967,0.666666667,0.666666667,68,102,102,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012710409,0.345794393,0.349056604,37,107,106,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Chemotherapy_Adjuvant,0.011679835,0.143459916,0.154545455,34,237,220,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  hasSmokingHabit  FormerSmoker,0.100806452,0.523012552,0.523012552,125,239,239,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Chemotherapy_Adjuvant,0.014771556,0.344,0.346774194,43,125,124,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Chemotherapy_Adjuvant,0.024390244,0.373684211,0.373684211,71,190,190,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012710409,0.402173913,0.406593407,37,92,91,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010305737,0.555555556,0.555555556,30,54,54,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.021985572,0.492307692,0.492307692,64,130,130,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Chemotherapy_Adjuvant,0.012710409,0.149797571,0.160869565,37,247,230,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Chemotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.010992786,0.561403509,0.561403509,32,57,57,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.0195809,0.395833333,0.401408451,57,144,142,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Chemotherapy_Adjuvant,0.010305737,0.306122449,0.306122449,30,98,98,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.016489179,0.340425532,0.355555556,48,141,135,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.011336311,0.366666667,0.388235294,33,90,85,?a
?a  hasGender  Female  ?a  patientDrug  Vp-16   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.013397458,0.6,0.609375,39,65,64,?a
?a  hasGender  Male  ?a  patientDrug  Cyclophosphamide   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.010305737,0.652173913,0.652173913,30,46,46,?a
?a  hasGender  Male  ?a  patientDrug  Vincristine   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.010649261,0.673913043,0.673913043,31,46,46,?a
?a  hasGender  Male  ?a  patientDrug  Doxorubicin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.011336311,0.6875,0.6875,33,48,48,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.024046719,0.382513661,0.391061453,70,183,179,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.026794916,0.366197183,0.371428571,78,213,210,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.010649261,0.525423729,0.525423729,31,59,59,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.015115081,0.349206349,0.349206349,44,126,126,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.018893851,0.392857143,0.392857143,55,140,140,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.019237375,0.339393939,0.339393939,56,165,165,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.010649261,0.336956522,0.336956522,31,92,92,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.021985572,0.351648352,0.351648352,64,182,182,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.032978358,0.377952756,0.377952756,96,254,254,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.011336311,0.297297297,0.297297297,33,111,111,?a
?a  hasStage  IIIB  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.010305737,0.344827586,0.352941176,30,87,85,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.024046719,0.752688172,0.752688172,70,93,93,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.01580213,0.410714286,0.410714286,46,112,112,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.029543112,0.301754386,0.301754386,86,285,285,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.024046719,0.348258706,0.348258706,70,201,201,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.043627619,0.309002433,0.309002433,127,411,411,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cyclophosphamide   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.013053933,0.655172414,0.655172414,38,58,58,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.021642047,0.406451613,0.406451613,63,155,155,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.040535898,0.303341902,0.303341902,118,389,389,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.018550326,0.321428571,0.325301205,54,168,166,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.025077293,0.421965318,0.429411765,73,173,170,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.015458605,0.330882353,0.333333333,45,136,135,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Vp-16   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.013053933,0.655172414,0.655172414,38,58,58,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.030917211,0.342205323,0.347490347,90,263,259,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vp-16   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.014084507,0.661290323,0.661290323,41,62,62,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.01202336,0.360824742,0.372340426,35,97,94,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.012366884,0.324324324,0.349514563,36,111,103,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.012710409,0.318965517,0.327433628,37,116,113,?a
?a  hasAgeCategory  Young  ?a  hasStage  IV   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.012710409,0.420454545,0.420454545,37,88,88,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.030230161,0.419047619,0.419047619,88,210,210,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.015115081,0.31884058,0.325925926,44,138,135,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.03160426,0.345864662,0.352490421,92,266,261,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.013740982,0.251572327,0.258064516,40,159,155,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vp-16   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.021985572,0.547008547,0.561403509,64,117,114,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.012366884,0.25,0.25,36,144,144,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.046375816,0.325301205,0.326086957,135,415,414,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.020267949,0.329608939,0.335227273,59,179,176,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.024390244,0.346341463,0.348039216,71,205,204,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.015458605,0.245901639,0.251396648,45,183,179,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vp-16   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.038474751,0.54368932,0.55721393,112,206,201,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vp-16   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.025420818,0.556390977,0.564885496,74,133,131,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.015458605,0.189873418,0.204545455,45,237,220,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Whole_Brain_Radiation_Therapy,0.023016146,0.201201201,0.213375796,67,333,314,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Thoracoscopy,0.018550326,0.388489209,0.409090909,54,139,132,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IB   ,?a  treatmentType  Thoracoscopy,0.012366884,0.782608696,0.782608696,36,46,46,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIA   ,?a  treatmentType  Thoracoscopy,0.016489179,0.4,0.403361345,48,120,119,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Thoracoscopy,0.011336311,0.35106383,0.362637363,33,94,91,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Thoracoscopy,0.012710409,0.336363636,0.336363636,37,110,110,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Thoracoscopy,0.019924425,0.644444444,0.644444444,58,90,90,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Thoracoscopy,0.025420818,0.582677165,0.616666667,74,127,120,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Thoracoscopy,0.051872209,0.317226891,0.331868132,151,476,455,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Thoracoscopy,0.020611474,0.340909091,0.342857143,60,176,175,?a
?a  hasGender  Female  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Thoracoscopy,0.011679835,0.641509434,0.641509434,34,53,53,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  treatmentType  Thoracoscopy,0.026451391,0.337719298,0.358139535,77,228,215,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Thoracoscopy,0.010992786,0.367816092,0.367816092,32,87,87,?a
?a  hasGender  Male  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Thoracoscopy,0.017863277,0.304093567,0.304093567,52,171,171,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Thoracoscopy,0.032634833,0.545977011,0.568862275,95,174,167,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Thoracoscopy,0.010649261,0.326315789,0.326315789,31,95,95,?a
?a  hasGender  Male  ?a  hasStage  IB   ,?a  treatmentType  Thoracoscopy,0.017519753,0.739130435,0.739130435,51,69,69,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Thoracoscopy,0.010649261,0.397435897,0.397435897,31,78,78,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IA   ,?a  treatmentType  Thoracoscopy,0.014084507,0.836734694,0.836734694,41,49,49,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Thoracoscopy,0.010305737,0.24,0.24,30,125,125,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIB   ,?a  treatmentType  Thoracoscopy,0.010992786,0.62745098,0.62745098,32,51,51,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Thoracoscopy,0.01580213,0.380165289,0.380165289,46,121,121,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Thoracoscopy,0.024390244,0.622807018,0.622807018,71,114,114,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Relapse   ,?a  treatmentType  Thoracoscopy,0.011679835,0.586206897,0.596491228,34,58,57,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Thoracoscopy,0.02335967,0.618181818,0.618181818,68,110,110,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Thoracoscopy,0.021985572,0.62745098,0.62745098,64,102,102,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Thoracoscopy,0.010992786,0.666666667,0.666666667,32,48,48,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  treatmentType  Thoracoscopy,0.024046719,0.384615385,0.386740331,70,182,181,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  treatmentType  Thoracoscopy,0.035039505,0.534031414,0.569832402,102,191,179,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Thoracoscopy,0.025420818,0.314893617,0.316239316,74,235,234,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Thoracoscopy,0.022329097,0.271966527,0.271966527,65,239,239,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIA   ,?a  hasGender  Male,0.027375201,0.871794872,0.871794872,34,39,39,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Thoracoscopy,0.013397458,0.211956522,0.217877095,39,184,179,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIA   ,?a  hasGender  Male,0.018518519,0.851851852,0.851851852,23,27,27,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Thoracoscopy,0.020611474,0.333333333,0.335195531,60,180,179,?a
?a  hasAgeCategory  Old  ?a  hasStage  IA   ,?a  hasGender  Male,0.048309179,0.75,0.75,60,80,80,?a
?a  hasStage  IIA  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.011272142,0.823529412,0.823529412,14,17,17,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Thoracoscopy,0.015458605,0.220588235,0.226130653,45,204,199,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIA   ,?a  hasGender  Male,0.014492754,0.9,0.9,18,20,20,?a
?a  hasStage  IIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.020933977,0.928571429,0.928571429,26,28,28,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IA   ,?a  hasGender  Male,0.012077295,0.714285714,0.714285714,15,21,21,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVA   ,?a  hasGender  Male,0.012077295,0.789473684,0.789473684,15,19,19,?a
?a  hasStage  IVA  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.020933977,0.787878788,0.787878788,26,33,33,?a
?a  hasStage  IVA  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.012077295,0.882352941,0.882352941,15,17,17,?a
?a  hasStage  IVA  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.012077295,0.833333333,0.833333333,15,18,18,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  hasGender  Male,0.037037037,0.741935484,0.741935484,46,62,62,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVA   ,?a  hasGender  Male,0.019323671,0.727272727,0.727272727,24,33,33,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVA   ,?a  hasGender  Male,0.01610306,0.769230769,0.769230769,20,26,26,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.012077295,0.75,0.75,15,20,20,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.030595813,0.76,0.76,38,50,50,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVA   ,?a  hasGender  Male,0.018518519,0.71875,0.71875,23,32,32,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVA   ,?a  hasGender  Male,0.024959742,0.720930233,0.720930233,31,43,43,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.012882448,0.8,0.8,16,20,20,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.02979066,0.770833333,0.770833333,37,48,48,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIB   ,?a  hasGender  Male,0.061191626,0.8,0.8,76,95,95,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVA   ,?a  hasGender  Male,0.012077295,0.789473684,0.789473684,15,19,19,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasGender  Male,0.025764895,0.744186047,0.744186047,32,43,43,?a
?a  hasStage  IIIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.041062802,0.728571429,0.728571429,51,70,70,?a
?a  hasStage  IIIB  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.016908213,0.84,0.84,21,25,25,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIB   ,?a  hasGender  Male,0.045088567,0.788732394,0.788732394,56,71,71,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.042673108,0.791044776,0.791044776,53,67,67,?a
?a  hasStage  IIIB  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Male,0.016908213,0.724137931,0.724137931,21,29,29,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.028985507,0.72,0.72,36,50,50,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.037037037,0.741935484,0.741935484,46,62,62,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IIIB   ,?a  hasGender  Male,0.010466989,0.764705882,0.764705882,13,17,17,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  hasGender  Male,0.086956522,0.794117647,0.794117647,108,136,136,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.028180354,0.714285714,0.714285714,35,49,49,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVB   ,?a  hasGender  Male,0.01610306,0.769230769,0.769230769,20,26,26,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.017713366,0.75862069,0.75862069,22,29,29,?a
?a  hasStage  IV  ?a  patientDrug  Doxorubicin   ,?a  hasGender  Male,0.020128824,0.833333333,0.833333333,25,30,30,?a
?a  hasStage  IV  ?a  treatmentType  Chemotherapy   ,?a  hasGender  Male,0.030595813,0.863636364,0.863636364,38,44,44,?a
?a  hasStage  IV  ?a  patientDrug  Vp-16   ,?a  hasGender  Male,0.057165862,0.78021978,0.78021978,71,91,91,?a
?a  hasStage  IV  ?a  patientDrug  Cyclophosphamide   ,?a  hasGender  Male,0.020128824,0.78125,0.78125,25,32,32,?a
?a  hasStage  IV  ?a  patientDrug  Vincristine   ,?a  hasGender  Male,0.019323671,0.774193548,0.774193548,24,31,31,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIB   ,?a  hasGender  Male,0.028180354,0.833333333,0.833333333,35,42,42,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIB   ,?a  hasGender  Male,0.012882448,0.8,0.8,16,20,20,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.103864734,0.720670391,0.720670391,129,179,179,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IB   ,?a  hasGender  Male,0.024959742,0.794871795,0.794871795,31,39,39,?a
?a  hasStage  IB  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.017713366,0.75862069,0.75862069,22,29,29,?a
?a  hasStage  IIB  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.023349436,0.90625,0.90625,29,32,32,?a
?a  hasStage  IIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.012882448,0.888888889,0.888888889,16,18,18,?a
?a  hasStage  IB  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.041062802,0.739130435,0.739130435,51,69,69,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIB   ,?a  hasGender  Male,0.033011272,0.803921569,0.803921569,41,51,51,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IIB   ,?a  hasGender  Male,0.017713366,0.916666667,0.916666667,22,24,24,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIB   ,?a  hasGender  Male,0.012882448,0.8,0.8,16,20,20,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IB   ,?a  hasGender  Male,0.012882448,0.727272727,0.727272727,16,22,22,?a
?a  hasRelapse_Progression  Relapse  ?a  hasStage  IB   ,?a  hasGender  Male,0.010466989,0.764705882,0.764705882,13,17,17,?a
?a  hasStage  IB  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.012882448,0.727272727,0.727272727,16,22,22,?a
?a  hasStage  IIIA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.037037037,0.793103448,0.793103448,46,58,58,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IB   ,?a  hasGender  Male,0.010466989,0.764705882,0.764705882,13,17,17,?a
?a  hasStage  IB  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.012077295,0.882352941,0.882352941,15,17,17,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  hasGender  Male,0.05958132,0.732673267,0.732673267,74,101,101,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  hasGender  Male,0.109500805,0.747252747,0.747252747,136,182,182,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IB   ,?a  hasGender  Male,0.019323671,0.827586207,0.827586207,24,29,29,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.034621578,0.728813559,0.728813559,43,59,59,?a
?a  hasStage  IIIA  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.014492754,0.782608696,0.782608696,18,23,23,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  hasGender  Male,0.052334944,0.730337079,0.730337079,65,89,89,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IIIA   ,?a  hasGender  Male,0.015297907,0.904761905,0.904761905,19,21,21,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.072463768,0.743801653,0.743801653,90,121,121,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  hasGender  Male,0.046698873,0.743589744,0.743589744,58,78,78,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IIIA   ,?a  hasGender  Male,0.022544283,0.823529412,0.823529412,28,34,34,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  hasGender  Male,0.036231884,0.775862069,0.775862069,45,58,58,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Male,0.202898551,0.775384615,0.775384615,252,325,325,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.208534622,0.764011799,0.764011799,259,339,339,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy   ,?a  hasGender  Male,0.028180354,0.875,0.875,35,40,40,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.10547504,0.803680982,0.803680982,131,163,163,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.31078905,0.81092437,0.81092437,386,476,476,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.068438003,0.772727273,0.772727273,85,110,110,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.170692432,0.754448399,0.754448399,212,281,281,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Doxorubicin   ,?a  hasGender  Male,0.028985507,0.923076923,0.923076923,36,39,39,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.060386473,0.78125,0.78125,75,96,96,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cyclophosphamide   ,?a  hasGender  Male,0.027375201,0.944444444,0.944444444,34,36,36,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.128824477,0.769230769,0.769230769,160,208,208,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.035426731,0.785714286,0.785714286,44,56,56,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vincristine   ,?a  hasGender  Male,0.028180354,0.945945946,0.945945946,35,37,37,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  hasGender  Male,0.057971014,0.827586207,0.827586207,72,87,87,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.15136876,0.8,0.8,188,235,235,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Male,0.172302738,0.748251748,0.748251748,214,286,286,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vp-16   ,?a  hasGender  Male,0.09178744,0.765100671,0.765100671,114,149,149,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.284219002,0.769063181,0.769063181,353,459,459,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy   ,?a  hasGender  Male,0.020128824,0.833333333,0.833333333,25,30,30,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Negative   ,?a  hasGender  Male,0.039452496,0.753846154,0.753846154,49,65,65,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy   ,?a  hasGender  Male,0.037037037,0.779661017,0.779661017,46,59,59,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy   ,?a  hasGender  Male,0.023349436,0.783783784,0.783783784,29,37,37,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.061191626,0.791666667,0.791666667,76,96,96,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  RET_Negative   ,?a  hasGender  Male,0.027375201,0.894736842,0.894736842,34,38,38,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.070853462,0.733333333,0.733333333,88,120,120,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Chemotherapy   ,?a  hasGender  Male,0.035426731,0.771929825,0.771929825,44,57,57,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.033011272,0.719298246,0.719298246,41,57,57,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Male,0.01610306,0.740740741,0.740740741,20,27,27,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.038647343,0.71641791,0.71641791,48,67,67,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.070853462,0.8,0.8,88,110,110,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Doxorubicin   ,?a  hasGender  Male,0.020128824,0.806451613,0.806451613,25,31,31,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.073268921,0.733870968,0.733870968,91,124,124,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.082930757,0.746376812,0.746376812,103,138,138,?a
?a  hasRelapse_Progression  Relapse  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Male,0.01610306,0.740740741,0.740740741,20,27,27,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.162640902,0.808,0.808,202,250,250,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.045088567,0.777777778,0.777777778,56,72,72,?a
?a  hasBiomarker  RET_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasGender  Male,0.018518519,0.884615385,0.884615385,23,26,26,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Surgery   ,?a  hasGender  Male,0.02979066,0.787234043,0.787234043,37,47,47,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.037037037,0.793103448,0.793103448,46,58,58,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.044283414,0.797101449,0.797101449,55,69,69,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Doxorubicin   ,?a  hasGender  Male,0.017713366,0.846153846,0.846153846,22,26,26,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cyclophosphamide   ,?a  hasGender  Male,0.017713366,0.846153846,0.846153846,22,26,26,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.202093398,0.784375,0.784375,251,320,320,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.035426731,0.785714286,0.785714286,44,56,56,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vincristine   ,?a  hasGender  Male,0.016908213,0.84,0.84,21,25,25,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.038647343,0.857142857,0.857142857,48,56,56,?a
?a  hasBiomarker  RET_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.016908213,0.954545455,0.954545455,21,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.110305958,0.778409091,0.778409091,137,176,176,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasGender  Male,0.079710145,0.785714286,0.785714286,99,126,126,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.123993559,0.814814815,0.814814815,154,189,189,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.019323671,0.857142857,0.857142857,24,28,28,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.020933977,0.742857143,0.742857143,26,35,35,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.033011272,0.672131148,0.672131148,41,61,61,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.141706924,0.803652968,0.803652968,176,219,219,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.020128824,0.714285714,0.714285714,25,35,35,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.012077295,0.714285714,0.714285714,15,21,21,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasGender  Male,0.086151369,0.816793893,0.816793893,107,131,131,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasGender  Male,0.022544283,0.717948718,0.717948718,28,39,39,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Male,0.024154589,0.769230769,0.769230769,30,39,39,?a
?a  patientDrug  Vincristine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Male,0.024959742,0.775,0.775,31,40,40,?a
?a  patientDrug  Doxorubicin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Male,0.026570048,0.825,0.825,33,40,40,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasGender  Male,0.013687601,0.772727273,0.772727273,17,22,22,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.041867955,0.764705882,0.764705882,52,68,68,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.026570048,0.868421053,0.868421053,33,38,38,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Surgery   ,?a  hasGender  Male,0.018518519,0.696969697,0.696969697,23,33,33,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Male,0.013687601,0.80952381,0.80952381,17,21,21,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Male,0.015297907,0.730769231,0.730769231,19,26,26,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.046698873,0.783783784,0.783783784,58,74,74,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.024154589,0.882352941,0.882352941,30,34,34,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasGender  Male,0.036231884,0.803571429,0.803571429,45,56,56,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Male,0.027375201,0.68,0.68,34,50,50,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Male,0.015297907,0.76,0.76,19,25,25,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasGender  Male,0.023349436,0.69047619,0.69047619,29,42,42,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.018518519,0.696969697,0.696969697,23,33,33,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Thoracoscopy   ,?a  hasGender  Male,0.076489533,0.714285714,0.714285714,95,133,133,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.074074074,0.686567164,0.686567164,92,134,134,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.020128824,0.806451613,0.806451613,25,31,31,?a
?a  patientDrug  Vincristine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.019323671,0.8,0.8,24,30,30,?a
?a  patientDrug  Doxorubicin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.020128824,0.833333333,0.833333333,25,30,30,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasGender  Male,0.099033816,0.698863636,0.698863636,123,176,176,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.02979066,0.725490196,0.725490196,37,51,51,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.058776167,0.715686275,0.715686275,73,102,102,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.033011272,0.694915254,0.694915254,41,59,59,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.012882448,0.888888889,0.888888889,16,18,18,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.010466989,0.764705882,0.764705882,13,17,17,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.032206119,0.833333333,0.833333333,40,48,48,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.016908213,0.807692308,0.807692308,21,26,26,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasGender  Male,0.022544283,0.756756757,0.756756757,28,37,37,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasGender  Male,0.011272142,0.736842105,0.736842105,14,19,19,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.034621578,0.693548387,0.693548387,43,62,62,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.079710145,0.692307692,0.692307692,99,143,143,?a
?a  patientDrug  Ipilimumab  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.011272142,0.777777778,0.777777778,14,18,18,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasGender  Male,0.02173913,0.84375,0.84375,27,32,32,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.016908213,0.488372093,0.488372093,21,43,43,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.019323671,0.8,0.8,24,30,30,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasGender  Male,0.020128824,0.480769231,0.480769231,25,52,52,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.033011272,0.759259259,0.759259259,41,54,54,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasGender  Male,0.020933977,0.702702703,0.702702703,26,37,37,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.055555556,0.75,0.75,69,92,92,?a
?a  hasRelapse_Progression  Relapse  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.012882448,0.695652174,0.695652174,16,23,23,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.022544283,0.756756757,0.756756757,28,37,37,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Relapse   ,?a  hasGender  Male,0.010466989,0.8125,0.8125,13,16,16,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Relapse   ,?a  hasGender  Male,0.012882448,0.761904762,0.761904762,16,21,21,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.022544283,0.777777778,0.777777778,28,36,36,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.046698873,0.743589744,0.743589744,58,78,78,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.017713366,0.709677419,0.709677419,22,31,31,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.051529791,0.735632184,0.735632184,64,87,87,?a
?a  patientDrug  Doxorubicin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.038647343,0.813559322,0.813559322,48,59,59,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.090982287,0.763513514,0.763513514,113,148,148,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasGender  Male,0.032206119,0.740740741,0.740740741,40,54,54,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.037037037,0.779661017,0.779661017,46,59,59,?a
?a  patientDrug  Vincristine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.037037037,0.779661017,0.779661017,46,59,59,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.112721417,0.736842105,0.736842105,140,190,190,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.028985507,0.857142857,0.857142857,36,42,42,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.013687601,0.944444444,0.944444444,17,18,18,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Doxorubicin   ,?a  hasGender  Male,0.036231884,0.803571429,0.803571429,45,56,56,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.039452496,0.803278689,0.803278689,49,61,61,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Doxorubicin   ,?a  hasGender  Male,0.03784219,0.824561404,0.824561404,47,57,57,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.018518519,0.766666667,0.766666667,23,30,30,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasGender  Male,0.070853462,0.721311475,0.721311475,88,122,122,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.026570048,0.804878049,0.804878049,33,41,41,?a
?a  patientDrug  Doxorubicin  ?a  patientDrug  Vp-16   ,?a  hasGender  Male,0.037037037,0.807017544,0.807017544,46,57,57,?a
?a  patientDrug  Doxorubicin  ?a  patientDrug  Vincristine   ,?a  hasGender  Male,0.037037037,0.807017544,0.807017544,46,57,57,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.039452496,0.731343284,0.731343284,49,67,67,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.019323671,0.827586207,0.827586207,24,29,29,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasGender  Male,0.037037037,0.741935484,0.741935484,46,62,62,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Gemcitabine   ,?a  hasGender  Male,0.017713366,0.6875,0.6875,22,32,32,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.01610306,0.689655172,0.689655172,20,29,29,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vp-16   ,?a  hasGender  Male,0.076489533,0.714285714,0.714285714,95,133,133,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Male,0.134460548,0.695833333,0.695833333,167,240,240,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Ipilimumab   ,?a  hasGender  Male,0.011272142,0.777777778,0.777777778,14,18,18,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Male,0.039452496,0.731343284,0.731343284,49,67,67,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Male,0.040257649,0.819672131,0.819672131,50,61,61,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cyclophosphamide   ,?a  hasGender  Male,0.036231884,0.775862069,0.775862069,45,58,58,?a
?a  hasBiomarker  RET_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Male,0.022544283,0.875,0.875,28,32,32,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasGender  Male,0.090982287,0.701863354,0.701863354,113,161,161,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vincristine   ,?a  hasGender  Male,0.037037037,0.779661017,0.779661017,46,59,59,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.010466989,0.8125,0.8125,13,16,16,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.01610306,0.869565217,0.869565217,20,23,23,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasGender  Male,0.041867955,0.693333333,0.693333333,52,75,75,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Docetaxel   ,?a  hasGender  Male,0.011272142,0.875,0.875,14,16,16,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.012882448,0.842105263,0.842105263,16,19,19,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasGender  Male,0.012882448,0.761904762,0.761904762,16,21,21,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.022544283,0.848484848,0.848484848,28,33,33,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.108695652,0.75,0.75,135,180,180,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.020128824,0.78125,0.78125,25,32,32,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasGender  Male,0.017713366,0.88,0.88,22,25,25,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.016908213,0.724137931,0.724137931,21,29,29,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.034621578,0.826923077,0.826923077,43,52,52,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasGender  Male,0.011272142,0.933333333,0.933333333,14,15,15,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Male,0.192431562,0.717717718,0.717717718,239,333,333,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.041867955,0.776119403,0.776119403,52,67,67,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.10547504,0.711956522,0.711956522,131,184,184,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Carboplatin   ,?a  hasGender  Male,0.013687601,1,1,17,17,17,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Male,0.138486312,0.696356275,0.696356275,172,247,247,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasGender  Male,0.033816425,0.875,0.875,42,48,48,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010649261,0.25,0.25203252,31,124,123,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013740982,0.289855072,0.289855072,40,138,138,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasGender  Male,0.070048309,0.776785714,0.776785714,87,112,112,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.018550326,0.113445378,0.118681319,54,476,455,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.018893851,0.48245614,0.48245614,55,114,114,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Male,0.1352657,0.708860759,0.708860759,168,237,237,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasGender  Male,0.070048309,0.769911504,0.769911504,87,113,113,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.020611474,0.363636364,0.363636364,60,165,165,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.017176228,0.149700599,0.152439024,50,334,328,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013740982,0.43956044,0.43956044,40,91,91,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013397458,0.146616541,0.149425287,39,266,261,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010992786,0.174863388,0.17877095,32,183,179,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.011679835,0.159624413,0.161904762,34,213,210,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.03160426,0.344569288,0.344569288,92,267,267,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.015458605,0.171102662,0.173745174,45,263,259,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.012710409,0.544117647,0.544117647,37,68,68,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.016489179,0.564705882,0.564705882,48,85,85,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.034008932,0.347368421,0.347368421,99,285,285,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.020954998,0.451851852,0.451851852,61,135,135,?a
?a  hasGender  Male  ?a  hasStage  IIIA   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.014771556,0.247126437,0.248554913,43,174,173,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013740982,0.434782609,0.434782609,40,92,92,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.019924425,0.397260274,0.397260274,58,146,146,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.039505325,0.653409091,0.653409091,115,176,176,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.029886637,0.514792899,0.514792899,87,169,169,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.016145654,0.465346535,0.465346535,47,101,101,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010305737,0.441176471,0.441176471,30,68,68,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.029886637,0.342519685,0.342519685,87,254,254,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.018893851,0.44,0.44,55,125,125,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013397458,0.348214286,0.348214286,39,112,112,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.011679835,0.404761905,0.404761905,34,84,84,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.011336311,0.492537313,0.492537313,33,67,67,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010305737,0.265486726,0.265486726,30,113,113,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010305737,0.20979021,0.20979021,30,143,143,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.025764342,0.112107623,0.11627907,75,669,645,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.011679835,0.369565217,0.369565217,34,92,92,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.016489179,0.571428571,0.571428571,48,84,84,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010305737,0.384615385,0.384615385,30,78,78,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.012366884,0.327272727,0.327272727,36,110,110,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.011679835,0.548387097,0.548387097,34,62,62,?a
?a  hasStage  IIIA  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.011336311,0.317307692,0.317307692,33,104,104,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.017863277,0.571428571,0.571428571,52,91,91,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010305737,0.340909091,0.340909091,30,88,88,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013740982,0.384615385,0.384615385,40,104,104,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.01580213,0.252747253,0.254143646,46,182,181,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.019924425,0.617021277,0.617021277,58,94,94,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013397458,0.239263804,0.240740741,39,163,162,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.017519753,0.25,0.251231527,51,204,203,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.015458605,0.340909091,0.340909091,45,132,132,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.021642047,0.268085106,0.269230769,63,235,234,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.025764342,0.614754098,0.614754098,75,122,122,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010305737,0.163043478,0.167597765,30,184,179,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.012710409,0.305785124,0.305785124,37,121,121,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.01202336,0.171568627,0.175879397,35,204,199,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.018206802,0.294444444,0.296089385,53,180,179,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.022672621,0.308411215,0.308411215,66,214,214,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.03160426,0.429906542,0.429906542,92,214,214,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010305737,0.280373832,0.283018868,30,107,106,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIA   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.014428032,0.304347826,0.304347826,42,138,138,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.010305737,0.126582278,0.136363636,30,237,220,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.012710409,0.296,0.298387097,37,125,124,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.013397458,0.136363636,0.144444444,39,286,270,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.023016146,0.161445783,0.161835749,67,415,414,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.011336311,0.157142857,0.157142857,33,210,210,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.014771556,0.413461538,0.413461538,43,104,104,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.012366884,0.140625,0.15,36,256,240,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.015458605,0.135135135,0.143312102,45,333,314,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.015115081,0.154385965,0.157706093,44,285,279,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.020611474,0.24,0.24,60,250,250,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.012366884,0.428571429,0.428571429,36,84,84,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.011336311,0.251908397,0.251908397,33,131,131,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.013740982,0.305343511,0.330578512,40,131,121,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.014428032,0.333333333,0.336,42,126,125,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Concurrent_Chemoradiotherapy,0.012710409,0.154166667,0.158119658,37,240,234,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  treatmentType  Immunotherapy,0.010992786,0.235294118,0.248062016,32,136,129,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.025420818,0.221556886,0.225609756,74,334,328,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.018893851,0.291005291,0.30726257,55,189,179,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.010305737,0.212765957,0.222222222,30,141,135,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Immunotherapy,0.010649261,0.224637681,0.224637681,31,138,138,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Immunotherapy,0.01202336,0.212121212,0.212121212,35,165,165,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.018206802,0.263681592,0.263681592,53,201,201,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.010992786,0.235294118,0.237037037,32,136,135,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.016145654,0.886792453,0.886792453,47,53,53,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.021985572,0.292237443,0.306220096,64,219,209,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.011336311,0.362637363,0.375,33,91,88,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.011336311,0.289473684,0.289473684,33,114,114,?a
?a  hasGender  Female  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.010305737,0.882352941,0.882352941,30,34,34,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Immunotherapy,0.011336311,0.471428571,0.515625,33,70,64,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.012366884,0.214285714,0.21686747,36,168,166,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.018550326,0.203007519,0.206896552,54,266,261,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.01580213,0.326241135,0.343283582,46,141,134,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.010649261,0.574074074,0.62,31,54,50,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.016489179,0.307692308,0.322147651,48,156,149,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.010305737,0.297029703,0.297029703,30,101,101,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.022329097,0.247148289,0.250965251,65,263,259,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.012366884,0.257142857,0.257142857,36,140,140,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  treatmentType  Immunotherapy,0.01202336,0.304347826,0.330188679,35,115,106,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  treatmentType  Immunotherapy,0.014084507,0.312977099,0.336065574,41,131,122,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Immunotherapy,0.01202336,0.35,0.368421053,35,100,95,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.011336311,0.279661017,0.279661017,33,118,118,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Immunotherapy,0.010305737,0.337078652,0.337078652,30,89,89,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.012710409,0.202185792,0.206703911,37,183,179,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Immunotherapy,0.010992786,0.351648352,0.351648352,32,91,91,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Immunotherapy,0.014428032,0.238636364,0.238636364,42,176,176,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Immunotherapy,0.013053933,0.316666667,0.316666667,38,120,120,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Immunotherapy,0.017863277,0.204724409,0.204724409,52,254,254,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  treatmentType  Immunotherapy,0.015115081,0.22,0.221105528,44,200,199,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.014771556,0.222797927,0.223958333,43,193,192,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Immunotherapy,0.013740982,0.909090909,0.909090909,40,44,44,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.012710409,0.402173913,0.402173913,37,92,92,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.028512539,0.954022989,0.954022989,83,87,87,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.015115081,0.297297297,0.297297297,44,148,148,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.013740982,0.930232558,0.930232558,40,43,43,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.034008932,0.212446352,0.216157205,99,466,458,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Immunotherapy,0.015458605,0.247252747,0.247252747,45,182,182,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Immunotherapy,0.014084507,0.24260355,0.24260355,41,169,169,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.01580213,0.37704918,0.37704918,46,122,122,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.01202336,0.333333333,0.333333333,35,105,105,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  treatmentType  Immunotherapy,0.01202336,0.357142857,0.380434783,35,98,92,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.014428032,0.270967742,0.270967742,42,155,155,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  treatmentType  Immunotherapy,0.013740982,0.307692308,0.322580645,40,130,124,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.015458605,0.323741007,0.323741007,45,139,139,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.011679835,0.557377049,0.557377049,34,61,61,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  treatmentType  Immunotherapy,0.010649261,0.632653061,0.688888889,31,49,45,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.01580213,0.272189349,0.272189349,46,169,169,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.013397458,0.906976744,0.906976744,39,43,43,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.013397458,0.906976744,0.906976744,39,43,43,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.010305737,0.25210084,0.25210084,30,119,119,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.037100653,0.262773723,0.262773723,108,411,411,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.011336311,0.340206186,0.35106383,33,97,94,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.013740982,0.231213873,0.235294118,40,173,170,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.0195809,0.919354839,0.919354839,57,62,62,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.022329097,0.342105263,0.342105263,65,190,190,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.018550326,0.257142857,0.257142857,54,210,210,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Immunotherapy,0.025077293,0.325892857,0.325892857,73,224,224,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Immunotherapy,0.01202336,0.301724138,0.309734513,35,116,113,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Immunotherapy,0.014771556,0.311594203,0.318518519,43,138,135,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Immunotherapy,0.010649261,0.352272727,0.364705882,31,88,85,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Immunotherapy,0.013053933,0.926829268,0.926829268,38,41,41,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.017519753,0.910714286,0.910714286,51,56,56,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.01202336,0.897435897,0.897435897,35,39,39,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.01202336,0.336538462,0.336538462,35,104,104,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.018550326,0.264705882,0.266009852,54,204,203,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.032978358,0.941176471,0.941176471,96,102,102,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Immunotherapy,0.011336311,0.294642857,0.294642857,33,112,112,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Immunotherapy,0.021298523,0.925373134,0.925373134,62,67,67,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Immunotherapy,0.010992786,0.262295082,0.262295082,32,122,122,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Immunotherapy,0.015458605,0.25,0.251396648,45,180,179,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.013397458,0.314516129,0.314516129,39,124,124,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.023703195,0.323943662,0.323943662,69,213,213,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.020611474,0.327868852,0.335195531,60,183,179,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.018550326,0.339622642,0.348387097,54,159,155,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.021985572,0.31372549,0.32160804,64,204,199,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Immunotherapy,0.016832704,0.485148515,0.52688172,49,101,93,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Immunotherapy,0.013397458,0.397959184,0.414893617,39,98,94,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Immunotherapy,0.018550326,0.252336449,0.252336449,54,214,214,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.0195809,0.238493724,0.238493724,57,239,239,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.018893851,0.257009346,0.257009346,55,214,214,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.025764342,0.3125,0.320512821,75,240,234,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.032291309,0.226506024,0.22705314,94,415,414,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.018893851,0.341614907,0.352564103,55,161,156,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.029199588,0.298245614,0.304659498,85,285,279,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Immunotherapy,0.011336311,0.317307692,0.317307692,33,104,104,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.020267949,0.320652174,0.329608939,59,184,179,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.015458605,0.357142857,0.371900826,45,126,121,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Immunotherapy,0.018206802,0.504761905,0.546391753,53,105,97,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Immunotherapy,0.014428032,0.5,0.525,42,84,80,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  treatmentType  Molecular_Targeted_Therapy,0.010992786,0.222222222,0.225352113,32,144,142,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Molecular_Targeted_Therapy,0.020611474,0.281690141,0.285714286,60,213,210,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Immunotherapy,0.025420818,0.312236287,0.336363636,74,237,220,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Immunotherapy,0.034352456,0.3003003,0.318471338,100,333,314,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  NonSmoker   ,?a  treatmentType  Molecular_Targeted_Therapy,0.017519753,0.6375,0.64556962,51,80,79,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Immunotherapy,0.011679835,0.492753623,0.515151515,34,69,66,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Molecular_Targeted_Therapy,0.010649261,0.2,0.2,31,155,155,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Immunotherapy,0.016489179,0.466019417,0.505263158,48,103,95,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Molecular_Targeted_Therapy,0.011336311,0.16751269,0.16751269,33,197,197,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  treatmentType  Molecular_Targeted_Therapy,0.011336311,0.366666667,0.388235294,33,90,85,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Molecular_Targeted_Therapy,0.016832704,0.231132075,0.231132075,49,212,212,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Molecular_Targeted_Therapy,0.011679835,0.323809524,0.323809524,34,105,105,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Erlotinib   ,?a  treatmentType  Molecular_Targeted_Therapy,0.01202336,0.945945946,0.972222222,35,37,36,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Erlotinib   ,?a  treatmentType  Molecular_Targeted_Therapy,0.011336311,0.942857143,0.970588235,33,35,34,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Afatinib   ,?a  treatmentType  Molecular_Targeted_Therapy,0.011336311,1,1,33,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Molecular_Targeted_Therapy,0.014771556,0.210784314,0.21182266,43,204,203,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Molecular_Targeted_Therapy,0.013397458,0.226744186,0.232142857,39,172,168,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IV   ,?a  treatmentType  Molecular_Targeted_Therapy,0.010649261,0.96875,0.96875,31,32,32,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  treatmentType  Molecular_Targeted_Therapy,0.016832704,0.23902439,0.240196078,49,205,204,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Molecular_Targeted_Therapy,0.018206802,0.252380952,0.252380952,53,210,210,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Molecular_Targeted_Therapy,0.010649261,0.224637681,0.22962963,31,138,135,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Molecular_Targeted_Therapy,0.012366884,0.168224299,0.168224299,36,214,214,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Molecular_Targeted_Therapy,0.010649261,0.192546584,0.198717949,31,161,156,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Molecular_Targeted_Therapy,0.017863277,0.244131455,0.244131455,52,213,213,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.095652174,0.325581395,0.719626168,154,473,214,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.026086957,0.75,0.75,42,56,56,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Molecular_Targeted_Therapy,0.017176228,0.175438596,0.17921147,50,285,279,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Molecular_Targeted_Therapy,0.018893851,0.948275862,0.948275862,55,58,58,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.108074534,0.794520548,0.794520548,174,219,219,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.01552795,0.277777778,0.694444444,25,90,36,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.017391304,0.549019608,0.8,28,51,35,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.023602484,0.197916667,0.730769231,38,192,52,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.051552795,0.658730159,0.768518519,83,126,108,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.025465839,0.706896552,0.788461538,41,58,52,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  hasBiomarker  ALK_Negative,0.038509317,0.455882353,0.704545455,62,136,88,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.01242236,0.666666667,0.869565217,20,30,23,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasBiomarker  ALK_Negative,0.033540373,0.397058824,0.72,54,136,75,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.02173913,0.318181818,0.760869565,35,110,46,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.068322981,0.44,0.714285714,110,250,154,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ALK_Negative,0.022360248,0.52173913,0.72,36,69,50,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.064596273,0.325,0.707482993,104,320,147,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.026708075,0.796296296,0.796296296,43,54,54,?a
?a  hasBiomarker  RET_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.016149068,1,1,26,26,26,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.085093168,0.878205128,0.878205128,137,156,156,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.033540373,0.362416107,0.683544304,54,149,79,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.01242236,0.350877193,0.833333333,20,57,24,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.013043478,0.313432836,0.84,21,67,25,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.028571429,0.534883721,0.766666667,46,86,60,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.032298137,0.945454545,0.945454545,52,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.061490683,0.99,0.99,99,100,100,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.055279503,0.273846154,0.767241379,89,325,116,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.020496894,0.34375,0.868421053,33,96,38,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.019254658,0.260504202,0.794871795,31,119,39,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasBiomarker  ALK_Negative,0.031055901,0.354609929,0.793650794,50,141,63,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.014906832,0.2,0.827586207,24,120,29,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  hasBiomarker  ALK_Negative,0.022981366,0.366336634,0.948717949,37,101,39,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.013043478,0.6,0.807692308,21,35,26,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.014285714,0.676470588,0.884615385,23,34,26,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.038509317,0.681318681,0.849315068,62,91,73,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.026708075,0.377192982,0.767857143,43,114,56,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.042857143,0.259398496,0.766666667,69,266,90,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.013664596,1,1,22,22,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.027950311,0.272727273,0.775862069,45,165,58,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.013664596,0.360655738,0.814814815,22,61,27,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.031677019,0.411290323,0.80952381,51,124,63,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ALK_Negative,0.01242236,1,1,20,20,20,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.038509317,0.984126984,0.984126984,62,63,63,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ALK_Negative,0.040372671,0.984848485,0.984848485,65,66,66,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  ALK_Negative,0.014906832,0.827586207,0.827586207,24,29,29,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Negative   ,?a  hasBiomarker  ALK_Negative,0.018012422,0.805555556,0.805555556,29,36,36,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.011801242,0.76,0.76,19,25,25,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasBiomarker  ALK_Negative,0.011180124,0.461538462,0.461538462,18,39,39,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.022981366,0.973684211,0.973684211,37,38,38,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.01242236,0.909090909,0.909090909,20,22,22,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.010559006,1,1,17,17,17,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.011180124,1,1,18,18,18,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.014906832,0.75,0.75,24,32,32,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.010559006,0.894736842,0.894736842,17,19,19,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ALK_Negative,0.029813665,1,1,48,48,48,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasBiomarker  ALK_Negative,0.029813665,1,1,48,48,48,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.031677019,1,1,51,51,51,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.021118012,1,1,34,34,34,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  ALK_Negative,0.013043478,1,1,21,21,21,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.025465839,0.788461538,0.788461538,41,52,52,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.014285714,1,1,23,23,23,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.013043478,0.75,0.75,21,28,28,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.029192547,0.770491803,0.770491803,47,61,61,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.030434783,0.753846154,0.753846154,49,65,65,?a
?a  hasBiomarker  RET_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ALK_Negative,0.019875776,1,1,32,32,32,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.058385093,0.895238095,0.895238095,94,105,105,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  hasBiomarker  ALK_Negative,0.027329193,0.785714286,0.785714286,44,56,56,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasBiomarker  ALK_Negative,0.022360248,0.857142857,0.857142857,36,42,42,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.023602484,0.904761905,0.904761905,38,42,42,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.013043478,0.724137931,0.724137931,21,29,29,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.01552795,0.961538462,0.961538462,25,26,26,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.013664596,0.814814815,0.814814815,22,27,27,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.014906832,0.727272727,0.727272727,24,33,33,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.022360248,0.923076923,0.923076923,36,39,39,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.031055901,0.724637681,0.724637681,50,69,69,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ALK_Negative,0.064596273,0.928571429,0.928571429,104,112,112,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.067701863,0.96460177,0.96460177,109,113,113,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.011180124,0.947368421,0.947368421,18,19,19,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Female   ,?a  hasBiomarker  ALK_Negative,0.016770186,0.964285714,0.964285714,27,28,28,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  BRAF_Negative   ,?a  hasBiomarker  ALK_Negative,0.019875776,0.96969697,0.96969697,32,33,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.022360248,0.947368421,0.947368421,36,38,38,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ALK_Negative,0.037888199,0.726190476,0.726190476,61,84,84,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.02484472,0.952380952,0.952380952,40,42,42,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.011180124,1,1,18,18,18,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.031055901,0.961538462,0.961538462,50,52,52,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasBiomarker  ALK_Negative,0.035403727,0.93442623,0.93442623,57,61,61,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIB   ,?a  hasBiomarker  ALK_Negative,0.014906832,0.96,0.96,24,25,25,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.02484472,0.930232558,0.930232558,40,43,43,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.01242236,0.952380952,0.952380952,20,21,21,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.035403727,0.95,0.95,57,60,60,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  hasBiomarker  ALK_Negative,0.02173913,0.546875,0.714285714,35,64,49,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.017391304,0.965517241,0.965517241,28,29,29,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.040372671,0.970149254,0.970149254,65,67,67,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.026086957,0.567567568,0.777777778,42,74,54,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.013043478,0.807692308,0.875,21,26,24,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.023602484,0.513513514,0.745098039,38,74,51,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.02173913,0.853658537,0.897435897,35,41,39,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.014906832,0.705882353,0.8,24,34,30,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVB   ,?a  hasBiomarker  ALK_Negative,0.019875776,0.727272727,0.820512821,32,44,39,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.01242236,0.571428571,0.8,20,35,25,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.016149068,0.896551724,0.896551724,26,29,29,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.02173913,0.714285714,0.777777778,35,49,45,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.013664596,0.956521739,0.956521739,22,23,23,?a
?a  hasStage  IVB  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.023602484,0.520547945,0.745098039,38,73,51,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  hasBiomarker  ALK_Negative,0.01242236,0.465116279,0.625,20,43,32,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ALK_Negative,0.019875776,0.744186047,0.8,32,43,40,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  ALK_Negative,0.043478261,0.786516854,0.786516854,70,89,89,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  hasBiomarker  ALK_Negative,0.034782609,0.965517241,0.965517241,56,58,58,?a
?a  hasGender  Male  ?a  hasStage  IIIA   ,?a  hasBiomarker  ALK_Negative,0.036024845,0.333333333,0.763157895,58,174,76,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.026086957,0.512195122,0.777777778,42,82,54,?a
?a  hasStage  IIIA  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.011801242,0.59375,0.76,19,32,25,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.02173913,0.384615385,0.744680851,35,91,47,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.01863354,0.454545455,0.731707317,30,66,41,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.013043478,0.355932203,0.724137931,21,59,29,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  hasBiomarker  ALK_Negative,0.036645963,0.324175824,0.7375,59,182,80,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.014906832,0.52173913,0.774193548,24,46,31,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.022981366,0.305785124,0.725490196,37,121,51,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  ALK_Negative,0.106832298,0.955555556,0.955555556,172,180,180,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.041614907,0.797619048,0.797619048,67,84,84,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasBiomarker  ALK_Negative,0.10310559,0.948571429,0.948571429,166,175,175,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.034161491,0.982142857,0.982142857,55,56,56,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.026086957,0.442105263,0.75,42,95,56,?a
?a  hasGender  Male  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.036024845,0.339181287,0.828571429,58,171,70,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.016149068,0.464285714,0.8125,26,56,32,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.029813665,0.48,0.75,48,100,64,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.014285714,0.5,0.821428571,23,46,28,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasBiomarker  ALK_Negative,0.030434783,0.300613497,0.742424242,49,163,66,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.025465839,0.953488372,0.953488372,41,43,43,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.022981366,1,1,37,37,37,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  hasBiomarker  ALK_Negative,0.142857143,0.804195804,0.804195804,230,286,286,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.044099379,0.946666667,0.946666667,71,75,75,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasBiomarker  ALK_Negative,0.050310559,0.964285714,0.964285714,81,84,84,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.057763975,0.948979592,0.948979592,93,98,98,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.026708075,0.796296296,0.796296296,43,54,54,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.040372671,0.955882353,0.955882353,65,68,68,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.027950311,0.818181818,0.818181818,45,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.072049689,0.950819672,0.950819672,116,122,122,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.026086957,0.976744186,0.976744186,42,43,43,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  hasBiomarker  ALK_Negative,0.148447205,0.815699659,0.815699659,239,293,293,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.02484472,0.975609756,0.975609756,40,41,41,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.041614907,0.817073171,0.817073171,67,82,82,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.073913043,0.944444444,0.944444444,119,126,126,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.062111801,0.869565217,0.869565217,100,115,115,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.038509317,0.861111111,0.861111111,62,72,72,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.027950311,0.918367347,0.918367347,45,49,49,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ALK_Negative,0.036645963,0.880597015,0.880597015,59,67,67,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.010559006,0.607142857,0.85,17,28,20,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.018012422,0.547169811,0.725,29,53,40,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.10310559,0.81372549,0.81372549,166,204,204,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.030434783,0.340277778,0.720588235,49,144,68,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.016149068,0.619047619,0.787878788,26,42,33,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.020496894,0.6,0.717391304,33,55,46,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasBiomarker  ALK_Negative,0.010559006,0.772727273,0.80952381,17,22,21,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.01242236,0.384615385,0.714285714,20,52,28,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.027329193,0.293333333,0.785714286,44,150,56,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ALK_Negative,0.026708075,0.530864198,0.74137931,43,81,58,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.02173913,0.238095238,0.673076923,35,147,52,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.047204969,0.270462633,0.678571429,76,281,112,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasBiomarker  ALK_Negative,0.02484472,0.666666667,0.769230769,40,60,52,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.021118012,0.309090909,0.693877551,34,110,49,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.022360248,0.375,0.734693878,36,96,49,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.014285714,0.621621622,0.92,23,37,25,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.042857143,0.423312883,0.726315789,69,163,95,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.063975155,0.66025641,0.768656716,103,156,134,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.07826087,0.371681416,0.684782609,126,339,184,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.042857143,0.579831933,0.775280899,69,119,89,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.024223602,0.696428571,0.8125,39,56,48,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.033540373,0.312138728,0.675,54,173,80,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  hasBiomarker  ALK_Negative,0.043478261,0.35,0.714285714,70,200,98,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.011180124,0.352941176,0.72,18,51,25,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.013043478,0.238636364,0.75,21,88,28,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.01552795,0.324675325,0.694444444,25,77,36,?a
?a  hasGender  Male  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.022981366,0.330357143,0.74,37,112,50,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.01242236,0.37037037,0.666666667,20,54,30,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.010559006,0.459459459,0.80952381,17,37,21,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.019875776,0.31372549,0.695652174,32,102,46,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.019254658,0.407894737,0.738095238,31,76,42,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasBiomarker  ALK_Negative,0.022981366,0.336363636,0.711538462,37,110,52,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.010559006,0.333333333,0.708333333,17,51,24,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.030434783,0.202479339,0.753846154,49,242,65,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Thoracoscopy   ,?a  hasBiomarker  ALK_Negative,0.010559006,0.515151515,0.80952381,17,33,21,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.037267081,0.340909091,0.666666667,60,176,90,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.038509317,0.673913043,0.794871795,62,92,78,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.019254658,0.333333333,0.704545455,31,93,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.01552795,0.396825397,0.675675676,25,63,37,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasBiomarker  ALK_Negative,0.029192547,0.350746269,0.68115942,47,134,69,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasBiomarker  ALK_Negative,0.026708075,0.36440678,0.671875,43,118,64,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.011801242,0.633333333,0.904761905,19,30,21,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.011180124,0.367346939,0.72,18,49,25,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.039130435,0.677419355,0.797468354,63,93,79,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.013043478,0.807692308,0.875,21,26,24,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.016149068,0.702702703,0.962962963,26,37,27,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.016770186,0.321428571,0.692307692,27,84,39,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.027950311,0.661764706,0.789473684,45,68,57,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.021118012,0.607142857,0.790697674,34,56,43,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.029813665,0.813559322,0.872727273,48,59,55,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasBiomarker  ALK_Negative,0.026086957,0.724137931,0.807692308,42,58,52,?a
?a  hasGender  Male  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.020496894,0.311320755,0.733333333,33,106,45,?a
?a  hasGender  Male  ?a  patientDrug  Pembrolizumab   ,?a  hasBiomarker  ALK_Negative,0.016149068,0.604651163,0.896551724,26,43,29,?a
?a  hasGender  Male  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.042857143,0.543307087,0.741935484,69,127,93,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.01242236,0.740740741,0.869565217,20,27,23,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.033540373,0.710526316,0.830769231,54,76,65,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasBiomarker  ALK_Negative,0.036645963,0.522123894,0.7375,59,113,80,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.019254658,0.352272727,0.720930233,31,88,43,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  hasBiomarker  ALK_Negative,0.047204969,0.393782383,0.703703704,76,193,108,?a
?a  hasGender  Male  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.086956522,0.395480226,0.707070707,140,354,198,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  hasBiomarker  ALK_Negative,0.014906832,0.558139535,0.727272727,24,43,33,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.066459627,0.648484848,0.786764706,107,165,136,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  hasBiomarker  ALK_Negative,0.08136646,0.291759465,0.704301075,131,449,186,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  No_Progression   ,?a  hasBiomarker  ALK_Negative,0.01552795,0.143678161,0.714285714,25,174,35,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasBiomarker  ALK_Negative,0.041614907,0.482014388,0.676767677,67,139,99,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.024223602,0.696428571,0.847826087,39,56,46,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.021642047,0.707865169,0.707865169,63,89,89,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.025465839,0.436170213,0.719298246,41,94,57,?a
?a  hasGender  Male  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.02713844,0.622047244,0.622047244,79,127,127,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  hasBiomarker  ALK_Negative,0.052795031,0.397196262,0.658914729,85,214,129,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  hasBiomarker  ALK_Negative,0.066459627,0.622093023,0.753521127,107,172,142,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.044314668,0.483146067,0.483146067,129,267,267,?a
?a  hasGender  Male  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.010649261,0.476923077,0.476923077,31,65,65,?a
?a  hasGender  Male  ?a  hasStage  IIIB   ,?a  treatmentType  Intravenous_Chemotherapy,0.017519753,0.51,0.520408163,51,100,98,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.016489179,0.648648649,0.676056338,48,74,71,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.030573686,0.593333333,0.593333333,89,150,150,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  treatmentType  Intravenous_Chemotherapy,0.013053933,0.644067797,0.745098039,38,59,51,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.021642047,0.926470588,0.926470588,63,68,68,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.032634833,0.475,0.477386935,95,200,199,?a
?a  hasGender  Male  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.021985572,0.711111111,0.711111111,64,90,90,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.034008932,0.512953368,0.515625,99,193,192,?a
?a  hasGender  Male  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.038818276,0.455645161,0.457489879,113,248,247,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.041909997,0.61928934,0.655913978,122,197,186,?a
?a  hasGender  Male  ?a  patientDrug  Cyclophosphamide   ,?a  treatmentType  Intravenous_Chemotherapy,0.01580213,1,1,46,46,46,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.016832704,0.680555556,0.720588235,49,72,68,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.049124012,0.866666667,0.87195122,143,165,164,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.040192374,0.582089552,0.582089552,117,201,201,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.05496393,0.546075085,0.565371025,160,293,283,?a
?a  hasGender  Male  ?a  patientDrug  Vincristine   ,?a  treatmentType  Intravenous_Chemotherapy,0.01580213,1,1,46,46,46,?a
?a  hasGender  Male  ?a  patientDrug  Doxorubicin   ,?a  treatmentType  Intravenous_Chemotherapy,0.016489179,1,1,48,48,48,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  treatmentType  Intravenous_Chemotherapy,0.010649261,0.885714286,0.885714286,31,35,35,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.069391962,0.427061311,0.441048035,202,473,458,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Surgery   ,?a  treatmentType  Intravenous_Chemotherapy,0.011679835,0.772727273,0.772727273,34,44,44,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.014428032,0.763636364,0.763636364,42,55,55,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.011336311,0.70212766,0.70212766,33,47,47,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.011336311,0.846153846,0.846153846,33,39,39,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.019924425,0.950819672,0.950819672,58,61,61,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.020267949,0.776315789,0.776315789,59,76,76,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.022329097,0.833333333,0.833333333,65,78,78,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.013397458,0.464285714,0.493670886,39,84,79,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.099622123,0.622317597,0.633187773,290,466,458,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.048093439,0.544747082,0.566801619,140,257,247,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  treatmentType  Intravenous_Chemotherapy,0.030230161,0.488888889,0.514619883,88,180,171,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.011336311,0.622641509,0.622641509,33,53,53,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.015115081,0.709677419,0.709677419,44,62,62,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.013053933,0.678571429,0.678571429,38,56,56,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.010992786,0.761904762,0.761904762,32,42,42,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.016145654,0.758064516,0.758064516,47,62,62,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.040535898,0.666666667,0.666666667,118,177,177,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.013053933,0.730769231,0.730769231,38,52,52,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.021642047,0.588785047,0.588785047,63,107,107,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  treatmentType  Intravenous_Chemotherapy,0.029543112,0.716666667,0.716666667,86,120,120,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.043627619,0.644670051,0.644670051,127,197,197,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.018893851,0.670731707,0.670731707,55,82,82,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.010305737,0.638297872,0.638297872,30,47,47,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.018550326,0.9,0.9,54,60,60,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.016832704,0.875,0.875,49,56,56,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.024046719,0.588235294,0.588235294,70,119,119,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.016832704,0.680555556,0.680555556,49,72,72,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.015458605,0.661764706,0.661764706,45,68,68,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.010305737,0.612244898,0.612244898,30,49,49,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.013397458,0.696428571,0.696428571,39,56,56,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.032291309,0.467661692,0.467661692,94,201,201,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.026794916,0.472727273,0.472727273,78,165,165,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.010649261,0.5,0.5,31,62,62,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.018206802,0.576086957,0.576086957,53,92,92,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.010992786,0.653061224,0.653061224,32,49,49,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.010649261,1,1,31,31,31,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.011336311,0.75,0.75,33,44,44,?a
?a  patientDrug  Doxorubicin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.010305737,1,1,30,30,30,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.023016146,0.496296296,0.496296296,67,135,135,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIB   ,?a  treatmentType  Intravenous_Chemotherapy,0.010992786,0.533333333,0.542372881,32,60,59,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIB   ,?a  treatmentType  Intravenous_Chemotherapy,0.016145654,0.494736842,0.522222222,47,95,90,?a
?a  patientDrug  Vincristine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.010305737,1,1,30,30,30,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.028512539,0.775700935,0.775700935,83,107,107,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.013053933,0.612903226,0.612903226,38,62,62,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.013397458,0.582089552,0.582089552,39,67,67,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.01580213,0.686567164,0.686567164,46,67,67,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  treatmentType  Intravenous_Chemotherapy,0.020267949,0.526785714,0.526785714,59,112,112,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  treatmentType  Intravenous_Chemotherapy,0.020267949,0.641304348,0.641304348,59,92,92,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.018206802,0.61627907,0.61627907,53,86,86,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.015458605,0.725806452,0.725806452,45,62,62,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.037100653,0.755244755,0.755244755,108,143,143,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.025077293,0.613445378,0.613445378,73,119,119,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.020611474,0.618556701,0.618556701,60,97,97,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.022329097,0.625,0.625,65,104,104,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.025077293,0.634782609,0.634782609,73,115,115,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.015458605,0.849056604,0.849056604,45,53,53,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.01202336,0.714285714,0.714285714,35,49,49,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.012710409,1,1,37,37,37,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.015115081,0.676923077,0.676923077,44,65,65,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Intravenous_Chemotherapy,0.028856063,0.743362832,0.743362832,84,113,113,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  treatmentType  Intravenous_Chemotherapy,0.014084507,0.661290323,0.759259259,41,62,54,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.024390244,0.724489796,0.77173913,71,98,92,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.010649261,0.720930233,0.720930233,31,43,43,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.014428032,0.875,0.913043478,42,48,46,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.016489179,0.96,0.96,48,50,50,?a
?a  hasAgeCategory  Old  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.040879423,0.59798995,0.650273224,119,199,183,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.023016146,0.603603604,0.650485437,67,111,103,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.050841635,0.72195122,0.725490196,148,205,204,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.011679835,0.829268293,0.829268293,34,41,41,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.021642047,0.73255814,0.73255814,63,86,86,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.019924425,0.716049383,0.716049383,58,81,81,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Gemcitabine   ,?a  treatmentType  Intravenous_Chemotherapy,0.015115081,0.846153846,0.846153846,44,52,52,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.032978358,0.914285714,0.914285714,96,105,105,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.044658193,0.726256983,0.738636364,130,179,176,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.017176228,0.724637681,0.724637681,50,69,69,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.010992786,0.62745098,0.695652174,32,51,46,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.010305737,1,1,30,30,30,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.012366884,0.837209302,0.837209302,36,43,43,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.029543112,0.632352941,0.666666667,86,136,129,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.028856063,0.823529412,0.823529412,84,102,102,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.016145654,0.758064516,0.758064516,47,62,62,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Gemcitabine   ,?a  treatmentType  Intravenous_Chemotherapy,0.011336311,0.868421053,0.868421053,33,38,38,?a
?a  hasGender  Female  ?a  patientDrug  Vp-16   ,?a  treatmentType  Intravenous_Chemotherapy,0.013397458,0.6,0.609375,39,65,64,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  treatmentType  Intravenous_Chemotherapy,0.032634833,0.730769231,0.766129032,95,130,124,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.017519753,0.76119403,0.76119403,51,67,67,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  treatmentType  Intravenous_Chemotherapy,0.010992786,0.820512821,0.820512821,32,39,39,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.012366884,0.87804878,0.923076923,36,41,39,?a
?a  hasStage  IVB  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.022329097,0.890410959,0.928571429,65,73,70,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.020611474,0.722891566,0.740740741,60,83,81,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vp-16   ,?a  treatmentType  Intravenous_Chemotherapy,0.032291309,0.706766917,0.717557252,94,133,131,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  treatmentType  Intravenous_Chemotherapy,0.012366884,0.734693878,0.765957447,36,49,47,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.0195809,0.606382979,0.606382979,57,94,94,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.016145654,0.734375,0.734375,47,64,64,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vp-16   ,?a  treatmentType  Intravenous_Chemotherapy,0.029886637,0.583892617,0.608391608,87,149,143,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vp-16   ,?a  treatmentType  Intravenous_Chemotherapy,0.024046719,0.598290598,0.614035088,70,117,114,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.022329097,0.496183206,0.496183206,65,131,131,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.029199588,0.590277778,0.590277778,85,144,144,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.014428032,0.56,0.56,42,75,75,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.027481965,0.454545455,0.457142857,80,176,175,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.022672621,0.554621849,0.554621849,66,119,119,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.043971144,0.62745098,0.630541872,128,204,203,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.023016146,0.598214286,0.598214286,67,112,112,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.014084507,0.891304348,0.891304348,41,46,46,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.024733768,0.590163934,0.590163934,72,122,122,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.017863277,0.52,0.52,52,100,100,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.045688767,0.621495327,0.621495327,133,214,214,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.014428032,0.5,0.506024096,42,84,83,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Intravenous_Chemotherapy,0.014428032,0.933333333,0.933333333,42,45,45,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.019237375,0.949152542,0.949152542,56,59,59,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.050841635,0.860465116,0.880952381,148,172,168,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.011336311,0.868421053,0.891891892,33,38,37,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cyclophosphamide   ,?a  treatmentType  Intravenous_Chemotherapy,0.012366884,1,1,36,36,36,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.05496393,0.87431694,0.893854749,160,183,179,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.037444177,0.865079365,0.872,109,126,125,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.011679835,0.80952381,0.871794872,34,42,39,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.046375816,0.865384615,0.870967742,135,156,155,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.064239093,0.877934272,0.877934272,187,213,213,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.047062865,0.86163522,0.883870968,137,159,155,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.030230161,0.590604027,0.590604027,88,149,149,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Intravenous_Chemotherapy,0.028512539,0.846938776,0.882978723,83,98,94,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.018550326,0.642857143,0.642857143,54,84,84,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.037100653,0.624277457,0.635294118,108,173,170,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.05118516,0.696261682,0.696261682,149,214,214,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vincristine   ,?a  treatmentType  Intravenous_Chemotherapy,0.012710409,1,1,37,37,37,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.013053933,0.584615385,0.584615385,38,65,65,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.02782549,0.653225806,0.653225806,81,124,124,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.022672621,0.578947368,0.578947368,66,114,114,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.047749914,0.661904762,0.661904762,139,210,210,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.022672621,0.634615385,0.634615385,66,104,104,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.01580213,0.522727273,0.541176471,46,88,85,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.0391618,0.62295082,0.636871508,114,183,179,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.053589832,0.764705882,0.783919598,156,204,199,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.019237375,0.965517241,0.965517241,56,58,58,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.021642047,0.463235294,0.466666667,63,136,135,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.017863277,0.776119403,0.8,52,67,65,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.021985572,0.551724138,0.566371681,64,116,113,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.011336311,0.634615385,0.6875,33,52,48,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.026107867,0.550724638,0.562962963,76,138,135,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.017519753,0.739130435,0.772727273,51,69,66,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.031260735,0.722222222,0.752066116,91,126,121,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.068704912,0.625,0.634920635,200,320,315,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.071796633,0.625748503,0.637195122,209,334,328,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.012710409,0.660714286,0.755102041,37,56,49,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.047062865,0.744565217,0.765363128,137,184,179,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.017863277,0.928571429,0.928571429,52,56,56,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Intravenous_Chemotherapy,0.108553762,0.761445783,0.763285024,316,415,414,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.010992786,0.457142857,0.5,32,70,64,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.04294057,0.570776256,0.598086124,125,219,209,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.023703195,0.526717557,0.570247934,69,131,121,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.013740982,0.606060606,0.666666667,40,66,60,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.037787702,0.582010582,0.61452514,110,189,179,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.016832704,0.731343284,0.753846154,49,67,65,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Doxorubicin   ,?a  treatmentType  Intravenous_Chemotherapy,0.013397458,1,1,39,39,39,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Positive   ,?a  treatmentType  Intravenous_Chemotherapy,0.014771556,0.43877551,0.477777778,43,98,90,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.021298523,0.439716312,0.459259259,62,141,135,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.030230161,0.946236559,0.946236559,88,93,93,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.018550326,0.642857143,0.675,54,84,80,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.011336311,0.942857143,0.942857143,33,35,35,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Intravenous_Chemotherapy,0.055650979,0.615969582,0.625482625,162,263,259,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.021298523,0.939393939,0.939393939,62,66,66,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  treatmentType  Intravenous_Chemotherapy,0.013740982,0.930232558,0.930232558,40,43,43,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.065956716,0.673684211,0.688172043,192,285,279,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIB,0.025764895,0.15920398,0.15920398,32,201,201,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIB,0.01610306,0.327868852,0.327868852,20,61,61,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Intravenous_Chemotherapy,0.060116798,0.525525526,0.557324841,175,333,314,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIB,0.024154589,0.178571429,0.178571429,30,168,168,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  hasStage  IIIB,0.031400966,0.146616541,0.146616541,39,266,266,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.055307454,0.670833333,0.688034188,161,240,234,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIB,0.011272142,0.518518519,0.518518519,14,27,27,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIB,0.01610306,0.141843972,0.141843972,20,141,141,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIB,0.02173913,0.236842105,0.236842105,27,114,114,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.016908213,0.176470588,0.176470588,21,119,119,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIB,0.032206119,0.152091255,0.152091255,40,263,263,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.024959742,0.246031746,0.246031746,31,126,126,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.034621578,0.260606061,0.260606061,43,165,165,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasStage  IIIB,0.012882448,0.122137405,0.122137405,16,131,131,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIB,0.020128824,0.201612903,0.201612903,25,124,124,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIB,0.024959742,0.224637681,0.224637681,31,138,138,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  hasStage  IIIB,0.02173913,0.147540984,0.147540984,27,183,183,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIB,0.010466989,0.295454545,0.295454545,13,44,44,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIB,0.024154589,0.14084507,0.14084507,30,213,213,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.025764895,0.285714286,0.285714286,32,112,112,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIB,0.010466989,0.317073171,0.317073171,13,41,41,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  hasStage  IIIB,0.017713366,0.152777778,0.152777778,22,144,144,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.017713366,0.146666667,0.146666667,22,150,150,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIB,0.020128824,0.210084034,0.210084034,25,119,119,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIB,0.017713366,0.22,0.22,22,100,100,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasStage  IIIB,0.020933977,0.150289017,0.150289017,26,173,173,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.012882448,0.14953271,0.14953271,16,107,107,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIB,0.027375201,0.161904762,0.161904762,34,210,210,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIB,0.018518519,0.148387097,0.148387097,23,155,155,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IIIB,0.045088567,0.118393235,0.118393235,56,473,473,?a
?a  hasGender  Male  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIB,0.041062802,0.144067797,0.144067797,51,354,354,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIB,0.01610306,0.238095238,0.238095238,20,84,84,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIB,0.028985507,0.186528497,0.186528497,36,193,193,?a
?a  hasGender  Male  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIB,0.042673108,0.213709677,0.213709677,53,248,248,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIB,0.037037037,0.228855721,0.228855721,46,201,201,?a
?a  hasGender  Male  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIB,0.016908213,0.525,0.525,21,40,40,?a
?a  hasGender  Male  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIB,0.016908213,0.198113208,0.198113208,21,106,106,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.010466989,0.25,0.25,13,52,52,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.024154589,0.169491525,0.169491525,30,177,177,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.022544283,0.14213198,0.14213198,28,197,197,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIB,0.012077295,0.6,0.6,15,25,25,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.024959742,0.274336283,0.274336283,31,113,113,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.018518519,0.159722222,0.159722222,23,144,144,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIB,0.015297907,0.166666667,0.166666667,19,114,114,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIB,0.012077295,0.178571429,0.178571429,15,84,84,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIB,0.020128824,0.595238095,0.595238095,25,42,42,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIB,0.010466989,0.180555556,0.180555556,13,72,72,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Intravenous_Chemotherapy,0.034352456,0.621118012,0.641025641,100,161,156,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIB,0.014492754,0.692307692,0.692307692,18,26,26,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIB,0.014492754,0.666666667,0.666666667,18,27,27,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIB,0.018518519,0.221153846,0.221153846,23,104,104,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.044283414,0.3125,0.3125,55,176,176,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIB,0.011272142,0.179487179,0.179487179,14,78,78,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.042673108,0.291208791,0.291208791,53,182,182,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.012882448,0.235294118,0.235294118,16,68,68,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.032206119,0.298507463,0.298507463,40,134,134,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.028180354,0.259259259,0.259259259,35,135,135,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.037037037,0.272189349,0.272189349,46,169,169,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.057971014,0.252631579,0.252631579,72,285,285,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIB,0.031400966,0.263513514,0.263513514,39,148,148,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIB,0.020933977,0.456140351,0.456140351,26,57,57,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.014492754,0.257142857,0.257142857,18,70,70,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIB,0.02173913,0.194244604,0.194244604,27,139,139,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIB,0.049919485,0.244094488,0.244094488,62,254,254,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IIIB,0.011272142,0.144329897,0.144329897,14,97,97,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIB,0.030595813,0.224852071,0.224852071,38,169,169,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIB,0.02173913,0.303370787,0.303370787,27,89,89,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIB,0.047504026,0.143552311,0.143552311,59,411,411,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIB,0.027375201,0.336633663,0.336633663,34,101,101,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIB,0.027375201,0.278688525,0.278688525,34,122,122,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  hasStage  IIIB,0.010466989,0.149425287,0.149425287,13,87,87,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIB,0.031400966,0.216666667,0.216666667,39,180,180,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIB,0.038647343,0.224299065,0.224299065,48,214,214,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IIIB,0.024959742,0.108391608,0.108391608,31,286,286,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IIIB,0.010466989,0.116071429,0.116071429,13,112,112,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIB,0.019323671,0.255319149,0.255319149,24,94,94,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIB,0.041867955,0.242990654,0.242990654,52,214,214,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IIIB,0.047504026,0.12394958,0.12394958,59,476,476,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IIIB,0.015297907,0.108571429,0.108571429,19,175,175,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IIIA,0.023349436,0.213235294,0.213235294,29,136,136,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  hasStage  IIIB,0.046698873,0.139759036,0.139759036,58,415,415,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IIIB,0.037037037,0.137724551,0.137724551,46,334,334,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IIIA,0.022544283,0.201438849,0.201438849,28,139,139,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIB,0.033816425,0.205882353,0.205882353,42,204,204,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIA,0.011272142,0.538461538,0.538461538,14,26,26,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasStage  IIIA,0.052334944,0.203125,0.203125,65,320,320,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.010466989,0.481481481,0.481481481,13,27,27,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.038647343,0.25,0.25,48,192,192,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IIIA,0.011272142,0.291666667,0.291666667,14,48,48,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IIIA,0.038647343,0.219178082,0.219178082,48,219,219,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IIIA,0.023349436,0.221374046,0.221374046,29,131,131,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.010466989,0.481481481,0.481481481,13,27,27,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Docetaxel   ,?a  hasStage  IIIA,0.011272142,0.24137931,0.24137931,14,58,58,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.05958132,0.209631728,0.209631728,74,353,353,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.025764895,0.266666667,0.266666667,32,120,120,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.02979066,0.262411348,0.262411348,37,141,141,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.044283414,0.209125475,0.209125475,55,263,263,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.020128824,0.438596491,0.438596491,25,57,57,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.061191626,0.233846154,0.233846154,76,325,325,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.044283414,0.398550725,0.398550725,55,138,138,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.024959742,0.316326531,0.316326531,31,98,98,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.040257649,0.746268657,0.746268657,50,67,67,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.013687601,0.309090909,0.309090909,17,55,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.028985507,0.230769231,0.230769231,36,156,156,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.020933977,0.26,0.26,26,100,100,?a
?a  hasGender  Female  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.019323671,0.421052632,0.421052632,24,57,57,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.032206119,0.350877193,0.350877193,40,114,114,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.03784219,0.373015873,0.373015873,47,126,126,?a
?a  hasGender  Female  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.019323671,0.452830189,0.452830189,24,53,53,?a
?a  hasBiomarker  RET_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IIIA,0.010466989,0.5,0.5,13,26,26,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.02979066,0.415730337,0.415730337,37,89,89,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.030595813,0.436781609,0.436781609,38,87,87,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIA,0.024959742,0.206666667,0.206666667,31,150,150,?a
?a  hasGender  Female  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.023349436,0.256637168,0.256637168,29,113,113,?a
?a  hasGender  Male  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IIIA,0.012077295,0.230769231,0.230769231,15,65,65,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.034621578,0.462365591,0.462365591,43,93,93,?a
?a  hasGender  Female  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.02979066,0.840909091,0.840909091,37,44,44,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  No_Progression   ,?a  hasStage  IIIA,0.016908213,0.291666667,0.291666667,21,72,72,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  hasStage  IIIA,0.046698873,0.225680934,0.225680934,58,257,257,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIA,0.078904992,0.210300429,0.210300429,98,466,466,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  hasStage  IIIA,0.109500805,0.20328849,0.20328849,136,669,669,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.050724638,0.313432836,0.313432836,63,201,201,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasStage  IIIA,0.022544283,0.304347826,0.304347826,28,92,92,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  hasStage  IIIA,0.072463768,0.200445434,0.200445434,90,449,449,?a
?a  hasBiomarker  RET_Negative  ?a  hasGender  Male   ,?a  hasStage  IIIA,0.015297907,0.422222222,0.422222222,19,45,45,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.010466989,0.590909091,0.590909091,13,22,22,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.020128824,0.367647059,0.367647059,25,68,68,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.033816425,0.446808511,0.446808511,42,94,94,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.012882448,0.533333333,0.533333333,16,30,30,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.028985507,0.782608696,0.782608696,36,46,46,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  hasStage  IIIA,0.052334944,0.221843003,0.221843003,65,293,293,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.050724638,0.386503067,0.386503067,63,163,163,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasStage  IIIA,0.036231884,0.25,0.25,45,180,180,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.041062802,0.51,0.51,51,100,100,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.035426731,0.556962025,0.556962025,44,79,79,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.028180354,0.603448276,0.603448276,35,58,58,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.015297907,0.413043478,0.413043478,19,46,46,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.041867955,0.547368421,0.547368421,52,95,95,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.020933977,0.464285714,0.464285714,26,56,56,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.033816425,0.567567568,0.567567568,42,74,74,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.018518519,0.605263158,0.605263158,23,38,38,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.035426731,0.523809524,0.523809524,44,84,84,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.028180354,0.625,0.625,35,56,56,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.028180354,0.416666667,0.416666667,35,84,84,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IIIA,0.015297907,0.558823529,0.558823529,19,34,34,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasStage  IIIA,0.014492754,0.321428571,0.321428571,18,56,56,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.056360709,0.262172285,0.262172285,70,267,267,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IIIA,0.011272142,0.225806452,0.225806452,14,62,62,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.086956522,0.384341637,0.384341637,108,281,281,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.06763285,0.763636364,0.763636364,84,110,110,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIA,0.077294686,0.205128205,0.205128205,96,468,468,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.078099839,0.412765957,0.412765957,97,235,235,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IIIA,0.052334944,0.227272727,0.227272727,65,286,286,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.05394525,0.411042945,0.411042945,67,163,163,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIA,0.015297907,0.463414634,0.463414634,19,41,41,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.037037037,0.403508772,0.403508772,46,114,114,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.057971014,0.346153846,0.346153846,72,208,208,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.037037037,0.479166667,0.479166667,46,96,96,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIA,0.015297907,0.404255319,0.404255319,19,47,47,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  hasStage  IIIA,0.047504026,0.23046875,0.23046875,59,256,256,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  hasStage  IIIA,0.044283414,0.287958115,0.287958115,55,191,191,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IIIA,0.035426731,0.251428571,0.251428571,44,175,175,?a
?a  treatmentType  Sequential_Chemoradiation  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IIIA,0.010466989,0.684210526,0.684210526,13,19,19,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.024154589,0.405405405,0.405405405,30,74,74,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  hasStage  IIIA,0.020933977,0.298850575,0.298850575,26,87,87,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.037037037,0.353846154,0.353846154,46,130,130,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.02979066,0.480519481,0.480519481,37,77,77,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.025764895,0.326530612,0.326530612,32,98,98,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.015297907,0.422222222,0.422222222,19,45,45,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IIIA,0.020933977,0.234234234,0.234234234,26,111,111,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IIIA,0.013687601,0.386363636,0.386363636,17,44,44,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IIIA,0.015297907,0.513513514,0.513513514,19,37,37,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.023349436,0.432835821,0.432835821,29,67,67,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIA,0.015297907,0.487179487,0.487179487,19,39,39,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IIIA,0.012077295,0.5,0.5,15,30,30,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.011272142,0.4375,0.4375,14,32,32,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.036231884,0.441176471,0.441176471,45,102,102,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.014492754,0.5,0.5,18,36,36,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.020933977,0.361111111,0.361111111,26,72,72,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IIIA,0.024154589,0.365853659,0.365853659,30,82,82,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IIIA,0.012882448,0.285714286,0.285714286,16,56,56,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIA,0.019323671,0.48,0.48,24,50,50,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasStage  IIIA,0.010466989,0.8125,0.8125,13,16,16,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.057165862,0.525925926,0.525925926,71,135,135,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.071658615,0.526627219,0.526627219,89,169,169,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.025764895,0.592592593,0.592592593,32,54,54,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.053140097,0.776470588,0.776470588,66,85,85,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.046698873,0.432835821,0.432835821,58,134,134,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.024959742,0.407894737,0.407894737,31,76,76,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.054750403,0.386363636,0.386363636,68,176,176,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.026570048,0.589285714,0.589285714,33,56,56,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.024154589,0.588235294,0.588235294,30,51,51,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.019323671,0.648648649,0.648648649,24,37,37,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.024154589,0.441176471,0.441176471,30,68,68,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.014492754,0.45,0.45,18,40,40,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.040257649,0.454545455,0.454545455,50,110,110,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.033011272,0.401960784,0.401960784,41,102,102,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.022544283,0.8,0.8,28,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.010466989,0.5,0.5,13,26,26,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.034621578,0.425742574,0.425742574,43,101,101,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.014492754,0.5,0.5,18,36,36,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.033816425,0.777777778,0.777777778,42,54,54,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.020933977,0.838709677,0.838709677,26,31,31,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasStage  IIIA,0.043478261,0.432,0.432,54,125,125,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.053140097,0.785714286,0.785714286,66,84,84,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.032206119,0.563380282,0.563380282,40,71,71,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasStage  IIIA,0.026570048,0.559322034,0.559322034,33,59,59,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.012882448,0.842105263,0.842105263,16,19,19,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.010466989,0.433333333,0.433333333,13,30,30,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.026570048,0.523809524,0.523809524,33,63,63,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.015297907,0.76,0.76,19,25,25,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.041867955,0.440677966,0.440677966,52,118,118,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.036231884,0.505617978,0.505617978,45,89,89,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.013687601,0.772727273,0.772727273,17,22,22,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.046698873,0.743589744,0.743589744,58,78,78,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.050724638,0.75,0.75,63,84,84,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasStage  IIIA,0.02979066,0.787234043,0.787234043,37,47,47,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.010466989,0.684210526,0.684210526,13,19,19,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.016908213,0.446808511,0.446808511,21,47,47,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  hasStage  IIIA,0.018518519,0.247311828,0.247311828,23,93,93,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIA,0.017713366,0.360655738,0.360655738,22,61,61,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasStage  IIIA,0.012077295,0.25862069,0.25862069,15,58,58,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Gemcitabine   ,?a  hasStage  IIIA,0.011272142,0.4375,0.4375,14,32,32,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.062801932,0.382352941,0.382352941,78,204,204,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.071658615,0.41588785,0.41588785,89,214,214,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasStage  IIIA,0.020128824,0.454545455,0.454545455,25,55,55,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.033816425,0.375,0.375,42,112,112,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIA,0.010466989,0.224137931,0.224137931,13,58,58,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.073268921,0.478947368,0.478947368,91,190,190,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.034621578,0.457446809,0.457446809,43,94,94,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.013687601,0.548387097,0.548387097,17,31,31,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.013687601,0.485714286,0.485714286,17,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.012077295,0.46875,0.46875,15,32,32,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.024154589,0.4,0.4,30,75,75,?a
?a  hasBiomarker  RET_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIA,0.015297907,0.59375,0.59375,19,32,32,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.044283414,0.450819672,0.450819672,55,122,122,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IIIA,0.028985507,0.223602484,0.223602484,36,161,161,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  hasStage  IIIA,0.02173913,0.421875,0.421875,27,64,64,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasStage  IIIA,0.016908213,0.4375,0.4375,21,48,48,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.018518519,0.479166667,0.479166667,23,48,48,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.015297907,0.413043478,0.413043478,19,46,46,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasStage  IIIA,0.012077295,0.288461538,0.288461538,15,52,52,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.023349436,0.537037037,0.537037037,29,54,54,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.040257649,0.46728972,0.46728972,50,107,107,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.010466989,0.52,0.52,13,25,25,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.032206119,0.476190476,0.476190476,40,84,84,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.017713366,0.611111111,0.611111111,22,36,36,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasStage  IIIA,0.012077295,0.416666667,0.416666667,15,36,36,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasStage  IIIA,0.011272142,0.5,0.5,14,28,28,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasStage  IIIA,0.047504026,0.472,0.472,59,125,125,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.031400966,0.314516129,0.314516129,39,124,124,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.020933977,0.4,0.4,26,65,65,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasStage  IIIA,0.028180354,0.336538462,0.336538462,35,104,104,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Carboplatin   ,?a  hasStage  IIIA,0.02979066,0.402173913,0.402173913,37,92,92,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasStage  IIIA,0.023349436,0.23015873,0.23015873,29,126,126,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasStage  IIIA,0.016908213,0.411764706,0.411764706,21,51,51,?a
?a  hasBiomarker  RET_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IIIA,0.016908213,0.411764706,0.411764706,21,51,51,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasStage  IIIA,0.015297907,0.431818182,0.431818182,19,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IIIA,0.056360709,0.21021021,0.21021021,70,333,333,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IIIA,0.045088567,0.226720648,0.226720648,56,247,247,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IA,0.011272142,0.100719424,0.100719424,14,139,139,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IA,0.020933977,0.204724409,0.204724409,26,127,127,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IA,0.023349436,0.241666667,0.241666667,29,120,120,?a
?a  hasGender  Female  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IA,0.02173913,0.238938053,0.238938053,27,113,113,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IA,0.012077295,0.136363636,0.136363636,15,110,110,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IA,0.01610306,0.227272727,0.227272727,20,88,88,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasStage  IA,0.019323671,0.147239264,0.147239264,24,163,163,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  No_Progression   ,?a  hasStage  IA,0.014492754,0.25,0.25,18,72,72,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Thoracoscopy   ,?a  hasStage  IA,0.033011272,0.308270677,0.308270677,41,133,133,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Radiotherapy_To_Lung,0.015115081,0.44,0.44,44,100,100,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.017176228,0.35971223,0.378787879,50,139,132,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.018206802,0.378571429,0.378571429,53,140,140,?a
?a  hasGender  Female  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.010305737,0.681818182,0.681818182,30,44,44,?a
?a  hasGender  Female  ?a  hasStage  IIIB   ,?a  treatmentType  Radiotherapy_To_Lung,0.010649261,0.756097561,0.815789474,31,41,38,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  treatmentType  Radiotherapy_To_Lung,0.010649261,0.369047619,0.369047619,31,84,84,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Lung,0.010992786,0.363636364,0.376470588,32,88,85,?a
?a  hasGender  Female  ?a  patientDrug  Vp-16   ,?a  treatmentType  Radiotherapy_To_Lung,0.011336311,0.507692308,0.515625,33,65,64,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.019924425,0.411347518,0.42962963,58,141,135,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.019237375,0.470588235,0.470588235,56,119,119,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIB   ,?a  treatmentType  Radiotherapy_To_Lung,0.014771556,0.716666667,0.728813559,43,60,59,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.02782549,0.442622951,0.452513966,81,183,179,?a
?a  hasGender  Female  ?a  hasStage  IIIA   ,?a  treatmentType  Radiotherapy_To_Lung,0.016145654,0.691176471,0.691176471,47,68,68,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Lung,0.0195809,0.395833333,0.401408451,57,144,142,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.018206802,0.595505618,0.595505618,53,89,89,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.017519753,0.586206897,0.586206897,51,87,87,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.038474751,0.425855513,0.432432432,112,263,259,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.026794916,0.388059701,0.388059701,78,201,201,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Lung,0.03160426,0.431924883,0.438095238,92,213,210,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.017863277,0.333333333,0.348993289,52,156,149,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  treatmentType  Radiotherapy_To_Lung,0.01580213,0.351145038,0.37704918,46,131,122,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.037100653,0.332307692,0.346153846,108,325,312,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.01202336,0.406976744,0.406976744,35,86,86,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.020611474,0.983606557,0.983606557,60,61,61,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.032978358,0.542372881,0.542372881,96,177,177,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.023703195,0.46,0.46,69,150,150,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.017176228,0.458715596,0.458715596,50,109,109,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.024390244,0.514492754,0.514492754,71,138,138,?a
?a  hasStage  IIIA  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.012710409,0.804347826,0.804347826,37,46,46,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.01202336,0.673076923,0.673076923,35,52,52,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.026107867,0.666666667,0.666666667,76,114,114,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.014428032,0.583333333,0.583333333,42,72,72,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.038131226,0.417293233,0.425287356,111,266,261,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.011336311,0.33,0.347368421,33,100,95,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.023016146,0.455782313,0.455782313,67,147,147,?a
?a  hasStage  IIIB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.010649261,0.861111111,0.861111111,31,36,36,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.024046719,0.614035088,0.614035088,70,114,114,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.032291309,0.376,0.376,94,250,250,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIA   ,?a  treatmentType  Radiotherapy_To_Lung,0.025420818,0.616666667,0.621848739,74,120,119,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vp-16   ,?a  treatmentType  Radiotherapy_To_Lung,0.015458605,0.505617978,0.523255814,45,89,86,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.045688767,0.415625,0.422222222,133,320,315,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.05118516,0.446107784,0.454268293,149,334,328,?a
?a  hasGender  Male  ?a  treatmentType  Sequential_Chemoradiation   ,?a  treatmentType  Radiotherapy_To_Lung,0.011679835,0.85,0.85,34,40,40,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Sequential_Chemoradiation   ,?a  treatmentType  Radiotherapy_To_Lung,0.012366884,0.857142857,0.857142857,36,42,42,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  treatmentType  Radiotherapy_To_Lung,0.053589832,0.327731092,0.342857143,156,476,455,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.030573686,0.505681818,0.508571429,89,176,175,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.030917211,0.604026846,0.604026846,90,149,149,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.016489179,0.979591837,0.979591837,48,49,49,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Sequential_Chemoradiation   ,?a  treatmentType  Radiotherapy_To_Lung,0.01202336,0.897435897,0.897435897,35,39,39,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Radiotherapy_To_Lung,0.017176228,0.510204082,0.510204082,50,98,98,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.019924425,0.659090909,0.659090909,58,88,88,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.022672621,0.634615385,0.634615385,66,104,104,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  treatmentType  Radiotherapy_To_Lung,0.010305737,0.365853659,0.365853659,30,82,82,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.020954998,0.726190476,0.726190476,61,84,84,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  treatmentType  Radiotherapy_To_Lung,0.012366884,0.507042254,0.507042254,36,71,71,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.014084507,0.630769231,0.630769231,41,65,65,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.014428032,0.626865672,0.626865672,42,67,67,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.017863277,0.460176991,0.460176991,52,113,113,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.020954998,0.726190476,0.726190476,61,84,84,?a
?a  hasStage  IIIB  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.013740982,1,1,40,40,40,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.015115081,0.369747899,0.369747899,44,119,119,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.011336311,0.611111111,0.611111111,33,54,54,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.018893851,0.887096774,0.887096774,55,62,62,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.015458605,0.391304348,0.391304348,45,115,115,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Immunotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.013740982,0.373831776,0.373831776,40,107,107,?a
?a  hasStage  IIIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.018206802,0.757142857,0.757142857,53,70,70,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIB   ,?a  treatmentType  Radiotherapy_To_Lung,0.010992786,0.695652174,0.695652174,32,46,46,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.034008932,0.98019802,0.98019802,99,101,101,?a
?a  hasStage  IIIB  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.021298523,0.712643678,0.729411765,62,87,85,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.016145654,1,1,47,47,47,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.018893851,1,1,55,55,55,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.01580213,0.686567164,0.686567164,46,67,67,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  treatmentType  Radiotherapy_To_Lung,0.024733768,0.782608696,0.782608696,72,92,92,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.03160426,0.989247312,0.989247312,92,93,93,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.019237375,0.98245614,0.98245614,56,57,57,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.011336311,0.379310345,0.379310345,33,87,87,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.019924425,0.983050847,0.983050847,58,59,59,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.01202336,0.7,0.7,35,50,50,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.010305737,1,1,30,30,30,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.010649261,0.525423729,0.525423729,31,59,59,?a
?a  patientDrug  Vincristine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.010305737,0.508474576,0.508474576,30,59,59,?a
?a  hasStage  IIIA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.014084507,0.706896552,0.706896552,41,58,58,?a
?a  patientDrug  Doxorubicin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.010305737,0.508474576,0.508474576,30,59,59,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.026794916,0.527027027,0.527027027,78,148,148,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.017863277,0.52,0.52,52,100,100,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.032634833,0.989583333,0.989583333,95,96,96,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.020267949,0.380645161,0.380645161,59,155,155,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  treatmentType  Radiotherapy_To_Lung,0.023016146,0.482014388,0.482014388,67,139,139,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIA   ,?a  treatmentType  Radiotherapy_To_Lung,0.013053933,0.633333333,0.633333333,38,60,60,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.02335967,0.747252747,0.747252747,68,91,91,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIA   ,?a  treatmentType  Radiotherapy_To_Lung,0.034695981,0.731884058,0.731884058,101,138,138,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.020954998,0.512605042,0.512605042,61,119,119,?a
?a  hasStage  IIIA  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.024390244,0.682692308,0.682692308,71,104,104,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.028169014,0.67768595,0.67768595,82,121,121,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.030573686,0.674242424,0.674242424,89,132,132,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  treatmentType  Radiotherapy_To_Lung,0.011336311,0.340206186,0.35106383,33,97,94,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  treatmentType  Radiotherapy_To_Lung,0.018550326,0.606741573,0.606741573,54,89,89,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.017863277,0.619047619,0.619047619,52,84,84,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.025077293,0.421965318,0.429411765,73,173,170,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.013053933,0.413043478,0.417582418,38,92,91,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vp-16   ,?a  treatmentType  Radiotherapy_To_Lung,0.022672621,0.44295302,0.461538462,66,149,143,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.042253521,0.611940299,0.611940299,123,201,201,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  treatmentType  Radiotherapy_To_Lung,0.072827207,0.316890882,0.328682171,212,669,645,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  treatmentType  Radiotherapy_To_Lung,0.010305737,0.344827586,0.357142857,30,87,84,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.033321883,0.510526316,0.510526316,97,190,190,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.02782549,0.861702128,0.861702128,81,94,94,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.038818276,0.553921569,0.556650246,113,204,203,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Progression   ,?a  treatmentType  Radiotherapy_To_Lung,0.067674339,0.420940171,0.430131004,197,468,458,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.01580213,0.71875,0.71875,46,64,64,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  treatmentType  Radiotherapy_To_Lung,0.063208519,0.443373494,0.444444444,184,415,414,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.033321883,0.538888889,0.541899441,97,180,179,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.034352456,0.819672131,0.819672131,100,122,122,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.048093439,0.654205607,0.654205607,140,214,214,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.014771556,0.511904762,0.518072289,43,84,83,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  treatmentType  Radiotherapy_To_Lung,0.014084507,0.630769231,0.630769231,41,65,65,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  treatmentType  Radiotherapy_To_Lung,0.011679835,0.303571429,0.320754717,34,112,106,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IVB,0.011272142,0.175,0.175,14,80,80,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.044314668,0.602803738,0.602803738,129,214,214,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.018550326,0.504672897,0.509433962,54,107,106,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasStage  IVB,0.010466989,0.433333333,0.433333333,13,30,30,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  treatmentType  Radiotherapy_To_Lung,0.023016146,0.536,0.540322581,67,125,124,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IVB,0.010466989,0.254901961,0.254901961,13,51,51,?a
?a  hasGender  Female  ?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IVB,0.012077295,0.163043478,0.163043478,15,92,92,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IVB,0.012077295,0.227272727,0.227272727,15,66,66,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IVB,0.010466989,0.40625,0.40625,13,32,32,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.01610306,0.168067227,0.168067227,20,119,119,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IVB,0.020933977,0.166666667,0.166666667,26,156,156,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IVB,0.016908213,0.388888889,0.388888889,21,54,54,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  hasStage  IVB,0.025764895,0.120300752,0.120300752,32,266,266,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IVB,0.011272142,0.388888889,0.388888889,14,36,36,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.012077295,0.267857143,0.267857143,15,56,56,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IVB,0.017713366,0.130952381,0.130952381,22,168,168,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IVB,0.022544283,0.19858156,0.19858156,28,141,141,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IVB,0.02173913,0.27,0.27,27,100,100,?a
?a  hasGender  Female  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IVB,0.011272142,0.194444444,0.194444444,14,72,72,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IVB,0.015297907,0.220930233,0.220930233,19,86,86,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.016908213,0.230769231,0.230769231,21,91,91,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.020933977,0.185714286,0.185714286,26,140,140,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.028985507,0.179104478,0.179104478,36,201,201,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Female   ,?a  hasStage  IVB,0.010466989,0.25,0.25,13,52,52,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  hasStage  IVB,0.020933977,0.180555556,0.180555556,26,144,144,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.012882448,0.181818182,0.181818182,16,88,88,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasStage  IVB,0.017713366,0.167938931,0.167938931,22,131,131,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  hasStage  IVB,0.020933977,0.142076503,0.142076503,26,183,183,?a
?a  hasGender  Female  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.014492754,0.173076923,0.173076923,18,104,104,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.011272142,0.304347826,0.304347826,14,46,46,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IVB,0.010466989,0.213114754,0.213114754,13,61,61,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IVB,0.027375201,0.129277567,0.129277567,34,263,263,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasStage  IVB,0.020933977,0.226086957,0.226086957,26,115,115,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  hasStage  IVB,0.018518519,0.410714286,0.410714286,23,56,56,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasStage  IVB,0.020128824,0.301204819,0.301204819,25,83,83,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IVB,0.028180354,0.164319249,0.164319249,35,213,213,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  hasStage  IVB,0.011272142,0.466666667,0.466666667,14,30,30,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.01610306,0.206185567,0.206185567,20,97,97,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.012882448,0.290909091,0.290909091,16,55,55,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.015297907,0.177570093,0.177570093,19,107,107,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasStage  IVB,0.020128824,0.144508671,0.144508671,25,173,173,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IVB,0.010466989,0.173333333,0.173333333,13,75,75,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasStage  IVB,0.01610306,0.217391304,0.217391304,20,92,92,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IVB,0.012077295,0.217391304,0.217391304,15,69,69,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  hasStage  IVB,0.012077295,0.340909091,0.340909091,15,44,44,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IVB,0.024154589,0.340909091,0.340909091,30,88,88,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IVB,0.024959742,0.147619048,0.147619048,31,210,210,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.022544283,0.180645161,0.180645161,28,155,155,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.010466989,0.216666667,0.216666667,13,60,60,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasStage  IVB,0.017713366,0.523809524,0.523809524,22,42,42,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IVB,0.02173913,0.195652174,0.195652174,27,138,138,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  hasStage  IVB,0.025764895,0.275862069,0.275862069,32,116,116,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.01610306,0.408163265,0.408163265,20,49,49,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.020128824,0.173611111,0.173611111,25,144,144,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vp-16   ,?a  hasStage  IVB,0.013687601,0.11409396,0.11409396,17,149,149,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.017713366,0.282051282,0.282051282,22,78,78,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.01610306,0.243902439,0.243902439,20,82,82,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.012077295,0.357142857,0.357142857,15,42,42,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.017713366,0.35483871,0.35483871,22,62,62,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.016908213,0.276315789,0.276315789,21,76,76,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.013687601,0.607142857,0.607142857,17,28,28,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IVB,0.011272142,0.184210526,0.184210526,14,76,76,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.013687601,0.278688525,0.278688525,17,61,61,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.01610306,0.277777778,0.277777778,20,72,72,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IVB,0.012077295,0.333333333,0.333333333,15,45,45,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IVB,0.014492754,0.25,0.25,18,72,72,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IVB,0.012077295,0.555555556,0.555555556,15,27,27,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasStage  IVB,0.012077295,0.25862069,0.25862069,15,58,58,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IVB,0.012077295,0.348837209,0.348837209,15,43,43,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasStage  IVB,0.010466989,0.302325581,0.302325581,13,43,43,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IVB,0.012882448,0.390243902,0.390243902,16,41,41,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IVB,0.017713366,0.511627907,0.511627907,22,43,43,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IVB,0.019323671,0.208695652,0.208695652,24,115,115,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IVB,0.019323671,0.311688312,0.311688312,24,77,77,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.015297907,0.206521739,0.206521739,19,92,92,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  hasStage  IVB,0.010466989,0.196969697,0.196969697,13,66,66,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.011272142,0.16091954,0.16091954,14,87,87,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IVB,0.019323671,0.230769231,0.230769231,24,104,104,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.028180354,0.15625,0.15625,35,224,224,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.028985507,0.169811321,0.169811321,36,212,212,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasStage  IVB,0.017713366,0.488888889,0.488888889,22,45,45,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.052334944,0.167095116,0.167095116,65,389,389,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  hasStage  IVB,0.014492754,0.193548387,0.193548387,18,93,93,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.030595813,0.2,0.2,38,190,190,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.018518519,0.37704918,0.37704918,23,61,61,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasStage  IVB,0.012077295,0.384615385,0.384615385,15,39,39,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.028180354,0.286885246,0.286885246,35,122,122,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.011272142,0.368421053,0.368421053,14,38,38,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.028985507,0.209302326,0.209302326,36,172,172,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.015297907,0.155737705,0.155737705,19,122,122,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.028180354,0.220125786,0.220125786,35,159,159,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IVB,0.018518519,0.37704918,0.37704918,23,61,61,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasStage  IVB,0.017713366,0.536585366,0.536585366,22,41,41,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasStage  IVB,0.018518519,0.343283582,0.343283582,23,67,67,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  hasStage  IVB,0.010466989,0.12745098,0.12745098,13,102,102,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasStage  IVB,0.017713366,0.448979592,0.448979592,22,49,49,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.016908213,0.5,0.5,21,42,42,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.025764895,0.174863388,0.174863388,32,183,183,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IVB,0.027375201,0.346938776,0.346938776,34,98,98,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasStage  IVB,0.01610306,0.512820513,0.512820513,20,39,39,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasStage  IVB,0.027375201,0.166666667,0.166666667,34,204,204,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasStage  IVB,0.033011272,0.405940594,0.405940594,41,101,101,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  hasStage  IVB,0.020128824,0.225225225,0.225225225,25,111,111,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasStage  IVB,0.014492754,0.45,0.45,18,40,40,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  hasStage  IVB,0.030595813,0.206521739,0.206521739,38,184,184,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  hasStage  IVB,0.045088567,0.134939759,0.134939759,56,415,415,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IVB,0.011272142,0.24137931,0.24137931,14,58,58,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasStage  IVB,0.028180354,0.277777778,0.277777778,35,126,126,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IVB,0.016908213,0.333333333,0.333333333,21,63,63,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IVB,0.01610306,0.298507463,0.298507463,20,67,67,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IVB,0.052334944,0.263157895,0.263157895,65,247,247,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasStage  IVB,0.032206119,0.380952381,0.380952381,40,105,105,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasStage  IVB,0.033816425,0.40776699,0.40776699,42,103,103,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Nivolumab,0.010745467,0.253968254,0.253968254,32,126,126,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.016789792,0.2,0.2,50,250,250,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.019476158,0.597938144,0.597938144,58,97,97,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Nivolumab,0.01208865,0.19047619,0.213017751,36,189,169,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Nivolumab,0.013096038,0.178082192,0.201030928,39,219,194,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IVB,0.026570048,0.392857143,0.392857143,33,84,84,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Nivolumab,0.013431833,0.588235294,0.588235294,40,68,68,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Nivolumab,0.018804567,0.167664671,0.186666667,56,334,300,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.01208865,0.179104478,0.179104478,36,201,201,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Nivolumab,0.018468771,0.11627907,0.152777778,55,473,360,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Nivolumab,0.014775017,0.16730038,0.178861789,44,263,246,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Nivolumab,0.011081263,0.181318681,0.181318681,33,182,182,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Nivolumab,0.010409671,0.295238095,0.295238095,31,105,105,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  patientDrug  Nivolumab,0.010073875,0.152284264,0.167597765,30,197,179,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  patientDrug  Nivolumab,0.01208865,0.175609756,0.181818182,36,205,198,?a
?a  hasGender  Male  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.021490934,0.18079096,0.18079096,64,354,354,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  patientDrug  Nivolumab,0.010745467,0.326530612,0.372093023,32,98,86,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Nivolumab,0.013767629,0.154135338,0.154135338,41,266,266,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.013431833,0.816326531,0.833333333,40,49,48,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.010409671,0.179190751,0.179190751,31,173,173,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.010073875,0.326086957,0.326086957,30,92,92,?a
?a  hasGender  Male  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.025856279,0.606299213,0.606299213,77,127,127,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.013096038,0.629032258,0.629032258,39,62,62,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.027871054,0.72173913,0.72173913,83,115,115,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.01208865,0.258992806,0.258992806,36,139,139,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  patientDrug  Nivolumab,0.011752854,0.269230769,0.304347826,35,130,115,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.011417058,0.22972973,0.22972973,34,148,148,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.012760242,0.224852071,0.224852071,38,169,169,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.015782404,0.247368421,0.247368421,47,190,190,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.0322364,0.671328671,0.671328671,96,143,143,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.02820685,0.204379562,0.204379562,84,411,411,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.012760242,0.584615385,0.584615385,38,65,65,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.014775017,0.656716418,0.656716418,44,67,67,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.0241773,0.637168142,0.637168142,72,113,113,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.022834117,0.571428571,0.576271186,68,119,118,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  patientDrug  Nivolumab,0.010409671,0.155,0.186746988,31,200,166,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Nivolumab,0.020819342,0.138084633,0.138084633,62,449,449,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.010745467,0.262295082,0.262295082,32,122,122,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Nivolumab,0.010409671,0.160621762,0.160621762,31,193,193,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Nivolumab,0.017125588,0.227678571,0.227678571,51,224,224,?a
?a  hasGender  Male  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Nivolumab,0.013096038,0.236363636,0.236363636,39,165,165,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Nivolumab,0.013767629,0.191588785,0.191588785,41,214,214,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Nivolumab,0.013431833,0.199004975,0.199004975,40,201,201,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Nivolumab,0.017125588,0.671052632,0.671052632,51,76,76,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Male   ,?a  patientDrug  Nivolumab,0.015446608,0.178988327,0.211009174,46,257,218,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Male   ,?a  patientDrug  Nivolumab,0.016453996,0.167235495,0.196787149,49,293,249,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Nivolumab,0.013431833,0.196078431,0.196078431,40,204,204,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Nivolumab,0.024513096,0.156652361,0.173396675,73,466,421,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Nivolumab,0.014439221,0.16796875,0.199074074,43,256,216,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Nivolumab,0.016789792,0.234741784,0.234741784,50,213,213,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Nivolumab,0.013096038,0.245283019,0.245283019,39,159,159,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Nivolumab,0.016453996,0.205020921,0.205020921,49,239,239,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Nivolumab,0.015446608,0.214953271,0.214953271,46,214,214,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Nivolumab,0.014103425,0.229508197,0.229508197,42,183,183,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Nivolumab,0.019811954,0.177177177,0.209964413,59,333,281,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Nivolumab,0.012760242,0.180952381,0.185365854,38,210,205,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Nivolumab,0.013096038,0.191176471,0.191176471,39,204,204,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Nivolumab,0.016789792,0.208333333,0.226244344,50,240,221,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Nivolumab,0.011081263,0.204968944,0.224489796,33,161,147,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Nivolumab,0.023841504,0.171084337,0.171084337,71,415,415,?a
?a  hasGender  Male  ?a  hasSmokingHabit  NonSmoker   ,?a  hasRelapse_Progression  No_Progression,0.01,0.238095238,0.322580645,10,42,31,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Nivolumab,0.012424446,0.201086957,0.201086957,37,184,184,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Nivolumab,0.018804567,0.196491228,0.211320755,56,285,265,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Nivolumab,0.012424446,0.156118143,0.184079602,37,237,201,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasRelapse_Progression  No_Progression,0.033,0.237410072,0.286956522,33,139,115,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIA   ,?a  hasRelapse_Progression  No_Progression,0.01,0.37037037,0.588235294,10,27,17,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIB   ,?a  hasRelapse_Progression  No_Progression,0.017,0.404761905,0.53125,17,42,32,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  No_Progression,0.074,0.385416667,0.524822695,74,192,141,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  No_Progression,0.033,0.3,0.388235294,33,110,85,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  No_Progression,0.031,0.344444444,0.436619718,31,90,71,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IB   ,?a  hasRelapse_Progression  No_Progression,0.015,0.326086957,0.46875,15,46,32,?a
?a  hasGender  Female  ?a  hasStage  IA   ,?a  hasRelapse_Progression  No_Progression,0.018,0.545454545,0.642857143,18,33,28,?a
?a  hasAgeCategory  Old  ?a  hasGender  Female   ,?a  hasRelapse_Progression  No_Progression,0.053,0.23245614,0.291208791,53,228,182,?a
?a  hasStage  IIA  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  No_Progression,0.014,0.451612903,0.636363636,14,31,22,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIA   ,?a  hasRelapse_Progression  No_Progression,0.015,0.384615385,0.6,15,39,25,?a
?a  hasGender  Female  ?a  hasStage  IIIA   ,?a  hasRelapse_Progression  No_Progression,0.021,0.308823529,0.338709677,21,68,62,?a
?a  hasGender  Female  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.013,0.295454545,0.342105263,13,44,38,?a
?a  hasStage  IA  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  No_Progression,0.041,0.532467532,0.683333333,41,77,60,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasRelapse_Progression  No_Progression,0.07,0.198300283,0.262172285,70,353,267,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasRelapse_Progression  No_Progression,0.071,0.218461538,0.286290323,71,325,248,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  No_Progression,0.045,0.375,0.548780488,45,120,82,?a
?a  hasAgeCategory  Young  ?a  hasStage  IA   ,?a  hasRelapse_Progression  No_Progression,0.012,0.48,0.705882353,12,25,17,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  hasRelapse_Progression  No_Progression,0.031,0.306930693,0.360465116,31,101,86,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IB   ,?a  hasRelapse_Progression  No_Progression,0.012,0.307692308,0.545454545,12,39,22,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.012,0.307692308,0.363636364,12,39,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.018,0.268656716,0.346153846,18,67,52,?a
?a  hasGender  Male  ?a  hasStage  IIB   ,?a  hasRelapse_Progression  No_Progression,0.022,0.407407407,0.564102564,22,54,39,?a
?a  hasGender  Male  ?a  hasStage  IB   ,?a  hasRelapse_Progression  No_Progression,0.024,0.347826087,0.5,24,69,48,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  No_Progression,0.095,0.392561983,0.549132948,95,242,173,?a
?a  hasGender  Male  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  No_Progression,0.043,0.251461988,0.36440678,43,171,118,?a
?a  hasGender  Male  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  No_Progression,0.04,0.357142857,0.470588235,40,112,85,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.011,0.366666667,0.458333333,11,30,24,?a
?a  hasStage  IIB  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  No_Progression,0.012,0.375,0.631578947,12,32,19,?a
?a  hasStage  IIB  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  No_Progression,0.017,0.404761905,0.586206897,17,42,29,?a
?a  hasStage  IB  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  No_Progression,0.024,0.347826087,0.533333333,24,69,45,?a
?a  hasAgeCategory  Old  ?a  hasStage  IB   ,?a  hasRelapse_Progression  No_Progression,0.022,0.305555556,0.468085106,22,72,47,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vp-16   ,?a  hasRelapse_Progression  No_Progression,0.012,0.193548387,0.218181818,12,62,55,?a
?a  treatmentType  Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  No_Progression,0.011,0.333333333,0.366666667,11,33,30,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  hasRelapse_Progression  No_Progression,0.011,0.112244898,0.13253012,11,98,83,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  No_Progression,0.022,0.192982456,0.215686275,22,114,102,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  No_Progression,0.043,0.263803681,0.36440678,43,163,118,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.016,0.271186441,0.333333333,16,59,48,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  hasRelapse_Progression  No_Progression,0.055,0.302197802,0.35483871,55,182,155,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  No_Progression,0.102,0.382022472,0.523076923,102,267,195,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  No_Progression,0.037,0.324561404,0.425287356,37,114,87,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.025,0.227272727,0.290697674,25,110,86,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  No_Progression,0.021,0.225806452,0.25,21,93,84,?a
?a  hasStage  IIIA  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  No_Progression,0.01,0.434782609,0.5,10,23,20,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  No_Progression,0.037,0.305785124,0.345794393,37,121,107,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.01,0.4,0.454545455,10,25,22,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  No_Progression,0.02,0.256410256,0.3125,20,78,64,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  No_Progression,0.037,0.362745098,0.435294118,37,102,85,?a
?a  patientDrug  Durvalumab  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  No_Progression,0.01,0.526315789,0.625,10,19,16,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasRelapse_Progression  No_Progression,0.034,0.102102102,0.1328125,34,333,256,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasRelapse_Progression  No_Progression,0.011,0.106796117,0.150684932,11,103,73,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasRelapse_Progression  No_Progression,0.011,0.104761905,0.144736842,11,105,76,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vp-16   ,?a  hasRelapse_Progression  No_Progression,0.033,0.160194175,0.195266272,33,206,169,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasRelapse_Progression  No_Progression,0.026,0.105263158,0.146067416,26,247,178,?a
?a  hasGender  Female  ?a  treatmentType  Surgery   ,?a  hasStage  IV,0.012882448,0.484848485,0.484848485,16,33,33,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasRelapse_Progression  No_Progression,0.027,0.113924051,0.154285714,27,237,175,?a
?a  hasGender  Female  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.026570048,0.458333333,0.458333333,33,72,72,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.041062802,0.364285714,0.364285714,51,140,140,?a
?a  hasGender  Female  ?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IV,0.022544283,0.304347826,0.304347826,28,92,92,?a
?a  hasGender  Female  ?a  patientDrug  Erlotinib   ,?a  hasStage  IV,0.011272142,0.451612903,0.451612903,14,31,31,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  hasStage  IV,0.02979066,0.256944444,0.256944444,37,144,144,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IV,0.028180354,0.257352941,0.257352941,35,136,136,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.030595813,0.431818182,0.431818182,38,88,88,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IV,0.053140097,0.309859155,0.309859155,66,213,213,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.014492754,0.295081967,0.295081967,18,61,61,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Female   ,?a  hasStage  IV,0.016908213,0.403846154,0.403846154,21,52,52,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Nivolumab   ,?a  hasStage  IV,0.012882448,0.372093023,0.372093023,16,43,43,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasStage  IV,0.035426731,0.335877863,0.335877863,44,131,131,?a
?a  hasGender  Female  ?a  patientDrug  Nivolumab   ,?a  hasStage  IV,0.010466989,0.382352941,0.382352941,13,34,34,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasStage  IV,0.024959742,0.269565217,0.269565217,31,115,115,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasStage  IV,0.042673108,0.306358382,0.306358382,53,173,173,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IV,0.051529791,0.304761905,0.304761905,64,210,210,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IV,0.023349436,0.3625,0.3625,29,80,80,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.015297907,0.452380952,0.452380952,19,42,42,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.022544283,0.424242424,0.424242424,28,66,66,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.014492754,0.260869565,0.260869565,18,69,69,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vp-16   ,?a  hasStage  IV,0.024154589,0.483870968,0.483870968,30,62,62,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.013687601,0.472222222,0.472222222,17,36,36,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Carboplatin   ,?a  hasStage  IV,0.013687601,0.386363636,0.386363636,17,44,44,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IV,0.034621578,0.311594203,0.311594203,43,138,138,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.095813205,0.351032448,0.351032448,119,339,339,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasStage  IV,0.014492754,0.367346939,0.367346939,18,49,49,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy   ,?a  hasStage  IV,0.02173913,0.675,0.675,27,40,40,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IV,0.022544283,0.35,0.35,28,80,80,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Surgery   ,?a  hasStage  IV,0.026570048,0.47826087,0.47826087,33,69,69,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Afatinib   ,?a  hasStage  IV,0.012077295,0.652173913,0.652173913,15,23,23,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.026570048,0.44,0.44,33,75,75,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cyclophosphamide   ,?a  hasStage  IV,0.01610306,0.555555556,0.555555556,20,36,36,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Docetaxel   ,?a  hasStage  IV,0.014492754,0.321428571,0.321428571,18,56,56,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  hasStage  IV,0.056360709,0.2734375,0.2734375,70,256,256,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vincristine   ,?a  hasStage  IV,0.01610306,0.540540541,0.540540541,20,37,37,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.041062802,0.346938776,0.346938776,51,147,147,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Doxorubicin   ,?a  hasStage  IV,0.016908213,0.538461538,0.538461538,21,39,39,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Erlotinib   ,?a  hasStage  IV,0.012077295,0.405405405,0.405405405,15,37,37,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Docetaxel   ,?a  hasStage  IV,0.018518519,0.396551724,0.396551724,23,58,58,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.055555556,0.442307692,0.442307692,69,156,156,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  hasStage  IV,0.023349436,0.420289855,0.420289855,29,69,69,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Positive   ,?a  hasStage  IV,0.017713366,0.407407407,0.407407407,22,54,54,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  hasStage  IV,0.024154589,0.229007634,0.229007634,30,131,131,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy   ,?a  hasStage  IV,0.015297907,0.633333333,0.633333333,19,30,30,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.031400966,0.357798165,0.357798165,39,109,109,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IV,0.017713366,0.35483871,0.35483871,22,62,62,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IV,0.086956522,0.22832981,0.22832981,108,473,473,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.025764895,0.329896907,0.329896907,32,97,97,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IV,0.049919485,0.328042328,0.328042328,62,189,189,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasStage  IV,0.05958132,0.337899543,0.337899543,74,219,219,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.047504026,0.468253968,0.468253968,59,126,126,?a
?a  treatmentType  Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.017713366,0.666666667,0.666666667,22,33,33,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Chemotherapy   ,?a  hasStage  IV,0.032206119,0.701754386,0.701754386,40,57,57,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy   ,?a  hasStage  IV,0.032206119,0.677966102,0.677966102,40,59,59,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy   ,?a  hasStage  IV,0.020933977,0.702702703,0.702702703,26,37,37,?a
?a  hasGender  Male  ?a  treatmentType  Chemotherapy   ,?a  hasStage  IV,0.030595813,0.716981132,0.716981132,38,53,53,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IV,0.025764895,0.359550562,0.359550562,32,89,89,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.044283414,0.366666667,0.366666667,55,150,150,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  hasStage  IV,0.103864734,0.287305122,0.287305122,129,449,449,?a
?a  hasGender  Male  ?a  patientDrug  Cyclophosphamide   ,?a  hasStage  IV,0.020128824,0.543478261,0.543478261,25,46,46,?a
?a  hasGender  Male  ?a  patientDrug  Docetaxel   ,?a  hasStage  IV,0.017713366,0.323529412,0.323529412,22,68,68,?a
?a  treatmentType  Surgery  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.010466989,0.565217391,0.565217391,13,23,23,?a
?a  hasGender  Male  ?a  patientDrug  Vincristine   ,?a  hasStage  IV,0.019323671,0.52173913,0.52173913,24,46,46,?a
?a  hasGender  Male  ?a  patientDrug  Doxorubicin   ,?a  hasStage  IV,0.020128824,0.520833333,0.520833333,25,48,48,?a
?a  hasGender  Male  ?a  patientDrug  Vp-16   ,?a  hasStage  IV,0.057165862,0.48630137,0.48630137,71,146,146,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Surgery   ,?a  hasStage  IV,0.020128824,0.568181818,0.568181818,25,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Surgery   ,?a  hasStage  IV,0.01610306,0.625,0.625,20,32,32,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IV,0.010466989,0.448275862,0.448275862,13,29,29,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IV,0.020933977,0.426229508,0.426229508,26,61,61,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Surgery   ,?a  hasStage  IV,0.022544283,0.571428571,0.571428571,28,49,49,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.023349436,0.483333333,0.483333333,29,60,60,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Surgery   ,?a  hasStage  IV,0.01610306,0.625,0.625,20,32,32,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.020933977,0.361111111,0.361111111,26,72,72,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IV,0.026570048,0.362637363,0.362637363,33,91,91,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Surgery   ,?a  hasStage  IV,0.019323671,0.615384615,0.615384615,24,39,39,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.015297907,0.513513514,0.513513514,19,37,37,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cyclophosphamide   ,?a  hasStage  IV,0.025764895,0.561403509,0.561403509,32,57,57,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.057165862,0.360406091,0.360406091,71,197,197,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Vp-16   ,?a  hasStage  IV,0.024959742,0.534482759,0.534482759,31,58,58,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasStage  IV,0.024959742,0.37804878,0.37804878,31,82,82,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cyclophosphamide   ,?a  hasStage  IV,0.018518519,0.71875,0.71875,23,32,32,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.032206119,0.373831776,0.373831776,40,107,107,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasStage  IV,0.024959742,0.407894737,0.407894737,31,76,76,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.028180354,0.460526316,0.460526316,35,76,76,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  hasStage  IV,0.014492754,0.418604651,0.418604651,18,43,43,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.028180354,0.336538462,0.336538462,35,104,104,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cyclophosphamide   ,?a  hasStage  IV,0.024959742,0.534482759,0.534482759,31,58,58,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  hasStage  IV,0.028985507,0.352941176,0.352941176,36,102,102,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  hasStage  IV,0.028180354,0.52238806,0.52238806,35,67,67,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.012077295,0.405405405,0.405405405,15,37,37,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.017713366,0.35483871,0.35483871,22,62,62,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.026570048,0.578947368,0.578947368,33,57,57,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.024959742,0.356321839,0.356321839,31,87,87,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  hasStage  IV,0.011272142,0.466666667,0.466666667,14,30,30,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.024959742,0.553571429,0.553571429,31,56,56,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  hasStage  IV,0.020933977,0.393939394,0.393939394,26,66,66,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasStage  IV,0.032206119,0.347826087,0.347826087,40,115,115,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Erlotinib   ,?a  hasStage  IV,0.012882448,0.457142857,0.457142857,16,35,35,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasStage  IV,0.025764895,0.516129032,0.516129032,32,62,62,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.017713366,0.511627907,0.511627907,22,43,43,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasStage  IV,0.013687601,0.303571429,0.303571429,17,56,56,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.02173913,0.457627119,0.457627119,27,59,59,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.02173913,0.457627119,0.457627119,27,59,59,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.024959742,0.430555556,0.430555556,31,72,72,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.013687601,0.566666667,0.566666667,17,30,30,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Doxorubicin   ,?a  hasStage  IV,0.016908213,0.677419355,0.677419355,21,31,31,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.027375201,0.607142857,0.607142857,34,56,56,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasStage  IV,0.039452496,0.441441441,0.441441441,49,111,111,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  hasStage  IV,0.020933977,0.361111111,0.361111111,26,72,72,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vincristine   ,?a  hasStage  IV,0.018518519,0.696969697,0.696969697,23,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  hasStage  IV,0.064412238,0.30075188,0.30075188,80,266,266,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vincristine   ,?a  hasStage  IV,0.024959742,0.543859649,0.543859649,31,57,57,?a
?a  patientDrug  Vincristine  ?a  patientDrug  Vp-16   ,?a  hasStage  IV,0.024959742,0.525423729,0.525423729,31,59,59,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Gefitinib   ,?a  hasStage  IV,0.010466989,0.590909091,0.590909091,13,22,22,?a
?a  patientDrug  Gefitinib  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.010466989,0.722222222,0.722222222,13,18,18,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vp-16   ,?a  hasStage  IV,0.044283414,0.47008547,0.47008547,55,117,117,?a
?a  patientDrug  Gefitinib  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.011272142,0.736842105,0.736842105,14,19,19,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.077294686,0.452830189,0.452830189,96,212,212,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.057165862,0.373684211,0.373684211,71,190,190,?a
?a  patientDrug  Doxorubicin  ?a  patientDrug  Vp-16   ,?a  hasStage  IV,0.024154589,0.526315789,0.526315789,30,57,57,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasStage  IV,0.065217391,0.307984791,0.307984791,81,263,263,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vincristine   ,?a  hasStage  IV,0.024959742,0.525423729,0.525423729,31,59,59,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Gefitinib   ,?a  hasStage  IV,0.012882448,0.5,0.5,16,32,32,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Doxorubicin   ,?a  hasStage  IV,0.024154589,0.526315789,0.526315789,30,57,57,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.119162641,0.360097324,0.360097324,148,411,411,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Doxorubicin   ,?a  hasStage  IV,0.024154589,0.526315789,0.526315789,30,57,57,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Osimertinib   ,?a  hasStage  IV,0.010466989,0.371428571,0.371428571,13,35,35,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.010466989,0.590909091,0.590909091,13,22,22,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vp-16   ,?a  hasStage  IV,0.05394525,0.503759398,0.503759398,67,133,133,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasStage  IV,0.076489533,0.424107143,0.424107143,95,224,224,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.011272142,0.7,0.7,14,20,20,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasStage  IV,0.012882448,0.213333333,0.213333333,16,75,75,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vp-16   ,?a  hasStage  IV,0.072463768,0.436893204,0.436893204,90,206,206,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.070048309,0.475409836,0.475409836,87,183,183,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.074879227,0.436619718,0.436619718,93,213,213,?a
?a  hasBiomarker  ALK_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IV,0.012077295,0.555555556,0.555555556,15,27,27,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.05394525,0.421383648,0.421383648,67,159,159,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasStage  IV,0.011272142,0.56,0.56,14,25,25,?a
?a  hasBiomarker  ALK_Positive  ?a  hasBiomarker  EGFR_Negative   ,?a  hasStage  IV,0.012882448,0.5,0.5,16,32,32,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  hasStage  IV,0.111916264,0.334939759,0.334939759,139,415,415,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IV,0.018518519,0.396551724,0.396551724,23,58,58,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasStage  IV,0.079710145,0.347368421,0.347368421,99,285,285,?a
?a  hasGender  Female  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Cisplatin,0.011752854,0.251798561,0.324074074,35,139,108,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.011081263,0.340206186,0.340206186,33,97,97,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  patientDrug  Cisplatin,0.015110813,0.445544554,0.517241379,45,101,87,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.010409671,0.508196721,0.508196721,31,61,61,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.028878442,0.623188406,0.623188406,86,138,138,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.014439221,0.377192982,0.377192982,43,114,114,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Cisplatin,0.017125588,0.375,0.435897436,51,136,117,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.017125588,0.361702128,0.428571429,51,141,119,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.027871054,0.315589354,0.337398374,83,263,246,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.011081263,0.34375,0.55,33,96,60,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.030557421,0.257790368,0.334558824,91,353,272,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.013767629,0.450549451,0.450549451,41,91,91,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.011081263,0.33,0.397590361,33,100,83,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.011417058,0.373626374,0.373626374,34,91,91,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Cisplatin,0.019811954,0.378205128,0.446969697,59,156,132,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.017797179,0.420634921,0.441666667,53,126,120,?a
?a  hasGender  Male  ?a  hasStage  IIIB   ,?a  patientDrug  Cisplatin,0.01208865,0.36,0.382978723,36,100,94,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.019811954,0.357575758,0.375796178,59,165,157,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Cisplatin,0.010409671,0.543859649,0.563636364,31,57,55,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  patientDrug  Cisplatin,0.014103425,0.456521739,0.461538462,42,92,91,?a
?a  hasGender  Female  ?a  hasStage  IIIA   ,?a  patientDrug  Cisplatin,0.012424446,0.544117647,0.587301587,37,68,63,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.013431833,0.597014925,0.615384615,40,67,65,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.019476158,0.666666667,0.666666667,58,87,87,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.022162525,0.309859155,0.33,66,213,200,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  patientDrug  Cisplatin,0.01208865,0.313043478,0.36,36,115,100,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.011752854,0.380434783,0.388888889,35,92,90,?a
?a  hasGender  Female  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.010073875,0.681818182,0.697674419,30,44,43,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.013096038,0.443181818,0.443181818,39,88,88,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  patientDrug  Cisplatin,0.015782404,0.358778626,0.408695652,47,131,115,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  patientDrug  Cisplatin,0.024513096,0.365,0.439759036,73,200,166,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.023841504,0.48630137,0.518248175,71,146,137,?a
?a  hasStage  IIIA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.011081263,0.568965517,0.568965517,33,58,58,?a
?a  hasGender  Male  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.014439221,0.338582677,0.338582677,43,127,127,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  patientDrug  Cisplatin,0.017461383,0.288888889,0.339869281,52,180,153,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.014775017,0.536585366,0.647058824,44,82,68,?a
?a  hasStage  IIIA  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.030557421,0.689393939,0.689393939,91,132,132,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Cisplatin,0.014103425,0.538461538,0.608695652,42,78,69,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIA   ,?a  patientDrug  Cisplatin,0.026192075,0.565217391,0.619047619,78,138,126,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.011081263,0.733333333,0.733333333,33,45,45,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.011081263,0.559322034,0.559322034,33,59,59,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIA   ,?a  patientDrug  Cisplatin,0.012424446,0.616666667,0.672727273,37,60,55,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Cisplatin,0.013767629,0.569444444,0.569444444,41,72,72,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.013096038,0.364485981,0.364485981,39,107,107,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.01208865,0.413793103,0.413793103,36,87,87,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Cisplatin,0.0161182,0.539325843,0.615384615,48,89,78,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Cisplatin,0.013431833,0.392156863,0.392156863,40,102,102,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Cisplatin,0.010073875,0.517241379,0.566037736,30,58,53,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.027199463,0.460227273,0.460227273,81,176,176,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.019476158,0.491525424,0.491525424,58,118,118,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.019140363,0.337278107,0.337278107,57,169,169,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.023505709,0.573770492,0.573770492,70,122,122,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.011752854,0.538461538,0.538461538,35,65,65,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.012424446,0.44047619,0.44047619,37,84,84,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.016789792,0.403225806,0.403225806,50,124,124,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.014103425,0.6,0.6,42,70,70,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.011752854,0.460526316,0.460526316,35,76,76,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.011752854,0.760869565,0.760869565,35,46,46,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.026863667,0.43715847,0.43715847,80,183,183,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.023841504,0.747368421,0.747368421,71,95,95,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.02820685,0.392523364,0.392523364,84,214,214,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Cisplatin,0.013767629,0.394230769,0.394230769,41,104,104,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.032572196,0.573964497,0.573964497,97,169,169,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Cisplatin,0.023841504,0.645454545,0.645454545,71,110,110,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.017125588,0.525773196,0.525773196,51,97,97,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Cisplatin,0.031229013,0.436619718,0.436619718,93,213,213,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.022162525,0.425806452,0.425806452,66,155,155,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.010073875,0.434782609,0.434782609,30,69,69,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.042646071,0.593457944,0.593457944,127,214,214,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.010073875,0.625,0.625,30,48,48,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.027871054,0.664,0.664,83,125,125,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.017125588,0.607142857,0.607142857,51,84,84,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Cisplatin,0.011417058,0.386363636,0.425,34,88,80,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Cisplatin,0.011081263,0.362637363,0.362637363,33,91,91,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.025856279,0.740384615,0.740384615,77,104,104,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Cisplatin,0.010745467,0.62745098,0.64,32,51,50,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.025856279,0.77,0.77,77,100,100,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.030221625,0.428571429,0.43902439,90,210,205,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Cisplatin,0.014439221,0.370689655,0.421568627,43,116,102,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Cisplatin,0.022834117,0.635514019,0.635514019,68,107,107,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.020483546,0.544642857,0.554545455,61,112,110,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Cisplatin,0.020819342,0.449275362,0.504065041,62,138,123,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Cisplatin,0.012760242,0.316666667,0.339285714,38,120,112,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Cisplatin,0.01208865,0.43902439,0.48,36,82,75,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.010073875,0.517241379,0.555555556,30,58,54,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.010073875,0.652173913,0.697674419,30,46,43,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.015782404,0.47,0.552941176,47,100,85,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Cisplatin,0.011417058,0.346938776,0.414634146,34,98,82,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.014103425,0.5,0.617647059,42,84,68,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Cisplatin,0.014103425,0.591549296,0.6,42,71,70,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Cisplatin,0.014439221,0.387387387,0.387387387,43,111,111,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Cisplatin,0.010409671,0.607843137,0.62,31,51,50,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.016789792,0.531914894,0.549450549,50,94,91,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Cisplatin,0.01208865,0.610169492,0.620689655,36,59,58,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.019476158,0.682352941,0.682352941,58,85,85,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.022498321,0.368131868,0.368131868,67,182,182,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Cisplatin,0.012424446,0.5,0.616666667,37,74,60,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.037944929,0.396491228,0.421641791,113,285,268,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.022162525,0.528,0.545454545,66,125,121,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.010073875,0.526315789,0.526315789,30,57,57,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.010073875,0.612244898,0.612244898,30,49,49,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.010745467,0.470588235,0.484848485,32,68,66,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.017125588,0.504950495,0.504950495,51,101,101,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Cisplatin,0.018132975,0.377622378,0.377622378,54,143,143,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Cisplatin,0.0161182,0.475247525,0.494845361,48,101,97,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.019811954,0.702380952,0.710843373,59,84,83,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.010409671,0.659574468,0.704545455,31,47,44,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.022498321,0.352631579,0.352631579,67,190,190,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.012760242,0.655172414,0.655172414,38,58,58,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Cisplatin,0.010409671,0.563636364,0.563636364,31,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.014103425,0.344262295,0.344262295,42,122,122,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Cisplatin,0.015110813,0.391304348,0.391304348,45,115,115,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Cisplatin,0.011752854,0.648148148,0.7,35,54,50,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.039959704,0.41754386,0.449056604,119,285,265,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.033243788,0.209302326,0.275,99,473,360,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.010745467,0.463768116,0.463768116,32,69,69,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.014103425,0.432989691,0.432989691,42,97,97,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.018804567,0.347826087,0.380952381,56,161,147,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Cisplatin,0.030221625,0.375,0.407239819,90,240,221,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.036601746,0.436,0.436,109,250,250,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.019811954,0.433823529,0.479674797,59,136,123,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  NonSmoker   ,?a  patientDrug  Pemetrexed,0.010745467,0.4,0.438356164,32,80,73,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.034922767,0.311377246,0.346666667,104,334,300,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.032907992,0.447488584,0.505154639,98,219,194,?a
?a  hasStage  IVB  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.01208865,0.493150685,0.493150685,36,73,73,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.016453996,0.374045802,0.374045802,49,131,131,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.015782404,0.279761905,0.333333333,47,168,141,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Pemetrexed,0.017797179,0.404580153,0.452991453,53,131,117,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.020819342,0.439716312,0.521008403,62,141,119,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.011752854,0.514705882,0.555555556,35,68,63,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.010745467,0.533333333,0.592592593,32,60,54,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.011417058,0.507462687,0.557377049,34,67,61,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.01208865,0.486486486,0.486486486,36,74,74,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  patientDrug  Pemetrexed,0.010745467,0.385542169,0.415584416,32,83,77,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.012424446,0.37,0.445783133,37,100,83,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Pemetrexed,0.023169913,0.442307692,0.522727273,69,156,132,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.012760242,0.422222222,0.475,38,90,80,?a
?a  hasAgeCategory  Young  ?a  hasGender  Male   ,?a  patientDrug  Pemetrexed,0.019476158,0.29,0.34939759,58,200,166,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.011752854,0.714285714,0.729166667,35,49,48,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.013767629,0.460674157,0.525641026,41,89,78,?a
?a  hasAgeCategory  Young  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.01208865,0.409090909,0.413793103,36,88,87,?a
?a  hasStage  IV  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.011417058,0.586206897,0.586206897,34,58,58,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.010409671,0.720930233,0.720930233,31,43,43,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.0322364,0.554913295,0.554913295,96,173,173,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.014439221,0.811320755,0.811320755,43,53,53,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.01208865,0.620689655,0.620689655,36,58,58,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.018804567,0.602150538,0.602150538,56,93,93,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.022498321,0.683673469,0.779069767,67,98,86,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.017125588,0.476635514,0.476635514,51,107,107,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.016453996,0.680555556,0.680555556,49,72,72,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.031229013,0.453658537,0.46969697,93,205,198,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.014103425,0.626865672,0.626865672,42,67,67,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  patientDrug  Pemetrexed,0.029214238,0.669230769,0.756521739,87,130,115,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.010073875,0.32967033,0.32967033,30,91,91,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.018804567,0.608695652,0.608695652,56,92,92,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.010409671,0.720930233,0.720930233,31,43,43,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Pemetrexed,0.0161182,0.727272727,0.727272727,48,66,66,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.016789792,0.490196078,0.490196078,50,102,102,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Pemetrexed,0.011752854,0.372340426,0.372340426,35,94,94,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.015446608,0.528735632,0.528735632,46,87,87,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.027535259,0.589928058,0.589928058,82,139,139,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Pemetrexed,0.013096038,0.629032258,0.629032258,39,62,62,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.010073875,0.545454545,0.555555556,30,55,54,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.017125588,0.428571429,0.428571429,51,119,119,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.025856279,0.496774194,0.496774194,77,155,155,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.031229013,0.455882353,0.455882353,93,204,204,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Pemetrexed,0.018804567,0.482758621,0.549019608,56,116,102,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.021155138,0.5625,0.5625,63,112,112,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Pemetrexed,0.022162525,0.47826087,0.536585366,66,138,123,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.013096038,0.438202247,0.438202247,39,89,89,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.011752854,0.564516129,0.564516129,35,62,62,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.010409671,0.484375,0.484375,31,64,64,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.011081263,0.47826087,0.47826087,33,69,69,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.026863667,0.555555556,0.555555556,80,144,144,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.027871054,0.395238095,0.404878049,83,210,205,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Pemetrexed,0.013096038,0.52,0.52,39,75,75,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Pemetrexed,0.014775017,0.5,0.55,44,88,80,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.02014775,0.346820809,0.346820809,60,173,173,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.011752854,0.327102804,0.336538462,35,107,104,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.013767629,0.525641026,0.525641026,41,78,78,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.013096038,0.696428571,0.696428571,39,56,56,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.019476158,0.637362637,0.637362637,58,91,91,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.010409671,0.462686567,0.462686567,31,67,67,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.013431833,0.64516129,0.701754386,40,62,57,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.048018805,0.344578313,0.344578313,143,415,415,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.039288113,0.573529412,0.573529412,117,204,204,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.021155138,0.344262295,0.344262295,63,183,183,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.015110813,0.548780488,0.6,45,82,75,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.017125588,0.451327434,0.451327434,51,113,113,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.016453996,0.644736842,0.7,49,76,70,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.010073875,0.434782609,0.434782609,30,69,69,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.035930154,0.581521739,0.581521739,107,184,184,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.017461383,0.468468468,0.468468468,52,111,111,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Pemetrexed,0.022162525,0.523809524,0.523809524,66,126,126,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  patientDrug  Pemetrexed,0.012424446,0.493333333,0.552238806,37,75,67,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.023169913,0.492857143,0.492857143,69,140,140,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.025520484,0.356807512,0.38,76,213,200,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Pemetrexed,0.019140363,0.475,0.508928571,57,120,112,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  patientDrug  Pemetrexed,0.02014775,0.458015267,0.52173913,60,131,115,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Pemetrexed,0.013431833,0.555555556,0.597014925,40,72,67,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Pemetrexed,0.016453996,0.859649123,0.859649123,49,57,57,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  patientDrug  Pemetrexed,0.011081263,0.397590361,0.452054795,33,83,73,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Surgery   ,?a  patientDrug  Pemetrexed,0.010409671,0.413333333,0.442857143,31,75,70,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.013096038,0.506493506,0.506493506,39,77,77,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Pemetrexed,0.010409671,0.492063492,0.553571429,31,63,56,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.011081263,0.540983607,0.540983607,33,61,61,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.011752854,0.416666667,0.466666667,35,84,75,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  patientDrug  Pemetrexed,0.017461383,0.452173913,0.52,52,115,100,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.021155138,0.547826087,0.547826087,63,115,115,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.023169913,0.482517483,0.482517483,69,143,143,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.018132975,0.519230769,0.524271845,54,104,103,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Pemetrexed,0.02014775,0.52173913,0.526315789,60,115,114,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  patientDrug  Pemetrexed,0.011417058,0.515151515,0.586206897,34,66,58,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Pemetrexed,0.048018805,0.429429429,0.508896797,143,333,281,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.04600403,0.721052632,0.721052632,137,190,190,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.027871054,0.680327869,0.680327869,83,122,122,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.025520484,0.472049689,0.517006803,76,161,147,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.051040967,0.533333333,0.573584906,152,285,265,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.011417058,0.557377049,0.557377049,34,61,61,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Pemetrexed,0.043989255,0.545833333,0.592760181,131,240,221,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.062793821,0.454987835,0.454987835,187,411,411,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Pemetrexed,0.053727334,0.714285714,0.714285714,160,224,224,?a
?a  hasGender  Female  ?a  hasSmokingHabit  NonSmoker   ,?a  hasRelapse_Progression  Progression,0.06,0.652173913,0.821917808,60,92,73,?a
?a  hasRelapse_Progression  Relapse  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  Progression,0.014,0.583333333,0.583333333,14,24,24,?a
?a  hasGender  Female  ?a  hasStage  IIIB   ,?a  hasRelapse_Progression  Progression,0.03,0.731707317,0.857142857,30,41,35,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasRelapse_Progression  Progression,0.035,0.760869565,1,35,46,35,?a
?a  hasRelapse_Progression  Relapse  ?a  hasStage  IIIA   ,?a  hasRelapse_Progression  Progression,0.011,0.733333333,0.733333333,11,15,15,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.04,0.869565217,1,40,46,40,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  hasRelapse_Progression  Progression,0.066,0.733333333,0.868421053,66,90,76,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  hasRelapse_Progression  Progression,0.093,0.645833333,0.808695652,93,144,115,?a
?a  hasGender  Female  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.028,0.848484848,0.933333333,28,33,30,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.031,0.96875,1,31,32,31,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.092,0.73015873,0.807017544,92,126,114,?a
?a  hasGender  Female  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.06,0.833333333,0.967741935,60,72,62,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.121,0.864285714,0.968,121,140,125,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.059,0.67816092,0.786666667,59,87,75,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.076,0.863636364,0.95,76,88,80,?a
?a  hasGender  Female  ?a  patientDrug  Vincristine   ,?a  hasRelapse_Progression  Progression,0.014,1,1,14,14,14,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.034,0.772727273,0.790697674,34,44,43,?a
?a  hasGender  Female  ?a  patientDrug  Cyclophosphamide   ,?a  hasRelapse_Progression  Progression,0.014,1,1,14,14,14,?a
?a  hasGender  Female  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.016,0.888888889,1,16,18,16,?a
?a  hasGender  Female  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.027,0.870967742,1,27,31,27,?a
?a  hasGender  Female  ?a  patientDrug  Doxorubicin   ,?a  hasRelapse_Progression  Progression,0.012,1,1,12,12,12,?a
?a  hasGender  Female  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.029,0.852941176,0.90625,29,34,32,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.073,0.802197802,0.858823529,73,91,85,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.016,0.666666667,0.941176471,16,24,17,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.127,0.693989071,0.808917197,127,183,157,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Female   ,?a  hasRelapse_Progression  Progression,0.037,0.711538462,0.948717949,37,52,39,?a
?a  hasGender  Female  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.023,0.821428571,1,23,28,23,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.033,0.75,1,33,44,33,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.046,0.779661017,1,46,59,46,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasRelapse_Progression  Progression,0.073,0.634782609,0.858823529,73,115,85,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasRelapse_Progression  Progression,0.091,0.694656489,0.85046729,91,131,107,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.014,0.875,1,14,16,14,?a
?a  hasStage  IVA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.019,0.95,1,19,20,19,?a
?a  hasStage  IVA  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.015,0.882352941,1,15,17,15,?a
?a  hasStage  IVA  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.019,0.730769231,1,19,26,19,?a
?a  hasStage  IVA  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.019,0.95,1,19,20,19,?a
?a  hasAgeCategory  Young  ?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.015,0.789473684,1,15,19,15,?a
?a  hasStage  IVA  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.012,0.705882353,1,12,17,12,?a
?a  hasStage  IVA  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.037,0.770833333,1,37,48,37,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.032,0.695652174,1,32,46,32,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.041,0.82,1,41,50,41,?a
?a  hasStage  IVA  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.027,0.818181818,1,27,33,27,?a
?a  hasStage  IVA  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.011,0.916666667,1,11,12,11,?a
?a  hasStage  IVA  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.018,1,1,18,18,18,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.03,0.697674419,1,30,43,30,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.024,0.75,1,24,32,24,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.029,0.674418605,1,29,43,29,?a
?a  hasSmokingHabit  NonSmoker  ?a  hasStage  IVB   ,?a  hasRelapse_Progression  Progression,0.014,0.7,1,14,20,14,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVA   ,?a  hasRelapse_Progression  Progression,0.016,0.615384615,1,16,26,16,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.027,0.771428571,1,27,35,27,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.012,0.857142857,1,12,14,12,?a
?a  hasStage  IVB  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.015,0.652173913,1,15,23,15,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.06,0.810810811,1,60,74,60,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.025,0.735294118,1,25,34,25,?a
?a  hasStage  IVB  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.01,0.909090909,1,10,11,10,?a
?a  hasStage  IVB  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.016,0.888888889,1,16,18,16,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  hasRelapse_Progression  Progression,0.034,0.693877551,1,34,49,34,?a
?a  hasStage  IVB  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.018,0.947368421,1,18,19,18,?a
?a  hasStage  IVB  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.01,0.666666667,1,10,15,10,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  hasRelapse_Progression  Progression,0.052,0.684210526,1,52,76,52,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.029,0.852941176,1,29,34,29,?a
?a  hasStage  IVB  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.013,0.928571429,1,13,14,13,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.032,0.780487805,1,32,41,32,?a
?a  hasStage  IVB  ?a  patientDrug  Vp-16   ,?a  hasRelapse_Progression  Progression,0.016,0.727272727,1,16,22,16,?a
?a  hasStage  IVB  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.016,0.941176471,1,16,17,16,?a
?a  hasStage  IVB  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.056,0.767123288,1,56,73,56,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IVB   ,?a  hasRelapse_Progression  Progression,0.014,0.7,1,14,20,14,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIB   ,?a  hasRelapse_Progression  Progression,0.046,0.647887324,0.836363636,46,71,55,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.072,0.782608696,0.87804878,72,92,82,?a
?a  hasStage  IIIB  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.025,0.862068966,1,25,29,25,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasStage  IVB   ,?a  hasRelapse_Progression  Progression,0.02,0.666666667,1,20,30,20,?a
?a  hasStage  IIIB  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.018,0.782608696,0.9,18,23,20,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIB   ,?a  hasRelapse_Progression  Progression,0.034,0.739130435,0.894736842,34,46,38,?a
?a  hasStage  IIIB  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.014,0.823529412,1,14,17,14,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.042,0.84,0.954545455,42,50,44,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.048,0.71641791,0.888888889,48,67,54,?a
?a  hasStage  IIIB  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  hasStage  IIIB  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.023,0.92,0.958333333,23,25,24,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.052,0.838709677,0.928571429,52,62,56,?a
?a  hasStage  IIIB  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.034,0.85,0.918918919,34,40,37,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IIIB   ,?a  hasRelapse_Progression  Progression,0.011,0.846153846,0.916666667,11,13,12,?a
?a  hasStage  IIIB  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.012,0.923076923,0.923076923,12,13,13,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIB   ,?a  hasRelapse_Progression  Progression,0.017,0.68,0.85,17,25,20,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIB   ,?a  hasRelapse_Progression  Progression,0.024,0.75,0.888888889,24,32,27,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIB   ,?a  hasRelapse_Progression  Progression,0.037,0.822222222,0.925,37,45,40,?a
?a  hasSmokingHabit  NonSmoker  ?a  hasStage  IIIA   ,?a  hasRelapse_Progression  Progression,0.016,0.761904762,0.888888889,16,21,18,?a
?a  hasStage  IIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  Progression,0.04,0.606060606,0.677966102,40,66,59,?a
?a  hasStage  IIIA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.026,1,1,26,26,26,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  Progression,0.051,0.62195122,0.708333333,51,82,72,?a
?a  hasStage  IIIA  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.014,1,1,14,14,14,?a
?a  hasAgeCategory  Young  ?a  hasStage  IIIA   ,?a  hasRelapse_Progression  Progression,0.042,0.7,0.79245283,42,60,53,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasStage  IIIA   ,?a  hasRelapse_Progression  Progression,0.013,0.928571429,1,13,14,13,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.016,0.941176471,1,16,17,16,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.012,0.8,0.923076923,12,15,13,?a
?a  hasBiomarker  RET_Negative  ?a  hasStage  IIIA   ,?a  hasRelapse_Progression  Progression,0.019,0.904761905,1,19,21,19,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  Progression,0.012,0.666666667,0.8,12,18,15,?a
?a  hasSmokingHabit  NonSmoker  ?a  hasStage  IV   ,?a  hasRelapse_Progression  Progression,0.029,0.763157895,0.90625,29,38,32,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  NonSmoker   ,?a  hasRelapse_Progression  Progression,0.026,0.65,0.896551724,26,40,29,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  Progression,0.014,0.636363636,0.875,14,22,16,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.019,0.791666667,1,19,24,19,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.018,0.857142857,0.947368421,18,21,19,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.024,0.888888889,0.96,24,27,25,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.023,0.793103448,0.884615385,23,29,26,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasRelapse_Progression  Progression,0.025,0.595238095,0.862068966,25,42,29,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.039,0.928571429,0.975,39,42,40,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasRelapse_Progression  Progression,0.036,0.734693878,0.857142857,36,49,42,?a
?a  hasBiomarker  ALK_Positive  ?a  hasSmokingHabit  NonSmoker   ,?a  hasRelapse_Progression  Progression,0.015,0.9375,0.9375,15,16,16,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.025,0.925925926,0.961538462,25,27,26,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasRelapse_Progression  Progression,0.02,0.625,0.869565217,20,32,23,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.032,0.888888889,0.941176471,32,36,34,?a
?a  hasAgeCategory  Young  ?a  hasStage  IV   ,?a  hasRelapse_Progression  Progression,0.064,0.727272727,0.864864865,64,88,74,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.035,0.795454545,0.897435897,35,44,39,?a
?a  hasStage  IV  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.071,0.806818182,0.91025641,71,88,78,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.039,0.795918367,0.886363636,39,49,44,?a
?a  hasStage  IV  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.049,0.844827586,0.960784314,49,58,51,?a
?a  hasStage  IV  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.148,0.855491329,0.967320261,148,173,153,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.034,0.790697674,0.918918919,34,43,37,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.045,0.849056604,0.957446809,45,53,47,?a
?a  hasStage  IV  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.02,0.714285714,0.909090909,20,28,22,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.041,0.836734694,0.911111111,41,49,45,?a
?a  hasStage  IV  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  hasStage  IV  ?a  patientDrug  Cyclophosphamide   ,?a  hasRelapse_Progression  Progression,0.032,1,1,32,32,32,?a
?a  hasStage  IV  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.026,0.896551724,1,26,29,26,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.036,0.837209302,0.9,36,43,40,?a
?a  hasStage  IV  ?a  patientDrug  Vincristine   ,?a  hasRelapse_Progression  Progression,0.031,1,1,31,31,31,?a
?a  hasStage  IV  ?a  patientDrug  Doxorubicin   ,?a  hasRelapse_Progression  Progression,0.03,1,1,30,30,30,?a
?a  hasStage  IV  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.093,0.885714286,0.958762887,93,105,97,?a
?a  hasStage  IV  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.013,0.928571429,1,13,14,13,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.042,0.84,1,42,50,42,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.139,0.776536313,0.908496732,139,179,153,?a
?a  hasBiomarker  ALK_Positive  ?a  hasStage  IV   ,?a  hasRelapse_Progression  Progression,0.015,0.9375,0.9375,15,16,16,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.047,0.854545455,1,47,55,47,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.088,0.822429907,0.897959184,88,107,98,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.019,0.863636364,0.95,19,22,20,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.016,0.888888889,0.941176471,16,18,17,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.088,0.785714286,0.854368932,88,112,103,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  hasRelapse_Progression  Progression,0.099,0.761538462,0.876106195,99,130,113,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.053,0.85483871,0.981481481,53,62,54,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.054,0.782608696,0.9,54,69,60,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cyclophosphamide   ,?a  hasRelapse_Progression  Progression,0.024,1,1,24,24,24,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Nintedanib   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.019,0.904761905,1,19,21,19,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vincristine   ,?a  hasRelapse_Progression  Progression,0.023,1,1,23,23,23,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.018,0.6,0.9,18,30,20,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.083,0.855670103,0.965116279,83,97,86,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.139,0.896774194,0.985815603,139,155,141,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.07,0.833333333,0.886075949,70,84,79,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.033,0.804878049,0.846153846,33,41,39,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.09,0.756302521,0.873786408,90,119,103,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.07,0.7,0.833333333,70,100,84,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.043,0.977272727,0.977272727,43,44,44,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.018,1,1,18,18,18,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.038,0.88372093,0.88372093,38,43,43,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vp-16   ,?a  hasRelapse_Progression  Progression,0.043,0.693548387,0.781818182,43,62,55,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.015,0.833333333,1,15,18,15,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Doxorubicin   ,?a  hasRelapse_Progression  Progression,0.021,1,1,21,21,21,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.129,0.74566474,0.843137255,129,173,153,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  BRAF_Negative   ,?a  hasRelapse_Progression  Progression,0.014,0.424242424,0.875,14,33,16,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Negative   ,?a  hasRelapse_Progression  Progression,0.077,0.663793103,0.885057471,77,116,87,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.017,0.80952381,1,17,21,17,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  hasRelapse_Progression  Progression,0.098,0.710144928,0.899082569,98,138,109,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ALK_Positive   ,?a  hasRelapse_Progression  Progression,0.015,0.882352941,1,15,17,15,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Positive   ,?a  hasRelapse_Progression  Progression,0.023,0.547619048,0.92,23,42,25,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  RET_Negative   ,?a  hasRelapse_Progression  Progression,0.01,0.714285714,1,10,14,10,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Positive   ,?a  hasRelapse_Progression  Progression,0.022,0.75862069,0.956521739,22,29,23,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  ROS1_Negative   ,?a  hasRelapse_Progression  Progression,0.058,0.659090909,0.920634921,58,88,63,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  PDL1_Negative   ,?a  hasRelapse_Progression  Progression,0.03,0.833333333,0.9375,30,36,32,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasRelapse_Progression  Progression,0.257,0.543340381,0.704109589,257,473,365,?a
?a  hasGender  Male  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.059,0.556603774,0.710843373,59,106,83,?a
?a  hasGender  Male  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.099,0.779527559,0.883928571,99,127,112,?a
?a  hasGender  Male  ?a  treatmentType  Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.029,0.547169811,0.707317073,29,53,41,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.119,0.793333333,0.875,119,150,136,?a
?a  hasGender  Male  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.029,0.725,0.828571429,29,40,35,?a
?a  hasGender  Male  ?a  patientDrug  Vp-16   ,?a  hasRelapse_Progression  Progression,0.095,0.650684932,0.791666667,95,146,120,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.138,0.715025907,0.857142857,138,193,161,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Male   ,?a  hasRelapse_Progression  Progression,0.049,0.680555556,0.907407407,49,72,54,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.032,0.914285714,0.96969697,32,35,33,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasRelapse_Progression  Progression,0.05,0.543478261,0.862068966,50,92,58,?a
?a  hasGender  Male  ?a  patientDrug  Afatinib   ,?a  hasRelapse_Progression  Progression,0.02,0.952380952,0.952380952,20,21,21,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  hasRelapse_Progression  Progression,0.113,0.627777778,0.84962406,113,180,133,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.024,0.6,0.75,24,40,32,?a
?a  hasBiomarker  ALK_Positive  ?a  hasGender  Male   ,?a  hasRelapse_Progression  Progression,0.014,0.777777778,0.875,14,18,16,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasRelapse_Progression  Progression,0.055,0.654761905,0.887096774,55,84,62,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.028,0.875,0.903225806,28,32,31,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.013,1,1,13,13,13,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.044,0.75862069,0.830188679,44,58,53,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.016,0.533333333,0.727272727,16,30,22,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  Progression,0.026,0.565217391,0.702702703,26,46,37,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  Progression,0.012,0.75,0.8,12,16,15,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  Progression,0.021,0.954545455,1,21,22,21,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  Progression,0.045,0.478723404,0.6,45,94,75,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasRelapse_Progression  Progression,0.013,1,1,13,13,13,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.149,0.741293532,0.82320442,149,201,181,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.209,0.836,0.95,209,250,220,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.086,0.788990826,0.87755102,86,109,98,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.01,0.909090909,1,10,11,10,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.05,0.724637681,0.806451613,50,69,62,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.039,0.829787234,0.928571429,39,47,42,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.016,0.761904762,1,16,21,16,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.041,0.854166667,1,41,48,41,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.074,0.762886598,0.891566265,74,97,83,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.03,0.9375,0.967741935,30,32,31,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vp-16   ,?a  hasRelapse_Progression  Progression,0.056,0.629213483,0.767123288,56,89,73,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasRelapse_Progression  Progression,0.017,0.772727273,1,17,22,17,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.056,0.811594203,0.875,56,69,64,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasRelapse_Progression  Progression,0.124,0.656084656,0.861111111,124,189,144,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasRelapse_Progression  Progression,0.149,0.680365297,0.846590909,149,219,176,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Afatinib   ,?a  hasRelapse_Progression  Progression,0.011,0.916666667,1,11,12,11,?a
?a  treatmentType  Surgery  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.02,0.869565217,0.952380952,20,23,21,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.014,1,1,14,14,14,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.205,0.640625,0.791505792,205,320,259,?a
?a  treatmentType  Sequential_Chemoradiation  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.011,0.916666667,0.916666667,11,12,12,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.019,0.95,0.95,19,20,20,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasRelapse_Progression  Progression,0.044,0.628571429,0.88,44,70,50,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.046,0.93877551,0.978723404,46,49,47,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.031,0.96875,0.96875,31,32,32,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.037,0.840909091,0.948717949,37,44,39,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.029,0.90625,0.966666667,29,32,30,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.011,0.846153846,1,11,13,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.036,0.923076923,0.972972973,36,39,37,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.012,1,1,12,12,12,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.022,0.88,0.916666667,22,25,24,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.012,0.923076923,0.923076923,12,13,13,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Oral_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.015,1,1,15,15,15,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.019,0.95,0.95,19,20,20,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Thoracoscopy   ,?a  hasRelapse_Progression  Progression,0.012,0.923076923,1,12,13,12,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.033,1,1,33,33,33,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.014,0.823529412,1,14,17,14,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Surgery   ,?a  hasRelapse_Progression  Progression,0.013,0.928571429,0.928571429,13,14,14,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.026,0.896551724,1,26,29,26,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.086,0.945054945,1,86,91,86,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.038,0.904761905,1,38,42,38,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.025,0.925925926,1,25,27,25,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.027,0.964285714,1,27,28,27,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.066,0.868421053,0.985074627,66,76,67,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.034,0.971428571,1,34,35,34,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.013,1,1,13,13,13,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.057,0.93442623,1,57,61,57,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.035,1,1,35,35,35,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.074,0.948717949,1,74,78,74,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.013,0.928571429,1,13,14,13,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.021,0.954545455,1,21,22,21,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.011,0.785714286,1,11,14,11,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.038,0.974358974,1,38,39,38,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.023,0.821428571,1,23,28,23,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasRelapse_Progression  Progression,0.015,0.833333333,1,15,18,15,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Ipilimumab   ,?a  hasRelapse_Progression  Progression,0.01,0.833333333,0.909090909,10,12,11,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Afatinib   ,?a  hasRelapse_Progression  Progression,0.02,0.869565217,0.952380952,20,23,21,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.014,1,1,14,14,14,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.021,0.777777778,0.875,21,27,24,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.019,0.904761905,0.95,19,21,20,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.024,0.923076923,1,24,26,24,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.019,0.76,0.95,19,25,20,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.022,0.814814815,0.956521739,22,27,23,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.127,0.881944444,0.962121212,127,144,132,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasRelapse_Progression  Progression,0.016,0.888888889,0.941176471,16,18,17,?a
?a  treatmentType  Thoracoscopy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.02,0.833333333,0.869565217,20,24,23,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.036,0.857142857,0.972972973,36,42,37,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.033,0.891891892,1,33,37,33,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.048,0.923076923,0.96,48,52,50,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.016,0.888888889,1,16,18,16,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.025,0.892857143,0.961538462,25,28,26,?a
?a  patientDrug  Other  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.011,0.846153846,1,11,13,11,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.071,0.865853659,0.986111111,71,82,72,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.02,0.952380952,0.952380952,20,21,21,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.041,0.836734694,1,41,49,41,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.051,0.962264151,1,51,53,51,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.047,1,1,47,47,47,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.027,1,1,27,27,27,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.057,0.95,1,57,60,57,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.023,0.958333333,1,23,24,23,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.021,0.954545455,0.954545455,21,22,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.01,0.666666667,1,10,15,10,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.017,0.62962963,1,17,27,17,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.017,0.85,1,17,20,17,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.019,0.826086957,1,19,23,19,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasRelapse_Progression  Progression,0.061,0.847222222,0.983870968,61,72,62,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Nintedanib   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.033,0.942857143,0.970588235,33,35,34,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vincristine   ,?a  hasRelapse_Progression  Progression,0.033,1,1,33,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.013,0.866666667,1,13,15,13,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cyclophosphamide   ,?a  hasRelapse_Progression  Progression,0.032,1,1,32,32,32,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.01,0.833333333,1,10,12,10,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.077,0.846153846,0.950617284,77,91,81,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.022,0.647058824,0.916666667,22,34,24,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasRelapse_Progression  Progression,0.029,0.527272727,0.878787879,29,55,33,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Doxorubicin   ,?a  hasRelapse_Progression  Progression,0.031,1,1,31,31,31,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.083,0.669354839,0.855670103,83,124,97,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.022,0.916666667,0.956521739,22,24,23,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasRelapse_Progression  Progression,0.024,0.666666667,0.923076923,24,36,26,?a
?a  hasBiomarker  RET_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasRelapse_Progression  Progression,0.017,0.653846154,1,17,26,17,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  Progression,0.02,0.952380952,0.952380952,20,21,21,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.029,0.966666667,0.966666667,29,30,30,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  Progression,0.012,0.666666667,0.923076923,12,18,13,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasRelapse_Progression  Progression,0.017,1,1,17,17,17,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.012,1,1,12,12,12,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.012,1,1,12,12,12,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.043,0.977272727,1,43,44,43,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.034,0.944444444,1,34,36,34,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.053,0.929824561,1,53,57,53,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.033,0.733333333,1,33,45,33,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.013,0.928571429,1,13,14,13,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.036,0.972972973,1,36,37,36,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.052,0.928571429,1,52,56,52,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.031,0.720930233,0.96875,31,43,32,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.029,0.966666667,0.966666667,29,30,30,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.051,0.910714286,0.980769231,51,56,52,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasRelapse_Progression  Progression,0.05,0.847457627,0.961538462,50,59,52,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.057,0.838235294,0.890625,57,68,64,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.065,0.928571429,0.955882353,65,70,68,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.012,0.923076923,1,12,13,12,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.079,0.782178218,0.887640449,79,101,89,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.042,0.954545455,0.954545455,42,44,44,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.017,0.944444444,1,17,18,17,?a
?a  patientDrug  Other  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.113,0.837037037,0.88976378,113,135,127,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.129,0.763313609,0.837662338,129,169,154,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.068,0.653846154,0.790697674,68,104,86,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.14,0.795454545,0.858895706,140,176,163,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.1,0.8,0.877192982,100,125,114,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.014,0.823529412,1,14,17,14,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.051,0.75,0.85,51,68,60,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.021,0.84,0.913043478,21,25,23,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasRelapse_Progression  Progression,0.016,0.941176471,1,16,17,16,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.035,0.945945946,0.972222222,35,37,36,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.066,0.741573034,0.795180723,66,89,83,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.067,0.752808989,0.817073171,67,89,82,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.044,0.8,0.846153846,44,55,52,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.021,0.954545455,0.954545455,21,22,22,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.051,0.80952381,0.85,51,63,60,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.108,0.939130435,0.981818182,108,115,110,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nintedanib   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.092,0.779661017,0.828828829,92,118,111,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasRelapse_Progression  Progression,0.013,0.928571429,0.928571429,13,14,14,?a
?a  patientDrug  Nintedanib  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.017,1,1,17,17,17,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nintedanib   ,?a  hasRelapse_Progression  Progression,0.016,1,1,16,16,16,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nintedanib   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.034,0.918918919,1,34,37,34,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.096,0.897196262,0.932038835,96,107,103,?a
?a  patientDrug  Nintedanib  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.017,1,1,17,17,17,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.027,0.658536585,1,27,41,27,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nintedanib   ,?a  hasRelapse_Progression  Progression,0.018,1,1,18,18,18,?a
?a  patientDrug  Other  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.016,0.888888889,1,16,18,16,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nintedanib   ,?a  hasRelapse_Progression  Progression,0.015,1,1,15,15,15,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.069,0.907894737,0.971830986,69,76,71,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.094,0.831858407,0.886792453,94,113,106,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.075,0.721153846,0.892857143,75,104,84,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.085,0.739130435,0.885416667,85,115,96,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.055,0.714285714,0.901639344,55,77,61,?a
?a  patientDrug  Atezolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.013,0.928571429,1,13,14,13,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.054,0.870967742,0.915254237,54,62,59,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.018,1,1,18,18,18,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.019,0.904761905,1,19,21,19,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.026,0.8125,0.962962963,26,32,27,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.018,1,1,18,18,18,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasRelapse_Progression  Progression,0.042,0.646153846,0.893617021,42,65,47,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.021,0.913043478,1,21,23,21,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.018,0.9,1,18,20,18,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.016,0.761904762,1,16,21,16,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.017,1,1,17,17,17,?a
?a  patientDrug  Erlotinib  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.014,0.933333333,1,14,15,14,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.027,0.9,1,27,30,27,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.041,1,1,41,41,41,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.016,1,1,16,16,16,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.016,0.842105263,1,16,19,16,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Erlotinib   ,?a  hasRelapse_Progression  Progression,0.013,0.8125,1,13,16,13,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.071,0.825581395,0.87654321,71,86,81,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.084,0.965517241,1,84,87,84,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.056,0.835820896,0.875,56,67,64,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.023,0.851851852,1,23,27,23,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.04,0.930232558,0.952380952,40,43,42,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasRelapse_Progression  Progression,0.033,0.846153846,0.891891892,33,39,37,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.016,1,1,16,16,16,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.029,0.90625,0.966666667,29,32,30,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.027,0.964285714,1,27,28,27,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.012,1,1,12,12,12,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.015,1,1,15,15,15,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.014,1,1,14,14,14,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.02,1,1,20,20,20,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.012,1,1,12,12,12,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.044,0.956521739,0.977777778,44,46,45,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.093,0.894230769,0.948979592,93,104,98,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.057,0.890625,0.919354839,57,64,62,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.028,0.965517241,0.965517241,28,29,29,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Gemcitabine   ,?a  hasRelapse_Progression  Progression,0.033,0.970588235,0.970588235,33,34,34,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.128,0.920863309,0.984615385,128,139,130,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.015,0.789473684,0.9375,15,19,16,?a
?a  hasBiomarker  ALK_Positive  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.013,0.928571429,0.928571429,13,14,14,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.013,1,1,13,13,13,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.084,0.893617021,0.923076923,84,94,91,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.015,0.9375,1,15,16,15,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.056,0.746666667,0.888888889,56,75,63,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vp-16   ,?a  hasRelapse_Progression  Progression,0.015,0.789473684,0.833333333,15,19,18,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.09,0.803571429,0.909090909,90,112,99,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  hasRelapse_Progression  Progression,0.119,0.826388889,0.915384615,119,144,130,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.187,0.882075472,0.963917526,187,212,194,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.02,0.769230769,0.952380952,20,26,21,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.045,0.97826087,0.97826087,45,46,46,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.062,0.953846154,0.96875,62,65,64,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.028,0.736842105,0.965517241,28,38,29,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.131,0.823899371,0.949275362,131,159,138,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.056,0.949152542,1,56,59,56,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.152,0.830601093,0.944099379,152,183,161,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.019,0.655172414,1,19,29,19,?a
?a  patientDrug  Other  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.015,0.9375,1,15,16,15,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.019,0.95,1,19,20,19,?a
?a  patientDrug  Osimertinib  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.018,0.947368421,1,18,19,18,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.076,0.775510204,0.95,76,98,80,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.133,0.898648649,0.985185185,133,148,135,?a
?a  patientDrug  Osimertinib  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.103,0.844262295,0.903508772,103,122,114,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.121,0.672222222,0.790849673,121,180,153,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.035,0.833333333,0.972222222,35,42,36,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.025,0.757575758,1,25,33,25,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Pemetrexed   ,?a  hasRelapse_Progression  Progression,0.024,0.96,1,24,25,24,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.044,0.977777778,0.977777778,44,45,45,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.013,1,1,13,13,13,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.088,0.956521739,0.988764045,88,92,89,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.149,0.881656805,0.955128205,149,169,156,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.027,1,1,27,27,27,?a
?a  patientDrug  Other  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.024,0.923076923,1,24,26,24,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.093,0.744,0.861111111,93,125,108,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.021,0.954545455,1,21,22,21,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasRelapse_Progression  Progression,0.016,0.941176471,1,16,17,16,?a
?a  patientDrug  Osimertinib  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.019,0.95,1,19,20,19,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.032,0.761904762,0.96969697,32,42,33,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.161,0.847368421,0.964071856,161,190,167,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.025,0.961538462,1,25,26,25,?a
?a  patientDrug  Ipilimumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.1,0.819672131,0.961538462,100,122,104,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.011,1,1,11,11,11,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.049,0.803278689,1,49,61,49,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.03,1,1,30,30,30,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.192,0.857142857,0.955223881,192,224,201,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.056,0.965517241,1,56,58,56,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.054,0.885245902,0.981818182,54,61,55,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasRelapse_Progression  Progression,0.015,0.833333333,1,15,18,15,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.015,0.9375,1,15,16,15,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.063,0.954545455,1,63,66,63,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.015,0.9375,1,15,16,15,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Ipilimumab   ,?a  hasRelapse_Progression  Progression,0.014,1,1,14,14,14,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.068,0.944444444,0.985507246,68,72,69,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.017,0.944444444,1,17,18,17,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasRelapse_Progression  Progression,0.041,0.953488372,1,41,43,41,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.021,1,1,21,21,21,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.085,0.817307692,0.904255319,85,104,94,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.019,0.655172414,0.863636364,19,29,22,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.012,0.857142857,0.923076923,12,14,13,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.033,0.673469388,0.942857143,33,49,35,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.05,0.769230769,0.847457627,50,65,59,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.017,0.894736842,1,17,19,17,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.012,1,1,12,12,12,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.031,0.837837838,0.939393939,31,37,33,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Other   ,?a  hasRelapse_Progression  Progression,0.01,1,1,10,10,10,?a
?a  patientDrug  Other  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.014,1,1,14,14,14,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.025,0.862068966,0.925925926,25,29,27,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.029,0.644444444,0.935483871,29,45,31,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.102,0.822580645,0.894736842,102,124,114,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasRelapse_Progression  Progression,0.015,1,1,15,15,15,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.025,0.609756098,0.925925926,25,41,27,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.02,0.952380952,1,20,21,20,?a
?a  patientDrug  Afatinib  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.022,0.956521739,1,22,23,22,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Afatinib   ,?a  hasRelapse_Progression  Progression,0.011,0.785714286,1,11,14,11,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.019,0.904761905,0.95,19,21,20,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.048,0.71641791,0.96,48,67,50,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.134,0.72826087,0.881578947,134,184,152,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.032,0.615384615,0.864864865,32,52,37,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasRelapse_Progression  Progression,0.023,0.58974359,0.92,23,39,25,?a
?a  hasBiomarker  ALK_Positive  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.011,0.916666667,0.916666667,11,12,12,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.151,0.740196078,0.87283237,151,204,173,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.049,0.710144928,0.890909091,49,69,55,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.014,0.823529412,1,14,17,14,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Afatinib   ,?a  hasRelapse_Progression  Progression,0.01,0.909090909,1,10,11,10,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.03,0.769230769,0.967741935,30,39,31,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Osimertinib   ,?a  hasRelapse_Progression  Progression,0.013,0.684210526,1,13,19,13,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  BRAF_Negative   ,?a  hasRelapse_Progression  Progression,0.057,0.513513514,0.876923077,57,111,65,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.027,0.9,0.964285714,27,30,28,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasRelapse_Progression  Progression,0.086,0.682539683,0.86,86,126,100,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasRelapse_Progression  Progression,0.019,0.475,0.863636364,19,40,22,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasRelapse_Progression  Progression,0.056,0.495575221,0.848484848,56,113,66,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Positive   ,?a  hasRelapse_Progression  Progression,0.019,0.633333333,0.95,19,30,20,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasRelapse_Progression  Progression,0.013,0.590909091,0.928571429,13,22,14,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Vp-16,0.021490934,0.349726776,0.349726776,64,183,183,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasRelapse_Progression  Progression,0.061,0.603960396,0.85915493,61,101,71,?a
?a  hasStage  IV  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Vp-16,0.030221625,0.502793296,0.502793296,90,179,179,?a
?a  hasAgeCategory  Old  ?a  hasStage  IV   ,?a  patientDrug  Vp-16,0.020483546,0.306532663,0.354651163,61,199,172,?a
?a  hasStage  IV  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.010073875,1,1,30,30,30,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Vp-16,0.013431833,0.283687943,0.333333333,40,141,120,?a
?a  hasStage  IV  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Vp-16,0.010409671,0.96875,0.96875,31,32,32,?a
?a  hasStage  IV  ?a  patientDrug  Vincristine   ,?a  patientDrug  Vp-16,0.010409671,1,1,31,31,31,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  patientDrug  Vp-16,0.010073875,0.208333333,0.236220472,30,144,127,?a
?a  hasStage  IV  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.013431833,0.909090909,0.909090909,40,44,44,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  patientDrug  Vp-16,0.018468771,0.495495495,0.539215686,55,111,102,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vp-16,0.011081263,0.261904762,0.275,33,126,120,?a
?a  hasStage  IV  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.014439221,0.488636364,0.518072289,43,88,83,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vp-16,0.013096038,0.278571429,0.278571429,39,140,140,?a
?a  hasGender  Male  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.015446608,0.958333333,0.958333333,46,48,48,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.025184688,0.5,0.539568345,75,150,139,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  patientDrug  Vp-16,0.023841504,0.360406091,0.396648045,71,197,179,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.012760242,0.974358974,0.974358974,38,39,39,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Vp-16,0.010745467,1,1,32,32,32,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Vp-16,0.031900604,0.203862661,0.225653207,95,466,421,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  patientDrug  Vp-16,0.038280725,0.170403587,0.228915663,114,669,498,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.012760242,0.974358974,0.974358974,38,39,39,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.018468771,0.982142857,0.982142857,55,56,56,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Vp-16,0.019140363,0.982758621,0.982758621,57,58,58,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vincristine   ,?a  patientDrug  Vp-16,0.011081263,1,1,33,33,33,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.037609134,0.632768362,0.632768362,112,177,177,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Vp-16,0.01208865,1,1,36,36,36,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Vp-16,0.011081263,0.358695652,0.358695652,33,92,92,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vp-16,0.030221625,0.354330709,0.354330709,90,254,254,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Vp-16,0.020483546,0.352601156,0.352601156,61,173,173,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.01208865,0.9,0.947368421,36,40,38,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vincristine   ,?a  patientDrug  Vp-16,0.012424446,1,1,37,37,37,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Vp-16,0.038280725,0.428571429,0.428571429,114,266,266,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.018804567,0.98245614,0.98245614,56,57,57,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Vp-16,0.010073875,0.967741935,0.967741935,30,31,31,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.018804567,0.949152542,0.949152542,56,59,59,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vp-16,0.022162525,0.234875445,0.255813953,66,281,258,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.024513096,0.496598639,0.536764706,73,147,136,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.011417058,0.871794872,0.944444444,34,39,36,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Vp-16,0.014439221,0.255952381,0.304964539,43,168,141,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vp-16,0.029214238,0.256637168,0.256637168,87,339,339,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vp-16,0.015782404,0.284848485,0.299363057,47,165,157,?a
?a  treatmentType  Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.010745467,0.96969697,0.96969697,32,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vp-16,0.023505709,0.348258706,0.348258706,70,201,201,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.021490934,0.537815126,0.561403509,64,119,114,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Vp-16,0.010745467,0.864864865,0.914285714,32,37,35,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vp-16,0.018468771,0.302197802,0.302197802,55,182,182,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Vp-16,0.023505709,0.619469027,0.619469027,70,113,113,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.017797179,0.212,0.212,53,250,250,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Docetaxel,0.015446608,0.097251586,0.127777778,46,473,360,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Docetaxel,0.017797179,0.158682635,0.176666667,53,334,300,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Docetaxel,0.010073875,0.229007634,0.229007634,30,131,131,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Docetaxel,0.012760242,0.301587302,0.301587302,38,126,126,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Docetaxel,0.011417058,0.186813187,0.186813187,34,182,182,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Docetaxel,0.013767629,0.216931217,0.24260355,41,189,169,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Docetaxel,0.015446608,0.210045662,0.237113402,46,219,194,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.010073875,0.344827586,0.344827586,30,87,87,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.012424446,0.32173913,0.32173913,37,115,115,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Docetaxel,0.011417058,0.237762238,0.237762238,34,143,143,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Docetaxel,0.010409671,0.145539906,0.155,31,213,200,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.016453996,0.352517986,0.352517986,49,139,139,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.014103425,0.283783784,0.283783784,42,148,148,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.018804567,0.264150943,0.264150943,56,212,212,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.022162525,0.294642857,0.294642857,66,224,224,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.013431833,0.258064516,0.258064516,40,155,155,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.029550034,0.214111922,0.214111922,88,411,411,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.013431833,0.327868852,0.327868852,40,122,122,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Docetaxel,0.011081263,0.317307692,0.317307692,33,104,104,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Docetaxel,0.0161182,0.301886792,0.301886792,48,159,159,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Docetaxel,0.014775017,0.205607477,0.205607477,44,214,214,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Docetaxel,0.020819342,0.326315789,0.326315789,62,190,190,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Docetaxel,0.018804567,0.262910798,0.262910798,56,213,213,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Docetaxel,0.010409671,0.316326531,0.316326531,31,98,98,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Docetaxel,0.016453996,0.267759563,0.267759563,49,183,183,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Docetaxel,0.017125588,0.25,0.25,51,204,204,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Docetaxel,0.011417058,0.303571429,0.303571429,34,112,112,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Docetaxel,0.013767629,0.284722222,0.284722222,41,144,144,?a
?a  hasAgeCategory  Young  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Docetaxel,0.010073875,0.217391304,0.243902439,30,138,123,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Docetaxel,0.014103425,0.205882353,0.205882353,42,204,204,?a
?a  hasAgeCategory  Young  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Docetaxel,0.014439221,0.204761905,0.209756098,43,210,205,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Docetaxel,0.021155138,0.2625,0.285067873,63,240,221,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Docetaxel,0.013431833,0.168776371,0.199004975,40,237,201,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.011417058,0.390804598,0.390804598,34,87,87,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Docetaxel,0.022834117,0.238596491,0.256603774,68,285,265,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Docetaxel,0.014103425,0.22826087,0.22826087,42,184,184,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Paclitaxel,0.010073875,0.340909091,0.340909091,30,88,88,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.017461383,0.371428571,0.371428571,52,140,140,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.013431833,0.909090909,0.909090909,40,44,44,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Docetaxel,0.020819342,0.186186186,0.220640569,62,333,281,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Paclitaxel,0.011417058,0.382022472,0.382022472,34,89,89,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Docetaxel,0.013767629,0.254658385,0.278911565,41,161,147,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Paclitaxel,0.012760242,0.269503546,0.316666667,38,141,120,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.024848892,0.404371585,0.404371585,74,183,183,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Paclitaxel,0.024513096,0.342723005,0.365,73,213,200,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  patientDrug  Paclitaxel,0.011081263,0.286956522,0.33,33,115,100,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.025520484,0.460606061,0.484076433,76,165,157,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Paclitaxel,0.011081263,0.38372093,0.38372093,33,86,86,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.018468771,0.901639344,0.901639344,55,61,61,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Paclitaxel,0.014439221,0.346774194,0.346774194,43,124,124,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.018468771,0.398550725,0.398550725,55,138,138,?a
?a  hasAgeCategory  Young  ?a  hasGender  Female   ,?a  patientDrug  Paclitaxel,0.014439221,0.298611111,0.338582677,43,144,127,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  patientDrug  Paclitaxel,0.014439221,0.328244275,0.373913043,43,131,115,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Paclitaxel,0.028878442,0.326996198,0.349593496,86,263,246,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Paclitaxel,0.038616521,0.243128964,0.319444444,115,473,360,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  patientDrug  Paclitaxel,0.013431833,0.396039604,0.459770115,40,101,87,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Paclitaxel,0.015782404,0.55952381,0.55952381,47,84,84,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Paclitaxel,0.012760242,0.38,0.447058824,38,100,85,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.030221625,0.447761194,0.478723404,90,201,188,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Paclitaxel,0.014439221,0.304964539,0.361344538,43,141,119,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.029550034,0.352,0.352,88,250,250,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Paclitaxel,0.015110813,0.288461538,0.340909091,45,156,132,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.014103425,0.583333333,0.6,42,72,70,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.04197448,0.390625,0.390625,125,320,320,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Paclitaxel,0.035258563,0.314371257,0.35,105,334,300,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Paclitaxel,0.037944929,0.237394958,0.321937322,113,476,351,?a
?a  hasGender  Male  ?a  hasStage  IIIB   ,?a  patientDrug  Paclitaxel,0.015446608,0.46,0.489361702,46,100,94,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Paclitaxel,0.010409671,0.397435897,0.397435897,31,78,78,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.041302888,0.460674157,0.495967742,123,267,248,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Paclitaxel,0.013096038,0.342105263,0.351351351,39,114,111,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Paclitaxel,0.012760242,0.493506494,0.542857143,38,77,70,?a
?a  hasStage  IIIA  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Paclitaxel,0.010073875,0.340909091,0.441176471,30,88,68,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.019811954,0.756410256,0.756410256,59,78,78,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Paclitaxel,0.021826729,0.5,0.5,65,130,130,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.015446608,0.4,0.4,46,115,115,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Paclitaxel,0.012760242,0.387755102,0.463414634,38,98,82,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.0161182,0.979591837,0.979591837,48,49,49,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Paclitaxel,0.017125588,0.5,0.5,51,102,102,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Paclitaxel,0.019140363,0.504424779,0.504424779,57,113,113,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  patientDrug  Paclitaxel,0.053727334,0.23916293,0.321285141,160,669,498,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.018132975,0.642857143,0.65060241,54,84,83,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.014103425,0.617647059,0.617647059,42,68,68,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.020483546,0.717647059,0.717647059,61,85,85,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Paclitaxel,0.011081263,0.868421053,0.868421053,33,38,38,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Paclitaxel,0.010745467,0.492307692,0.492307692,32,65,65,?a
?a  hasStage  IIIA  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.022162525,0.594594595,0.611111111,66,111,108,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Paclitaxel,0.018468771,0.384615385,0.384615385,55,143,143,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.021490934,0.581818182,0.592592593,64,110,108,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.010409671,0.574074074,0.62,31,54,50,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.019476158,0.920634921,0.920634921,58,63,63,?a
?a  hasStage  IIIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.012760242,0.542857143,0.542857143,38,70,70,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.011417058,0.507462687,0.507462687,34,67,67,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIB   ,?a  patientDrug  Paclitaxel,0.014103425,0.442105263,0.477272727,42,95,88,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.030893217,0.910891089,0.910891089,92,101,101,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  patientDrug  Paclitaxel,0.017461383,0.565217391,0.571428571,52,92,91,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.018468771,0.597826087,0.611111111,55,92,90,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.017461383,0.912280702,0.912280702,52,57,57,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.027199463,0.91011236,0.91011236,81,89,89,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.01208865,0.87804878,0.87804878,36,41,41,?a
?a  hasStage  IIIB  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.015782404,0.540229885,0.540229885,47,87,87,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.014439221,0.914893617,0.914893617,43,47,47,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.016789792,0.909090909,0.909090909,50,55,55,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.030893217,0.505494505,0.505494505,92,182,182,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.041638684,0.441281139,0.480620155,124,281,258,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Paclitaxel,0.017461383,0.881355932,0.881355932,52,59,59,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.027199463,0.6,0.6,81,135,135,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.012760242,0.542857143,0.542857143,38,70,70,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.043317663,0.507874016,0.507874016,129,254,254,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.02014775,0.594059406,0.618556701,60,101,97,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.024513096,0.584,0.603305785,73,125,121,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.013767629,0.602941176,0.621212121,41,68,66,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.022834117,0.465753425,0.496350365,68,146,137,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.027199463,0.361607143,0.361607143,81,224,224,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Paclitaxel,0.013096038,0.481481481,0.481481481,39,81,81,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.033579584,0.591715976,0.591715976,100,169,169,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.018132975,0.348387097,0.348387097,54,155,155,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  patientDrug  Paclitaxel,0.0241773,0.395604396,0.473684211,72,182,152,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Paclitaxel,0.047011417,0.49122807,0.52238806,140,285,268,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.019140363,0.410071942,0.410071942,57,139,139,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.022498321,0.553719008,0.553719008,67,121,121,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.0241773,0.486486486,0.486486486,72,148,148,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Paclitaxel,0.011752854,0.448717949,0.507246377,35,78,69,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Paclitaxel,0.013096038,0.438202247,0.5,39,89,78,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.05003358,0.362530414,0.362530414,149,411,411,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Paclitaxel,0.022162525,0.347368421,0.347368421,66,190,190,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Paclitaxel,0.016453996,0.569767442,0.569767442,49,86,86,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Paclitaxel,0.011752854,0.336538462,0.336538462,35,104,104,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIA   ,?a  patientDrug  Paclitaxel,0.019476158,0.420289855,0.46031746,58,138,126,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.023505709,0.368421053,0.368421053,70,190,190,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Paclitaxel,0.015782404,0.734375,0.734375,47,64,64,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Paclitaxel,0.013767629,0.366071429,0.366071429,41,112,112,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Paclitaxel,0.016789792,0.347222222,0.347222222,50,144,144,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.022834117,0.393063584,0.393063584,68,173,173,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.028878442,0.477777778,0.477777778,86,180,180,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Paclitaxel,0.019140363,0.349693252,0.349693252,57,163,163,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Paclitaxel,0.02820685,0.411764706,0.411764706,84,204,204,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.012760242,0.38,0.38,38,100,100,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.056749496,0.407228916,0.407228916,169,415,415,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Paclitaxel,0.0241773,0.28125,0.333333333,72,256,216,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Paclitaxel,0.0483546,0.307692308,0.346153846,144,468,416,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Paclitaxel,0.028542646,0.297202797,0.352697095,85,286,241,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Paclitaxel,0.032572196,0.291291291,0.34519573,97,333,281,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.0322364,0.470588235,0.470588235,96,204,204,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.014439221,0.401869159,0.401869159,43,107,107,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Paclitaxel,0.028542646,0.354166667,0.384615385,85,240,221,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Paclitaxel,0.015446608,0.262857143,0.315068493,46,175,146,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.021155138,0.715909091,0.715909091,63,88,88,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.017797179,0.424,0.424,53,125,125,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Paclitaxel,0.034251175,0.357894737,0.38490566,102,285,265,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.027535259,0.445652174,0.445652174,82,184,184,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Paclitaxel,0.017125588,0.404761905,0.404761905,51,126,126,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.029550034,0.624113475,0.733333333,88,141,120,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.011417058,0.404761905,0.404761905,34,84,84,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Paclitaxel,0.034586971,0.481308411,0.481308411,103,214,214,?a
?a  hasGender  Female  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.021490934,0.984615385,0.984615385,64,65,65,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.038280725,0.814285714,0.814285714,114,140,140,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Carboplatin,0.010745467,0.727272727,0.727272727,32,44,44,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIB   ,?a  patientDrug  Carboplatin,0.020483546,0.642105263,0.693181818,61,95,88,?a
?a  hasStage  IIIB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.010073875,0.833333333,0.833333333,30,36,36,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.015446608,0.92,0.92,46,50,50,?a
?a  hasStage  IV  ?a  patientDrug  Vincristine   ,?a  patientDrug  Carboplatin,0.010409671,1,1,31,31,31,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVA   ,?a  patientDrug  Carboplatin,0.010073875,0.681818182,0.810810811,30,44,37,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  patientDrug  Carboplatin,0.012424446,0.627118644,0.74,37,59,50,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVA   ,?a  patientDrug  Carboplatin,0.01208865,0.5625,0.692307692,36,64,52,?a
?a  hasStage  IV  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.030221625,0.989010989,0.989010989,90,91,91,?a
?a  hasStage  IVA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.014103425,0.84,0.84,42,50,50,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVA   ,?a  patientDrug  Carboplatin,0.012424446,0.596774194,0.74,37,62,50,?a
?a  hasAgeCategory  Old  ?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.042310275,0.633165829,0.73255814,126,199,172,?a
?a  hasStage  IV  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Carboplatin,0.010409671,0.96875,0.96875,31,32,32,?a
?a  hasGender  Male  ?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.043317663,0.654822335,0.720670391,129,197,179,?a
?a  hasStage  IV  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Carboplatin,0.010073875,1,1,30,30,30,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.026863667,0.720720721,0.784313725,80,111,102,?a
?a  hasStage  IV  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Carboplatin,0.013431833,0.909090909,0.909090909,40,44,44,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.012424446,0.755102041,0.770833333,37,49,48,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  patientDrug  Carboplatin,0.046675621,0.67804878,0.702020202,139,205,198,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.010745467,0.653061224,0.711111111,32,49,45,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.01208865,0.87804878,0.87804878,36,41,41,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.021826729,0.878378378,0.878378378,65,74,74,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.018804567,0.674698795,0.727272727,56,83,77,?a
?a  hasGender  Male  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Carboplatin,0.015110813,0.97826087,0.97826087,45,46,46,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.011417058,0.666666667,0.739130435,34,51,46,?a
?a  hasGender  Male  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.015782404,0.635135135,0.712121212,47,74,66,?a
?a  hasAgeCategory  Old  ?a  hasStage  IVB   ,?a  patientDrug  Carboplatin,0.0161182,0.631578947,0.71641791,48,76,67,?a
?a  hasGender  Male  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Carboplatin,0.015782404,0.979166667,0.979166667,47,48,48,?a
?a  hasGender  Male  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.035930154,0.713333333,0.769784173,107,150,139,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.055406313,0.820895522,0.820895522,165,201,201,?a
?a  hasGender  Male  ?a  patientDrug  Vincristine   ,?a  patientDrug  Carboplatin,0.015446608,1,1,46,46,46,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  patientDrug  Carboplatin,0.11853593,0.527653214,0.708835341,353,669,498,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.05809268,0.647940075,0.697580645,173,267,248,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Male   ,?a  patientDrug  Carboplatin,0.017461383,0.722222222,0.8,52,72,65,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Carboplatin,0.023169913,0.396551724,0.71875,69,174,96,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Carboplatin,0.084284755,0.530655391,0.697222222,251,473,360,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.030221625,0.371900826,0.697674419,90,242,129,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Carboplatin,0.01208865,1,1,36,36,36,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.096709201,0.618025751,0.684085511,288,466,421,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.012760242,0.974358974,0.974358974,38,39,39,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Carboplatin,0.018468771,0.982142857,0.982142857,55,56,56,?a
?a  patientDrug  Cyclophosphamide  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.019140363,0.982758621,0.982758621,57,58,58,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cyclophosphamide   ,?a  patientDrug  Carboplatin,0.010409671,0.96875,0.96875,31,32,32,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.014103425,0.636363636,0.636363636,42,66,66,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Carboplatin,0.014103425,0.583333333,0.583333333,42,72,72,?a
?a  hasStage  IIIA  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.015446608,0.522727273,0.676470588,46,88,68,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Carboplatin,0.013767629,0.621212121,0.640625,41,66,64,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.011081263,0.75,0.75,33,44,44,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.019476158,0.716049383,0.716049383,58,81,81,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.013767629,0.773584906,0.773584906,41,53,53,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Vincristine   ,?a  patientDrug  Carboplatin,0.012424446,1,1,37,37,37,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.016453996,0.859649123,0.859649123,49,57,57,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Carboplatin,0.023841504,0.696078431,0.696078431,71,102,102,?a
?a  patientDrug  Doxorubicin  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.018804567,0.98245614,0.98245614,56,57,57,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Doxorubicin   ,?a  patientDrug  Carboplatin,0.012760242,0.974358974,0.974358974,38,39,39,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pembrolizumab   ,?a  patientDrug  Carboplatin,0.010409671,0.704545455,0.704545455,31,44,44,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.015110813,0.692307692,0.692307692,45,65,65,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Vinorelbine   ,?a  patientDrug  Carboplatin,0.010073875,0.857142857,0.857142857,30,35,35,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.0402955,0.983606557,0.983606557,120,122,122,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.020483546,0.983870968,0.983870968,61,62,62,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.029214238,0.97752809,0.97752809,87,89,89,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Carboplatin,0.018804567,0.98245614,0.98245614,56,57,57,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.037609134,0.98245614,0.98245614,112,114,114,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Vp-16   ,?a  patientDrug  Carboplatin,0.011081263,1,1,33,33,33,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.029214238,0.69047619,0.69047619,87,126,126,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.037609134,0.717948718,0.717948718,112,156,156,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.010073875,0.714285714,0.714285714,30,42,42,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.04197448,0.838926174,0.838926174,125,149,149,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Carboplatin,0.015782404,0.839285714,0.839285714,47,56,56,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  patientDrug  Carboplatin,0.013096038,0.696428571,0.696428571,39,56,56,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.021826729,0.878378378,0.878378378,65,74,74,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  patientDrug  Carboplatin,0.010409671,0.815789474,0.815789474,31,38,38,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Carboplatin,0.017125588,0.927272727,0.927272727,51,55,55,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.019140363,0.850746269,0.850746269,57,67,67,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.010409671,0.861111111,0.861111111,31,36,36,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.010409671,0.885714286,0.885714286,31,35,35,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.048690396,0.857988166,0.857988166,145,169,169,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Carboplatin,0.057421088,0.822115385,0.822115385,171,208,208,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Carboplatin,0.083613163,0.523109244,0.709401709,249,476,351,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.024848892,0.385416667,0.691588785,74,192,107,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.044660846,0.661691542,0.707446809,133,201,188,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.059435863,0.544615385,0.705179283,177,325,251,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.067159167,0.8,0.8,200,250,250,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Carboplatin,0.011752854,0.875,0.921052632,35,40,38,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Carboplatin,0.013096038,0.696428571,0.795918367,39,56,49,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.034922767,0.707482993,0.764705882,104,147,136,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  patientDrug  Carboplatin,0.0161182,0.6,0.695652174,48,80,69,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.033915379,0.378277154,0.706293706,101,267,143,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.060779046,0.644128114,0.701550388,181,281,258,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.09435863,0.828908555,0.828908555,281,339,339,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Carboplatin,0.023841504,0.371727749,0.717171717,71,191,99,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy   ,?a  patientDrug  Carboplatin,0.011417058,0.871794872,0.944444444,34,39,36,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  PDL1_Negative   ,?a  patientDrug  Carboplatin,0.014103425,0.646153846,0.736842105,42,65,57,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.030893217,0.773109244,0.807017544,92,119,114,?a
?a  treatmentType  Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.010409671,0.939393939,0.939393939,31,33,33,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.0322364,0.849557522,0.849557522,96,113,113,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  patientDrug  Carboplatin,0.039623909,0.819444444,0.819444444,118,144,144,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.053727334,0.7960199,0.7960199,160,201,201,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.015446608,0.469387755,0.779661017,46,98,59,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Carboplatin,0.05809268,0.657794677,0.703252033,173,263,246,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.015446608,0.383333333,0.707692308,46,120,65,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.037273338,0.672727273,0.707006369,111,165,157,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.019811954,0.602040816,0.719512195,59,98,82,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Sequential_Chemoradiation   ,?a  patientDrug  Carboplatin,0.011752854,0.7,0.7,35,50,50,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Carboplatin,0.012424446,0.770833333,0.770833333,37,48,48,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.013096038,0.541666667,0.709090909,39,72,55,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.021490934,0.659793814,0.680851064,64,97,94,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.013096038,0.722222222,0.722222222,39,54,54,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.017461383,0.764705882,0.764705882,52,68,68,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.015782404,0.886792453,0.886792453,47,53,53,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Carboplatin,0.015110813,0.548780488,0.703125,45,82,64,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Carboplatin,0.010073875,0.789473684,0.789473684,30,38,38,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.048690396,0.796703297,0.796703297,145,182,182,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Carboplatin,0.012760242,0.678571429,0.716981132,38,56,53,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.017461383,0.852459016,0.852459016,52,61,61,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Carboplatin,0.055742109,0.498498498,0.590747331,166,333,281,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Carboplatin,0.017125588,0.836065574,0.836065574,51,61,61,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  patientDrug  Carboplatin,0.014439221,0.651515152,0.74137931,43,66,58,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Carboplatin,0.0161182,0.71641791,0.761904762,48,67,63,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Carboplatin,0.039623909,0.497890295,0.587064677,118,237,201,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.014103425,0.4375,0.7,42,96,60,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.013431833,0.655737705,0.655737705,40,61,61,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  patientDrug  Carboplatin,0.018132975,0.514285714,0.586956522,54,105,92,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIB   ,?a  patientDrug  Vinorelbine,0.010409671,0.516666667,0.534482759,31,60,58,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.028878442,0.693548387,0.693548387,86,124,124,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Vinorelbine,0.016453996,0.314102564,0.371212121,49,156,132,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Vinorelbine,0.018468771,0.48245614,0.48245614,55,114,114,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Vinorelbine,0.04600403,0.289640592,0.380555556,137,473,360,?a
?a  hasGender  Male  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Vinorelbine,0.034586971,0.291784703,0.378676471,103,353,272,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.014775017,0.771929825,0.8,44,57,55,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Vinorelbine,0.010409671,0.360465116,0.360465116,31,86,86,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Vinorelbine,0.015110813,0.319148936,0.378151261,45,141,119,?a
?a  hasAgeCategory  Young  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Vinorelbine,0.0161182,0.352941176,0.41025641,48,136,117,?a
?a  hasAgeCategory  Old  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Vinorelbine,0.031900604,0.292307692,0.378486056,95,325,251,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  patientDrug  Vinorelbine,0.011752854,0.35,0.421686747,35,100,83,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.029885829,0.44278607,0.473404255,89,201,188,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.022498321,0.558333333,0.656862745,67,120,102,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  patientDrug  Vinorelbine,0.010409671,0.244094488,0.46969697,31,127,66,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.015110813,0.652173913,0.652173913,45,69,69,?a
?a  hasGender  Female  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.012760242,0.716981132,0.730769231,38,53,52,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.015446608,0.5,0.511111111,46,92,90,?a
?a  hasStage  IIIB  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Vinorelbine,0.011417058,0.548387097,0.548387097,34,62,62,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.02014775,0.3125,0.560747664,60,192,107,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.016789792,0.694444444,0.714285714,50,72,70,?a
?a  hasGender  Male  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.04432505,0.683937824,0.683937824,132,193,193,?a
?a  hasGender  Male  ?a  hasStage  IIIB   ,?a  patientDrug  Vinorelbine,0.017797179,0.53,0.563829787,53,100,94,?a
?a  hasStage  IIIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.013096038,0.557142857,0.557142857,39,70,70,?a
?a  hasGender  Male  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.023169913,0.403508772,0.638888889,69,171,108,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.011752854,0.7,0.7,35,50,50,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  patientDrug  Vinorelbine,0.0161182,0.52173913,0.527472527,48,92,91,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Vinorelbine,0.029550034,0.437810945,0.437810945,88,201,201,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIB   ,?a  patientDrug  Vinorelbine,0.015110813,0.473684211,0.511363636,45,95,88,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.023505709,0.289256198,0.542635659,70,242,129,?a
?a  hasGender  Male  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.031564809,0.540229885,0.652777778,94,174,144,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.021155138,0.677419355,0.677419355,63,93,93,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.039623909,0.441947566,0.475806452,118,267,248,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.014103425,0.456521739,0.456521739,42,92,92,?a
?a  hasGender  Male  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.024848892,0.698113208,0.718446602,74,106,103,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  patientDrug  Vinorelbine,0.014775017,0.47311828,0.47311828,44,93,93,?a
?a  hasAgeCategory  Old  ?a  hasGender  Male   ,?a  patientDrug  Vinorelbine,0.063129617,0.281016442,0.37751004,188,669,498,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Vinorelbine,0.013767629,0.235632184,0.427083333,41,174,96,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Vinorelbine,0.012760242,0.355140187,0.355140187,38,107,107,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  patientDrug  Vinorelbine,0.013767629,0.401960784,0.401960784,41,102,102,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Male   ,?a  patientDrug  Vinorelbine,0.020483546,0.338888889,0.39869281,61,180,153,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.023841504,0.898734177,0.898734177,71,79,79,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.018804567,0.835820896,0.835820896,56,67,67,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.023841504,0.934210526,0.934210526,71,76,76,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.011417058,0.390804598,0.390804598,34,87,87,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.016453996,0.777777778,0.777777778,49,63,63,?a
?a  hasAgeCategory  Old  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.037944929,0.693251534,0.693251534,113,163,163,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.032572196,0.718518519,0.718518519,97,135,135,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.010073875,0.857142857,0.857142857,30,35,35,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.025856279,0.875,0.875,77,88,88,?a
?a  hasStage  IIIA  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.030557421,0.875,0.875,91,104,104,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Vinorelbine,0.023505709,0.744680851,0.744680851,70,94,94,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.0241773,0.426035503,0.426035503,72,169,169,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.015782404,0.734375,0.734375,47,64,64,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  patientDrug  Vinorelbine,0.017125588,0.68,0.68,51,75,75,?a
?a  hasAgeCategory  Young  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Vinorelbine,0.012760242,0.452380952,0.452380952,38,84,84,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.033579584,0.568181818,0.568181818,100,176,176,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Vinorelbine,0.017797179,0.427419355,0.427419355,53,124,124,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Vinorelbine,0.010745467,0.47761194,0.47761194,32,67,67,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.017461383,0.464285714,0.472727273,52,112,110,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Vinorelbine,0.034586971,0.481308411,0.481308411,103,214,214,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.017461383,0.634146341,0.764705882,52,82,68,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.016789792,0.641025641,0.724637681,50,78,69,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Paclitaxel   ,?a  patientDrug  Vinorelbine,0.011417058,0.523076923,0.523076923,34,65,65,?a
?a  hasStage  IIIA  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.015110813,0.511363636,0.661764706,45,88,68,?a
?a  hasAgeCategory  Young  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.012424446,0.725490196,0.74,37,51,50,?a
?a  hasStage  IIIA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.012760242,0.655172414,0.655172414,38,58,58,?a
?a  hasStage  IIIA  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.016789792,0.757575758,0.78125,50,66,64,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.015110813,0.762711864,0.762711864,45,59,59,?a
?a  hasStage  IIIA  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.029885829,0.609589041,0.649635036,89,146,137,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.019811954,0.662921348,0.756410256,59,89,78,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.013431833,0.689655172,0.754716981,40,58,53,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Vinorelbine,0.015110813,0.398230088,0.398230088,45,113,113,?a
?a  hasAgeCategory  Old  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.032572196,0.532967033,0.638157895,97,182,152,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIA   ,?a  patientDrug  Vinorelbine,0.029885829,0.644927536,0.706349206,89,138,126,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  patientDrug  Vinorelbine,0.010073875,0.434782609,0.434782609,30,69,69,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.01208865,0.620689655,0.666666667,36,58,54,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.021826729,0.691489362,0.714285714,65,94,91,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.022498321,0.411042945,0.656862745,67,163,102,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.015446608,0.547619048,0.676470588,46,84,68,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.011081263,0.589285714,0.733333333,33,56,45,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.011752854,0.426829268,0.546875,35,82,64,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.022834117,0.701030928,0.723404255,68,97,94,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.015110813,0.584415584,0.642857143,45,77,70,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.010409671,0.455882353,0.688888889,31,68,45,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.01208865,0.666666667,0.72,36,54,50,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.010745467,0.695652174,0.744186047,32,46,43,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Vinorelbine,0.014103425,0.352941176,0.355932203,42,119,118,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.015782404,0.479591837,0.573170732,47,98,82,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Thoracoscopy   ,?a  patientDrug  Vinorelbine,0.010745467,0.444444444,0.581818182,32,72,55,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  patientDrug  Vinorelbine,0.014103425,0.567567568,0.7,42,74,60,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.022162525,0.653465347,0.653465347,66,101,101,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.022162525,0.776470588,0.776470588,66,85,85,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.013431833,0.816326531,0.816326531,40,49,49,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.010073875,0.810810811,0.810810811,30,37,37,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.013767629,0.602941176,0.602941176,41,68,68,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  patientDrug  Vinorelbine,0.018132975,0.377622378,0.377622378,54,143,143,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.012760242,0.666666667,0.666666667,38,57,57,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.012424446,0.672727273,0.672727273,37,55,55,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.022834117,0.80952381,0.819277108,68,84,83,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  patientDrug  Vinorelbine,0.014775017,0.382608696,0.382608696,44,115,115,?a
?a  hasAgeCategory  Old  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  patientDrug  Vinorelbine,0.021155138,0.65625,0.65625,63,96,96,?a
?a  hasAgeCategory  Old  ?a  hasRelapse_Progression  No_Progression   ,?a  patientDrug  Vinorelbine,0.013767629,0.214659686,0.414141414,41,191,99,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  BRAF_Negative   ,?a  patientDrug  Vinorelbine,0.012424446,0.425287356,0.513888889,37,87,72,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Vinorelbine,0.029214238,0.304195804,0.360995851,87,286,241,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Vinorelbine,0.031229013,0.326315789,0.350943396,93,285,265,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ALK_Negative   ,?a  patientDrug  Vinorelbine,0.025856279,0.30078125,0.356481481,77,256,216,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.014439221,0.632352941,0.651515152,43,68,66,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  patientDrug  Vinorelbine,0.018804567,0.347826087,0.380952381,56,161,147,?a
?a  hasAgeCategory  Old  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Vinorelbine,0.02014775,0.342857143,0.410958904,60,175,146,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Vinorelbine,0.015110813,0.401785714,0.489130435,45,112,92,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Vinorelbine,0.027199463,0.327935223,0.383886256,81,247,211,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.018132975,0.534653465,0.556701031,54,101,97,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.016453996,0.690140845,0.7,49,71,70,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.043317663,0.452631579,0.481343284,129,285,268,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.022498321,0.536,0.553719008,67,125,121,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.014439221,0.728813559,0.74137931,43,59,58,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  patientDrug  Vinorelbine,0.013431833,0.740740741,0.740740741,40,54,54,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  patientDrug  Vinorelbine,0.032572196,0.291291291,0.34519573,97,333,281,?a
?a  hasGender  Male  ?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Young,0.010475423,0.30952381,0.30952381,13,42,42,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.015310234,0.452380952,0.452380952,19,42,42,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  patientDrug  Vinorelbine,0.012424446,0.725490196,0.74,37,51,50,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.011281225,0.518518519,0.518518519,14,27,27,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Young,0.015310234,0.387755102,0.387755102,19,49,49,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  patientDrug  Vinorelbine,0.026192075,0.329113924,0.388059701,78,237,201,?a
?a  hasGender  Female  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.054794521,0.482269504,0.482269504,68,141,141,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIB   ,?a  hasAgeCategory  Young,0.024174053,0.5,0.5,30,60,60,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IV   ,?a  hasAgeCategory  Young,0.033037873,0.369369369,0.369369369,41,111,111,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.017727639,0.448979592,0.448979592,22,49,49,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy   ,?a  hasAgeCategory  Young,0.018533441,0.58974359,0.58974359,23,39,39,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasAgeCategory  Young,0.016116035,0.350877193,0.350877193,20,57,57,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.045930701,0.345454545,0.345454545,57,165,165,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Young,0.020950846,0.325,0.325,26,80,80,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.029008864,0.418604651,0.418604651,36,86,86,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cyclophosphamide   ,?a  hasAgeCategory  Young,0.010475423,0.40625,0.40625,13,32,32,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.012892828,0.457142857,0.457142857,16,35,35,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.043513296,0.453781513,0.453781513,54,119,119,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.020145044,0.446428571,0.446428571,25,56,56,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vincristine   ,?a  hasAgeCategory  Young,0.010475423,0.393939394,0.393939394,13,33,33,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.058823529,0.36318408,0.36318408,73,201,201,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.043513296,0.435483871,0.435483871,54,124,124,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.037872683,0.516483516,0.516483516,47,91,91,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.018533441,0.37704918,0.37704918,23,61,61,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Young,0.034649476,0.367521368,0.367521368,43,117,117,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.032232071,0.350877193,0.350877193,40,114,114,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Young,0.016116035,0.377358491,0.377358491,20,53,53,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.014504432,0.5,0.5,18,36,36,?a
?a  hasRelapse_Progression  Progression  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.078162772,0.368821293,0.370229008,97,263,262,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.018533441,0.425925926,0.425925926,23,54,54,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.033037873,0.41,0.41,41,100,100,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.019339243,0.5,0.5,24,48,48,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.041901692,0.368794326,0.368794326,52,141,141,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasSmokingHabit  CurrentSmoker   ,?a  hasAgeCategory  Young,0.046736503,0.371794872,0.371794872,58,156,156,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Young,0.016921837,0.291666667,0.291666667,21,72,72,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.012892828,0.533333333,0.533333333,16,30,30,?a
?a  hasGender  Female  ?a  hasStage  IA   ,?a  hasAgeCategory  Young,0.010475423,0.393939394,0.393939394,13,33,33,?a
?a  hasStage  IA  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Young,0.016116035,0.25974026,0.25974026,20,77,77,?a
?a  hasGender  Male  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.024174053,0.461538462,0.461538462,30,65,65,?a
?a  hasGender  Male  ?a  hasStage  IVA   ,?a  hasAgeCategory  Young,0.012087027,0.254237288,0.25862069,15,59,58,?a
?a  hasGender  Female  ?a  hasStage  IIIB   ,?a  hasAgeCategory  Young,0.017727639,0.536585366,0.536585366,22,41,41,?a
?a  hasGender  Female  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.048348106,0.428571429,0.428571429,60,140,140,?a
?a  hasGender  Female  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.018533441,0.522727273,0.522727273,23,44,44,?a
?a  hasGender  Female  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasAgeCategory  Young,0.018533441,0.433962264,0.433962264,23,53,53,?a
?a  hasGender  Female  ?a  hasStage  IV   ,?a  hasAgeCategory  Young,0.029814666,0.411111111,0.411111111,37,90,90,?a
?a  hasGender  Female  ?a  patientDrug  Erlotinib   ,?a  hasAgeCategory  Young,0.010475423,0.419354839,0.419354839,13,31,31,?a
?a  hasGender  Female  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.016116035,0.625,0.625,20,32,32,?a
?a  hasGender  Female  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.020950846,0.565217391,0.565217391,26,46,46,?a
?a  hasGender  Female  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.020145044,0.438596491,0.438596491,25,57,57,?a
?a  hasGender  Female  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.045930701,0.548076923,0.548076923,57,104,104,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.020145044,0.543478261,0.543478261,25,46,46,?a
?a  hasGender  Female  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.045930701,0.452380952,0.452380952,57,126,126,?a
?a  hasGender  Female  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Young,0.015310234,0.431818182,0.431818182,19,44,44,?a
?a  hasGender  Female  ?a  patientDrug  Other   ,?a  hasAgeCategory  Young,0.010475423,0.722222222,0.722222222,13,18,18,?a
?a  hasGender  Female  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.020145044,0.409836066,0.409836066,25,61,61,?a
?a  hasGender  Female  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.037066882,0.516853933,0.516853933,46,89,89,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.018533441,0.410714286,0.410714286,23,56,56,?a
?a  hasGender  Female  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Young,0.032232071,0.459770115,0.459770115,40,87,87,?a
?a  hasGender  Female  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.031426269,0.443181818,0.443181818,39,88,88,?a
?a  hasGender  Female  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.011281225,0.583333333,0.583333333,14,24,24,?a
?a  hasGender  Female  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.034649476,0.472527473,0.472527473,43,91,91,?a
?a  hasStage  IIIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.025785657,0.347826087,0.347826087,32,92,92,?a
?a  hasStage  IIIB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.018533441,0.328571429,0.328571429,23,70,70,?a
?a  hasStage  IIIB  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.020145044,0.5,0.5,25,50,50,?a
?a  hasStage  IIIB  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Young,0.017727639,0.328358209,0.328358209,22,67,67,?a
?a  hasGender  Female  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Young,0.062046737,0.420765027,0.420765027,77,183,183,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.010475423,0.448275862,0.448275862,13,29,29,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.074939565,0.436619718,0.436619718,93,213,213,?a
?a  hasBiomarker  ALK_Negative  ?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.037066882,0.4,0.4,46,115,115,?a
?a  hasStage  IVB  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.016116035,0.487804878,0.487804878,20,41,41,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.010475423,0.464285714,0.464285714,13,28,28,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.047542305,0.450381679,0.450381679,59,131,131,?a
?a  hasStage  IVB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.02256245,0.378378378,0.378378378,28,74,74,?a
?a  hasStage  IVB  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.012087027,0.441176471,0.441176471,15,34,34,?a
?a  hasGender  Female  ?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Young,0.024174053,0.461538462,0.461538462,30,65,65,?a
?a  hasStage  IIIB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.012892828,0.444444444,0.444444444,16,36,36,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasGender  Female   ,?a  hasAgeCategory  Young,0.029814666,0.445783133,0.445783133,37,83,83,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.024979855,0.373493976,0.373493976,31,83,83,?a
?a  hasStage  IVB  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.012087027,0.789473684,0.789473684,15,19,19,?a
?a  hasStage  IVB  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.015310234,0.542857143,0.542857143,19,35,35,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.025785657,0.470588235,0.470588235,32,68,68,?a
?a  hasStage  IV  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Young,0.012892828,0.372093023,0.372093023,16,43,43,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.021756648,0.45,0.45,27,60,60,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.017727639,0.423076923,0.423076923,22,52,52,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IVB   ,?a  hasAgeCategory  Young,0.024174053,0.447761194,0.447761194,30,67,67,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIIB   ,?a  hasAgeCategory  Young,0.02739726,0.369565217,0.369565217,34,92,92,?a
?a  hasStage  IVB  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.011281225,0.608695652,0.608695652,14,23,23,?a
?a  hasStage  IV  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.01369863,0.346938776,0.346938776,17,49,49,?a
?a  hasStage  IV  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.014504432,0.367346939,0.367346939,18,49,49,?a
?a  hasStage  IVB  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.012892828,0.470588235,0.470588235,16,34,34,?a
?a  hasStage  IV  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.021756648,0.509433962,0.509433962,27,53,53,?a
?a  hasStage  IV  ?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Young,0.024174053,0.32967033,0.32967033,30,91,91,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IV   ,?a  hasAgeCategory  Young,0.051571313,0.312195122,0.312195122,64,205,205,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IV   ,?a  hasAgeCategory  Young,0.034649476,0.330769231,0.330769231,43,130,130,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IV   ,?a  hasAgeCategory  Young,0.012087027,0.394736842,0.394736842,15,38,38,?a
?a  hasStage  IB  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Young,0.015310234,0.275362319,0.275362319,19,69,69,?a
?a  hasStage  IIIA  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.016921837,0.362068966,0.362068966,21,58,58,?a
?a  hasStage  IV  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.014504432,0.36,0.36,18,50,50,?a
?a  hasStage  IIIA  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.011281225,0.538461538,0.538461538,14,26,26,?a
?a  hasStage  IIB  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.011281225,0.4375,0.4375,14,32,32,?a
?a  hasStage  IIIA  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.012892828,0.5,0.5,16,32,32,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.029814666,0.37,0.37,37,100,100,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.024979855,0.329787234,0.329787234,31,94,94,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.033843674,0.461538462,0.461538462,42,91,91,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.012087027,0.5,0.5,15,30,30,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.020145044,0.337837838,0.337837838,25,74,74,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.014504432,0.5625,0.5625,18,32,32,?a
?a  treatmentType  Open_Surgical_Procedure  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.016116035,0.344827586,0.344827586,20,58,58,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.016116035,0.434782609,0.434782609,20,46,46,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.017727639,0.392857143,0.392857143,22,56,56,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.029814666,0.486842105,0.486842105,37,76,76,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.011281225,0.636363636,0.636363636,14,22,22,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.021756648,0.321428571,0.321428571,27,84,84,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.017727639,0.564102564,0.564102564,22,39,39,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Young,0.02256245,0.333333333,0.333333333,28,84,84,?a
?a  patientDrug  Cyclophosphamide  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.014504432,0.461538462,0.461538462,18,39,39,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.012892828,0.666666667,0.666666667,16,24,24,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.024174053,0.491803279,0.491803279,30,61,61,?a
?a  treatmentType  Radiotherapy_To_Bone  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.01369863,0.62962963,0.62962963,17,27,27,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.010475423,0.464285714,0.464285714,13,28,28,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.021756648,0.627906977,0.627906977,27,43,43,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.016921837,0.567567568,0.567567568,21,37,37,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.050765512,0.4375,0.4375,63,144,144,?a
?a  treatmentType  Immunotherapy  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.017727639,0.523809524,0.523809524,22,42,42,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.070910556,0.446700508,0.446700508,88,197,197,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.012892828,0.571428571,0.571428571,16,28,28,?a
?a  patientDrug  Vincristine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.014504432,0.45,0.45,18,40,40,?a
?a  patientDrug  Doxorubicin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.01369863,0.425,0.425,17,40,40,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.016921837,0.446808511,0.446808511,21,47,47,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Bone   ,?a  hasAgeCategory  Young,0.026591459,0.532258065,0.532258065,33,62,62,?a
?a  treatmentType  Molecular_Targeted_Therapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.016116035,0.555555556,0.555555556,20,36,36,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.024979855,0.543859649,0.543859649,31,57,57,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.028203062,0.583333333,0.583333333,35,60,60,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.011281225,0.636363636,0.636363636,14,22,22,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.011281225,0.518518519,0.518518519,14,27,27,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.035455278,0.536585366,0.536585366,44,82,82,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.02256245,0.571428571,0.571428571,28,49,49,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Young,0.010475423,0.295454545,0.295454545,13,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.024174053,0.566037736,0.566037736,30,53,53,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.02256245,0.636363636,0.636363636,28,44,44,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.019339243,0.461538462,0.461538462,24,52,52,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Whole_Brain_Radiation_Therapy   ,?a  hasAgeCategory  Young,0.029814666,0.513888889,0.513888889,37,72,72,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.021756648,0.482142857,0.482142857,27,56,56,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.012087027,0.5,0.5,15,30,30,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.020950846,0.464285714,0.464285714,26,56,56,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.016921837,0.466666667,0.466666667,21,45,45,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.024979855,0.525423729,0.525423729,31,59,59,?a
?a  hasBiomarker  ALK_Positive  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.011281225,0.7,0.7,14,20,20,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.011281225,0.583333333,0.583333333,14,24,24,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.016921837,0.567567568,0.567567568,21,37,37,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.042707494,0.477477477,0.477477477,53,111,111,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Young,0.011281225,0.274509804,0.274509804,14,51,51,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Young,0.021756648,0.329268293,0.329268293,27,82,82,?a
?a  treatmentType  Chemotherapy_Adjuvant  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.014504432,0.333333333,0.333333333,18,54,54,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Young,0.017727639,0.511627907,0.511627907,22,43,43,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.047542305,0.324175824,0.324175824,59,182,182,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.01369863,0.386363636,0.386363636,17,44,44,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.049153908,0.451851852,0.451851852,61,135,135,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasAgeCategory  Young,0.012892828,0.32,0.32,16,50,50,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.041901692,0.307692308,0.307692308,52,169,169,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.020145044,0.294117647,0.294117647,25,85,85,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.058823529,0.287401575,0.287401575,73,254,254,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasAgeCategory  Young,0.012892828,0.380952381,0.380952381,16,42,42,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasAgeCategory  Young,0.029814666,0.336363636,0.336363636,37,110,110,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.026591459,0.471428571,0.471428571,33,70,70,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Young,0.041901692,0.295454545,0.295454545,52,176,176,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasAgeCategory  Young,0.024174053,0.422535211,0.422535211,30,71,71,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasAgeCategory  Young,0.014504432,0.352941176,0.352941176,18,51,51,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasAgeCategory  Young,0.010475423,0.351351351,0.351351351,13,37,37,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.012892828,0.421052632,0.421052632,16,38,38,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Young,0.010475423,0.351351351,0.351351351,13,37,37,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.015310234,0.463414634,0.463414634,19,41,41,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.024174053,0.483870968,0.483870968,30,62,62,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.026591459,0.434210526,0.434210526,33,76,76,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.010475423,0.40625,0.40625,13,32,32,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.043513296,0.377622378,0.377622378,54,143,143,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.034649476,0.373913043,0.373913043,43,115,115,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.019339243,0.369230769,0.369230769,24,65,65,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.02256245,0.314606742,0.314606742,28,89,89,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.026591459,0.326732673,0.326732673,33,101,101,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.024979855,0.402597403,0.402597403,31,77,77,?a
?a  patientDrug  Docetaxel  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.01369863,0.459459459,0.459459459,17,37,37,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Young,0.020145044,0.373134328,0.373134328,25,67,67,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.016921837,0.368421053,0.368421053,21,57,57,?a
?a  patientDrug  Pemetrexed  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.011281225,0.482758621,0.482758621,14,29,29,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cyclophosphamide   ,?a  hasAgeCategory  Young,0.019339243,0.421052632,0.421052632,24,57,57,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.020145044,0.446428571,0.446428571,25,56,56,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Young,0.016116035,0.444444444,0.444444444,20,45,45,?a
?a  patientDrug  Docetaxel  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.023368251,0.491525424,0.491525424,29,59,59,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Young,0.029008864,0.305084746,0.305084746,36,118,118,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.018533441,0.534883721,0.534883721,23,43,43,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Erlotinib   ,?a  hasAgeCategory  Young,0.015310234,0.395833333,0.395833333,19,48,48,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Docetaxel   ,?a  hasAgeCategory  Young,0.034649476,0.462365591,0.462365591,43,93,93,?a
?a  patientDrug  Pembrolizumab  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.010475423,0.481481481,0.481481481,13,27,27,?a
?a  patientDrug  Other  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.012087027,0.576923077,0.576923077,15,26,26,?a
?a  patientDrug  Cisplatin  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.053182917,0.474820144,0.474820144,66,139,139,?a
?a  patientDrug  Afatinib  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.010475423,0.590909091,0.590909091,13,22,22,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.037066882,0.37704918,0.37704918,46,122,122,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.043513296,0.319526627,0.319526627,54,169,169,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Young,0.016116035,0.465116279,0.465116279,20,43,43,?a
?a  hasRelapse_Progression  Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.112006446,0.338199513,0.338199513,139,411,411,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.051571313,0.336842105,0.336842105,64,190,190,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.061240935,0.339285714,0.339285714,76,224,224,?a
?a  hasBiomarker  EGFR_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.011281225,0.538461538,0.538461538,14,26,26,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.041901692,0.351351351,0.351351351,52,148,148,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vincristine   ,?a  hasAgeCategory  Young,0.018533441,0.403508772,0.403508772,23,57,57,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Young,0.030620467,0.37254902,0.37254902,38,102,102,?a
?a  hasBiomarker  PDL1_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Young,0.019339243,0.393442623,0.393442623,24,61,61,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Young,0.012087027,0.365853659,0.365853659,15,41,41,?a
?a  patientDrug  Nivolumab  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.019339243,0.428571429,0.428571429,24,56,56,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Young,0.010475423,0.448275862,0.448275862,13,29,29,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Young,0.012087027,0.384615385,0.384615385,15,39,39,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.017727639,0.536585366,0.536585366,22,41,41,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Doxorubicin   ,?a  hasAgeCategory  Young,0.016921837,0.368421053,0.368421053,21,57,57,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Young,0.015310234,0.487179487,0.487179487,19,39,39,?a
?a  patientDrug  Pembrolizumab  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.012087027,0.576923077,0.576923077,15,26,26,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Osimertinib   ,?a  hasAgeCategory  Young,0.01369863,0.485714286,0.485714286,17,35,35,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.017727639,0.488888889,0.488888889,22,45,45,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.020950846,0.530612245,0.530612245,26,49,49,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Pembrolizumab   ,?a  hasAgeCategory  Young,0.015310234,0.487179487,0.487179487,19,39,39,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.07252216,0.441176471,0.441176471,90,204,204,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Gemcitabine   ,?a  hasAgeCategory  Young,0.014504432,0.346153846,0.346153846,18,52,52,?a
?a  hasBiomarker  EGFR_Negative  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.04995971,0.430555556,0.430555556,62,144,144,?a
?a  patientDrug  Pemetrexed  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Young,0.020145044,0.543478261,0.543478261,25,46,46,?a
?a  patientDrug  Paclitaxel  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Young,0.030620467,0.31147541,0.31147541,38,122,122,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Young,0.011281225,0.424242424,0.424242424,14,33,33,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Young,0.056406124,0.327102804,0.327102804,70,214,214,?a
?a  patientDrug  Cisplatin  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.04109589,0.490384615,0.490384615,51,104,104,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.023368251,0.453125,0.453125,29,64,64,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Young,0.034649476,0.323308271,0.323308271,43,133,133,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.066881547,0.389671362,0.389671362,83,213,213,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Young,0.02739726,0.453333333,0.453333333,34,75,75,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.035455278,0.448979592,0.448979592,44,98,98,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Young,0.049153908,0.296116505,0.296116505,61,206,206,?a
?a  hasRelapse_Progression  Progression  ?a  hasRelapse_Progression  Relapse   ,?a  hasAgeCategory  Young,0.010475423,0.351351351,0.351351351,13,37,37,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Pemetrexed   ,?a  hasAgeCategory  Young,0.01369863,0.447368421,0.447368421,17,38,38,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasAgeCategory  Young,0.023368251,0.386666667,0.386666667,29,75,75,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Young,0.018533441,0.365079365,0.365079365,23,63,63,?a
?a  hasBiomarker  PDL1_Negative  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Young,0.020145044,0.373134328,0.373134328,25,67,67,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Young,0.056406124,0.327102804,0.327102804,70,214,214,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Young,0.011281225,0.466666667,0.466666667,14,30,30,?a
?a  hasRelapse_Progression  Progression  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Young,0.103948429,0.310843373,0.310843373,129,415,415,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasAgeCategory  Young,0.021756648,0.409090909,0.409090909,27,66,66,?a
?a  hasBiomarker  PDL1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.024174053,0.447761194,0.447761194,30,67,67,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasAgeCategory  Young,0.029008864,0.356435644,0.356435644,36,101,101,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.017727639,0.379310345,0.379310345,22,58,58,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Positive   ,?a  hasAgeCategory  Young,0.010475423,0.325,0.325,13,40,40,?a
?a  hasBiomarker  ALK_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.012087027,0.555555556,0.555555556,15,27,27,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.078968574,0.343859649,0.343859649,98,285,285,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasBiomarker  ROS1_Negative   ,?a  hasAgeCategory  Young,0.029008864,0.349514563,0.349514563,36,103,103,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.046736503,0.360248447,0.360248447,58,161,161,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Young,0.062046737,0.320833333,0.320833333,77,240,240,?a
?a  hasGender  Female  ?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Old,0.052377115,0.706521739,0.706521739,65,92,92,?a
?a  hasGender  Female  ?a  hasStage  IVA   ,?a  hasAgeCategory  Old,0.016921837,0.84,0.84,21,25,25,?a
?a  hasGender  Female  ?a  hasRelapse_Progression  Relapse   ,?a  hasAgeCategory  Old,0.014504432,0.782608696,0.782608696,18,23,23,?a
?a  hasGender  Female  ?a  patientDrug  Gefitinib   ,?a  hasAgeCategory  Old,0.012892828,0.727272727,0.727272727,16,22,22,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IA   ,?a  hasAgeCategory  Old,0.035455278,0.830188679,0.830188679,44,53,53,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasGender  Female   ,?a  hasAgeCategory  Old,0.028203062,0.673076923,0.673076923,35,52,52,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIA   ,?a  hasAgeCategory  Old,0.018533441,0.851851852,0.851851852,23,27,27,?a
?a  hasGender  Male  ?a  hasStage  IIA   ,?a  hasAgeCategory  Old,0.02739726,0.829268293,0.829268293,34,41,41,?a
?a  hasStage  IIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Old,0.018533441,0.821428571,0.821428571,23,28,28,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IIA   ,?a  hasAgeCategory  Old,0.012087027,0.789473684,0.789473684,15,19,19,?a
?a  hasGender  Male  ?a  hasStage  IA   ,?a  hasAgeCategory  Old,0.048348106,0.833333333,0.833333333,60,72,72,?a
?a  hasStage  IA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Old,0.019339243,0.827586207,0.827586207,24,29,29,?a
?a  hasGender  Male  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.170829976,0.794007491,0.794007491,212,267,267,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IA   ,?a  hasAgeCategory  Old,0.015310234,0.904761905,0.904761905,19,21,21,?a
?a  hasGender  Male  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.311039484,0.816067653,0.816067653,386,473,473,?a
?a  hasGender  Male  ?a  hasStage  IIIA   ,?a  hasAgeCategory  Old,0.109589041,0.781609195,0.781609195,136,174,174,?a
?a  hasGender  Male  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.060435133,0.806451613,0.806451613,75,93,93,?a
?a  hasGender  Male  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.038678485,0.827586207,0.827586207,48,58,58,?a
?a  hasGender  Male  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.153102337,0.785123967,0.785123967,190,242,242,?a
?a  hasGender  Male  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.068493151,0.801886792,0.801886792,85,106,106,?a
?a  hasGender  Male  ?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.111200645,0.793103448,0.793103448,138,174,174,?a
?a  hasGender  Male  ?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Old,0.091861402,0.780821918,0.780821918,114,146,146,?a
?a  hasGender  Male  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.284448026,0.786191537,0.786191537,353,449,449,?a
?a  hasGender  Male  ?a  patientDrug  Gemcitabine   ,?a  hasAgeCategory  Old,0.021756648,0.771428571,0.771428571,27,35,35,?a
?a  hasGender  Male  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.128928284,0.7960199,0.7960199,160,201,201,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasGender  Male   ,?a  hasAgeCategory  Old,0.058017728,0.782608696,0.782608696,72,92,92,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasGender  Male   ,?a  hasAgeCategory  Old,0.052377115,0.773809524,0.773809524,65,84,84,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IVA   ,?a  hasAgeCategory  Old,0.028203062,0.795454545,0.795454545,35,44,44,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIIB   ,?a  hasAgeCategory  Old,0.047542305,0.830985915,0.830985915,59,71,71,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIB   ,?a  hasAgeCategory  Old,0.020145044,0.78125,0.78125,25,32,32,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IIIB   ,?a  hasAgeCategory  Old,0.010475423,1,1,13,13,13,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasStage  IIIB   ,?a  hasAgeCategory  Old,0.024979855,0.688888889,0.688888889,31,45,45,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIB   ,?a  hasAgeCategory  Old,0.015310234,0.76,0.76,19,25,25,?a
?a  hasStage  IVB  ?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Old,0.01369863,0.772727273,0.772727273,17,22,22,?a
?a  hasStage  IV  ?a  patientDrug  Doxorubicin   ,?a  hasAgeCategory  Old,0.016921837,0.7,0.7,21,30,30,?a
?a  hasStage  IV  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.026591459,0.76744186,0.76744186,33,43,43,?a
?a  hasSmokingHabit  FormerSmoker  ?a  hasStage  IIB   ,?a  hasAgeCategory  Old,0.026591459,0.785714286,0.785714286,33,42,42,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IV   ,?a  hasAgeCategory  Old,0.056406124,0.714285714,0.714285714,70,98,98,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  hasStage  IIIA   ,?a  hasAgeCategory  Old,0.061240935,0.752475248,0.752475248,76,101,101,?a
?a  hasStage  IIB  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.025785657,0.761904762,0.761904762,32,42,42,?a
?a  hasStage  IIB  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.012087027,0.833333333,0.833333333,15,18,18,?a
?a  hasStage  IIB  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.02256245,0.875,0.875,28,32,32,?a
?a  hasStage  IIIA  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasAgeCategory  Old,0.015310234,0.76,0.76,19,25,25,?a
?a  hasRelapse_Progression  Progression  ?a  hasStage  IIB   ,?a  hasAgeCategory  Old,0.012892828,0.8,0.8,16,20,20,?a
?a  hasStage  IIIA  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Old,0.050765512,0.768292683,0.768292683,63,82,82,?a
?a  hasStage  IIIA  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.067687349,0.756756757,0.756756757,84,111,111,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasStage  IIIA   ,?a  hasAgeCategory  Old,0.044319098,0.833333333,0.833333333,55,66,66,?a
?a  hasStage  IIIA  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.056406124,0.795454545,0.795454545,70,88,88,?a
?a  hasStage  IIIA  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.074939565,0.768595041,0.768595041,93,121,121,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasStage  IIIA   ,?a  hasAgeCategory  Old,0.020950846,0.764705882,0.764705882,26,34,34,?a
?a  hasStage  IIIA  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.037066882,0.779661017,0.779661017,46,59,59,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasStage  IIIA   ,?a  hasAgeCategory  Old,0.011281225,0.875,0.875,14,16,16,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasStage  IIIA   ,?a  hasAgeCategory  Old,0.035455278,0.75862069,0.75862069,44,58,58,?a
?a  hasStage  IIIA  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.058017728,0.791208791,0.791208791,72,91,91,?a
?a  hasBiomarker  ALK_Negative  ?a  hasStage  IIIA   ,?a  hasAgeCategory  Old,0.047542305,0.756410256,0.756410256,59,78,78,?a
?a  hasStage  IB  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.012087027,0.882352941,0.882352941,15,17,17,?a
?a  hasStage  IB  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Old,0.019339243,0.827586207,0.827586207,24,29,29,?a
?a  hasStage  IB  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.01369863,0.772727273,0.772727273,17,22,22,?a
?a  hasSmokingHabit  NonSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.026591459,0.76744186,0.76744186,33,43,43,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Old,0.015310234,0.904761905,0.904761905,19,21,21,?a
?a  hasBiomarker  ALK_Negative  ?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Old,0.025785657,0.761904762,0.761904762,32,42,42,?a
?a  hasBiomarker  EGFR_Positive  ?a  hasSmokingHabit  NonSmoker   ,?a  hasAgeCategory  Old,0.029814666,0.725490196,0.725490196,37,51,51,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Erlotinib   ,?a  hasAgeCategory  Old,0.015310234,0.76,0.76,19,25,25,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasAgeCategory  Old,0.016921837,0.807692308,0.807692308,21,26,26,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.121676068,0.786458333,0.786458333,151,192,192,?a
?a  hasSmokingHabit  NonSmoker  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.016921837,0.724137931,0.724137931,21,29,29,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.031426269,0.829787234,0.829787234,39,47,47,?a
?a  hasSmokingHabit  FormerSmoker  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.043513296,0.782608696,0.782608696,54,69,69,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Vp-16   ,?a  hasAgeCategory  Old,0.058017728,0.808988764,0.808988764,72,89,89,?a
?a  hasRelapse_Progression  Relapse  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.029008864,0.857142857,0.857142857,36,42,42,?a
?a  hasRelapse_Progression  No_Progression  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.081385979,0.795275591,0.795275591,101,127,127,?a
?a  hasSmokingHabit  FormerSmoker  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.200644641,0.778125,0.778125,249,320,320,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Old,0.056406124,0.729166667,0.729166667,70,96,96,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasSmokingHabit  FormerSmoker   ,?a  hasAgeCategory  Old,0.045124899,0.8,0.8,56,70,70,?a
?a  hasSmokingHabit  CurrentSmoker  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.04109589,0.76119403,0.76119403,51,67,67,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Old,0.02256245,0.736842105,0.736842105,28,38,38,?a
?a  treatmentType  Neoadjuvant_Chemotherapy  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Old,0.029008864,0.782608696,0.782608696,36,46,46,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Open_Surgical_Procedure   ,?a  hasAgeCategory  Old,0.020145044,0.735294118,0.735294118,25,34,34,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.012892828,0.8,0.8,16,20,20,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.020145044,0.78125,0.78125,25,32,32,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.024174053,0.769230769,0.769230769,30,39,39,?a
?a  treatmentType  Radiotherapy_To_Lung  ?a  treatmentType  Surgery   ,?a  hasAgeCategory  Old,0.02256245,0.848484848,0.848484848,28,33,33,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasAgeCategory  Old,0.010475423,0.8125,0.8125,13,16,16,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.081385979,0.776923077,0.776923077,101,130,130,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Sequential_Chemoradiation   ,?a  hasAgeCategory  Old,0.011281225,0.777777778,0.777777778,14,18,18,?a
?a  treatmentType  Intravenous_Chemotherapy  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.034649476,0.811320755,0.811320755,43,53,53,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Thoracoscopy   ,?a  hasAgeCategory  Old,0.016116035,0.909090909,0.909090909,20,22,22,?a
?a  patientDrug  Erlotinib  ?a  treatmentType  Molecular_Targeted_Therapy   ,?a  hasAgeCategory  Old,0.028203062,0.673076923,0.673076923,35,52,52,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.040290089,0.735294118,0.735294118,50,68,68,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.035455278,0.785714286,0.785714286,44,56,56,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.061240935,0.752475248,0.752475248,76,101,101,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.024174053,0.833333333,0.833333333,30,36,36,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.021756648,0.818181818,0.818181818,27,33,33,?a
?a  hasBiomarker  RET_Negative  ?a  treatmentType  Radiotherapy_To_Lung   ,?a  hasAgeCategory  Old,0.012087027,0.882352941,0.882352941,15,17,17,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Chemotherapy_Adjuvant   ,?a  hasAgeCategory  Old,0.060435133,0.735294118,0.735294118,75,102,102,?a
?a  patientDrug  Nivolumab  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.015310234,0.76,0.76,19,25,25,?a
?a  patientDrug  Carboplatin  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.050765512,0.807692308,0.807692308,63,78,78,?a
?a  treatmentType  Concurrent_Chemoradiotherapy  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.029008864,0.734693878,0.734693878,36,49,49,?a
?a  patientDrug  Paclitaxel  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.051571313,0.761904762,0.761904762,64,84,84,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Neoadjuvant_Chemotherapy   ,?a  hasAgeCategory  Old,0.011281225,0.736842105,0.736842105,14,19,19,?a
?a  patientDrug  Durvalumab  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.011281225,0.736842105,0.736842105,14,19,19,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Immunotherapy   ,?a  hasAgeCategory  Old,0.015310234,0.76,0.76,19,25,25,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.011281225,0.933333333,0.933333333,14,15,15,?a
?a  hasBiomarker  EGFR_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.029008864,0.818181818,0.818181818,36,44,44,?a
?a  patientDrug  Vinorelbine  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.050765512,0.707865169,0.707865169,63,89,89,?a
?a  hasRelapse_Progression  No_Progression  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.012892828,0.842105263,0.842105263,16,19,19,?a
?a  hasBiomarker  ALK_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.029008864,0.765957447,0.765957447,36,47,47,?a
?a  hasBiomarker  EGFR_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.031426269,0.709090909,0.709090909,39,55,55,?a
?a  hasBiomarker  ROS1_Negative  ?a  treatmentType  Concurrent_Chemoradiotherapy   ,?a  hasAgeCategory  Old,0.018533441,0.766666667,0.766666667,23,30,30,?a
?a  hasBiomarker  ALK_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.02256245,0.777777778,0.777777778,28,36,36,?a
?a  hasBiomarker  ROS1_Negative  ?a  hasRelapse_Progression  No_Progression   ,?a  hasAgeCategory  Old,0.019339243,0.857142857,0.857142857,24,28,28,?a
?a  hasRelapse_Progression  No_Progression  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.024174053,0.833333333,0.833333333,30,36,36,?a
?a  patientDrug  Vp-16  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.070104754,0.713114754,0.713114754,87,122,122,?a
?a  patientDrug  Gemcitabine  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.026591459,0.717391304,0.717391304,33,46,46,?a
?a  hasBiomarker  BRAF_Negative  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.025785657,0.761904762,0.761904762,32,42,42,?a
?a  hasBiomarker  PDL1_Positive  ?a  treatmentType  Intravenous_Chemotherapy   ,?a  hasAgeCategory  Old,0.034649476,0.704918033,0.704918033,43,61,61,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Erlotinib   ,?a  hasAgeCategory  Old,0.012087027,0.714285714,0.714285714,15,21,21,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Erlotinib   ,?a  hasAgeCategory  Old,0.020145044,0.714285714,0.714285714,25,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Old,0.037872683,0.770491803,0.770491803,47,61,61,?a
?a  hasBiomarker  PDL1_Positive  ?a  hasRelapse_Progression  Progression   ,?a  hasAgeCategory  Old,0.049153908,0.726190476,0.726190476,61,84,84,?a
?a  hasBiomarker  EGFR_Positive  ?a  patientDrug  Gefitinib   ,?a  hasAgeCategory  Old,0.012087027,0.681818182,0.681818182,15,22,22,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.110394843,0.761111111,0.761111111,137,180,180,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.062046737,0.719626168,0.719626168,77,107,107,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Cisplatin   ,?a  hasAgeCategory  Old,0.01369863,0.739130435,0.739130435,17,23,23,?a
?a  patientDrug  Gemcitabine  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.016921837,0.724137931,0.724137931,21,29,29,?a
?a  patientDrug  Carboplatin  ?a  patientDrug  Gemcitabine   ,?a  hasAgeCategory  Old,0.020145044,0.735294118,0.735294118,25,34,34,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.016116035,0.8,0.8,20,25,25,?a
?a  hasBiomarker  ROS1_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.048348106,0.714285714,0.714285714,60,84,84,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.029814666,0.770833333,0.770833333,37,48,48,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Vinorelbine   ,?a  hasAgeCategory  Old,0.02256245,0.8,0.8,28,35,35,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  PDL1_Negative   ,?a  hasAgeCategory  Old,0.012892828,0.8,0.8,16,20,20,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.020145044,0.78125,0.78125,25,32,32,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Paclitaxel   ,?a  hasAgeCategory  Old,0.010475423,0.866666667,0.866666667,13,15,15,?a
?a  hasBiomarker  ALK_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasAgeCategory  Old,0.185334408,0.690690691,0.690690691,230,333,333,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  EGFR_Negative   ,?a  hasAgeCategory  Old,0.066881547,0.741071429,0.741071429,83,112,112,?a
?a  hasBiomarker  BRAF_Negative  ?a  hasBiomarker  RET_Negative   ,?a  hasAgeCategory  Old,0.029008864,0.75,0.75,36,48,48,?a
?a  hasBiomarker  BRAF_Negative  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.032232071,0.769230769,0.769230769,40,52,52,?a
?a  hasBiomarker  ALK_Negative  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.034649476,0.693548387,0.693548387,43,62,62,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Nivolumab   ,?a  hasAgeCategory  Old,0.016921837,0.777777778,0.777777778,21,27,27,?a
?a  hasBiomarker  RET_Negative  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.010475423,0.764705882,0.764705882,13,17,17,?a
?a  hasBiomarker  PDL1_Positive  ?a  patientDrug  Carboplatin   ,?a  hasAgeCategory  Old,0.041901692,0.753623188,0.753623188,52,69,69,?a
